Citrus Sinensis ID: 024537
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.657 | 0.206 | 0.594 | 1e-60 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.657 | 0.214 | 0.6 | 7e-60 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.657 | 0.205 | 0.611 | 2e-59 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.661 | 0.214 | 0.602 | 2e-59 | |
| Q9SY95 | 802 | G-type lectin S-receptor- | no | no | 0.740 | 0.245 | 0.541 | 5e-59 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.661 | 0.214 | 0.596 | 6e-59 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.661 | 0.211 | 0.613 | 7e-59 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.661 | 0.215 | 0.590 | 1e-58 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.661 | 0.216 | 0.585 | 1e-58 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.661 | 0.209 | 0.596 | 2e-58 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 233 bits (593), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 104/175 (59%), Positives = 136/175 (77%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
F L + +ATN F N+LG GGFGPVY+G++ +G+EIAVK+LS S QG+ EF NE+ L
Sbjct: 517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIIL 576
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
+ K+QH+NLV L GCC EG EKMLVYEY+PNKSLD+F+FD+TK + +DW R+ I+ G+A
Sbjct: 577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIA 636
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RGLLYLH ++ RIIHRD+K SN+LLD ++NPKISDFG+AR+F G NT R+
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRV 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (587), Expect = 7e-60, Method: Compositional matrix adjust.
Identities = 105/175 (60%), Positives = 139/175 (79%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
FD +T+ +AT+ FS +N LG GGFGPVY+G + +GQEIAVK+LS +S QG+ EF NEVKL
Sbjct: 488 FDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKL 547
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
+ K+QH+NLV L GCC +G E ML+YEY+PNKSLD+FIFD+ +S+ LDW R I+ GVA
Sbjct: 548 IAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVA 607
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RG+LYLH+++ RIIHRD+KA N+LLD +NPKISDFGLA+ F G+ + +T R+
Sbjct: 608 RGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRV 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 107/175 (61%), Positives = 136/175 (77%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
F+L T+ AT+ FS+ N+LG GGFGPVY+G+ P QEIAVK+LS S QGL EF NEV L
Sbjct: 520 FELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEFKNEVVL 579
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
+ K+QH+NLV L G C G EK+L+YEY+P+KSLD+FIFD+ LDW R I++G+A
Sbjct: 580 IAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCNIILGIA 639
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RGLLYLH+++ RIIHRD+K SNILLDE++NPKISDFGLAR+F G +T NT R+
Sbjct: 640 RGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRV 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 106/176 (60%), Positives = 132/176 (75%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
F+ + L ATN FS N+LG GGFGPVY+G + GQEIAVK+LS S QGL E NEV
Sbjct: 496 LFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVV 555
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
++ K+QH+NLV L GCC G E+MLVYE++P KSLDY++FD ++ LDW TR+ I+ G+
Sbjct: 556 VISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGI 615
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RGLLYLH ++ RIIHRD+KASNILLDE L PKISDFGLAR+FPG + NT R+
Sbjct: 616 CRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRV 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY95|Y1155_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 OS=Arabidopsis thaliana GN=At1g61550 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 110/203 (54%), Positives = 145/203 (71%), Gaps = 6/203 (2%)
Query: 48 KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM 107
K SL+G +ED G FF+++T+++ATN FS +N+LG GGFGPVY+G +
Sbjct: 455 KVSLQGAWRNDLKSEDVSGL------YFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKL 508
Query: 108 PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167
+G+EIAVK+LS S QG EF NE+ L+ K+QH NLV + GCC EG E++LVYE++ NK
Sbjct: 509 QDGKEIAVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNK 568
Query: 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
SLD FIFD K +DW R+ I+ G+ARGLLYLH ++ RIIHRD+K SNILLD+++NP
Sbjct: 569 SLDTFIFDSRKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNP 628
Query: 228 KISDFGLARLFPGEDTHVNTFRI 250
KISDFGLAR++ G NT RI
Sbjct: 629 KISDFGLARMYEGTKYQDNTRRI 651
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (579), Expect = 6e-59, Method: Compositional matrix adjust.
Identities = 105/176 (59%), Positives = 133/176 (75%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
F+ + L AT+ FS N+LG GGFGPVY+G++ GQEIAVK+LS S QGL E EV
Sbjct: 496 LFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVV 555
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
++ K+QH+NLV LFGCC G E+MLVYE++P KSLD++IFD ++ LDW TR+ I+ G+
Sbjct: 556 VISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGI 615
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RGLLYLH ++ RIIHRD+KASNILLDE L PKISDFGLAR+FPG + NT R+
Sbjct: 616 CRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRV 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 7e-59, Method: Compositional matrix adjust.
Identities = 108/176 (61%), Positives = 134/176 (76%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
FDL T+ ATN FS N+LG GGFGPVY+G++ N EIAVK+LS +S QG+ EF NEVK
Sbjct: 502 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 561
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
L+ K+QH+NLV + GCC E EKMLVYEYLPNKSLDYFIF + + + LDW R IV G+
Sbjct: 562 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 621
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
ARG+LYLH+++ RIIHRD+KASNILLD ++ PKISDFG+AR+F G T R+
Sbjct: 622 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRV 677
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 104/176 (59%), Positives = 136/176 (77%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
F ++ AT+ FSD N+LG GGFGPVY+G + NG+E+A+K+LS+ S QGL EF NE L
Sbjct: 484 FSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAIL 543
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
+ K+QH NLV + GCC E EKML+YEY+ NKSLDYF+FD + + LDWT R+RI+ G+
Sbjct: 544 IAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGII 603
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
+GLLYLH+ + ++IHRDIKASNILLDE +NPKISDFGLAR+F E+T NT R++
Sbjct: 604 QGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTKRVA 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 103/176 (58%), Positives = 134/176 (76%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
FFD++T+ TN FS N+LG GGFGPVY+G + +G+EIA+K+LS S QGL EF NE+
Sbjct: 488 FFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEII 547
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
L+ K+QH+NLV L GCC EG EK+L+YE++ NKSL+ FIFD TK LDW R+ I+ G+
Sbjct: 548 LISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGI 607
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
A GLLYLH ++ R++HRD+K SNILLDE++NPKISDFGLAR+F G NT R+
Sbjct: 608 ACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRV 663
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 105/176 (59%), Positives = 131/176 (74%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
F+ + L +T+ FS N+LG GGFGPVY+G +P GQEIAVK+LS S QGL E NEV
Sbjct: 511 LFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVV 570
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
++ K+QH+NLV L GCC EG E+MLVYEY+P KSLD ++FD K LDW TR+ I+ G+
Sbjct: 571 VISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGI 630
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
RGLLYLH ++ +IIHRD+KASNILLDE LNPKISDFGLAR+F + NT R+
Sbjct: 631 CRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRV 686
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | ||||||
| 225455972 | 389 | PREDICTED: G-type lectin S-receptor-like | 0.796 | 0.544 | 0.802 | 1e-95 | |
| 255586073 | 395 | serine-threonine protein kinase, plant-t | 0.793 | 0.534 | 0.774 | 2e-92 | |
| 357500315 | 227 | Cysteine-rich receptor-like protein kina | 0.842 | 0.986 | 0.743 | 7e-92 | |
| 224118794 | 393 | predicted protein [Populus trichocarpa] | 0.793 | 0.536 | 0.774 | 8e-92 | |
| 356522771 | 387 | PREDICTED: G-type lectin S-receptor-like | 0.789 | 0.542 | 0.753 | 3e-87 | |
| 449439411 | 391 | PREDICTED: G-type lectin S-receptor-like | 0.721 | 0.491 | 0.755 | 1e-86 | |
| 357500311 | 384 | Cysteine-rich receptor-like protein kina | 0.680 | 0.471 | 0.825 | 6e-86 | |
| 357500313 | 215 | Cysteine-rich receptor-like protein kina | 0.680 | 0.841 | 0.825 | 2e-85 | |
| 388494528 | 384 | unknown [Medicago truncatula] | 0.680 | 0.471 | 0.814 | 9e-85 | |
| 297839253 | 414 | predicted protein [Arabidopsis lyrata su | 0.748 | 0.480 | 0.728 | 9e-79 |
| >gi|225455972|ref|XP_002278538.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120 [Vitis vinifera] gi|297734222|emb|CBI15469.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (911), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 171/213 (80%), Positives = 189/213 (88%), Gaps = 1/213 (0%)
Query: 39 FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
F+S L CL+ L+G AG+ DA G DS++LFFDLR LQVATNFFS+ N+LGHGG
Sbjct: 3 FLSLLCSCLERRLKGRGGAGDDEADAASDG-DSFDLFFDLRALQVATNFFSEFNELGHGG 61
Query: 99 FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
FGPVY+GLMPNG +IAVKKLS+DSRQG+REFTNEVKLLLKIQHKNLVTL GCC EGPEKM
Sbjct: 62 FGPVYKGLMPNGTQIAVKKLSLDSRQGVREFTNEVKLLLKIQHKNLVTLLGCCVEGPEKM 121
Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
LVYEYLPNKSLD F+FDKTKS+SLDW TR+RIVMGV RGLLYLHEEAP RIIHRDIKASN
Sbjct: 122 LVYEYLPNKSLDCFLFDKTKSASLDWATRFRIVMGVVRGLLYLHEEAPERIIHRDIKASN 181
Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
ILLDE+LNPKISDFGLARLFPG++THVNTFRIS
Sbjct: 182 ILLDEKLNPKISDFGLARLFPGDETHVNTFRIS 214
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586073|ref|XP_002533701.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526396|gb|EEF28684.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 345 bits (884), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 165/213 (77%), Positives = 189/213 (88%), Gaps = 2/213 (0%)
Query: 39 FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
+S+L CL+ L+ GR G + + +S +LFFDLRTLQ+ATNFFS+LNQLGHGG
Sbjct: 3 LLSSLCACLEKRLKSGRGGGGADDAD--DEVESHDLFFDLRTLQIATNFFSELNQLGHGG 60
Query: 99 FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
FGPV++GL+PNG+E+AVKKLS+ SRQGLREF+NEVKLLLKIQHKNLVTL GCC EGPEKM
Sbjct: 61 FGPVFKGLIPNGEEVAVKKLSLSSRQGLREFSNEVKLLLKIQHKNLVTLLGCCVEGPEKM 120
Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
LVYEYLPNKSLDYF+FDK KS+SLDWTTR++IV GVARGLLYLHEEAP RIIHRDIKASN
Sbjct: 121 LVYEYLPNKSLDYFLFDKQKSASLDWTTRFKIVTGVARGLLYLHEEAPVRIIHRDIKASN 180
Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
ILLDE+LNPKISDFGLARLFPGEDTH+NTF+IS
Sbjct: 181 ILLDERLNPKISDFGLARLFPGEDTHMNTFKIS 213
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500315|ref|XP_003620446.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355495461|gb|AES76664.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 168/226 (74%), Positives = 191/226 (84%), Gaps = 2/226 (0%)
Query: 39 FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
F S L CL+ G G ++ DS NL F+L TLQ+ATNFFS+LNQLG GG
Sbjct: 2 FFSRLCFCLQKKHGTGSEDGGDDDEDTVDPGDSGNLLFELNTLQLATNFFSELNQLGRGG 61
Query: 99 FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
FGPV++GLMPNG+E+A+KKLS++SRQG+REFTNEV+LLL+IQHKNLVTL GCCAEGPEKM
Sbjct: 62 FGPVFKGLMPNGEEVAIKKLSMESRQGIREFTNEVRLLLRIQHKNLVTLLGCCAEGPEKM 121
Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
LVYEYLPNKSLD+F+FDK + SLDW TR+RIV G+ARGLLYLHEEAP RIIHRDIKASN
Sbjct: 122 LVYEYLPNKSLDHFLFDKKR--SLDWMTRFRIVTGIARGLLYLHEEAPERIIHRDIKASN 179
Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264
ILLDE+LNPKISDFGLARLFPGEDTHV TFRISVVTW NMHC+DI
Sbjct: 180 ILLDEKLNPKISDFGLARLFPGEDTHVQTFRISVVTWLLNMHCVDI 225
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118794|ref|XP_002317908.1| predicted protein [Populus trichocarpa] gi|222858581|gb|EEE96128.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 8e-92, Method: Compositional matrix adjust.
Identities = 165/213 (77%), Positives = 188/213 (88%), Gaps = 2/213 (0%)
Query: 39 FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
SNL CL+T LR R +AE A ++ +LFF+LRTL++ATNFFS+LNQLGHGG
Sbjct: 3 LFSNLCACLQTKLRIRRH--NAAEGAPDEVVETNDLFFELRTLELATNFFSELNQLGHGG 60
Query: 99 FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
FGPVY+GL+PNGQE+AVKKLS+ SRQG+REFTNEVKLLLKIQHKNLV+L GCCA+GPEKM
Sbjct: 61 FGPVYKGLIPNGQEVAVKKLSLTSRQGIREFTNEVKLLLKIQHKNLVSLLGCCAQGPEKM 120
Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
LVYEYLPN+SLDYF+FDK KS+ LDWTTR++IV GVARGLLYLHEEAP RIIHRDIKASN
Sbjct: 121 LVYEYLPNRSLDYFLFDKVKSTRLDWTTRFQIVTGVARGLLYLHEEAPERIIHRDIKASN 180
Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
ILLDE LNPKISDFGLARLFPG+DTH+NTFRIS
Sbjct: 181 ILLDENLNPKISDFGLARLFPGDDTHMNTFRIS 213
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522771|ref|XP_003530019.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 327 bits (838), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 162/215 (75%), Positives = 184/215 (85%), Gaps = 5/215 (2%)
Query: 39 FISNLFPCLKTSLRGGRA--AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGH 96
F+ L PCL +GG A G+ + DS++L F L TLQ+ATNFFSD+N+LGH
Sbjct: 3 FLRRLCPCLH---KGGAAFHDGDDDDIDRNHPGDSFDLIFGLHTLQLATNFFSDINRLGH 59
Query: 97 GGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156
GGFGPV+RGLMPNGQE+AVKKLS++SRQG REFTNEV+LLL+IQHKNLVTL GCCAEGPE
Sbjct: 60 GGFGPVFRGLMPNGQEVAVKKLSLESRQGDREFTNEVRLLLRIQHKNLVTLLGCCAEGPE 119
Query: 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA 216
KMLVYEYLPNKSLD F+FDK +SSSLDW TR+RIV GVARGLLYLHEEAP RIIHRDIKA
Sbjct: 120 KMLVYEYLPNKSLDRFLFDKRRSSSLDWATRFRIVTGVARGLLYLHEEAPERIIHRDIKA 179
Query: 217 SNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
SNILLDE+LNPKISDFGLARLFPGED+++ TFRIS
Sbjct: 180 SNILLDEKLNPKISDFGLARLFPGEDSYMQTFRIS 214
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439411|ref|XP_004137479.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Cucumis sativus] gi|449516693|ref|XP_004165381.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 325 bits (832), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 148/196 (75%), Positives = 177/196 (90%), Gaps = 4/196 (2%)
Query: 56 AAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAV 115
A + A+D D S ++FF+L TLQ+ATNFFS++N+LG+GGFGPVY+GLMPNGQ++AV
Sbjct: 24 AGADEADDED----VSTDIFFELNTLQIATNFFSEVNKLGNGGFGPVYKGLMPNGQQVAV 79
Query: 116 KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175
KKLS+DSRQG+++F+NEVKLLL+IQH+NLV L GCC EGPEKMLVYEYLPN+SLDYFIFD
Sbjct: 80 KKLSIDSRQGVKQFSNEVKLLLRIQHRNLVILLGCCVEGPEKMLVYEYLPNRSLDYFIFD 139
Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
K KS SLDWTTR+ I+ G+ RGLLYLHEEAP+RIIHRDIKASNILLDE+LNPKISDFGLA
Sbjct: 140 KKKSPSLDWTTRFHIITGIVRGLLYLHEEAPSRIIHRDIKASNILLDEKLNPKISDFGLA 199
Query: 236 RLFPGEDTHVNTFRIS 251
RLFPGEDTH+NTF+I+
Sbjct: 200 RLFPGEDTHLNTFKIA 215
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500311|ref|XP_003620444.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355495459|gb|AES76662.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 323 bits (827), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 151/183 (82%), Positives = 170/183 (92%), Gaps = 2/183 (1%)
Query: 69 ADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE 128
DS NL F+L TLQ+ATNFFS+LNQLG GGFGPV++GLMPNG+E+A+KKLS++SRQG+RE
Sbjct: 32 GDSGNLLFELNTLQLATNFFSELNQLGRGGFGPVFKGLMPNGEEVAIKKLSMESRQGIRE 91
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
FTNEV+LLL+IQHKNLVTL GCCAEGPEKMLVYEYLPNKSLD+F+FDK + SLDW TR+
Sbjct: 92 FTNEVRLLLRIQHKNLVTLLGCCAEGPEKMLVYEYLPNKSLDHFLFDKKR--SLDWMTRF 149
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
RIV G+ARGLLYLHEEAP RIIHRDIKASNILLDE+LNPKISDFGLARLFPGEDTHV TF
Sbjct: 150 RIVTGIARGLLYLHEEAPERIIHRDIKASNILLDEKLNPKISDFGLARLFPGEDTHVQTF 209
Query: 249 RIS 251
RIS
Sbjct: 210 RIS 212
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500313|ref|XP_003620445.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355495460|gb|AES76663.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 321 bits (822), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 151/183 (82%), Positives = 170/183 (92%), Gaps = 2/183 (1%)
Query: 69 ADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE 128
DS NL F+L TLQ+ATNFFS+LNQLG GGFGPV++GLMPNG+E+A+KKLS++SRQG+RE
Sbjct: 32 GDSGNLLFELNTLQLATNFFSELNQLGRGGFGPVFKGLMPNGEEVAIKKLSMESRQGIRE 91
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
FTNEV+LLL+IQHKNLVTL GCCAEGPEKMLVYEYLPNKSLD+F+FDK + SLDW TR+
Sbjct: 92 FTNEVRLLLRIQHKNLVTLLGCCAEGPEKMLVYEYLPNKSLDHFLFDKKR--SLDWMTRF 149
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
RIV G+ARGLLYLHEEAP RIIHRDIKASNILLDE+LNPKISDFGLARLFPGEDTHV TF
Sbjct: 150 RIVTGIARGLLYLHEEAPERIIHRDIKASNILLDEKLNPKISDFGLARLFPGEDTHVQTF 209
Query: 249 RIS 251
RIS
Sbjct: 210 RIS 212
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388494528|gb|AFK35330.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 149/183 (81%), Positives = 168/183 (91%), Gaps = 2/183 (1%)
Query: 69 ADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE 128
DS NL F+L LQ+ATNFFS+LNQLG GGFGPV++GLMPNG+E+A+KKLS++SRQG+RE
Sbjct: 32 GDSGNLLFELNALQLATNFFSELNQLGRGGFGPVFKGLMPNGEEVAIKKLSMESRQGIRE 91
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
FTNEV+LLL+IQHKNLVTL GCCAEGPEKMLVYEYLPNKSLD+F+FDK + SLDW TR+
Sbjct: 92 FTNEVRLLLRIQHKNLVTLLGCCAEGPEKMLVYEYLPNKSLDHFLFDKKR--SLDWMTRF 149
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
RIV G+ARGLLYLHEEAP RIIH DIKASNILLDE+LNPKISDFGLARLFPGEDTHV TF
Sbjct: 150 RIVTGIARGLLYLHEEAPERIIHGDIKASNILLDEKLNPKISDFGLARLFPGEDTHVQTF 209
Query: 249 RIS 251
RIS
Sbjct: 210 RIS 212
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297839253|ref|XP_002887508.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297333349|gb|EFH63767.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 299 bits (765), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 145/199 (72%), Positives = 162/199 (81%)
Query: 53 GGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQE 112
G +G DG +FF L+ L+VAT+FFS+ N+LG GGFGPVY+G MPNG+E
Sbjct: 15 GHSGSGGEISSEDGLDGGDRGIFFSLQELEVATDFFSEKNRLGTGGFGPVYKGSMPNGEE 74
Query: 113 IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF 172
IAVKKLSVDSRQG REFTNEVKLLL+IQHKNLV+L GCC GPEKMLVYEYLPN+SLDYF
Sbjct: 75 IAVKKLSVDSRQGSREFTNEVKLLLRIQHKNLVSLLGCCFHGPEKMLVYEYLPNRSLDYF 134
Query: 173 IFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232
+FDK K SL W R+RI++GVARGLLYLHEEAP RIIHRDIKASNILLD LNPKISDF
Sbjct: 135 LFDKIKPGSLGWDHRWRIIIGVARGLLYLHEEAPIRIIHRDIKASNILLDNNLNPKISDF 194
Query: 233 GLARLFPGEDTHVNTFRIS 251
GLARLFPG+ TH NT RIS
Sbjct: 195 GLARLFPGDGTHTNTSRIS 213
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 266 | ||||||
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.770 | 0.251 | 0.535 | 5.9e-57 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.699 | 0.219 | 0.566 | 9.6e-57 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.661 | 0.207 | 0.568 | 2.2e-56 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.740 | 0.245 | 0.541 | 2.3e-55 | |
| TAIR|locus:2125766 | 654 | CRK40 "cysteine-rich RLK (RECE | 0.763 | 0.310 | 0.553 | 2.3e-55 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.710 | 0.230 | 0.573 | 3.2e-55 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.710 | 0.227 | 0.568 | 6.6e-55 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.661 | 0.216 | 0.585 | 8.2e-55 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.672 | 0.267 | 0.581 | 2.1e-54 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.718 | 0.286 | 0.554 | 2.1e-54 |
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 5.9e-57, P = 5.9e-57
Identities = 112/209 (53%), Positives = 152/209 (72%)
Query: 43 LFPCLKTSLRGGRAAGESAEDADGSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGP 101
+F C + + R GE+ G + +L FD +T+ +AT+ FS +N LG GGFGP
Sbjct: 457 VFACFRKKIMK-RYRGENFRK--GIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGP 513
Query: 102 VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161
VY+G + +GQEIAVK+LS +S QG+ EF NEVKL+ K+QH+NLV L GCC +G E ML+Y
Sbjct: 514 VYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIY 573
Query: 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221
EY+PNKSLD+FIFD+ +S+ LDW R I+ GVARG+LYLH+++ RIIHRD+KA N+LL
Sbjct: 574 EYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLL 633
Query: 222 DEQLNPKISDFGLARLFPGEDTHVNTFRI 250
D +NPKISDFGLA+ F G+ + +T R+
Sbjct: 634 DNDMNPKISDFGLAKSFGGDQSESSTNRV 662
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 9.6e-57, P = 9.6e-57
Identities = 106/187 (56%), Positives = 141/187 (75%)
Query: 65 DGSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR 123
+G ++ L F L + +ATN F N+LG GGFGPVY+G++ +G+EIAVK+LS S
Sbjct: 505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSG 564
Query: 124 QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLD 183
QG+ EF NE+ L+ K+QH+NLV L GCC EG EKMLVYEY+PNKSLD+F+FD+TK + +D
Sbjct: 565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624
Query: 184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
W R+ I+ G+ARGLLYLH ++ RIIHRD+K SN+LLD ++NPKISDFG+AR+F G
Sbjct: 625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQN 684
Query: 244 HVNTFRI 250
NT R+
Sbjct: 685 EANTVRV 691
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 2.2e-56, Sum P(2) = 2.2e-56
Identities = 100/176 (56%), Positives = 135/176 (76%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
F ++ AT++FSD N+LG GGFGPVY+G + +G+E+A+K+LS+ S QGL EF NE L
Sbjct: 515 FSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAML 574
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
+ K+QH NLV L GCC E EKML+YEY+PNKSLDYF+FD + LDW R+RI+ G+
Sbjct: 575 IAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGII 634
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
+GLLYLH+ + ++IHRDIKA NILLDE +NPKISDFG+AR+F +++ NT R++
Sbjct: 635 QGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 690
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
Identities = 110/203 (54%), Positives = 145/203 (71%)
Query: 48 KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM 107
K SL+G +ED G FF+++T+++ATN FS +N+LG GGFGPVY+G +
Sbjct: 455 KVSLQGAWRNDLKSEDVSGL------YFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKL 508
Query: 108 PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167
+G+EIAVK+LS S QG EF NE+ L+ K+QH NLV + GCC EG E++LVYE++ NK
Sbjct: 509 QDGKEIAVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNK 568
Query: 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
SLD FIFD K +DW R+ I+ G+ARGLLYLH ++ RIIHRD+K SNILLD+++NP
Sbjct: 569 SLDTFIFDSRKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNP 628
Query: 228 KISDFGLARLFPGEDTHVNTFRI 250
KISDFGLAR++ G NT RI
Sbjct: 629 KISDFGLARMYEGTKYQDNTRRI 651
|
|
| TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
Identities = 114/206 (55%), Positives = 147/206 (71%)
Query: 47 LKTSLRGGRAAGE-SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRG 105
+K R G+ SAE +D G + L FDL + +AT+ FS N LG GGFG VY+G
Sbjct: 308 IKVYARRGKLNNVGSAEYSDSDG--QFMLRFDLGMIVMATDDFSSENTLGQGGFGTVYKG 365
Query: 106 LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165
PNGQE+AVK+L+ S QG EF NEV LL ++QHKNLV L G C EG E++LVYE++P
Sbjct: 366 TFPNGQEVAVKRLTKGSGQGDMEFKNEVSLLTRLQHKNLVKLLGFCNEGDEEILVYEFVP 425
Query: 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225
N SLD+FIFD+ K S L W R+RI+ G+ARGLLYLHE++ +IIHRD+KASNILLD ++
Sbjct: 426 NSSLDHFIFDEDKRSLLTWEVRFRIIEGIARGLLYLHEDSQLKIIHRDLKASNILLDAEM 485
Query: 226 NPKISDFGLARLFPGEDTHVNTFRIS 251
NPK++DFG ARLF ++T T RI+
Sbjct: 486 NPKVADFGTARLFDSDETRAETKRIA 511
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 3.2e-55, P = 3.2e-55
Identities = 109/190 (57%), Positives = 139/190 (73%)
Query: 59 ESAEDADGSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK 117
E A +D D L FF++ LQ ATN FS LN+LG GGFG VY+G + +G+EIAVK+
Sbjct: 468 EGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKR 527
Query: 118 LSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT 177
L+ S QG EF NE+KL+ K+QH+NL+ L GCC +G EK+LVYEY+ NKSLD FIFD
Sbjct: 528 LTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLK 587
Query: 178 KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
K +DW TR+ I+ G+ARGLLYLH ++ R++HRD+K SNILLDE++NPKISDFGLARL
Sbjct: 588 KKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARL 647
Query: 238 FPGEDTHVNT 247
F G +T
Sbjct: 648 FHGNQHQDST 657
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 569 (205.4 bits), Expect = 6.6e-55, P = 6.6e-55
Identities = 108/190 (56%), Positives = 138/190 (72%)
Query: 61 AEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSV 120
A+D + NLF D+ T++ ATN FS N+LG GGFGPVY+G + +G+EIAVK+LS
Sbjct: 494 AKDMEPQDVSGVNLF-DMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSS 552
Query: 121 DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS 180
S QG EF NE++L+ K+QHKNLV L GCC +G EK+L+YEYL NKSLD F+FD T
Sbjct: 553 SSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKF 612
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
+DW R+ I+ GVARGLLYLH ++ R+IHRD+K SNILLDE++ PKISDFGLAR+ G
Sbjct: 613 EIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQG 672
Query: 241 EDTHVNTFRI 250
NT R+
Sbjct: 673 TQYQDNTRRV 682
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 8.2e-55, P = 8.2e-55
Identities = 103/176 (58%), Positives = 134/176 (76%)
Query: 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
FFD++T+ TN FS N+LG GGFGPVY+G + +G+EIA+K+LS S QGL EF NE+
Sbjct: 488 FFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEII 547
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
L+ K+QH+NLV L GCC EG EK+L+YE++ NKSL+ FIFD TK LDW R+ I+ G+
Sbjct: 548 LISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGI 607
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
A GLLYLH ++ R++HRD+K SNILLDE++NPKISDFGLAR+F G NT R+
Sbjct: 608 ACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRV 663
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 2.1e-54, P = 2.1e-54
Identities = 104/179 (58%), Positives = 134/179 (74%)
Query: 73 NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNE 132
+L F +T++ AT+ FSD N +G GGFG VYRG + +G E+AVK+LS S QG EF NE
Sbjct: 330 SLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNE 389
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
L+ K+QHKNLV L G C EG EK+LVYE++PNKSLDYF+FD K LDWT RY I+
Sbjct: 390 AVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIG 449
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
G+ARG+LYLH+++ IIHRD+KASNILLD +NPKI+DFG+AR+F + + NT RI+
Sbjct: 450 GIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIA 508
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 2.1e-54, P = 2.1e-54
Identities = 107/193 (55%), Positives = 143/193 (74%)
Query: 59 ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL 118
++ ++D S DS L +D +T++ ATN FS N+LG GGFG VY+G + NG ++AVK+L
Sbjct: 323 KTESESDISTTDS--LVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRL 380
Query: 119 SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
S S QG REF NE L+ K+QH+NLV L G C E E++L+YE++ NKSLDYF+FD K
Sbjct: 381 SKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEK 440
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
S LDWT RY+I+ G+ARG+LYLH+++ +IIHRD+KASNILLD +NPKI+DFGLA +F
Sbjct: 441 QSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIF 500
Query: 239 PGEDTHVNTFRIS 251
E T NT RI+
Sbjct: 501 GVEQTQGNTNRIA 513
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 266 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.004 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 9e-42
Identities = 55/170 (32%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
LG GGFG VY G+++A+K + + L E E+++L K+ H N+V L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
+ LV EY SL + K L RI++ + GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 212 RDIKASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260
RD+K NILLD K++DFGL++L + + + T + P +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 4e-41
Identities = 55/161 (34%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 91 LNQLGHGGFGPVYRG-----LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+LG G FG VY+G E+AVK L D S Q + EF E +++ K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L G C E +V EY+ L ++ + L + + +ARG+ YL +
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
IHRD+ A N L+ E L KISDFGL+R +D +
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR 159
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-40
Identities = 57/152 (37%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 91 LNQLGHGGFGPVYRG-----LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+LG G FG VY+G E+AVK L D S Q + EF E +++ K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L G C E M+V EY+P L ++ K + L + + +ARG+ YL +
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
IHRD+ A N L+ E L KISDFGL+R
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 92 NQLGHGGFGPVYRG--LMPNGQEI--AVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G FG VY+G +G+ AVK L S + ++F E +++ K+ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIVMGVARGLLY 200
L G C E LV EY+ L ++ F + S+L + +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L + + +HRD+ A N L+ E L KISDFGL+R
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-36
Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNL 144
+ L +LG G FG VY+ G+ +AVK L S + + E+++L ++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L + LV EY L ++ L +I + + RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN 117
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
IIHRD+K NILLDE KI+DFGLA+ + + TF
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF 158
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-35
Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 93 QLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G FG VY+G + ++AVK L S + EF E ++ K+ H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L G C +G +V EY+P L F+ + L ++ + +A+G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+HRD+ A N L+ E L KISDFGL+R +D +
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
+ L +LG G FG VY G+ +A+K + + RE E+K+L K++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L+ + + LV EY L + K S D Y + + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFY--LRQILSALEYLHS-- 115
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
I+HRD+K NILLDE + K++DFGLAR + TF
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTF 156
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-29
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLF 148
LG G FG VY L G+ +AVK + + DS + L E+++L +QH N+V +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 149 GCCAEGPEKML-VY-EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G + + L ++ EY+ SL + K L + + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS--- 119
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRDIK +NIL+D K++DFG A+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAK 149
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 54/150 (36%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
F+ +LG G FG V+ GL N +A+K L D ++F EV+ L +++HK+L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
F C+ G ++ E + SL F+ + L + + VA G+ YL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237
IHRD+ A NIL+ E L K++DFGLARL
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 51/149 (34%), Positives = 83/149 (55%), Gaps = 6/149 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
F L ++G GGFG VY+ G+E+A+K + ++S++ + NE+++L K +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+G + E +V E+ SL + K+ + +L + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA 235
IIHRDIKA+NILL K+ DFGL+
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 92 NQLGHGGFGPVYRG--LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
+LGHG FG V +G LM +G+E+ AVK L + G +EF E ++ ++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L G C +G MLV E P L ++ + + D + VA G+ YL +
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESK-- 114
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGED 242
+HRD+ A N+LL + KISDFG++R L G D
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 15/175 (8%)
Query: 91 LNQLGHGGFGPVYRG-LMPN----GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNL 144
+ QLG G FG V P G+++AVK L+ Q +F E+++L + H+N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 145 VTLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
V G C G L+ EYLP+ SL ++ + ++ + +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTW 255
+ R IHRD+ A NIL++ + KISDFGLA++ P + + V S + W
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-23
Identities = 50/146 (34%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
+G G FG V G GQ++AVK L DS + F E ++ ++H NLV L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 153 EGPEKMLVYEYLPNKSL-DYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARII 210
+G +V EY+ SL DY +++ + + + + V G+ YL E+ +
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 211 HRDIKASNILLDEQLNPKISDFGLAR 236
HRD+ A N+L+ E L K+SDFGLA+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 51/145 (35%), Positives = 75/145 (51%), Gaps = 9/145 (6%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+G G FG VY+GL + G +A+K++S+ + L+ E+ LL ++H N+V G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
++ EY N SL I K Y V V +GL YLHE+ +I
Sbjct: 68 IETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVY--VYQVLQGLAYLHEQG---VI 121
Query: 211 HRDIKASNILLDEQLNPKISDFGLA 235
HRDIKA+NIL + K++DFG+A
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-23
Identities = 62/171 (36%), Positives = 85/171 (49%), Gaps = 31/171 (18%)
Query: 91 LNQLGHGGFGPVYRG--LMPNGQE----IAVKKL----SVDSRQGLREFTNEVKLLLKIQ 140
L +LG G FG VY+G PN + +A+K L +Q EF E +L+ +Q
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQ 66
Query: 141 HKNLVTLFGCCA-EGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTT 186
H N+V L G C E P ML +EYL + L F+ D+T SSLD +
Sbjct: 67 HPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
I + +A G+ YL + +HRD+ A N L+ E L KISDFGL+R
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
F L +LG G +G VY+ + GQ +A+K + V+ L+E E+ +L + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V +G + + +V EY S+ + K + +L I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ IHRDIKA NILL+E+ K++DFG++
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-22
Identities = 57/157 (36%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 91 LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
+ QLG G FG V Y L N G+ +AVKKL + + LR+F E+++L +QH N+V
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 146 TLFGCC--AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
G C A LV EYLP SL DY + + LD + +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLG 125
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ R +HRD+ NIL++ + KI DFGL ++ P
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-22
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
+ LG G G VY+ P G+ A+KK+ VD + R + E+K L + +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR----GLLYL 201
+G + E +V EY+ SL + K ++ +AR GL YL
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYL 115
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
H IIHRDIK SN+L++ + KI+DFG++++ NTF
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 8e-22
Identities = 51/148 (34%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 94 LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHKNLVTLFGC 150
LG G FG V+ G ++AVK L + G F E +++ K++H LV L+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C+E +V EY+ SL F+ L + +A G+ YL I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLF 238
HRD+ A NIL+ E L KI+DFGLARL
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-21
Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
++G G FG VY+G++ E+AVK L+ F E ++L + H N+V L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
+ +V E +P SL F+ + K + L ++ + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIH 116
Query: 212 RDIKASNILLDEQLNPKISDFGLAR 236
RD+ A N L+ E KISDFG++R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 40/187 (21%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQG-----LREFTNEVKLLLKIQHKN 143
+ Q+G G +G VY+ G+ +A+KK+ +++ ++G +RE +KLL K++H N
Sbjct: 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPN 59
Query: 144 LVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-------- 193
+V L + +V+EY+ + D + L + +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH---DL--------TGLLDSPEVKFTESQIKCYMKQ 108
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVV 253
+ GL YLH I+HRDIK SNIL++ K++DFGLAR + ++ T R V+
Sbjct: 109 LLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR--VI 163
Query: 254 T-W--PP 257
T W PP
Sbjct: 164 TLWYRPP 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 49/163 (30%), Positives = 86/163 (52%), Gaps = 20/163 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY+G+ +P G+ +A+K L ++ + +E +E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 148 FGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLHE 203
G C + L+ + +P L DY K S L+W + +A+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
+ R++HRD+ A N+L+ + KI+DFGLA+L ++ +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-21
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 94 LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
+G G FG V RG + P +EI A+K L S R +F E ++ + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G + M++ EY+ N SLD F+ + ++ G+A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+HRD+ A NIL++ L K+SDFGL+R + T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.6 bits (223), Expect = 5e-21
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQH-KN 143
+ L +LG G FG VY + + +A+K L+ + + F E+++L + H N
Sbjct: 2 YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L+ + LV EY+ SL+ + + L + I+ + L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 204 EAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDTHVNTFR 249
+ IIHRDIK NILLD K+ DFGLA+L P + +
Sbjct: 120 K---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-21
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 7/149 (4%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +LG G FG V+ GL N +AVK L + ++F E +++ K++H L+ L+
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
C +V E + SL +Y +L + VA G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLF 238
IHRD+ A N+L+ E K++DFGLAR+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 8e-21
Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD------SRQGLREFTNEVKLLLKIQ 140
+ L +LG G +G VY+ G+ +A+KK+ +D LRE + LL +++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELK 56
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N+V L + LV+EY + L ++ + L I+ + RGL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
H RI+HRD+K NIL++ K++DFGLAR F
Sbjct: 114 CHS---HRILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 9e-21
Identities = 54/157 (34%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 93 QLGHGGFGPVYRG--LMPNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTL 147
+LG G FG V RG G+ I AVK L D + +F E ++ + H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+G P M+V E P SL K +T + +A G+ YL +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSL-LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
R IHRD+ A NILL KI DFGL R P + H
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-20
Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTLFG 149
++G G FG V+ G +++A+K + R+G +F E ++++K+ H LV L+G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
C E LV+E++ + L ++ + + T + + V G+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES---SNV 121
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL 237
IHRD+ A N L+ E K+SDFG+ R
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF 149
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-20
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 19/168 (11%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKK---LSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+ Q+G G FG VY + ++ V K LS S + + NEVK+L K+ H N++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------LDWTTRYRIVMGVARGLLY 200
+ E + +V EY L I + K LDW + + + L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
LH +I+HRDIK NI L K+ DFG++++ T
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
+ +L ++G G G VY+ G+E+A+KK+ + Q NE+ ++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYRI--VMG-VAR 196
+V + G E +V EY+ SL + +I V V +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP---------QIAYVCREVLQ 127
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
GL YLH +IHRDIK+ NILL + + K++DFG A
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-20
Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQE--IAVKKLS-VDSRQGLREFTNEVKLLLKIQHKN 143
+LG G FG V+ G L P + +AVK L S ++F E +LL QH+N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-----------IFDKTKSSSLDWTTRYRIVM 192
+V +G C EG ++V+EY+ + L+ F + L + +I +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+A G++YL A +HRD+ N L+ L KI DFG++R
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-20
Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 16/150 (10%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLVTLFG 149
+LG G FG V+ G ++A+K L +QG F E L+ ++QH LV L+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG--VARGLLYLHEEAPA 207
+ P ++ EY+ N SL F+ KT + T I M +A G+ ++ +
Sbjct: 69 VVTQEP-IYIITEYMENGSLVDFL--KT-PEGIKLTINKLIDMAAQIAEGMAFIERK--- 121
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237
IHRD++A+NIL+ E L KI+DFGLARL
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-19
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 92 NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
++LG G +G VY G+ +AVK L D+ + + EF E ++ +I+H NLV L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
C P ++ E++ +L DY + ++ + ++ + YL ++
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
IHRD+ A N L+ E K++DFGL+RL G+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-19
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 18/152 (11%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSV-----DSRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY GL + +G AVK++S+ ++ +++ E+ LL K+QH N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 148 FGCCAEGPEKMLVY-EYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
G E + + ++ E +P SL + + TR +I++G+ YLH+
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+HRDIK +NIL+D K++DFG+A+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 57/165 (34%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 87 FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQGLREFTN---EVKLLLKIQHK 142
F+DL ++GHG FG VY E+ A+KK+S +Q ++ + EVK L +I+H
Sbjct: 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N + GC LV EY + D K ++ I G +GL YLH
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLH 142
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+IHRDIKA NILL E K++DFG A + ++ V T
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-19
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
F+ L +G G FG VY+ + Q +A+K + ++ + + + E++ L + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ +G +G + ++ EY S D K LD T I+ V GL YLHE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
E IHRDIKA+NILL E+ + K++DFG++
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-19
Identities = 55/165 (33%), Positives = 79/165 (47%), Gaps = 10/165 (6%)
Query: 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHK 142
FSDL ++GHG FG VY + N + +A+KK+S +Q ++ EV+ L K++H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N + GC LV EY + D K ++ + G +GL YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH 132
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+IHRD+KA NILL E K+ DFG A + + V T
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 9/169 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
F L +LG G + VY+G G+ +A+K++ +D+ +G E+ L+ +++H+N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L + MLV+EY+ +K L ++ +LD T + +G+ + HE
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT 254
R++HRD+K N+L++++ K++DFGLAR F VNTF VVT
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEVVT 163
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 55/162 (33%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 87 FFSDLNQLGHGGFGPV--YRGLMPN---GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQ 140
+ + LG G FG V Y N G+ +AVK L + Q + E+ +L +
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 141 HKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARG 197
H+N+V GCC+E K L+ EY+P SL DY K + L + G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ YLH + IHRD+ A N+LLD KI DFGLA+ P
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 94 LGHGGFGPVYRGL--MPNGQE--IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
+G G FG V+RG+ MP +E +A+K L + R +F +E ++ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEEAPA 207
G + M++ EY+ N +LD ++ D SS R G+A G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD---M 126
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
+HRD+ A NIL++ L K+SDFGL+R+ ED T+ S
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTS 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLF 148
+ +G G VY + +PN +++A+K++ ++ Q + E EV+ + + H N+V +
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G E LV YL SL + LD ++ V +GL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 209 IIHRDIKASNILLDEQLNPKISDFGL-ARLF-PGEDTH 244
IHRDIKA NILL E + KI+DFG+ A L G+ T
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 6/144 (4%)
Query: 94 LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCCA 152
LG G FG V++G + + +AVK D Q L+ +F +E ++L + H N+V L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
+ +V E +P D+ F + K L + + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 213 DIKASNILLDEQLNPKISDFGLAR 236
D+ A N L+ E KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 56/164 (34%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQ---GLREFTNEVKLLLKIQHKN 143
F L+++GHG FG VY + E+ AVKK+S +Q ++ EVK L +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ GC + LV EY + D K ++ I G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS 139
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+IHRDIKA NILL E K++DFG A ++ V T
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTL 147
L +LG G FG V+ G ++A+K + R+G +F E K+++K+ H NLV L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+G C + +V EY+ N L ++ ++ +W + V + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLES---N 119
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLAR 236
IHRD+ A N L+ E K+SDFGLAR
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-18
Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKL-SVDSRQGLREFTNEVK 134
+V + + L LGHG FG VY GL ++AVK L S Q +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRI 190
++ K H+N+V L G E + ++ E + L F+ + + SSL
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLAR 236
VA+G YL E IHRDI A N LL KI+DFG+AR
Sbjct: 122 ARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 55/164 (33%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN---EVKLLLKIQHKN 143
F+DL ++GHG FG VY + + +A+KK+S +Q ++ + EV+ L +++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ GC LV EY + D K ++ I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHS 133
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
IHRDIKA NILL E K++DFG A L ++ V T
Sbjct: 134 H---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 91 LNQLGHGGFGPVYRGL-----MPNGQEIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNL 144
+ +LG FG +Y+G M + Q +A+K L +++ Q EF E L+ ++ H N+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIF--------------DKTKSSSLDWTTRYRI 190
V L G + +++EYL L F+ D T SSLD I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFR 249
+ +A G+ YL + +H+D+ A NIL+ EQL+ KISD GL+R ++ + V
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 250 ISVVTWPP 257
+ + W P
Sbjct: 187 LLPIRWMP 194
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-17
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 9/164 (5%)
Query: 87 FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
F+ L ++G G FG VY+G+ +E+ A+K + ++ + + + E+ +L + +
Sbjct: 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+G +G + ++ EYL S D K L+ T I+ + +GL YLH E
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
R IHRDIKA+N+LL EQ + K++DFG+A NTF
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKI-Q 140
F +G G F V +E A+K L D RQ ++E E ++L ++
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDW-TTRY---RIVMGVA 195
H ++ L+ + E + V EY PN L +I K SLD TR+ I++ +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
YLH IIHRD+K NILLD+ ++ KI+DFG A++ + +
Sbjct: 117 ----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 20/163 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQEI----AVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY+G+ +P G+ + A+K L+ + EF +E ++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
G C P LV + +P+ L ++ + + L+W + +A+G++YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
R++HRD+ A N+L+ + KI+DFGLARL G++ N
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-17
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 89 SDLNQLGHGGFGPVYRGLMPNGQE------IAVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
++ LG G FG V+ +E + VK L EF E+ + K+ H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIVMGVA 195
KN+V L G C E ++ EY L F+ +K K L + + +A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
G+ +L + AR +HRD+ A N L+ Q K+S L++
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
L +LG G G V + L P G+ +AVK + ++ + ++ + E+ +L K +V
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT-TRY--RIVMGVARGLLYLH 202
+G + + EY+ SLD K R +I + V +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLD-----KILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
E+ +IIHRD+K SNIL++ + K+ DFG++
Sbjct: 118 EKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQHKNLVTL 147
LG G + VY+ G+ +A+KK+ + R+ ++ N E+KLL +++H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
LV+E++ L+ I DK+ + Y ++ RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMT--LRGLEYLHSNW-- 122
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
I+HRD+K +N+L+ K++DFGLAR F
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 18/163 (11%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-DSRQGLREFT-NEVKLLLKIQ---H 141
+ +L ++G G +G VY+ + G+ +A+KK+ V S +G+ T E+ LL +++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 142 KNLVTLFGCCAEGPEK------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
N+V L C GP LV+E++ ++ L ++ K L T ++ +
Sbjct: 61 PNIVRLLDVCH-GPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLL 117
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
RG+ +LH RI+HRD+K NIL+ KI+DFGLAR++
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS-----RQGLREFTNEVKLLLKIQH 141
+L++LG G G V + + N I A+K ++ D +Q LRE +++ +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE----LEINKSCKS 58
Query: 142 KNLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARG 197
+V +G + + EY SLD I+ K K + +I V +G
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
L YLH +IIHRDIK SNILL + K+ DFG
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-17
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 20/153 (13%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKK-----LSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY + G+E+AVK+ S ++++ + E++LL +QH+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 148 FGCCAEGPEKMLVY-EYLPNKSLDYFIFDKTKSSSLDWTTR---YRIVMGVARGLLYLHE 203
+GC + E + ++ EY+P S+ + K + + TR +I+ G+ YLH
Sbjct: 70 YGCLRD-DETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRDIK +NIL D N K+ DFG ++
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-17
Identities = 50/153 (32%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL------REFTNEVKLLLKIQHKNLV 145
LG G +G VY GL GQ IAVK++ +D+ L + EV LL ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
G C + + E++P S+ + F T+ +I+ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
++HRDIK +N++L K+ DFG AR
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 93 QLGHGGFGPVY----RGLMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G FG V+ L+P + +AVK L S ++F E +LL +QH+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYF---------IFDKTKSSSLDWTT---RYRIVMGV 194
+G C EG ++V+EY+ + L+ F I + + T I +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
A G++YL A +HRD+ N L+ + L KI DFG++R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-17
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 93 QLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G FG V+ L P +I AVK L S ++F E +LL +QH+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDKTKSSSLDWTTRYRIVMGVAR 196
+G C EG ++V+EY+ + L+ F+ + + + L + I +A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
G++YL A +HRD+ N L+ E L KI DFG++R
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-17
Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 31/170 (18%)
Query: 94 LGHGGFGPVYR----GLMPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G FG V++ GL+P + +AVK L + S +F E L+ + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYR------------- 189
L G CA G L++EY+ L+ F+ + + S T+ R
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 190 ---IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I VA G+ YL E + +HRD+ N L+ E + KI+DFGL+R
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-17
Identities = 49/157 (31%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
++ + ++G G +G VY+G GQ +A+KK+ ++S + T E+ LL ++QH N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 145 VTLFGCCAEGPEKMLVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
V L + L++E+L K LD + + L + Y+I+ G+ L+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFC 117
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
H R++HRD+K N+L+D + K++DFGLAR F
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-16
Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 7/163 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
F LN++G G FG V++ + + + A+K++ + +R+ E +E ++L K+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ + + + +V EY N L + + L +R + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+I+HRDIK+ N+ LD N KI D G+A+L NT
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-16
Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 11/160 (6%)
Query: 94 LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+G G FG V RG + P +EI A+K L + + R+F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G + M++ E++ N +LD F+ + ++ G+A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+HRD+ A NIL++ L K+SDFGL+R F +DT T+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTY 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 39/173 (22%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-DSRQG-----LREFTNEVKLLLKIQHKN 143
L +LG G FG VY+ + G+ +A+KK+ + + + G LRE +K+L K++H N
Sbjct: 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKHPN 68
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLD----YFIF---DKTKSSSLDWTTRYRIVMGVAR 196
+V L + E Y + D S L+ ++ +
Sbjct: 69 VVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118
Query: 197 --------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
G+ YLHE I+HRDIKA+NIL+D Q KI+DFGLAR + G
Sbjct: 119 CYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-16
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 15/152 (9%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+ +LG G FG V+ G N ++AVK L + ++ F E L+ +QH LV L+
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKS-----SSLDWTTRYRIVMGVARGLLYLHEEA 205
+ ++ EY+ SL F+ +D++ + +A G+ Y+ +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIERK- 122
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARL 237
IHRD++A+N+L+ E L KI+DFGLAR+
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQHKN 143
+G G FG VY G+ +G+ +AVK++ + S R L E+ LL ++QH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V G + + EY+P S+ + + + T V + +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
IIHRDIK +NIL+D + KISDFG+++
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 94 LGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVT 146
LG G FG V + +AVK L ++ LR+ +E LL ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMG 193
L+G C++ +L+ EY SL F+ + K SS LD + MG
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 194 --------VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
++RG+ YL E +++HRD+ A N+L+ E KISDFGL+R ED++V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 246 NTFRISV-VTW 255
+ + V W
Sbjct: 185 KRSKGRIPVKW 195
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH---K 142
+ L +G G +G VYRG +P G+ +A+K +++D+ + + EV LL +++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N+ +G +GP ++ EY S+ + K+ + I+ V L Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
+ +IHRDIKA+NIL+ N K+ DFG+A L
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-16
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 94 LGHGGFGPVYRG------LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLV 145
LG G FG V + +AVK L D + + L + +E++++ I +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK----TKSSSLDWT------TRYRIV---M 192
L G C + +V EY + +L F+ + +S D T+ +V
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ +L A + IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 29/160 (18%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSV--------DSRQG--LREFTNEVKLLLKIQHK 142
+G G +G VY L + G+ +AVK++ + DSRQ ++ +E++ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 143 NLVTLFGCCAEGPEKMLVY-EYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVAR 196
N+V G E + ++ EY+P S+ Y F++ T + V
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQ------VLE 119
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
GL YLH + I+HRD+KA N+L+D KISDFG+++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 4e-16
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 51/193 (26%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ L +G G +G V + G+++A+KK+S +D+++ LRE +KLL ++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHLR 57
Query: 141 HKNLVTLFGCCA-EGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKSSS 181
H+N++ L PE +V E + + L YF+
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL-------- 109
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
Y+I+ RGL YLH A +IHRD+K SNIL++ + KI DFGLAR +
Sbjct: 110 ------YQIL----RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 242 DTHVNTFRISVVT 254
+ VVT
Sbjct: 157 EDEKGFLTEYVVT 169
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-16
Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 88 FSDLNQLGHGGFGPVYR-GLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L +G G FG V + A+K K + +R NE ++L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
LV L+ + LV + L L Y + K K S + ++ I + L YLH
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS--EEQVKFWICE-IVLALEYLHS 118
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
+ IIHRDIK NILLDEQ + I+DF +A +
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-16
Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 94 LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+G G FG V G + P +EI A+K L + + R+F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G + M+V EY+ N SLD F+ + ++ G+A G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYLSDMG--- 126
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLF 238
+HRD+ A NIL++ L K+SDFGL+R+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-16
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
LG G +G VY + IA+K++ + ++ E+ L ++H+N+V G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
E + E +P SL + K ++ + T+ + GL YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLHDN--- 127
Query: 208 RIIHRDIKASNILLDEQLNP-KISDFG----LARLFPGEDTHVNTFR 249
+I+HRDIK N+L++ KISDFG LA + P +T T +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLKIQHKN 143
L ++G G G V++ G+ +A+KK+++ +G LRE +K L QH
Sbjct: 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPY 60
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L G +LV EY+P+ L + D+ + Y ++ +G+ Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA 117
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
I+HRD+K +N+L+ KI+DFGLARLF E+
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 9e-16
Identities = 55/163 (33%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 94 LGHGGFGPVY--RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
LG G FG V R G+ A+K L + R+ + E +L +I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 149 GCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEA 205
+ EK+ LV EY P L + K S + Y IV+ L YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLA----LEYLHSL- 112
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
II+RD+K NILLD + K++DFGLA+ E + NTF
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY G+E+AVK++ D + + + E++LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
+GC + E+ L E++P S I D+ KS +L + + G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRDIK +NIL D N K+ DFG ++
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
+LG G FG V+ G +A+K L + F E +++ K++H+ LV L+ +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
E P +V EY+ SL F+ + L + +A G+ Y+ +HR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 213 DIKASNILLDEQLNPKISDFGLARL 237
D++A+NIL+ E L K++DFGLARL
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
+ L ++G G +G VY+ G+ +A+KK+ + T E+KLL ++ H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ L + LV+E++ D + K + L + + + +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS- 116
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
I+HRD+K N+L++ + K++DFGLAR F
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSF 148
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 41/171 (23%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQG-----LREFTNEVKLLLKIQ 140
F LN++G G +G VYR +G+ +A+KK+ +D R G LRE T LLL ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT----LLLNLR 64
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF------DKTKSSSLDWTTR------- 187
H N+V L E + K LD IF ++ +S LD
Sbjct: 65 HPNIVEL-------------KEVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQV 110
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
+++ + RGL YLHE IIHRD+K SN+LL ++ KI+DFGLAR +
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 49/147 (33%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+ +LG+G FG V+ G ++AVK L + F E +++ K++H LV L+
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+E P +V EY+ SL F+ D + +L + VA G+ Y+ I
Sbjct: 70 VSEEP-IYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 211 HRDIKASNILLDEQLNPKISDFGLARL 237
HRD++++NIL+ + L KI+DFGLARL
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 44/158 (27%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
+ + ++G G +G VY+ G+ +A+KK+ +++ +RE + LL ++
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELN 56
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N+V L + LV+E+L + L ++ D + + LD + + +G+ Y
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
H R++HRD+K N+L+D + K++DFGLAR F
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
+G G FG V +G GQ++AVK + D + F E ++ K+ HKNLV L G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY-RIVMGVARGLLYLHEEAPARIIH 211
+V E + +L F+ +T+ +L + + + VA G+ YL + +++H
Sbjct: 70 HN-GLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 212 RDIKASNILLDEQLNPKISDFGLARLFP-GEDT 243
RD+ A NIL+ E K+SDFGLAR+ G D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDN 156
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 20/159 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG V++G+ +P G I A+K + S RQ +E T+ + + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
G C G LV + P SL + S L+W + +A+G+ YL E
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
R++HR++ A NILL +I+DFG+A L +D
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 91 LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKN 143
+ +LG FG VY+G + Q +A+K L + LRE F +E + ++QH N
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRI 190
+V L G + +++ Y + L F+ DKT S+L+ I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
V +A G+ +L ++H+D+ N+L+ ++LN KISD GL R
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 55/176 (31%), Positives = 85/176 (48%), Gaps = 26/176 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGLMP---NGQEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHK 142
F D+ +G G FG V R ++ A+K L S R+F E+++L K+ H
Sbjct: 6 FEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTR--YR 189
N++ L G C + EY P +L F+ F K ++ T++ +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
VA G+ YL E+ + IHRD+ A N+L+ E L KI+DFGL+R GE+ +V
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV 173
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-15
Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +LG G FG V G ++A+K + S EF E K+++K+ H+ LV L+G
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C + +V EY+ N L ++ + K + + V G+ YL + + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 211 HRDIKASNILLDEQLNPKISDFGLAR 236
HRD+ A N L+D+Q K+SDFGL+R
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 41/170 (24%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
+ +L+ +G G +G V P G ++A+KK+S Q + T E+K+L + +H+N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 146 TLFGC-CAEGPEKM----LVYEYLP-------------NKSLDYFIFDKTKSSSLDWTTR 187
+ E +V E + N + YF+
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------------- 112
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
Y+I+ RGL Y+H A ++HRD+K SN+LL+ + KI DFGLAR+
Sbjct: 113 YQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-15
Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 17/152 (11%)
Query: 94 LGHGGFGPVYRG--LMPNGQEI--AVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
+G G FG VY G + +GQ+I AVK L+ + + + +F E ++ H N+++L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG--VARGLLYLHEE 204
G C +EG ++V Y+ + L FI +T + T + I G VA+G+ YL
Sbjct: 63 GICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYL--- 114
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
A + +HRD+ A N +LDE K++DFGLAR
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-15
Identities = 53/152 (34%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN---EVKLLLKIQHKNLVTL 147
LG G FG VY G+E+AVK++ D S++ +E E++LL ++H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
+GC + EK L EY+P S I D+ K+ +L R + +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRDIK +NIL D N K+ DFG ++
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-15
Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 88 FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQHKNL 144
F L +LG G +G VY+ + + Q A+K++ + S Q RE NE+++L + H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT-TRYRIVMGVARGLLYLHE 203
++ +G + +V EY P L I + K L +RI + + RGL LHE
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+ +I+HRD+K++NILL KI D G++++
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 87 FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
F+ L ++G G FG V++G+ Q++ A+K + ++ + + + E+ +L + +
Sbjct: 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+G +G + ++ EYL S D ++ D ++ + +GL YLH E
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ IHRDIKA+N+LL EQ + K++DFG+A NTF
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 20/161 (12%)
Query: 85 TNFFSDLNQLGHGGFGPV--YRGLMPNGQEIAVKKL------SVDSRQGLREFTNEVKLL 136
TN + DL +G G FG V R + GQ +A+KK+ V +++ RE +KLL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRE----LKLL 63
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
++H+N+++L E + L L + + Y+I+ R
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL----R 119
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
GL Y+H A ++HRD+K SNIL++E + KI DFGLAR+
Sbjct: 120 GLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+ + ++G G +G VY+ G+ +A+K + ++ E+ +L + +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLH 202
FG + +V EY SL I+ T + + R +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRE-----TLKGLAYLH 118
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
E IHRDIK +NILL E + K++DFG++
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 93 QLGHGGFGPVYRG----LMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G FG V+ L P + +AVK L + ++F E +LL +QH+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRIVMG 193
+G C +G ++V+EY+ + L+ F+ + L + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+A G++YL A +HRD+ N L+ L KI DFG++R
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-14
Identities = 51/152 (33%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN---EVKLLLKIQHKNLVTL 147
LG G FG VY + G+E+A K++ D S + +E + E++LL +QH+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 148 FGCCAEGPEKMLV--YEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
+GC + EK L EY+P S+ D+ K+ +L + + + G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRDIK +NIL D N K+ DFG ++
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQE-IAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
+ + ++G G +G VY+ E IA+KK+ ++ +G+ E+ LL ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG----VARGLLY 200
V L LV+EYL LD K SS D+ R++ + RG+ Y
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISVVT 254
H R++HRD+K N+L+D + N K++DFGLAR F V TF VVT
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVVT 166
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 11/170 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
F + ++G G +G VY+ G+ +A+KK+ +D+ +G+ E+ LL ++ H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L + LV+E+L ++ L F+ D + S + + + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT 254
R++HRD+K N+L++ + K++DFGLAR F V T+ VVT
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVT 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-14
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 94 LGHGGFGPVYRGLM--PNG--QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG V G + +G ++AVK + +D + + EF +E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 148 FGCCAEG------PEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYRIVMGVARGL 198
G C E P+ M++ ++ + L F+ L T + ++ +A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
YL IHRD+ A N +L E + ++DFGL++ D
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 93 QLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
+LG G FG VY+ G A K + ++S + L +F E+ +L + +H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
+ ++ E+ +LD I + + + RY + + L +LH ++IH
Sbjct: 72 FYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
RD+KA NILL + K++DFG++ +TF
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 50/165 (30%), Positives = 86/165 (52%), Gaps = 20/165 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
F + LG G FG VY+GL +P G+++ A+K+L S + +E +E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
++ L G C + L+ + +P L DY K S L+W + +A+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ YL E R++HRD+ A N+L+ + KI+DFGLA+L ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 58/167 (34%), Positives = 83/167 (49%), Gaps = 28/167 (16%)
Query: 94 LGHGGFGPVYR----GLMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
LG G FG V R G+ + + +AVK L + + + L + +E++L+ I +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 144 LVTLFGCCA-EGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSS--LDWTTRYR 189
++ L G C EGP ++V EY +L F+ FD TK L +
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ YL R IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 15/177 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
+ L ++G G +G V++ EI A+K++ +D +G+ E+ LL +++HKN+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L+ + LV+EY YF + + +D + + +GL + H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PPN 258
++HRD+K N+L+++ K++DFGLAR F V + VVT W PP+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPD 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 91 LNQLGHGGFGPVYRGLMPN-GQEIAVKK-LSVDSRQGLREFT-NEVKLLLKIQHKNLVTL 147
L +G G +G V + G+ +A+KK + + +++ EVK+L +++H+N+V L
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
LV+EY+ L+ + L + + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
IIHRDIK NIL+ E K+ DFG AR
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-14
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 93 QLGHGGFGPVYRGLMPNG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
++G+G FG V G + +G ++ VK+L V S Q +F E + +QH NL+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL--DWTTRYRIVMGVARGLLYLHEEAP 206
G C E +LV E+ P L ++ K+ + D TT R+ +A GLL+LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISV 252
IH D+ N LL L KI D+GL+ ED +V ++ V
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 97 GGFGPVYRGLM----PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
G FG ++ G++ P +E K D S + E LL + H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 151 CAEGPEKMLVYEYLPNKS-LDYF-----IFDKTKSSSLDWTTRYRIVMG--VARGLLYLH 202
C E E V N L F + + +L +T+ + M +A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIACGMSYLH 134
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTH 244
+ +IH+DI A N ++DE+L KI+D L+R LFP D H
Sbjct: 135 KR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPM-DYH 173
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-14
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 93 QLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
+LG G FG VY GL +A+K ++ ++ R EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIF----DKTKSSSLDWTTR---YRIVMGVARGL 198
L G + G ++V E + L ++ + + L T ++ +A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
YL + + +HRD+ A N ++ E L KI DFG+ R
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-14
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNL 144
+ +L +G G +G V + GQ +A+KK S D + + E+++L +++H+NL
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L LV+E++ + LD + + LD + + + + RG+ + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGED 242
IIHRDIK NIL+ + K+ DFG AR PGE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-14
Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 16/159 (10%)
Query: 93 QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
+LG G FG V +G+ M Q ++A+K L ++ + +R E E +++ ++ + +V +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM---GVARGLLYLHEEA 205
G C E MLV E L+ F+ S D T +V V+ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+HRD+ A N+LL Q KISDFGL++ +D++
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-14
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 94 LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
+G G FG VY+G+ P ++I AVK + +RE F E ++ + H ++V L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G E P +V E P L ++ + SLD + ++ L YL + R
Sbjct: 74 GVITENP-VWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HRDI A N+L+ K+ DFGL+R E
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-14
Identities = 51/164 (31%), Positives = 71/164 (43%), Gaps = 24/164 (14%)
Query: 92 NQLGHGGFGPVYRG-----LMPNGQEIAV-----KKLSVDSRQGLREFTNEVKLLLKIQH 141
N LG G FG VY G L P I V +K + D + +EF E L+ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARG 197
N+V L G C + ++ E + L ++ D + L I + VA+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-----KISDFGLAR 236
+YL + IHRD+ A N L+ E+ KI DFGLAR
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-14
Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 87 FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
F+ L ++G G FG V++G+ Q++ A+K + ++ + + + E+ +L + +
Sbjct: 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+G + + ++ EYL S D + LD T I+ + +GL YLH E
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ IHRDIKA+N+LL E K++DFG+A
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-14
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 14/171 (8%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTL 147
+ +LG G FG V+ G ++A+K + +G +F E K+++K+ H LV L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+G C + +V E++ N L ++ + S D + V G+ YL +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERNS-- 120
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISV-VTWPP 257
IHRD+ A N L+ K+SDFG+ R + +D + ++ V W P
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSP 169
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-14
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 94 LGHGGFGPVYRGLMPNG---QEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHKNLVTLF 148
+G G FG V + + + A+K++ S+ R+F E+++L K+ H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 149 GCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYRIVMGVA 195
G C L EY P+ +L D+ F + +S+L VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
RG+ YL ++ + IHRD+ A NIL+ E KI+DFGL+R G++ +V
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 166
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 53/189 (28%), Positives = 98/189 (51%), Gaps = 26/189 (13%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
F + Q+G G +G VY+ G+ +A+KK+ +D+ + T E+K+L ++ H+N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 145 VTLFGCCAEGPEKM----------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
V L + + + LV+EY+ D+ + +S + ++ + +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISV 252
+ GL Y H++ +HRDIK SNILL+ + K++DFGLARL+ E++ T ++ +
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV-I 179
Query: 253 VTW--PPNM 259
W PP +
Sbjct: 180 TLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 26/176 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKLS-VDSRQGLREFTNEVKLLLKI-QHK 142
F D+ +G G FG V + + + A+K++ S+ R+F E+++L K+ H
Sbjct: 11 FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYR 189
N++ L G C L EY P+ +L D+ F + +S+L
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
VARG+ YL ++ + IHRD+ A NIL+ E KI+DFGL+R G++ +V
Sbjct: 129 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 178
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-13
Identities = 46/145 (31%), Positives = 74/145 (51%), Gaps = 6/145 (4%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
+LG G FG V+ G ++A+K L + F E +++ K++H LV L+ +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
E P +V E++ SL F+ + L + +A G+ Y+ IHR
Sbjct: 72 EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 213 DIKASNILLDEQLNPKISDFGLARL 237
D++A+NIL+ + L KI+DFGLARL
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 93 QLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGC 150
++G G FG V+ G L + +AVK L+ +F E ++L + H N+V L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C + +V E + + D+ F +T+ L ++V A G+ YL + I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCI 116
Query: 211 HRDIKASNILLDEQLNPKISDFGLAR 236
HRD+ A N L+ E+ KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 93 QLGHGGFGPV----------YRGLMPNGQE-----IAVKKLSVDSRQGLR-EFTNEVKLL 136
+LG G FG V + G + +AVK L D + R +F E+K++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRI 190
++++ N++ L G C ++ EY+ N L+ F+ + T ++++ + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 191 V---MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE 241
+ + +A G+ YL A +HRD+ N L+ KI+DFG++R L+ G+
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-VDSRQG-LREFTNEVKLLLKIQHKNLVTL 147
N++G G FG VY + + G+ +AVK++ D+ ++E +E+K+L ++H NLV
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 148 FGCCAEGPEKMLVY-EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+G EK+ ++ EY +L+ + LD + + GL YLH
Sbjct: 65 YGVEVH-REKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHS--- 117
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA 235
I+HRDIK +NI LD K+ DFG A
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 30/181 (16%)
Query: 91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTL 147
L++LG G + VY+G GQ +A+K++ ++ +G FT E LL ++H N+VTL
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL 68
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR------YRIVM-GVARGLLY 200
LV+EYL D +D R+ + + RGL Y
Sbjct: 69 HDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
H+ R++HRD+K N+L+ E+ K++DFGLAR + T+ VVT W PP
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPP 172
Query: 258 N 258
+
Sbjct: 173 D 173
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQE--IAVKKLSV----------DSRQGLREFTNEVKLLLK 138
L LG G FG VY+ N + +A+K+++V + + + + +EV ++ +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 139 -IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVAR 196
++H N+V + E +V + + L ++F K K + I + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L YLH+E RI+HRD+ +NI+L E I+DFGLA+
Sbjct: 125 ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 14/174 (8%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQE-IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
L +LG G + V++G + +A+K++ ++ +G EV LL ++H N+VTL
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
LV+EYL +K L ++ D S+ + + + RGL Y H +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---K 124
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PPNM 259
++HRD+K N+L++E+ K++DFGLAR + T+ VVT W PP++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDV 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-13
Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 20/160 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQEI----AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG VY+G+ +P+G+ + A+K L + S + +E +E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 148 FGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLHE 203
G C + LV + +P L DY +K + S L+W + +A+G+ YL E
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
R++HRD+ A N+L+ + KI+DFGLARL ++T
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-13
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 94 LGHGGFGPVYRGLMPNGQEI---AVK--KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
LG G FG V G + I AVK K+++ +R + +F +E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 149 GCCAEG------PEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRY--RIVMGVARGLL 199
G C + P +++ ++ + L + ++ + T+ + + +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
YL + IHRD+ A N +L+E +N ++DFGL++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 5e-13
Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKL-----SVDSRQGLREFTNEVKLLLKIQ-HKN 143
+ QLG G FG VY G+ +A+KK+ S + LRE VK L K+ H N
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE----VKSLRKLNEHPN 59
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L E E V+EY+ +L Y + K + I+ + +GL ++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
HRD+K N+L+ KI+DFGLAR
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 56/176 (31%), Positives = 93/176 (52%), Gaps = 18/176 (10%)
Query: 91 LNQLGHGGFGPVYRG---LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVT 146
L++LG G + VY+G L N +A+K++ ++ +G EV LL ++H N+VT
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L LV+EYL +K L ++ D S ++ + + + RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR-- 123
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PPNM 259
+++HRD+K N+L++E+ K++DFGLAR + T+ VVT W PP++
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDI 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-13
Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 16/182 (8%)
Query: 84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQ 140
A + +L +LG G + VY+G+ NGQ +A+K +S+ + +G+ FT E LL ++
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLK 61
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N+V L V+EY+ Y I L + + RGL Y
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
+H + I+HRD+K N+L+ K++DFGLAR + T+ VVT W PP
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPP 172
Query: 258 NM 259
++
Sbjct: 173 DV 174
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-13
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 94 LGHGGFGPVYRGLMPNGQ------EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+G G FG V+ Q +I V++++ D R + NE ++L + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+ E M+V EY P +L +I K +S LD T I+ + LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDT---ILHFFVQILLALHHVHTK 120
Query: 208 RIIHRDIKASNILLDE-QLNPKISDFGLARL 237
I+HRD+K NILLD+ ++ KI DFG++++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV------DSRQGLREFTNEVKLLL 137
F ++G G F VY+ + + +G+ +A+KK+ + +RQ + E+ LL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVA 195
++ H N++ E E +V E L I F K K + T ++ + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
L ++H + RI+HRDIK +N+ + K+ D GL R F + T
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 33/191 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
+ L ++G G FG V++ Q +A+KK+ +++ + LRE +K+L ++
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLK 69
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----------KTKSSSLDWTTRYRI 190
H+N+V L C Y K Y +F+ K+ + ++
Sbjct: 70 HENVVNLIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFR 249
+ + GL Y+H +I+HRD+KA+NIL+ + K++DFGLAR F +++ N +
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 250 ISVVT-W--PP 257
VVT W PP
Sbjct: 182 NRVVTLWYRPP 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 16/170 (9%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNL 144
L +G G FG V + +G+ + K++ + +Q L +EV +L +++H N+
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNI 61
Query: 145 VTLFGCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLY 200
V + + +Y EY L I K ++ +RI+ + L
Sbjct: 62 VRYYDRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 201 LHEEAPA--RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
H + ++HRD+K +NI LD N K+ DFGLA++ + + T+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
L++LG G + V++G +A+K++ ++ +G EV LL ++H N+VTL
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM-GVARGLLYLHEEAPA 207
LV+EYL + Y +L +I M + RGL Y H+
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PPNM 259
+I+HRD+K N+L++E+ K++DFGLAR + T+ VVT W PP++
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
DL L+ F + +G+G +G VY+G + GQ A+K + V + E E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINM 65
Query: 136 LLKI-QHKNLVTLFGC-CAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSL--DWTT 186
L K H+N+ T +G + P + LV E+ S+ + TK ++L DW
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIA 124
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
I + RGL +LH ++IHRDIK N+LL E K+ DFG++ N
Sbjct: 125 Y--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179
Query: 247 TF 248
TF
Sbjct: 180 TF 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-12
Identities = 45/150 (30%), Positives = 67/150 (44%), Gaps = 9/150 (6%)
Query: 92 NQLGHGGFGPVYRGLMPNGQEIA---VKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTL 147
+++G+G FG V G G A VK+L + F EV+ ++ H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEA 205
G C E +LV E+ P L ++ + R+ VA GLL+LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA 235
A IH D+ N L L+ KI D+GLA
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 87 FFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQ 140
F + LG G FG V Y N G+++AVK L +S + + E+++L +
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 141 HKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARG 197
H+N+V G C E L+ E+LP+ SL +Y +K K ++ + + + + +G
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKG 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ YL + +HRD+ A N+L++ + KI DFGL +
Sbjct: 122 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 93 QLGHGGFGPVYRGLMPN---GQEIAVKKLSVDSRQG-------LREFTNEVKLLLKIQHK 142
+G G +G VY+ N G+E A+KK D Q RE LL +++H+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA----LLRELKHE 62
Query: 143 NLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLL 199
N+V+L E +K L+++Y + F + K S+ + ++ + G+
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 200 YLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLF 238
YLH ++HRD+K +NIL+ E+ KI D GLARLF
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 93 QLGHGGFGPVYRGLMPNGQEI-----------------AVKKLSVDSRQGLR-EFTNEVK 134
+LG G FG V+ Q+ AVK L D+ R +F EVK
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--------FDKTKSSSLDWTT 186
+L ++ N+ L G C P ++ EY+ N L+ F+ S SL ++T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ +A G+ YL +HRD+ N L+ + KI+DFG++R
Sbjct: 132 LLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+ DL LG G G V+ + + + +AVKK+ + Q ++ E+K++ ++ H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 147 LFGCCAEGPEKM--------------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
++ + +V EY+ L + S Y+++
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLL- 124
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRIS 251
RGL Y+H A ++HRD+K +N+ ++ E L KI DFGLAR+ +H
Sbjct: 125 ---RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 252 VVT 254
+VT
Sbjct: 179 LVT 181
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 30/162 (18%)
Query: 90 DLNQLGHGGFGPVYRGLMPN-GQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQH-KNLV 145
DL ++G G FG V + L G +AVK++ VD ++ + ++ ++++ +V
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-QKRLLMDLDVVMRSSDCPYIV 66
Query: 146 TLFG-------C--CAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMG 193
+G C C E L + SLD F +++ KS + +I +
Sbjct: 67 KFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSV-IPEEILGKIAVA 115
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ L YL EE +IIHRD+K SNILLD N K+ DFG++
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 93 QLGHGGFGPVY--RGLMPNGQEIAVKKLSVD-SRQGLREFT-NEVKLLLKIQ---HKNLV 145
++G G +G V+ R L G+ +A+K++ V +G+ T EV +L ++ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 146 TLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
LF C + LV+E++ Y DK + T ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
LH R++HRD+K NIL+ K++DFGLAR++
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+ ++G G G V G+++AVKK+ + +Q NEV ++ QH N+V
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
++ G E +V E+L +L D + ++ + + V + L +LH +
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQG- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFG 233
+IHRDIK+ +ILL K+SDFG
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++ ++G G G VY + + GQE+A+K++++ + NE+ ++ + +H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E +V EYL SL D + +D + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFP 239
++IHRDIK+ NILL + K++DFG A++ P
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 17/164 (10%)
Query: 80 TLQVATNFFSDL---NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
+ A S+L N++G G G VY+ + P G+ A+K + + +R + E++
Sbjct: 65 SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE 124
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-YFIFDKTKSSSLDWTTRYRIVMG 193
+L + H N+V E ++ E++ SL+ I D+ + + +I+ G
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV----ARQILSG 180
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+A YLH I+HRDIK SN+L++ N KI+DFG++R+
Sbjct: 181 IA----YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 6e-12
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++ ++G G G VY + + GQE+A+K++++ + NE+ ++ + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E +V EYL SL D + +D + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFP 239
++IHRDIK+ NILL + K++DFG A++ P
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 25/156 (16%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLVT 146
+G G +G V +++A+KK++ +D+++ LRE +KLL + H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68
Query: 147 LFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
+ P + +VYE L + L I ++ + D +Y + + RGL Y
Sbjct: 69 IKD-IMPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHCQY-FLYQLLRGLKY 123
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+H A ++HRD+K SN+LL+ + KI DFGLAR
Sbjct: 124 IHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-12
Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKI- 139
T F + +G G +G VY+ GQ +A+K + + D + ++E E +L K
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYS 60
Query: 140 QHKNLVTLFGC------CAEGPEKMLVYEYLPNKS---LDYFIFDKTKSSSLDWTTRYRI 190
H N+ T +G + LV E S L + K K +W Y I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-I 118
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ RGL YLHE ++IHRDIK NILL + K+ DFG++
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 93 QLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQ-GLREFT-NEVKLLLKIQ---HKNLVT 146
++G G +G VY+ P+ G +A+K + V + + GL T EV LL +++ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 147 LFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
L CA + LV+E++ Y DK L T ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
H I+HRD+K NIL+ K++DFGLAR++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
L+ F + +G+G +G VY+G + GQ A+K + V + E E+ +L K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 140 -QHKNLVTLFGC-CAEGPEKM-----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
H+N+ T +G + P M LV E+ S+ I TK ++L I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICR 118
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ RGL +LH+ ++IHRDIK N+LL E K+ DFG++ NTF
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 29/167 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQG-----LREFTNEVKLLLKIQ 140
+ LN++ G +G VYR G+ +A+KKL ++ ++G LRE + +LLK+Q
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLRE----INILLKLQ 62
Query: 141 HKNLVTL----FGCCAEGPEKM-LVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMG 193
H N+VT+ G +K+ +V EY+ + KSL +T + +++
Sbjct: 63 HPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLM-----ETMKQPFLQSEVKCLMLQ 114
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
+ G+ +LH+ I+HRD+K SN+LL+ + KI DFGLAR +
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +G G FG V G G ++AVK + D+ + F E ++ +++H NLV L G
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
E + +V EY+ SL ++ + +S L + + V + YL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
+HRD+ A N+L+ E K+SDFGL +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKIQHKNLVTLF 148
LGHG G VY+ + + +AVK + +D L ++ +E+++L K ++ +
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G + E++ SLD ++ K L RI + V +GL YL +
Sbjct: 66 GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LK 115
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLAR 236
I+HRD+K SN+L++ + K+ DFG++
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 94 LGHGGFGPVYR----GLMPNGQ--EIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
LG G FG V GL + ++AVK L + RE +E+K++ + H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G C G +++ EY L F+ K + S L VA+G+ +L A
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLAR 236
IHRD+ A N+LL KI DFGLAR
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
+LG G FG V+ ++AVK + S + F E ++ +QH LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 153 EGPEKMLVYEYLPNKSL-DYFIFDKTKSSSL----DWTTRYRIVMGVARGLLYLHEEAPA 207
+ P ++ E++ SL D+ D+ L D++ + +A G+ ++ +
Sbjct: 72 KEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQR--- 121
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237
IHRD++A+NIL+ L KI+DFGLAR+
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 16/178 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
+ L +LG G + VY+G NG+ +A+K + + +G FT E LL ++H N+
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L LV+EY+ Y DK L + + RGL Y+H+
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYM--DK-HPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PPNM 259
I+HRD+K N+L+ + K++DFGLAR + +T+ VVT W PP++
Sbjct: 123 ---YILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++ ++G G G VY + + GQE+A++++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E +V EYL SL D + +D + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFP 239
++IHRDIK+ NILL + K++DFG A++ P
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 20/185 (10%)
Query: 57 AGESAEDADGSGADSWNLFFDLRTLQVATNF-FSDLNQLGHGGFGPVYRGLMPNGQEIAV 115
A ES +D D + + +V + ++ + L G G V+ P + V
Sbjct: 41 ASESDDDDDDGLIPTKQ-----KAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVV 95
Query: 116 KKLSVDSRQGLREFT-NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF 174
K+ G + T E LL + H +++ + G +V LP+ S D + +
Sbjct: 96 LKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY 146
Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
+S L I + GL YLH + RIIHRD+K NI +++ I D G
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 235 ARLFP 239
A+ FP
Sbjct: 204 AQ-FP 207
|
Length = 357 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++ ++G G G V+ + + GQE+A+K++++ + NE+ ++ ++++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E +V EYL SL D + +D + + L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFP 239
++IHRDIK+ N+LL + K++DFG A++ P
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 49/184 (26%), Positives = 89/184 (48%), Gaps = 38/184 (20%)
Query: 93 QLGHGGFGPVYRGLMPNGQE-----------------IAVKKLSVDSRQGLR-EFTNEVK 134
+LG G FG V+ + N Q+ +AVK L D+ + R +F EVK
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----FDKTKSSS-------- 181
+L +++ N++ L G C + ++ EY+ N L+ F+ DK ++ +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 182 ---LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-L 237
+ +++ + + +A G+ YL + +HRD+ N L+ E L KI+DFG++R L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 238 FPGE 241
+ G+
Sbjct: 189 YAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 109 NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
G+++AVKK+ + +Q NEV ++ H+N+V ++ G E +V E+L +
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
L D + ++ + + V R L YLH + +IHRDIK+ +ILL K
Sbjct: 106 LT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIK 158
Query: 229 ISDFGL 234
+SDFG
Sbjct: 159 LSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 25/184 (13%)
Query: 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
DL T+ LG G G V + +P G +A K + + ++ +R + E++
Sbjct: 6 DLETIS----------DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ 55
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
++ + + +V+ +G + E++ SLD I+ K ++ + I + V
Sbjct: 56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGK--IAVAV 112
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG--------LARLFPGEDTHVN 246
GL YL+ RI+HRDIK SNIL++ + K+ DFG +A F G T+++
Sbjct: 113 VEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMS 170
Query: 247 TFRI 250
RI
Sbjct: 171 PERI 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 48/194 (24%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS------VDSRQGLRE 128
+T+ + + +L+ +G G +G V G+++A+KKLS + +++ RE
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIKKLSRPFQSAIHAKRTYRE 64
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFD 175
++LL + H+N++ L + P SL+ F + +
Sbjct: 65 ----LRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNN 108
Query: 176 KTKSSSL-DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
K L D ++ +V + RGL Y+H A IIHRD+K SNI ++E KI DFGL
Sbjct: 109 IVKCQKLSDDHIQF-LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 235 ARLFPGEDT-HVNT 247
AR E T +V T
Sbjct: 165 ARHTDDEMTGYVAT 178
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGFG V + G+ A KKL + R+G + NE K+L K+ + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
E + + LV + L Y I++ + + + + GL +LH+ R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---R 115
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
I++RD+K N+LLD+ N +ISD GLA G
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVK--KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
L++LG G +G VY+ L P G +A+K +L +D + + E+ +L K +V
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDF 64
Query: 148 FGC-CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+G EG M + EY+ SLD + + RI V +GL +L EE
Sbjct: 65 YGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA 235
IIHRD+K +N+L++ K+ DFG++
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-11
Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 18/139 (12%)
Query: 113 IAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170
+AVK L D + + L + +E++++ I +HKN++ L G C + ++ EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 171 YFI-----------FDKTKSSSLDWTTRYRI--VMGVARGLLYLHEEAPARIIHRDIKAS 217
++ +D + T + + VARG+ YL A + IHRD+ A
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 218 NILLDEQLNPKISDFGLAR 236
N+L+ E KI+DFGLAR
Sbjct: 167 NVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-11
Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 113 IAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170
+AVK L D + + L + +E++++ I +HKN++ L G C + ++ EY +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 171 YFI-----------FDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217
++ FD K L + VARG+ YL A + IHRD+ A
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 218 NILLDEQLNPKISDFGLAR 236
N+L+ E KI+DFGLAR
Sbjct: 164 NVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 94 LGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG V + + Q++AVK L D S + EF E + + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 148 FGCC----AEG--PEKMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGL 198
G A+G P M++ ++ + L F+ + +L T R ++ +A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
YL + IHRD+ A N +L+E + ++DFGL++
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 93 QLGHGGFGPVYRGL--MPNGQE-IAVKKLSVDSR-QGLR-EFTNEVKLLLKIQHKNLVTL 147
+LG G FG V +G+ M ++ +AVK L D+ L+ E E ++ ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
G C E MLV E L+ F+ K+ + +V V+ G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEE---T 114
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLAR 236
+HRD+ A N+LL Q KISDFGL++
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 42/161 (26%), Positives = 78/161 (48%), Gaps = 31/161 (19%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQH-KNLVT 146
+ +LG G +G V + +P G +AVK++ +V+S++ R ++ + ++ VT
Sbjct: 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKR-LLMDLDISMRSVDCPYTVT 64
Query: 147 LFGC---------CAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMGV 194
+G C E + + SLD F ++DK + D + I + +
Sbjct: 65 FYGALFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ L YLH + +IHRD+K SN+L++ K+ DFG++
Sbjct: 113 VKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 93 QLGHGGFGPVY--RGLMPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNL 144
QLG G F Y R + G +AVK+++ + + + E++L+ ++ H ++
Sbjct: 7 QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ + G E L E++ S+ + + +K + + RGL YLHE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 205 APARIIHRDIKASNILLDEQ-LNPKISDFGLA 235
+IIHRD+K +N+L+D +I+DFG A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 55/166 (33%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 94 LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
LG G FG V GL PN ++AVK L D + + L + +E++++ I +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 144 LVTLFGCCAE-GPEKMLV--------YEYLPNK---SLDY-FIFDKTKSSSLDWTTRYRI 190
++ L G C + GP ++V EYL + ++Y + + L +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ YL A + IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 47/169 (27%)
Query: 93 QLGHGGFGPVYRGLMP-NGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLV 145
+G+G FG V+ P +G+ +A+KK+ V ++ RE +K+L +H N++
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVL 62
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYF--IFDKTKSSSLDWTTRYRIVMG---------- 193
+ + L +D F I+ T+ L + ++I++
Sbjct: 63 SAL-------------DILQPPHIDPFEEIYVVTE---LMQSDLHKIIVSPQPLSSDHVK 106
Query: 194 -----VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+ RGL YLH A I+HRDIK N+L++ KI DFGLAR+
Sbjct: 107 VFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 94 LGHGGFGPVYRGLM--PNGQE--IAVKKL---SVDSRQGLREFTNEVKLLLKIQHKNLVT 146
LG G FG + RG + P+ +E +A+ L D ++ R F E L + H N+V
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHSNIVR 70
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L G G M+V EY+ N +LD F+ + L ++ G+A G+ YL E
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMG- 127
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFG 233
+H+ + A +L++ L KIS F
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 23/176 (13%)
Query: 62 EDADGSGADSWNL-FFDLR-----TLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIA 114
E+ DG+ W L FFD + T+ + + N + G G Y+G + NG +
Sbjct: 664 ENEDGT----WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 115 VKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI 173
VK+++ V+S ++E+ + K+QH N+V L G C L++EY+ K+L +
Sbjct: 720 VKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 174 FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
+L W R +I +G+A+ L +LH ++ ++ I++D + P +
Sbjct: 775 ------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 38/162 (23%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLVT 146
+G G +G V + +G+++A+KK+ +++ LRE +K+L +H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE----LKILRHFKHDNIIA 68
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD---YFIFDKTKS-------SSLDWTTRY-RIVMG-V 194
+ +L P + Y + D +S S T + R + +
Sbjct: 69 I--------RDIL----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
RGL Y+H A +IHRD+K SN+L++E +I DFG+AR
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-10
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 88 FSDLNQLGHGGFGPVY--RGLMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQH 141
+ + ++G G FG +Y + + EI + K+ V ++ + EV LL K++H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKH 58
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVAR 196
N+VT F E +V EY L I + ++ L W + ++
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISL 112
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLAR 236
GL ++H+ +I+HRDIK+ NI L + + K+ DFG+AR
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 94 LGHGGFGP--VYRGLMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG +YR + E+ + +LS R R+ NE+ +L +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNIIAY 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLD-----WTTRYRIVMGVARGLLYLH 202
+ + ++ EY +L Y + K + W ++IV V+ Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYL-FQIVSAVS----YIH 118
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+ I+HRDIK NI L + K+ DFG++++ E + T
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-10
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 25/161 (15%)
Query: 94 LGHGGFGPVYRGLMPN---------GQEIAV--KKLSVDSRQGLREFTNEVKLLLKIQHK 142
LG G F +Y+G++ GQE++V K L D R L F L+ ++ HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
+LV L+G C E ++V EY+ LD F+ + + SL W + + +A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 203 EEAPARIIHRDIKASNILL-----DEQLNP--KISDFGLAR 236
++ +++H ++ NIL+ +E P K+SD G+
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 86 NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
+ + ++G G G V + +G+ +AVKK+ + +Q NEV ++ QH+N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V ++ G E +V E+L +L D + ++ + + V + L LH +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGL 234
+IHRDIK+ +ILL K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
+ +LG G FG VY+ G A K + S + L ++ E+++L H +V L G
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
+ ++ E+ P ++D + + LD + + R +L YLH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHSM- 129
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA 235
+IIHRD+KA N+LL + K++DFG++
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 31/165 (18%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL--REFTNEVKLLLKIQHKNL 144
+ DL Q+G G +G V L G ++A+KKL + L + E++LL ++H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDKTKSSSLDWTTRYRI---V 191
+ L + P+ SLD F D K + + RI V
Sbjct: 77 IGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ +GL Y+H A IIHRD+K N+ ++E KI DFGLAR
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 93 QLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLV 145
+LG G FG VY +G++ + E V +V+ +RE F NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIF----DKTKSSSLDWTTRYRIVM---GVARGL 198
L G ++G +++ E + L ++ + + + +++ +A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
YL+ + +HRD+ A N ++ E KI DFG+ R
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 109 NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
+G+++AVK + + +Q NEV ++ QH+N+V ++ G E ++ E+L +
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
L D + L+ + V + L YLH + +IHRDIK+ +ILL K
Sbjct: 105 LT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVK 157
Query: 229 ISDFGL 234
+SDFG
Sbjct: 158 LSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-10
Identities = 36/139 (25%), Positives = 71/139 (51%), Gaps = 13/139 (9%)
Query: 113 IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY 171
+AVK L D+ + R +F E+K++ +++ N++ L C ++ EY+ N L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 172 FI--------FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223
F+ +K ++ ++T + +A G+ YL + +HRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 224 QLNPKISDFGLAR-LFPGE 241
KI+DFG++R L+ G+
Sbjct: 166 NYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-10
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 94 LGHGGFGPVYRGLM-PNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGFG V M G+ A KKL+ + R+G E ++L K+ + +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ LV + L Y I++ ++ + GL +LH+ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLA 235
II+RD+K N+LLD N +ISD GLA
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-10
Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
F + ++G G +G VY+ N G+ A+K + ++ + E+ ++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
FG + + E+ SL Y + S + + +R + +GL YLH +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA 235
+HRDIK +NILL + + K++DFG++
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQHKNL 144
+ L ++G G +G VY+ G+ +A+KK ++ +G+ E+ LL +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 145 VTLFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVAR 196
+ EK LV+EYL + L F+ + L T + + +
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLF 238
G+ + H+ ++HRD+K N+L+D+Q KI+D GL R F
Sbjct: 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-------RQGLREFTNEVKLLLKIQHK 142
L+++G G +G V++ GQ +A+KK V+S + LRE +++L +++H
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALRE----IRMLKQLKHP 60
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
NLV L + LV+EY + L+ +K + +I+ + + + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EK-NPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ IHRD+K NIL+ +Q K+ DFG AR+ G
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 43/148 (29%)
Query: 110 GQEIAVKKLSVDSRQGLREFTN---------EVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160
GQ +A+KKLS R F N E+ L+ + HKN++ L
Sbjct: 41 GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 161 YEYLPNKSLD-----YFIFDKTKSS-------SLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ P KSL+ Y + + ++ LD ++ + G+ +LH A
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AG 138
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLAR 236
IIHRD+K SNI++ KI DFGLAR
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 91 LNQLGHGGFGPVYRGLMPN---GQ---EIAVKKLSVDSRQGLRE---FTNEVKLLLKIQH 141
L +LG G FG VY G + G+ +AVK +V+ LRE F NE ++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVK--TVNESASLRERIEFLNEASVMKGFTC 68
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYRIVMG--V 194
++V L G ++G ++V E + + L ++ + T + I M +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
A G+ YL+ + + +HRD+ A N ++ KI DFG+ R
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
++ L Q+G G +G V + G+++A+KKLS + +++ RE T LL +Q
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT----LLKHMQ 72
Query: 141 HKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
H+N++ L F G E Y +P D K L +V + G
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L Y+H A IIHRD+K N+ ++E KI DFGLAR
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK-LSVDSRQGLREFTNEVKLLLKIQHKNL 144
F+ + +LG G FG VY+ +A K + S + L ++ E+ +L H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV-MGVARGLLYLHE 203
V L ++ E+ ++D + + + + + R+V L YLHE
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHE 121
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+IIHRD+KA NIL + K++DFG++
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+ + ++G G +G VY+ + G+ AVK + ++ E+ ++ + +H N+V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
FG + + EY SL Y + + + R + +GL YLH +
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA 235
+HRDIK +NILL + + K++DFG+A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +L +G G +G V Q++AVKKLS + +R+ RE ++LL ++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE----LRLLKHMK 72
Query: 141 HKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
H+N++ L F VY L + + + K L ++ + RG
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVY--LVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L Y+H A IIHRD+K SN+ ++E +I DFGLAR
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 6e-09
Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFT-NEVKLLLKIQHKNLVTLFG 149
LG G FG V +G+ A+K LS + E NE ++L I+H LV L+G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPA 207
+ LV EY+P L K+ Y ++V+ L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLA----LEYLHSLD-- 121
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLAR 236
I++RD+K N+LLD KI+DFG A+
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 31/165 (18%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNL 144
+ +L+ +G G +G V G +AVKKLS S + E++LL ++H+N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYR---------IV 191
+ L + P +SL D ++ + L+ + + ++
Sbjct: 79 IGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ RGL Y+H A IIHRD+K SN+ ++E KI DFGLAR
Sbjct: 127 YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 13/165 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
F L +LG G G V + L P+G +A K + ++ + +R + E+K+L + +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G E + E++ SLD + K+ + +I + V RGL YL E+
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTF 248
+I+HRD+K SNIL++ + K+ DFG++ G+ D+ N+F
Sbjct: 120 --KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 158
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 27/171 (15%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREF--------TNEVKLLLKIQHKNL 144
+LG G FG VY L+ + + +A ++L V + E E +LL K+ H +
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------LDWTTRYRIVMGVARG 197
V E ++ EY + LD + + + +W + +++GV
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ--LLLGVH-- 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
Y+H+ RI+HRD+KA NI L L KI DFG++RL G TF
Sbjct: 121 --YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTF 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 44/165 (26%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
F +++LG G G V++ P+G +A K + ++ + +R + E+++L + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G E + E++ SLD + K+ + ++ + V +GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTF 248
+I+HRD+K SNIL++ + K+ DFG++ G+ D+ N+F
Sbjct: 124 --KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 162
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 45/152 (29%), Positives = 61/152 (40%), Gaps = 13/152 (8%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-----KNL 144
L + G FG VY G A+K L + TN VK I +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYV 59
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
L+ LV EYL I DW +Y + V G+ LH+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
IIHRDIK N+L+D+ + K++DFGL+R
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
+ L Y+H +IHRD+K SNILL+ K++DFGLAR
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 94 LGHGGFGPVYRG----LMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
LG G F +++G + G+ E+ +K L R F ++ ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G C G E ++V EY+ SLD ++ K + ++ + + + +A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 206 PARIIHRDIKASNILL-----DEQLNP---KISDFGLA 235
+ H ++ A N+LL + NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 94 LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGFG V + G+ A KKL + R+G NE ++L K+ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
LV + L + I++ + D + GL L E RI
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
++RD+K NILLD++ + +ISD GLA P +T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGFG V + N G+ A KKL + + G + E ++L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
LV + L Y I++ L+ + G+L+LH I
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPG 240
++RD+K N+LLD+Q N ++SD GLA
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 88 FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F LG GGFG V + G+ A KKL + R+G NE ++L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLY 200
+V+L LV + L + I+ ++ R V A GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLED 117
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
LH+E RI++RD+K NILLD+ + +ISD GLA P T
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 36/120 (30%), Positives = 51/120 (42%), Gaps = 7/120 (5%)
Query: 116 KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175
KK+ V + G + E+ +L I H+ ++ L +V +P D F +
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV 176
Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+S L I + L YLH IIHRD+K NI LDE N + DFG A
Sbjct: 177 D-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSV------DSRQGLREFTNEVKLLLKIQHKNLV 145
++G G F VYR + + + +A+KK+ + +RQ + E+ LL ++ H N++
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVI 65
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
E E +V E L I + K + + T ++ + + + ++H
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
R++HRDIK +N+ + K+ D GL R F + T
Sbjct: 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 92 NQLGHGGFGPVYRGLMPN-GQEIAVKKLSV--------DSRQGLRE----FT--NEVKLL 136
LG G +G V + G+ +A+KK+ + RQ + FT E+K++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
+I+H+N++ L EG LV + + L + K + L + I++ +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTESQVKCILLQILN 130
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
GL LH+ +HRD+ +NI ++ + KI+DFGLAR +
Sbjct: 131 GLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 110 GQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKML-VYEYLP 165
G E+A+K L D+ + + F E L ++ H N+V L P + V+EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---D 222
++L + +L R+++ V L H + I+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 223 EQLNPKISDFGLARLFPG 240
+ + K+ DFG+ L PG
Sbjct: 117 VRPHAKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 37/172 (21%)
Query: 94 LGHGGFGPVYR-GLMPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
LG GGFG V + + A+K + V++ Q +E ++L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKL- 58
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL-----------DWTTRYRIVMGVARG 197
Y +K Y + + L ++T R+ + V
Sbjct: 59 ------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLA 105
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTF 248
YLH II+RD+K N+LLD K+ DFG A+ L G+ T TF
Sbjct: 106 FEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TF 152
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 15/162 (9%)
Query: 94 LGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLL-LKIQHKNLVTLF 148
LG G FG V + E+ +KK + + E ++L L +H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 149 GCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHEEAP 206
C + +++ V EY+ L + I + R R + GL +LHE
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHERG- 116
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
II+RD+K N+LLD + + KI+DFG+ + +TF
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLF 148
LG G FG V + +G+ AVK L D + E T K +L + H L L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
CC + P+++ V E++ L +F KS D + L++LH++
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLAR 236
II+RD+K N+LLD + + K++DFG+ +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-08
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 91 LNQLGHGGFGPVYRGLM----PNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLV 145
L +G G FG R L+ + Q+ A+K++ + S + + E LL K++H N+V
Sbjct: 5 LRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLLY 200
+V EY L I + + + L W + + +GV +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ----H 115
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
+HE+ R++HRDIK+ NI L + K+ DFG ARL + T+ + PP +
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 94 LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGFG V + G+ A KKL + R+G NE ++L K+ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLYLHEEAP 206
LV + L + I++ R V A GL LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCGLEDLHRE-- 121
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
RI++RD+K NILLD+ + +ISD GLA P +T
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 52/172 (30%), Positives = 69/172 (40%), Gaps = 22/172 (12%)
Query: 88 FSDLNQLGHGGFGPV----YRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLL--- 137
F L LG G FG V Y+ G+ A+K L +R + E ++
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VAR 196
+H LV LF C V EY L I S R V
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVL 112
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
GL YLHE +I++RD+K N+LLD + KI+DFGL + G +TF
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF 161
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 16/147 (10%)
Query: 97 GGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTN---EVKLLLKIQHKNLVTLFGCCA 152
G +G V+ + G A+K + + E +L + Q +V L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 153 EGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARI 209
+G + + LV EYLP L + + S D Y IV+ L YLH I
Sbjct: 63 QGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLA----LEYLHSNG---I 114
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
IHRD+K NIL+D + K++DFGL++
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 7/150 (4%)
Query: 88 FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
F +++LG G G V + P+G +A K + ++ + +R + E+++L + +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G E + E++ SLD + ++ + ++ + V RGL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA 235
+I+HRD+K SNIL++ + K+ DFG++
Sbjct: 124 --QIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSV----DSRQGLREFTNEVKLLLKIQHK 142
F ++G G F VYR + +G +A+KK+ + D++ + E+ LL ++ H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHP 62
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIVMGVARGLLYL 201
N++ + E E +V E L I K L T ++ + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
H R++HRDIK +N+ + K+ D GL R F + T ++
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 14/163 (8%)
Query: 88 FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F LG GGFG V + G+ A K+L + R+G NE ++L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLY 200
+V L LV + L + I++ R + A GL
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLED 117
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
LH E ++RD+K NILLD+ + +ISD GLA P ++
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 44/166 (26%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK-----NL 144
L ++G G G VY+ G +AVK++ R G +E + + L + K +
Sbjct: 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 145 VTLFGC---------CAE----GPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
V +G C E +K+L + +P I K
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE-----DILGK------------- 118
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ + + + L YL E+ +IHRD+K SNILLD N K+ DFG++
Sbjct: 119 MTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-07
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNG--------QEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
+ + ++G G FG L+ + +EI + K+S R+ R+ EV +L +
Sbjct: 2 YVKVKKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNM 56
Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS------LDWTTRYRIVMG 193
+H N+V E +V +Y L Y + + LDW +
Sbjct: 57 KHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ 109
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
+ L ++H+ +I+HRDIK+ NI L + K+ DFG+AR+
Sbjct: 110 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F L Q+G GG+G V+ + EI A+K++ + +R E +L + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
LV L + L EY+P + + S D Y M A + LHE
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEA--VDALHE 119
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
IHRD+K N L+D + K++DFGL+
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 36/178 (20%)
Query: 80 TLQVATNFFS------DLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFT 130
++QVA + F+ L +G G G V G +AVKKLS ++ +
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 68
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFDKTKSS----- 180
E+ LL + HKN+++L + P KSL+ Y + + ++
Sbjct: 69 RELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVI 116
Query: 181 --SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
LD ++ + G+ +LH A IIHRD+K SNI++ KI DFGLAR
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 46/239 (19%)
Query: 13 ILDDQNHQHHHNHNHNL-----SVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGS 67
I +++NH+ + + +DE H + G E D D +
Sbjct: 12 IYEEKNHKANKGGSGKFEMNDKKLDEEERSH----------NNNAGEDEDEEKMIDNDIN 61
Query: 68 GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL 126
+ + ++ ++ N +G+G FG VY + + +++A+KK+ D +
Sbjct: 62 RSPN-------KSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN 107
Query: 127 REFTNEVKLLLKIQHKNLVTL----FGCCAEGPEKML----VYEYLPNKSLDYFIFDKTK 178
RE ++ + H N++ L + C + EK + V E++P Y
Sbjct: 108 RELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR 236
+ +L + R L Y+H + I HRD+K N+L+D + K+ DFG A+
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 94 LGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQGLRE------FTNEVKLLLKIQHKNLVT 146
LG G FG V + E+ A+K L D L++ T + L L +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 147 LFGCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHEE 204
L CC + +++ V EY+ L +F +S D R R V L++LH
Sbjct: 61 LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRH 115
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+I+RD+K NILLD + + K++DFG+ +
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 24/171 (14%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQE----IAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
L LG GG+G V++ G + A+K L V +++ E +L ++H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARGLL 199
+V L G + L+ EYL L F+ + + ++ T + I + L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA----LE 114
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTF 248
+LH++ II+RD+K NILLD Q + K++DFGL + + G TH TF
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH--TF 160
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 93 QLGHGGFGPVYRG-LMP----------NGQEIAV--KKLSVDSRQGLREFTNEVKLLLKI 139
LG G +Y G L +EI V K L R F ++ ++
Sbjct: 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61
Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
HK++V L+G C E ++V E++ LD F+ K+ + W ++++ +A L
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119
Query: 200 YLHEEAPARIIHRDIKASNILL-----DEQLNP--KISDFGL 234
YL ++ ++H ++ NILL D + P K+SD G+
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 91 LNQLGHGGFGPV----YRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
+ +G G +G V +R G++ +KKL++ SR+ + E +LL +++H N+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 145 VTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
V + EG + +L V + L Y + K L + +A L YLH
Sbjct: 62 VA-YRESWEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
E+ I+HRD+K N+ L K+ D G+AR+
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 24/43 (55%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ +L A + IHRD+ A NILL E KI DFGLAR
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 27/163 (16%)
Query: 91 LNQLGHGGFGPV----YRGLMPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +LG G +G V + +A+KK++ + +++ LRE +KLL +
Sbjct: 5 IKELGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRE----LKLLRHFR 59
Query: 141 -HKNLVTLFGCCAEGPEK---MLVYEYLPNKSLDYFIFDKTKSSSLDWTT-RYRIVMGVA 195
HKN+ L+ P + +YE L L I + + + Y+I+
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL---- 115
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
GL Y+H A ++HRD+K N+L++ KI DFGLAR F
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 21/52 (40%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDT 243
+A GL +LH + II+RD+K N++LD + + KI+DFG+ + +F G+ T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 22/159 (13%)
Query: 88 FSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHK 142
+ +G G FG V+ R + + A+K +++ L++ NE ++L ++ H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 143 NLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARG 197
++ LF E ++ L + EY+P L F + + + T + IV
Sbjct: 62 FIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCA---- 113
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L YLH + I++RD+K NILLD++ + K++DFG A+
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 88 FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
+ +L +G G G V Y ++ + +A+KKLS ++ + E+ L+ + HK
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
N+++L P+K L E + L + D + LD ++ + G+
Sbjct: 77 NIISLLNVFT--PQKSL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+LH A IIHRD+K SNI++ KI DFGLAR
Sbjct: 133 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 24/43 (55%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ +L A + IHRD+ A NILL E KI DFGLAR
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 88 FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
+ +L +G G G V Y ++ + +A+KKLS ++ + E+ L+ + HK
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFD----KTKSSSLDWTTRYRI 190
N++ L + P KSL+ F + D + LD +
Sbjct: 84 NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ + G+ +LH A IIHRD+K SNI++ KI DFGLAR
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 31/141 (21%), Positives = 55/141 (39%), Gaps = 7/141 (4%)
Query: 94 LGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
+ + P +AVKK+++D S++ L+ E+ ++QH N++
Sbjct: 10 FEDLMIVHLAKH-KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
E +V + S + + L I+ V L Y+H + IH
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIH 124
Query: 212 RDIKASNILLDEQLNPKISDF 232
R +KAS+ILL +S
Sbjct: 125 RSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 88 FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
F L LG G +G V+ G G+ A+K K ++ + E T + +L+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 141 HKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARG 197
+ LVTL + L+ +Y+ L F + R+ + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGEL----FTHLYQREHFTESEVRVYIAEIVLA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTF 248
L +LH+ II+RDIK NILLD + + ++DFGL++ F E+ +F
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 12/117 (10%)
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIV 191
L L +H L LF C + E + V EYL L + I + Y I+
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-EARARFYAAEII 106
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
G L +LH++ II+RD+K N+LLD+ + KI+DFG+ + + +TF
Sbjct: 107 CG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 52/166 (31%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLF 148
LG G FG V+ L Q A+K L D E T K +L + +H L L+
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFI-----FDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
C + E + V EYL L + I FD ++ T Y + GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA------TFY--AAEIICGLQFLH 113
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ I++RD+K NILLD + KI+DFG+ + D TF
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG--LREFT-NEVKLLLKIQHK 142
N F L +G G +G V + +EI K DS + ++E T E+K+L ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N+V L + LV+EY+ L+ + ++ + R I + + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ I+HRDIK N+L+ K+ DFG AR
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 2/57 (3%)
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDICQ 266
IHRDIK N+LLD + + K+SDFGL + +H F + P+ I +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDFISK 177
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 50/161 (31%), Positives = 73/161 (45%), Gaps = 30/161 (18%)
Query: 91 LNQLGHGGFGPVY--RGLMP--NGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
L LG G FG V+ R + GQ A+K K ++ R +R E +L ++ H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPF 59
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL-LYLH 202
+V L Y + L Y I D + L +T + VM + YL
Sbjct: 60 IVKLH------------YAFQTEGKL-YLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLA 105
Query: 203 EEAPAR-------IIHRDIKASNILLDEQLNPKISDFGLAR 236
E A A II+RD+K NILLDE+ + K++DFGL++
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 10/165 (6%)
Query: 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
L +L T+ + + +G G +G VY+ +A K+ E E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 138 KI-QHKNLVTLFGCCAE-----GPEKMLVYEYLPNKSLDYFIFDKTK-SSSLDWTTRYRI 190
+ H N+V +G + G + LV E S+ + LD I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ G GL +LH RIIHRD+K +NILL + K+ DFG++
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 20/153 (13%)
Query: 93 QLGHGGFGPVYRGLM---PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
++G+G FG V + + VK+L + S + EF + +QH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR-------YRIVMGVARGLLYL 201
G C E +LV+EY L K+ S W R R+ +A G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
H+ +H D+ N L L K+ D+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VA+G+ +L A + IHRD+ A NILL E KI DFGLAR
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
YLH + II+RD+K N+LLD + + K++DFG A+ P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 45/154 (29%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHKN- 143
F+ L LG G FG V E+ A+K L D + E T K +L +Q K
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 144 -LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
L L C V EY+ L Y I + ++ GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
II+RD+K N++LD + + KI+DFG+ +
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
F + + G FG VY G N ++ VKK + ++ + + E L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 144 LVTLFGCCAEGPEKMLVYEYLPN---KSL--DYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
+V L+ LV EYL KSL Y FD+ + +Y + VA L
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKY--ISEVALAL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
YLH IIHRD+K N+L+ + + K++DFGL+++
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 51/163 (31%), Positives = 72/163 (44%), Gaps = 17/163 (10%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKN-LVTLFG 149
LG G FG V L G+ AVK L D E T K +L + +N +T
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 150 CCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLYLHEEA 205
C + E + V E+L L + I DK + YR A GL +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD------LYRATFYAAEIVCGLQFLHSKG 116
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
II+RD+K N++LD + KI+DFG+ + D +TF
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 20/41 (48%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
R L Y+H A + HRD+K NIL + KI DFGLAR
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 39/120 (32%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 123 RQGLREFT-NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF--DKTKS 179
+ G R T E +L I H +++ L G L+ LP D + + K
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI 179
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ D R V+ R + YLHE RIIHRDIKA NI ++ + + DFG A FP
Sbjct: 180 AICDILAIERSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFP 232
|
Length = 391 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 23/144 (15%)
Query: 108 PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE---YL 164
P + + K++ SR + + NE+ L ++ H+N++ + E++L E Y+
Sbjct: 190 PKCERLIAKRVKAGSRAAI-QLENEILALGRLNHENILKI--------EEILRSEANTYM 240
Query: 165 PNKSLDY----FIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217
+ D+ F++D+ K L TR I+ + + Y+H++ ++IHRDIK
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLE 296
Query: 218 NILLDEQLNPKISDFGLARLFPGE 241
NI L+ + DFG A F E
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKE 320
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 26/62 (41%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
D S LD R VA+G+ +L A IHRD+ A N+LL + KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 235 AR 236
AR
Sbjct: 259 AR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-05
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 27/156 (17%)
Query: 94 LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK--------LLLKIQHKNLV 145
+G G FG V L + + + V ++ + + E K LL ++H LV
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLV 59
Query: 146 TL---FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLY 200
L F + +K+ V +Y+ L +F + +S R R +A L Y
Sbjct: 60 GLHYSF----QTADKLYFVLDYVNGGEL-FFHLQRERSFP---EPRARFYAAEIASALGY 111
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
LH II+RD+K NILLD Q + ++DFGL +
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 14/110 (12%)
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
+E +LL ++ H ++ L G LV LP D + + + L
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ--- 261
Query: 190 IVMGVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
V VAR LL Y+H E IIHRDIK N+L++ + + DFG A
Sbjct: 262 -VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 30/160 (18%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQ-HKNLVT 146
L ++G G F V + G+ A+K + + L + N E++ L ++ H N++
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 147 LFGCCAEGPEK----------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
L + M +YE + + + KS Y+++ +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKS------YMYQLL----K 111
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L ++H I HRDIK NIL+ K++DFG R
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 22/43 (51%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VA+G+ +L A IHRD+ A NILL KI DFGLAR
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 94 LGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
+G G FG V + + Q I ++K + SR + E +L ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ PEK+ LV ++ L + + + D +R R A L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFD-LSRARFY--TAELLCALENLHKFN 113
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+I+RD+K NILLD Q + + DFGL +L +D NTF
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 15/153 (9%)
Query: 89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT-- 146
S + L G VY L ++ +K + RE EV +L + K L
Sbjct: 1 SSIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+ L+ E++ ++LD + S + + A L LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQL---AELLAKLHQLPL 107
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ H D+ NIL+D+ I D+ A P
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 25/168 (14%)
Query: 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNE 132
+R LQ+ + + +G G FG V + Q++ KL + R F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSL-----DYFIFDKTKSSSLDWT 185
++ +V LF CA +K L V EY+P L +Y + +K W
Sbjct: 94 RDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-------WA 144
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
Y A +L L +IHRD+K N+LLD+ + K++DFG
Sbjct: 145 KFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
++G G +G VY+ +G++ L G+ E+ LL +++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 152 AEGPEKM--LVYEYLPNKSLDYFIFDKT-----KSSSLDWTTRYRIVMGVARGLLYLHEE 204
++ L+++Y + F + K L + ++ + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 205 APARIIHRDIKASNILL----DEQLNPKISDFGLARLF 238
++HRD+K +NIL+ E+ KI+D G ARLF
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
++G G +G VY+ +G++ L G+ E+ LL +++H N+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 152 AEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY-----LHEE 204
++ L+++Y + F + ++ ++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 205 APARIIHRDIKASNILL----DEQLNPKISDFGLARLF 238
++HRD+K +NIL+ E+ KI+D G ARLF
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 109 NGQEIAV--KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
NG+E+ V K L R F L+ ++ H +L + G C G E ++V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221
LD + + + W + + +A L YL ++ ++H ++ A NILL
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H LV L C V EY+ L +F + L ++ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDT 243
LHE II+RD+K N+LLD + + K++D+G+ + L PG+ T
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQ--EIAVK---KLSVDSRQGLREFTNEVKLLLKIQHK 142
F+ + LG G FG V N +A+K K + ++ + +E K+L I H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVARGLLYL 201
V L+G + LV E++ ++F F + K D Y A+ +L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFY-----AAQIVLIF 144
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
I++RD+K N+LLD+ K++DFG A++
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 10/151 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L +G G FG V + G A+K K + ++ + E +L++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V +F + L+ E+LP + + K D T +A +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDS 116
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGL 234
IHRDIK N+LLD + + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 25/168 (14%)
Query: 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS---RQGLREFTNE 132
+ L++ F + +G G FG V + +++ A+K LS R F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSL-----DYFIFDKTKSSSLDWT 185
++ + +V L A +K L V EY+P L +Y I +K W
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-------WA 144
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
Y V L +H IHRD+K N+LLD+ + K++DFG
Sbjct: 145 RFY--TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 17/29 (58%), Positives = 21/29 (72%)
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLF 238
IHRDIK NIL+D + K+SDFGL+ F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 18/43 (41%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+A GL +LH + II+RD+K N++LD + + KI+DFG+ +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 45/155 (29%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 94 LGHGGFGPVYRGLMP-NGQEIAVKKLS---VDSRQGLREFTNEVKLLLK-IQHKNLVTLF 148
+G G FG V +G+ AVK L V +R+ + E +LLK ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA- 207
Y + + L YF+ D L + + R Y E A A
Sbjct: 63 ------------YSFQTTEKL-YFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASAL 109
Query: 208 ------RIIHRDIKASNILLDEQLNPKISDFGLAR 236
I++RD+K NILLD Q + ++DFGL +
Sbjct: 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 210 IHRDIKASNILLDEQLNPKISDFGLA 235
IHRDIK NIL+D + K++DFGL
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 94 LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG V +G+ A+K L + ++ + E ++L +H L +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
V EY+ L +F + + S D T Y + L YLH +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALDYLHS---GKI 116
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
++RD+K N++LD+ + KI+DFGL +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 17/41 (41%), Positives = 26/41 (63%)
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
LL +H +IHRDIK++NILL K+ DFG ++++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+G G +G V++ L NG + AVK L D + + N +K L H N+V +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL--SDHPNVVKFYGM 83
Query: 151 -----CAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
G + LV E S+ + F K + Y I+ GL +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALMGLQHLHV 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ IHRD+K +NILL + K+ DFG++
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 17/145 (11%)
Query: 102 VYRGLMPNGQEIAV---KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG----CCAEG 154
+Y+G+ N +E+ + KK + + NE+K L +I N++ ++G +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL--LYLHEEAPARIIHR 212
P L+ EY L + DK K L + T+ + + +GL LY + P ++
Sbjct: 95 PRLSLILEYCTRGYLREVL-DKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP----YK 147
Query: 213 DIKASNILLDEQLNPKISDFGLARL 237
++ + + L+ E KI GL ++
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 10/151 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L +G G FG V + I ++K + ++ + E +L++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V +F + L+ E+LP + + K D + +A +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDA 116
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGL 234
IHRDIK N+LLD + + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 94 LGHGGFGPVYRGLMPNGQEI-AVK---KLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLF 148
+G G FG V ++ AVK K ++ ++ + +E +LLK ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ V +Y+ L Y + + + L+ R+ +A L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLAR 236
I++RD+K NILLD Q + ++DFGL +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVKKLSVD-SRQGL--REFTNEVKLLLKIQHKNLVTLFG 149
+G GG G VY P + +A+KK+ D S L + F E K+ + H +V ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 150 CCAEGPEKMLVYEYLPN------KSLDYFIFDK-TKSSSLDWTTR----YRIVMGVARGL 198
C++G VY +P KSL ++ K + S L T I + +
Sbjct: 70 ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
Y+H + ++HRD+K NILL I D+G A E+
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 16/39 (41%), Positives = 26/39 (66%), Gaps = 3/39 (7%)
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
L YLH +++RD+K N++LD+ + KI+DFGL +
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 12/122 (9%)
Query: 108 PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165
P G + V+ ++ + + L+ NEV L +H N++T + G ++ ++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 166 NKSLDYFI---FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222
S + + F + S +L I+ G RGL YLH+ IHR+IKAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 223 EQ 224
Sbjct: 136 GD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 22/55 (40%), Positives = 31/55 (56%), Gaps = 3/55 (5%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
VA + YLH II+RD+K NILLD Q + ++DFGL + + +TF
Sbjct: 105 VASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ +L A +HRD+ A N+LL + KI DFGLAR
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 8/102 (7%)
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
LV L C LV EY+ L +F + L + L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDT 243
II+RD+K N+LLD + K++D+G+ + L PG+ T
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 20/48 (41%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
GL ++H +++RD+K +NILLDE + +ISD GLA F + H
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 20/50 (40%), Positives = 31/50 (62%), Gaps = 3/50 (6%)
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
GL ++H +++RD+K +NILLDE + +ISD GLA F + H +
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 28/78 (35%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 94 LGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
LG G FG V G N +AVK L + RE +E+K+L + QHKN+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 146 TLFGCCAEGPEKMLVYEY 163
L G C G +++ EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 11/80 (13%)
Query: 94 LGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKI-QHKNLV 145
LG G FG V + + + +AVK L + + E+K+L+ I H N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 146 TLFGCCA--EGPEKMLVYEY 163
L G C GP M++ EY
Sbjct: 75 NLLGACTKPGGP-LMVIVEY 93
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 19/48 (39%), Positives = 32/48 (66%), Gaps = 5/48 (10%)
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDT 243
L +LHE II+RD+K N+LLD + + K++D+G+ + + PG+ T
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.004
Identities = 15/25 (60%), Positives = 19/25 (76%)
Query: 210 IHRDIKASNILLDEQLNPKISDFGL 234
IHRDIK NIL+D + K++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ L YLH E +++RD+K N++LD+ + KI+DFGL +
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.83 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.71 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.71 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.47 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.41 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.31 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.6 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.07 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.78 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.39 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.38 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.11 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.96 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.54 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.32 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.31 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.23 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.91 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.5 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.34 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.29 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 95.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.21 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.86 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.24 Aligned_cols=172 Identities=30% Similarity=0.474 Sum_probs=154.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|...+.||.|+||+||+|+ ..++..||||.+... .....+-+..|+.+|+.++|||||+++++...++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3568889999999999999999 557899999999876 5666677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC------CCeEEeccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ------LNPKISDFGLA 235 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~------~~~kl~DFG~a 235 (266)
|||.||+|.++++.+ +.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999543 47999999999999999999999999 9999999999999775 35899999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|.+. ......+.+|++.|||||+++.+
T Consensus 163 R~L~-~~~~a~tlcGSplYMAPEV~~~~ 189 (429)
T KOG0595|consen 163 RFLQ-PGSMAETLCGSPLYMAPEVIMSQ 189 (429)
T ss_pred hhCC-chhHHHHhhCCccccCHHHHHhc
Confidence 9886 45567788999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=293.61 Aligned_cols=173 Identities=27% Similarity=0.386 Sum_probs=153.7
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh-------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||++.+... .....+.+|+++|++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678899999999999999998 66899999999976421 12344679999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC---CCeEEecc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDF 232 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~---~~~kl~DF 232 (266)
..||||||++||+|.+.+ ..+..+.+...+.+++|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999988 34566788888999999999999999999 9999999999999776 77999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|+|+... ..+.+.|+|||+.|.|||++...
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~k 353 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASK 353 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecC
Confidence 9999876 67788999999999999999764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=286.93 Aligned_cols=175 Identities=28% Similarity=0.369 Sum_probs=160.1
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++++.||+|+||+||.++ ..+++.||+|.+++. .....+....|..||.+++||+||.++..|++++.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34679999999999999999999 567999999999866 33446778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|+||+.||.|...| ...+.+++..++.++..|+.||.|||++| ||||||||+|||+|.+|.++|+|||+|+...
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999888 44567999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.....+.+++||+.|+|||++..+.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred cCCCccccccCCccccChHHHhcCC
Confidence 7777888999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=274.87 Aligned_cols=173 Identities=29% Similarity=0.411 Sum_probs=154.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-EEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-KMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~ 161 (266)
.++.+.+..||+|+.|+||+|+ ..+++.+|+|.+..+ .....+++.+|+++++..+||+||.+||.|..++. +.|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3456678899999999999999 668999999999655 44556789999999999999999999999999995 99999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||.+|+|+.++. ..+++++...-.|+.++++||.|||. .+ ||||||||+|||++..|.|||||||.++.+.+
T Consensus 158 EYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999983 33679999999999999999999996 65 99999999999999999999999999998865
Q ss_pred CCceeeeeeEEeeeeCCCccccCCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
. ..+++.||..|||||-+.++.+
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Y 254 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESY 254 (364)
T ss_pred h--hcccccccccccChhhhcCCcC
Confidence 4 6689999999999999988753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=288.94 Aligned_cols=171 Identities=26% Similarity=0.383 Sum_probs=158.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..|+..+.||+|+|+.||.++. .+|+.||+|++.+. .....+.+.+|++|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4599999999999999999995 89999999999864 3445578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|+|..++|..++. ....+++.+++.++.||+.||.|||+.+ |||||||..|+|++++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 4567999999999999999999999998 999999999999999999999999999999888
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..+-.|.+|||-|.|||++..
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k 192 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNK 192 (592)
T ss_pred ccccceecCCCcccChhHhcc
Confidence 777889999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=281.71 Aligned_cols=189 Identities=51% Similarity=0.821 Sum_probs=165.3
Q ss_pred CccccchhhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEE
Q 024537 72 WNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151 (266)
Q Consensus 72 ~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 151 (266)
....|.+.++..++++|.....||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 44568999999999999999999999999999999888899999988765443135599999999999999999999999
Q ss_pred eeCCc-EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 152 AEGPE-KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 152 ~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
.+.+. .+||+||+++|+|.+.|+..... .++|..+++|+.++|.||+|||...+++||||||||+|||+|++++.||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999654433 88999999999999999999999887789999999999999999999999
Q ss_pred cccccccCCCCCceeeee-eEEeeeeCCCccc
Q 024537 231 DFGLARLFPGEDTHVNTF-RISVVTWPPNMHC 261 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~-~~t~~y~aPE~~~ 261 (266)
|||+|+..+.......+. .||..|.+||++.
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhc
Confidence 999997765413333333 7999999999885
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=274.14 Aligned_cols=180 Identities=25% Similarity=0.410 Sum_probs=159.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEe-EEeeCCc-EEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG-CCAEGPE-KML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~l 159 (266)
..+|+++++||+|+||+||++. ..+|..||.|.+... .......+..|+.+|++|+|||||++++ .|.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4569999999999999999998 779999999998865 4555678899999999999999999999 5666555 799
Q ss_pred EEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 160 VYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAP-ARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~-~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
|||+|.+|+|..++.. +...+.+++..+++++.|++.||..+|++-+ .-|+||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999865 3345679999999999999999999999431 1289999999999999999999999999999
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.+..+...++.|||.||+||.+....
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~ 204 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESG 204 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCC
Confidence 999999999999999999999987654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=264.35 Aligned_cols=172 Identities=28% Similarity=0.373 Sum_probs=156.0
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|+.++.||.|+||.|-+++ ..+|..||+|++.+.. ....+...+|..+|+.+.||+++++++.+.+.+.++|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34679999999999999999999 6689999999998763 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||++||.|.++++ +.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus 122 vmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999993 4567999999999999999999999999 9999999999999999999999999999985
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+. +.+.||||.|.|||++....
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ 217 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKG 217 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCC
Confidence 43 67889999999999997654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=266.04 Aligned_cols=172 Identities=23% Similarity=0.377 Sum_probs=151.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+.|+.+.++|+|+||+||+|+ ..+|+.||||++.-+.. ...+-.++|+.+|+++.|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999 66899999999875533 234556799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
||+..-|.++- .....++...+..|++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+..+.
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99766565443 33457899999999999999999999998 9999999999999999999999999999998676
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.....+..|.+|+|||++-++
T Consensus 156 d~YTDYVATRWYRaPELLvGD 176 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGD 176 (396)
T ss_pred chhhhhhhhhhccChhhhccc
Confidence 667778899999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=275.41 Aligned_cols=174 Identities=26% Similarity=0.452 Sum_probs=150.4
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 158 (266)
..+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.||++|.||||+++.+...+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34568999999999999999999 6789999999998764 33344567899999999999999999998877 6899
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
||+|||+. +|.-++. ...-.|++.+++.|+.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999965 6666662 34567999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCce-eeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTH-VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~-~~~~~~t~~y~aPE~~~~e 263 (266)
...... +.....|.+|+|||++.++
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCC
Confidence 655433 4455789999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.73 Aligned_cols=175 Identities=34% Similarity=0.561 Sum_probs=149.5
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-cEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e 162 (266)
+...+.+.||.|+||+||+|.|.....||||++..... ...+.|.+|+.+|.+++|||||+++|++.++. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 33455667999999999999995444499999976532 22568999999999999999999999999988 7999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGE 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~~~ 241 (266)
|+++|+|..++... ....+++..++.|+.||+.||+|||++++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999654 45789999999999999999999999974 99999999999999998 9999999999877543
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
........||..|+|||++..+
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~ 219 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGE 219 (362)
T ss_pred cccccCCCCCccccChhhhcCC
Confidence 2223336899999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.91 Aligned_cols=178 Identities=29% Similarity=0.371 Sum_probs=156.8
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.....+|.+++.||+|+|++|++|+ ..+++.||||++.+. .......+..|-.+|.+| .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4556789999999999999999999 668999999998765 223345577899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+|+|+||+++|+|.+++. +.+.+++..++.++.+|+.||+|||++| ||||||||+|||+|.+|.+||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999994 3467999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCc-------------eeeeeeEEeeeeCCCccccCCC
Q 024537 237 LFPGEDT-------------HVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 237 ~~~~~~~-------------~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.+.+... ...+|.||..|.+||++...+|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~ 264 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA 264 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC
Confidence 8853221 1256999999999999988775
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=253.17 Aligned_cols=171 Identities=27% Similarity=0.465 Sum_probs=151.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh--hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|..++.||+|.||+||+|+ ..+|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999999 678999999999876332 23467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+ ..+|...++ .+...++...++.|+.+++.||+|||++. |+||||||.|+|++.+|.+||+|||+|+.+.++.
T Consensus 82 fm-~tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 568988884 44567999999999999999999999999 9999999999999999999999999999998776
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
........|.+|+|||++-+
T Consensus 156 ~~~~~~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFG 175 (318)
T ss_pred cccccceeeeeccChHHhcc
Confidence 55554578999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.26 Aligned_cols=175 Identities=27% Similarity=0.392 Sum_probs=155.5
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc----Ch-hhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCc
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD----SR-QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPE 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 156 (266)
..+.|.+.+.||+|+||+|+.|. ..++..||+|++... .. ...+.+.+|+.+++.+. ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35679999999999999999998 557899999977654 11 22345668999999999 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEeccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLA 235 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~a 235 (266)
+++||||+.||+|.+.+.. ..++.+..+..++.|++.|++|||++| |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999944 467888999999999999999999999 9999999999999999 99999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
...........+++||+.|+|||++.+..
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~ 197 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKG 197 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCC
Confidence 98855566778899999999999998854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=263.26 Aligned_cols=173 Identities=25% Similarity=0.440 Sum_probs=157.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+|++.+.||+|.||.|-+|. ...|+.||||.++++ ...+.-.+.+|++||..|+||||+.+|.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 469999999999999999998 468999999999866 4455667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||..+|.|++++.+ .+.+++.+++.+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 99999999999944 467999999999999999999999998 99999999999999999999999999998754
Q ss_pred CceeeeeeEEeeeeCCCccccCCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.....+|+|++-|++||++.+-++
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY 229 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPY 229 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCC
Confidence 557789999999999999987664
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=270.72 Aligned_cols=178 Identities=27% Similarity=0.353 Sum_probs=160.2
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCC
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP 155 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 155 (266)
..+..++|.++++||+|+||+|++|. ..+++.||||.+++. ...+.+....|..|+.... ||.++.++..|++++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 45667889999999999999999999 668899999999876 4566788889999988875 999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
++|+||||+.||++... .....+++..+..|+..|+.||.|||++| ||+||||.+|||+|.+|.+||+|||+|
T Consensus 443 ~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999999995332 34467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
+........++|++||+.|+|||++..+.+
T Consensus 516 Ke~m~~g~~TsTfCGTpey~aPEil~e~~Y 545 (694)
T KOG0694|consen 516 KEGMGQGDRTSTFCGTPEFLAPEVLTEQSY 545 (694)
T ss_pred cccCCCCCccccccCChhhcChhhhccCcc
Confidence 988767778899999999999999987653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=252.06 Aligned_cols=172 Identities=26% Similarity=0.398 Sum_probs=150.3
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhh--HHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG--LREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 159 (266)
.+.|+.+..|++|+||.||+|+ ..+++.||+|+++...... --..++||.+|.+++|||||.+..+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3569999999999999999999 6689999999998764321 12346899999999999999999988654 67999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||+ -+|..++..- ..++...+++.++.|++.|++|||+++ |+||||||+|+|++..|.+||+|||+||.++
T Consensus 155 VMe~~E-hDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHH-hhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999995 5888888432 367999999999999999999999999 9999999999999999999999999999999
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
++.........|.+|+|||++-+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG 251 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLG 251 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcC
Confidence 88777777889999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=268.83 Aligned_cols=173 Identities=25% Similarity=0.414 Sum_probs=157.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|.+.+.||+|+||+||+|+ +.+.+.||+|.+.+. ..+.++.+.+|++|++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568889999999999999998 668999999998765 45567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+.| +|..++. ....++++.+..++.+++.||.|||+++ |+|||+||.|||++..|.+|+||||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999983 4467999999999999999999999998 9999999999999999999999999999987766
Q ss_pred ceeeeeeEEeeeeCCCccccCCC
Q 024537 243 THVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.......|||.|+|||++..+++
T Consensus 155 ~vltsikGtPlYmAPElv~e~py 177 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPY 177 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCc
Confidence 66777799999999999987764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=266.99 Aligned_cols=174 Identities=25% Similarity=0.361 Sum_probs=151.2
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhh-HHHHHHHHHHHHhcC-CCCceeEEeEEeeCC-cE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP-EK 157 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~ 157 (266)
....++|.++++||.|.||.||+|+ ..++..||||+++.+-... .-.-++|+..|++++ ||||+++..++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3456789999999999999999999 6789999999988663322 122358999999999 999999999999988 89
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||| ..+|++++..+ ++.++++.++.|+.||+.||+|+|.+| +.|||+||||||+.....+||+|||+||.
T Consensus 86 ~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999999 67999999654 678999999999999999999999999 99999999999999888999999999999
Q ss_pred CCCCCceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.+... ...+..|.+|+|||++-.
T Consensus 160 v~SkpP-YTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 160 VRSKPP-YTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred cccCCC-cchhhhcccccchHHhhh
Confidence 865543 234578999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.42 Aligned_cols=154 Identities=25% Similarity=0.371 Sum_probs=139.7
Q ss_pred hhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
+..++..++|+++..||+|+||.||+|+ ..+|..+|+|+++++ .....+.+..|-.+|.....|.||+++..|++.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 3345566889999999999999999999 568999999999876 344567788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+++||||||++||++..+| .....+++..+..++.+++.|++-||..| +|||||||+|+|||..|.+||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999998 44567999999999999999999999999 99999999999999999999999999
Q ss_pred cccC
Q 024537 235 ARLF 238 (266)
Q Consensus 235 a~~~ 238 (266)
|.-+
T Consensus 288 s~gl 291 (550)
T KOG0605|consen 288 STGL 291 (550)
T ss_pred cchh
Confidence 9543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=247.98 Aligned_cols=176 Identities=26% Similarity=0.404 Sum_probs=151.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCC-----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGP----- 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~----- 155 (266)
...|+.+++||+|+||+||+|+ ..+|+.||+|++..... ..-....+|+.+++.++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457788999999999999999 67899999999986633 22245678999999999999 999999998877
Q ss_pred -cEEEEEeccCCCCHHHHHhhcCCC-CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 156 -EKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
..++|+||+ ..+|..++...... ..++...++.++.||+.||+|||+++ |+||||||.||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 789999999 67888888543322 46777889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+.+.-+........+|.+|+|||++.+.-
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCC
Confidence 9998875666567779999999999998763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.31 Aligned_cols=172 Identities=28% Similarity=0.439 Sum_probs=148.1
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC--cEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e 162 (266)
.+|...+.||+|+||.||++.. .+|...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4577789999999999999994 458999999987764443677899999999999999999999855444 6899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCC-
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPG- 240 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~- 240 (266)
|+++|+|.+++.... + .+++..++.++.|++.||+|||++| ||||||||+|||++. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999995432 2 7999999999999999999999999 999999999999999 79999999999998763
Q ss_pred --CCceeeeeeEEeeeeCCCcccc
Q 024537 241 --EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 --~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......+.||+.|+|||++.+
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred cccccccccccCCccccCchhhcC
Confidence 1223446789999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.54 Aligned_cols=171 Identities=26% Similarity=0.433 Sum_probs=158.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
..|....+||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 458888999999999999998 6688999999999888777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+||+|.+.+. ...+++.++..|+++++.||+|||.+| |+|||||.+|||++.+|.+||+|||+|..+......
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 9999988882 235999999999999999999999999 999999999999999999999999999999888878
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
-.+..||+.|+|||++...
T Consensus 426 R~TmVGTPYWMAPEVvtrk 444 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRK 444 (550)
T ss_pred cccccCCCCccchhhhhhc
Confidence 8899999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=253.43 Aligned_cols=176 Identities=28% Similarity=0.425 Sum_probs=147.8
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--------------hhHHHHHHHHHHHHhcCCCCce
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--------------QGLREFTNEVKLLLKIQHKNLV 145 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv 145 (266)
-....+.|++.+.||+|.||.|-+|+ ..+++.||||++.+... ..++.+.+|+.+|+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34445789999999999999999999 55899999999865421 1246788999999999999999
Q ss_pred eEEeEEeeC--CcEEEEEeccCCCCHHHHHhhcCCCCC-cCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc
Q 024537 146 TLFGCCAEG--PEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222 (266)
Q Consensus 146 ~l~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~ 222 (266)
+|+.+..++ +.+|||+|||..|.+... ..... +.+.+++.|+.+++.||+|||.+| ||||||||+|+||+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 999999875 578999999999988433 22333 889999999999999999999999 99999999999999
Q ss_pred CCCCeEEecccccccCC-----CCCceeeeeeEEeeeeCCCccccC
Q 024537 223 EQLNPKISDFGLARLFP-----GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 223 ~~~~~kl~DFG~a~~~~-----~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.+|.|||+|||.+..+. +.+.....-.|||.|+|||++..+
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 99999999999998772 222233345899999999998773
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=259.50 Aligned_cols=177 Identities=30% Similarity=0.505 Sum_probs=150.7
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+....++.++.||+|-||+||.|.|.....||+|.++..... .+.|.+|+.+|++|+|+|||++++++..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3444456678999999999999999977779999998865333 267889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||+.|+|.++|.. .....+...+.+.++.|||+||+||.+++ +|||||-++|||++++..|||+|||+||.+.++
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999965 34567888999999999999999999998 999999999999999999999999999966555
Q ss_pred Cceeeee-eEEeeeeCCCccccC
Q 024537 242 DTHVNTF-RISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~-~~t~~y~aPE~~~~e 263 (266)
......- ...+.|.|||.+.-.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~ 379 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYG 379 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhC
Confidence 4332221 335579999987643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=262.70 Aligned_cols=174 Identities=26% Similarity=0.303 Sum_probs=155.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+-|++.+.||.|+-|.|-+|+ -.+|+..|||++... .......+.+|+-||+.+.|||++++|++|.....+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 348889999999999999999 568999999999765 2333466789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||++||.|.+++.. .+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|.++++||+|||+|.+-. +
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-P 164 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence 99999999999944 357899999999999999999999998 9999999999999999999999999998754 3
Q ss_pred CceeeeeeEEeeeeCCCccccCCCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDICQ 266 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~~~ 266 (266)
+....+.||++.|++||++++++++
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCC
Confidence 5566778999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=246.36 Aligned_cols=178 Identities=25% Similarity=0.358 Sum_probs=155.6
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
....+.|++...||.|..++||+|+ .+.++.||||++.... ......+..|+..|..++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3445779999999999999999999 7788999999998763 3346889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||.||.+|++.+++..... ..+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+.-+-
T Consensus 102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999976543 45999999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCce----eeeeeEEeeeeCCCccccC
Q 024537 240 GEDTH----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~----~~~~~~t~~y~aPE~~~~e 263 (266)
..... ..++.||+.|+|||+++.+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~ 205 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQ 205 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhc
Confidence 32221 1567899999999996543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=236.20 Aligned_cols=175 Identities=27% Similarity=0.352 Sum_probs=155.1
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|.||.||.|+ ..++..||+|++.++.. ....++.+|++|-..|+||||+++|++|.+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 35679999999999999999999 66888999999876532 223578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
++||..+|++...|.. .....+++.....+..|++.||.|+|.++ ||||||||+|+|++..+.+||+|||-+..-+
T Consensus 100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999988843 35567899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..+-.+++||..|.||||..+..
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~ 198 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRG 198 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCC
Confidence 55567889999999999987753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=252.11 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=147.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|. ..+++.||+|++.... ......+..|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468999999999999999998 4578999999987542 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998843 356899999999999999999999998 999999999999999999999999999865321
Q ss_pred Cc-----------------------------------eeeeeeEEeeeeCCCccccC
Q 024537 242 DT-----------------------------------HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~-----------------------------------~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......||+.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 211 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence 10 01245789999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=254.10 Aligned_cols=177 Identities=25% Similarity=0.362 Sum_probs=160.2
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-EEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-KMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv 160 (266)
.++|..++++|+|+||.++.++ ..+++.|++|++... .....+...+|+.+++++.|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4679999999999999999998 667889999998765 33334567899999999999999999999999988 8999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|+||+||++.+.+... ++..++++.+..|+.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999654 3567999999999999999999999887 99999999999999999999999999999998
Q ss_pred CCceeeeeeEEeeeeCCCccccCCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
+.....+..||+.|++||++.+.++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pY 183 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPY 183 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCC
Confidence 8888899999999999999988664
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=245.39 Aligned_cols=166 Identities=23% Similarity=0.276 Sum_probs=144.7
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||.||+|. ..+++.||+|++... .......+..|+.+++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998 557899999998754 2333456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeee
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 247 (266)
+|...+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99888843 356889999999999999999999998 999999999999999999999999999875444444556
Q ss_pred eeEEeeeeCCCccccC
Q 024537 248 FRISVVTWPPNMHCMD 263 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e 263 (266)
..||+.|+|||++.+.
T Consensus 155 ~~gt~~y~aPE~~~~~ 170 (323)
T cd05571 155 FCGTPEYLAPEVLEDN 170 (323)
T ss_pred eecCccccChhhhcCC
Confidence 7899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=249.16 Aligned_cols=148 Identities=25% Similarity=0.374 Sum_probs=132.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+ ..+++.||||++.... ......+.+|+.++..++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468999999999999999999 4578999999987542 233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999998843 346899999999999999999999998 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=249.14 Aligned_cols=147 Identities=26% Similarity=0.366 Sum_probs=131.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|. ..+++.||||++.... ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368899999999999999998 5578999999986532 233466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999988843 356888999999999999999999999 999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=248.77 Aligned_cols=146 Identities=23% Similarity=0.362 Sum_probs=130.2
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||.||+|+ ..+++.||||++.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999998 5578999999986532 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 99999999999843 346888899999999999999999998 99999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=248.78 Aligned_cols=146 Identities=24% Similarity=0.382 Sum_probs=130.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.|++++.||+|+||+||+|+ ..+++.||||++... .......+..|+.++..++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999998 557899999998754 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999988843 346888999999999999999999998 999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=244.40 Aligned_cols=170 Identities=24% Similarity=0.312 Sum_probs=148.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|+. .+++.||||++.... ......+..|+.++..++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999994 468999999987542 233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 346888999999999999999999998 99999999999999999999999999987644
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
......||+.|+|||++.+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~ 174 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKG 174 (333)
T ss_pred --ccCCcccCccccChhHhcCCC
Confidence 234457899999999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=248.56 Aligned_cols=145 Identities=23% Similarity=0.370 Sum_probs=130.1
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+|++++.||+|+||+||+|+ ..+++.||+|++.... ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999998 4578899999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999988843 346888999999999999999999998 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=245.43 Aligned_cols=170 Identities=22% Similarity=0.302 Sum_probs=148.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++.+++||||+++++.+..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 35699999999999999999994 478999999987542 23346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988843 346888999999999999999999998 99999999999999999999999999987744
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. .+..||+.|+|||++...
T Consensus 171 ~~---~~~~gt~~y~aPE~~~~~ 190 (329)
T PTZ00263 171 RT---FTLCGTPEYLAPEVIQSK 190 (329)
T ss_pred Cc---ceecCChhhcCHHHHcCC
Confidence 32 345789999999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=249.31 Aligned_cols=175 Identities=23% Similarity=0.250 Sum_probs=149.5
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
.....++|++.+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.+++.++||||+++++.+..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44445789999999999999999999 456889999998643 22234557789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998842 34788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+.... ....+..||+.|+|||++..
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhc
Confidence 764332 22345679999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=242.54 Aligned_cols=166 Identities=23% Similarity=0.288 Sum_probs=143.8
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998 557899999998754 2334467788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeee
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 247 (266)
+|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99888733 346889999999999999999999998 999999999999999999999999999875444444455
Q ss_pred eeEEeeeeCCCccccC
Q 024537 248 FRISVVTWPPNMHCMD 263 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e 263 (266)
..||+.|+|||++...
T Consensus 155 ~~gt~~y~aPE~~~~~ 170 (328)
T cd05593 155 FCGTPEYLAPEVLEDN 170 (328)
T ss_pred ccCCcCccChhhhcCC
Confidence 6789999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=245.95 Aligned_cols=174 Identities=25% Similarity=0.318 Sum_probs=154.6
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 157 (266)
.....|++.+.||+|.||+||+|+ ..+|+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345679999999999999999999 55699999999976633 23468899999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC----CCeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ----LNPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~----~~~kl~DFG 233 (266)
++|||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998554 3999999999999999999999999 9999999999999543 479999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|..+.. .....+.+||+.|+|||++....
T Consensus 185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~ 214 (382)
T KOG0032|consen 185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRP 214 (382)
T ss_pred CceEccC-CceEeeecCCccccCchhhcCCC
Confidence 9999877 66778889999999999998544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=241.00 Aligned_cols=166 Identities=29% Similarity=0.440 Sum_probs=138.2
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cEEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKMLVY 161 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~ 161 (266)
|...+.+|.|+||.||.|. ..+++.||||++-.+.+-. .+|+.+|+.+.|||||++.-+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 6678999999999999999 5567999999987664422 37999999999999999999986532 235799
Q ss_pred eccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEecccccccCC
Q 024537 162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARLFP 239 (266)
Q Consensus 162 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~a~~~~ 239 (266)
||++ -+|...++.. ..+..++.-.++-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 9995 5788887542 23456888889999999999999999988 9999999999999986 889999999999886
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..... .++.+|..|+|||++-+
T Consensus 178 ~~epn-iSYicSRyYRaPELifg 199 (364)
T KOG0658|consen 178 KGEPN-ISYICSRYYRAPELIFG 199 (364)
T ss_pred cCCCc-eeEEEeccccCHHHHcC
Confidence 54433 56789999999999865
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=242.07 Aligned_cols=166 Identities=23% Similarity=0.290 Sum_probs=143.7
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||.||+|+ ..+++.||+|.+... .......+.+|+.+++.++||||+++++.+...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999998 457899999998754 2334456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeee
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 247 (266)
+|...+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99888743 346889999999999999999999998 999999999999999999999999999875444444455
Q ss_pred eeEEeeeeCCCccccC
Q 024537 248 FRISVVTWPPNMHCMD 263 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e 263 (266)
..||+.|+|||++.+.
T Consensus 155 ~~gt~~y~aPE~~~~~ 170 (323)
T cd05595 155 FCGTPEYLAPEVLEDN 170 (323)
T ss_pred ccCCcCcCCcccccCC
Confidence 6789999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=244.47 Aligned_cols=171 Identities=22% Similarity=0.280 Sum_probs=147.4
Q ss_pred hhcCccccceecccCceEEEEEEec-C-CCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP-N-GQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|++.+.||+|+||.||+|... + +..||+|.+... .......+.+|+.++..++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3456999999999999999999843 3 368999988643 2233466789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999998843 346889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
... ..+..||+.|+|||++.+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~ 203 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNV 203 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCC
Confidence 432 2455789999999998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=240.76 Aligned_cols=169 Identities=23% Similarity=0.319 Sum_probs=147.0
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999994 478999999986542 233456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998843 346888999999999999999999998 999999999999999999999999999876433
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ....|++.|+|||++...
T Consensus 155 ~---~~~~gt~~y~aPE~~~~~ 173 (291)
T cd05612 155 T---WTLCGTPEYLAPEVIQSK 173 (291)
T ss_pred c---ccccCChhhcCHHHHcCC
Confidence 2 345789999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=243.14 Aligned_cols=180 Identities=29% Similarity=0.430 Sum_probs=145.0
Q ss_pred HHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeEEee
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE 153 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 153 (266)
.+..++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 44567899999999999999999963 235689999987542 33446788999999999 89999999998876
Q ss_pred CC-cEEEEEeccCCCCHHHHHhhcCC------------------------------------------------------
Q 024537 154 GP-EKMLVYEYLPNKSLDYFIFDKTK------------------------------------------------------ 178 (266)
Q Consensus 154 ~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 178 (266)
.+ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 57999999999999998854211
Q ss_pred -----CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc--eeeeeeEE
Q 024537 179 -----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRIS 251 (266)
Q Consensus 179 -----~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t 251 (266)
...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 134778888999999999999999998 99999999999999999999999999987643322 11223455
Q ss_pred eeeeCCCccccCC
Q 024537 252 VVTWPPNMHCMDI 264 (266)
Q Consensus 252 ~~y~aPE~~~~e~ 264 (266)
..|+|||++..+.
T Consensus 240 ~~y~aPE~~~~~~ 252 (338)
T cd05102 240 LKWMAPESIFDKV 252 (338)
T ss_pred ccccCcHHhhcCC
Confidence 7899999886553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=239.76 Aligned_cols=166 Identities=23% Similarity=0.278 Sum_probs=142.8
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||.||+|. ..+++.||+|++... .......+..|+.++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998 557899999998754 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
+|...+.. ...+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99888733 3468899999999999999999997 67 99999999999999999999999999986544444445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++.+.
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (325)
T cd05594 155 TFCGTPEYLAPEVLEDN 171 (325)
T ss_pred cccCCcccCCHHHHccC
Confidence 56799999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=236.32 Aligned_cols=171 Identities=26% Similarity=0.435 Sum_probs=145.5
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||.|+||.||+|+ ..++..||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 569999999999999999998 4578999999987542 22234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 964 88887743 2345788899999999999999999998 99999999999999999999999999987654443
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred cccCceecccccChHHhcC
Confidence 4445578999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=239.44 Aligned_cols=164 Identities=24% Similarity=0.274 Sum_probs=142.8
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||+|+||.||+|+. .+++.||+|++... .......+..|+.++.+++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999994 46889999998653 233456678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 988843 346889999999999999999999998 99999999999999999999999999987654444445667
Q ss_pred EEeeeeCCCccccC
Q 024537 250 ISVVTWPPNMHCMD 263 (266)
Q Consensus 250 ~t~~y~aPE~~~~e 263 (266)
||+.|+|||++...
T Consensus 155 gt~~y~aPE~~~~~ 168 (312)
T cd05585 155 GTPEYLAPELLLGH 168 (312)
T ss_pred CCcccCCHHHHcCC
Confidence 99999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=251.54 Aligned_cols=179 Identities=32% Similarity=0.521 Sum_probs=153.7
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
..+++..+...+...||+|+||+||+|+|. -.||||+++.. .....+.|.+|+..+++-+|.||+-++|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 445555666778899999999999999984 36999999876 45567899999999999999999999999998887
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.||+.+|+|.+|+.+++. ....++....+.|+.|++.||.|||.++ |||||||..||++.++++|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999853 3357889999999999999999999999 9999999999999999999999999995
Q ss_pred cCC--CCCceeeeeeEEeeeeCCCccccCCC
Q 024537 237 LFP--GEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 237 ~~~--~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.-. ..........|..-|+|||++..+-|
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~ 567 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD 567 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhccc
Confidence 421 33444556688889999999986543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=244.12 Aligned_cols=173 Identities=22% Similarity=0.302 Sum_probs=147.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|. ..+++.||+|++... .......+..|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468899999999999999998 457899999998643 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 346889999999999999999999998 999999999999999999999999999865321
Q ss_pred Cc-----------------------------------eeeeeeEEeeeeCCCccccCC
Q 024537 242 DT-----------------------------------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~-----------------------------------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ......||+.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 212 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 212 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC
Confidence 10 012346899999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=236.44 Aligned_cols=169 Identities=27% Similarity=0.486 Sum_probs=147.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeec--ccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-----CCcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-----GPEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~ 157 (266)
..|..++.||+|+||.|+.|. ..+|+.||||++. .......++..+|+.+|+.++|+||+.+.+.+.. -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 456668999999999999998 6689999999997 5567777888999999999999999999999876 3468
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
|+|+|+| +.+|...+. .+..++...+..+++|++.||+|+|+.+ |+||||||.|+|++.++.+||+|||+|+.
T Consensus 102 YiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 778988883 3345889999999999999999999998 99999999999999999999999999998
Q ss_pred CCC--CCceeeeeeEEeeeeCCCccc
Q 024537 238 FPG--EDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 238 ~~~--~~~~~~~~~~t~~y~aPE~~~ 261 (266)
... ....+..+..|.+|+|||++-
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll 200 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLL 200 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHh
Confidence 853 244455668899999999873
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=238.76 Aligned_cols=172 Identities=26% Similarity=0.302 Sum_probs=146.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCC-CceeEEeEEeeCCcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK-NLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~ 161 (266)
+|++++.||+|+||.||+|. ..+++.||||++... .....+.+..|+.++..+.|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48889999999999999998 446789999998754 233456678899999999765 5888999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|...+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888843 345888999999999999999999998 999999999999999999999999999865433
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
........||+.|+|||++....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~ 177 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQP 177 (324)
T ss_pred CCceeeecCCccccChhhhcCCC
Confidence 34445567899999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=245.26 Aligned_cols=178 Identities=23% Similarity=0.254 Sum_probs=151.2
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
.+......++|++.+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34455566889999999999999999999 457889999998643 22234557789999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..++||||+++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999988843 34788889999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|+.+.... ....+..||+.|+|||++..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhc
Confidence 998765332 22335579999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=236.98 Aligned_cols=172 Identities=26% Similarity=0.427 Sum_probs=144.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36799999999999999999994 4789999999875432 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 577666643 2346888999999999999999999998 9999999999999999999999999998654443
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLG 177 (303)
T ss_pred ccCCCCcccCCCCChHHHcC
Confidence 33344568889999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=247.27 Aligned_cols=172 Identities=27% Similarity=0.453 Sum_probs=156.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..|..++.||+|+||.||+|. ..+++.||+|++... ....++.+++|+.++.+++++||.++|+.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 347778999999999999999 668999999999876 345578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
|.||++.+++ ..+..+++..+..++.+++.||.|||..+ .+|||||+.|||+...|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 33344578888889999999999999998 99999999999999999999999999999988888
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
...+|.||++|||||++..+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~ 186 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQS 186 (467)
T ss_pred ccccccccccccchhhhccc
Confidence 88999999999999999853
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=245.95 Aligned_cols=174 Identities=22% Similarity=0.247 Sum_probs=148.3
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
....++|++.+.||+|+||.||+|+ ..+++.||+|++... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3445679999999999999999998 457899999998643 223334577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++|+|..++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999988843 34788889999999999999999998 99999999999999999999999999987
Q ss_pred CCCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.... .......||+.|+|||++..
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhcc
Confidence 64332 12234578999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=243.26 Aligned_cols=172 Identities=25% Similarity=0.330 Sum_probs=149.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|.+.+.||+|+||+||+|+. .+++.||||++.... ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4689999999999999999994 478999999987542 233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998443 56889999999999999999999998 999999999999999999999999999876544
Q ss_pred C-----------------------------ceeeeeeEEeeeeCCCccccC
Q 024537 242 D-----------------------------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~-----------------------------~~~~~~~~t~~y~aPE~~~~e 263 (266)
. .......||+.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 3 223445789999999998765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.33 Aligned_cols=174 Identities=26% Similarity=0.412 Sum_probs=156.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
....|.+...||+|.|++|.+|+ ..++..||||++.+. .......+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34679999999999999999999 557999999999766 344456688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+.+|.+.+++.. ...+.+..+..++.|++.|++|||+++ |+|||||++|||++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999943 345666888999999999999999999 9999999999999999999999999999987
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
......+++|++.|+|||+..+..
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~ 230 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKK 230 (596)
T ss_pred ccccccccCCCCCccChHhhcCcc
Confidence 566778999999999999988764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=236.15 Aligned_cols=152 Identities=28% Similarity=0.361 Sum_probs=137.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-CCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
..+..+.|++++.||.|.-|+||+|+.. ++..+|+|++.+. ......+...|.+||+.++||.++.||..|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 4455567899999999999999999954 5689999999866 34456678889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|++||||+||+|..++ +++....+++..++.++..++.||+|||..| ||+|||||+||||.++|.+.|+||.++.
T Consensus 152 ~cl~meyCpGGdL~~Lr-qkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLR-QKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eEEEEecCCCccHHHHH-hhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999998776 5667788999999999999999999999999 9999999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.28 Aligned_cols=163 Identities=29% Similarity=0.475 Sum_probs=146.5
Q ss_pred ccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
...++.||.|+-|.||+|++ .++.||||+++.... .+|+-|++|+||||+.|.|+|....-+|||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 44468899999999999998 568899998864322 4677899999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeee
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 247 (266)
.|..+|+ ....+.......|..+|+.||.|||... |||||||.-||||+.+..|||+|||.++.+... +....
T Consensus 198 qL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS 270 (904)
T KOG4721|consen 198 QLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS 270 (904)
T ss_pred cHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence 9999993 4567888999999999999999999988 999999999999999999999999999998766 44567
Q ss_pred eeEEeeeeCCCccccCCC
Q 024537 248 FRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e~~ 265 (266)
|.||+.|||||+|.+|+|
T Consensus 271 FaGTVaWMAPEvIrnePc 288 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPC 288 (904)
T ss_pred hhhhHhhhCHHHhhcCCc
Confidence 899999999999999999
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=232.69 Aligned_cols=171 Identities=29% Similarity=0.373 Sum_probs=146.0
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++..++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 7788999999999999998 5689999999986542 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|...+... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++.+....
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999998777432 2346889999999999999999999998 9999999999999999999999999998764332
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......|+..|+|||++...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNE 176 (285)
T ss_pred eecCCCCCCCccCHhhhcCC
Confidence 22344689999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=239.06 Aligned_cols=171 Identities=22% Similarity=0.242 Sum_probs=146.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+++ ..+++.||+|++... .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468999999999999999999 457899999998643 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2346889999999999999999999998 999999999999999999999999999876543
Q ss_pred Cc-eeeeeeEEeeeeCCCccc
Q 024537 242 DT-HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~-~~~~~~~t~~y~aPE~~~ 261 (266)
.. ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCccccceeccccccCHHHHh
Confidence 32 222346899999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=245.62 Aligned_cols=184 Identities=29% Similarity=0.421 Sum_probs=153.6
Q ss_pred chhhHHHhhcCccccceecccCceEEEEEEec--CC---CEEEEEeecc---cChhhHHHHHHHHHHHHhcCCCCceeEE
Q 024537 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP--NG---QEIAVKKLSV---DSRQGLREFTNEVKLLLKIQHKNLVTLF 148 (266)
Q Consensus 77 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~--~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~ 148 (266)
....+++..++..+.++||+|+||.||+|.+. ++ ..||||.... .....+..+.+|+++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 44556667777778899999999999999843 22 2389998875 3466678899999999999999999999
Q ss_pred eEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
|+......+++|||+|.||+|.++|... ...++..+...++.+.+.||+|||+++ +|||||-.+|+|++.++.+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999543 236899999999999999999999998 99999999999999999999
Q ss_pred EecccccccCCCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 229 ISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
|+|||+++.-...............|.|||.+...++
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCcc
Confidence 9999999875422222212245678999999876554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=238.07 Aligned_cols=167 Identities=20% Similarity=0.272 Sum_probs=143.4
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|. ..+++.||+|++... .......+..|..++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999998 457899999999754 233345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999887733 356899999999999999999999998 99999999999999999999999999986443344445
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
+..||..|+|||++.++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (329)
T cd05588 155 TFCGTPNYIAPEILRGED 172 (329)
T ss_pred cccCCccccCHHHHcCCC
Confidence 668999999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=237.40 Aligned_cols=169 Identities=30% Similarity=0.386 Sum_probs=143.6
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHH---HhcCCCCceeEEeEEeeCCcEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLL---LKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
|++++.||+|+||.||+|. ..+++.||||++.... ....+.+..|+.++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6778999999999999998 4578999999987542 22345566676665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|...+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987763 246899999999999999999999998 99999999999999999999999999987554
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........|++.|+|||++...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~ 176 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTET 176 (324)
T ss_pred CCCcccccccCccccCHhHhcCC
Confidence 44445567899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=236.94 Aligned_cols=167 Identities=28% Similarity=0.370 Sum_probs=142.0
Q ss_pred cceecccCceEEEEEEe----cCCCEEEEEeecccC----hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.+++.++||||+++++.+..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999984 357899999987532 2233557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+.+.. ...+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999888843 345778888899999999999999998 9999999999999999999999999998654444
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......|++.|+|||++.+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~ 175 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRS 175 (323)
T ss_pred CcccccCCCccccChhhccCC
Confidence 444455789999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=238.34 Aligned_cols=172 Identities=20% Similarity=0.203 Sum_probs=147.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+++ ..+++.||+|++... .......+.+|+.++..+.|+||+++++.+.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468999999999999999998 457889999998653 2223445778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|..++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 346888999999999999999999998 999999999999999999999999999877544
Q ss_pred Cc-eeeeeeEEeeeeCCCcccc
Q 024537 242 DT-HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~-~~~~~~~t~~y~aPE~~~~ 262 (266)
.. ......|++.|+|||++..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CceeeccccCCcccCCHHHHhc
Confidence 32 2233568999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=236.06 Aligned_cols=176 Identities=24% Similarity=0.281 Sum_probs=159.2
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
-++..++|..++.||+|.||+|-+|+ +.+++.||+|++++. .......-+.|-.+|+..+||.+..+-..|+..+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 35567889999999999999999999 779999999999865 34445566789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+|+||||..||.|...| ...+.+++...+.+-..|+.||.|||+++ ||+||||.+|+|+|.+|.+||+|||+++
T Consensus 243 lCFVMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 99999999999998777 34567899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.-......+.+|+|||.|.|||++-.
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred hcccccceeccccCChhhcCchhhcc
Confidence 88888888999999999999999854
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=238.54 Aligned_cols=167 Identities=26% Similarity=0.399 Sum_probs=142.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|+.++.||+|+||.||+|. ..+++.||||++.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 457788999999999999998 4578999999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|... ....+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998532 23456778889999999999999998 99999999999999999999999999988754433
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......||..|+|||++..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINT 242 (353)
T ss_pred cccccccCccccCcccccc
Confidence 3345578999999998743
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=233.58 Aligned_cols=176 Identities=26% Similarity=0.423 Sum_probs=144.1
Q ss_pred hcCccccceecccCceEEEEEEecC-----------------CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCcee
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN-----------------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~ 146 (266)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+... .......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999997432 346999998765 3334567889999999999999999
Q ss_pred EEeEEeeCCcEEEEEeccCCCCHHHHHhhcC----------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024537 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT----------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210 (266)
Q Consensus 147 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~ii 210 (266)
+++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 1124677889999999999999999998 99
Q ss_pred eCCCCCCceEEcCCCCeEEecccccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 211 HrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
||||||+|||++.++.+||+|||+++.+...... .....++..|+|||++...
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence 9999999999999999999999999876433221 1122346689999987543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=251.31 Aligned_cols=165 Identities=34% Similarity=0.507 Sum_probs=145.5
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.|..++.||.|+||.||-|+ ..+.+.||||++..+. ......++.|+..|.++.|||++.+-|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 37778999999999999999 6688999999997653 3345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|| -|+..+++.- -..++.+-++..|..+.+.||.|||+.+ .||||||+.|||+++.|.|||+|||.|....+
T Consensus 107 YC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 99 5677777632 2356888999999999999999999998 99999999999999999999999999988643
Q ss_pred ceeeeeeEEeeeeCCCccc
Q 024537 243 THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~ 261 (266)
.++|.|||+|+|||+|.
T Consensus 179 --AnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVIL 195 (948)
T ss_pred --hhcccCCccccchhHhe
Confidence 46789999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-34 Score=233.82 Aligned_cols=174 Identities=25% Similarity=0.362 Sum_probs=153.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+.|++-+.||+|.|++|+++. ..+|+.+|+|++..+ .....+.+.+|+.|.+.|+|||||++.+.+.+.+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4668888999999999999998 668999999988754 3335678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---CeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl~DFG~a~~~ 238 (266)
|++.|++|..-+..+ ..+++..+-.++.||++||.|+|+++ |||||+||+|+|+-... -+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997766443 45788889999999999999999999 99999999999995543 4899999999998
Q ss_pred CCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
. +...+..+.|||.|+|||++..++.
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred C-CccccccccCCCcccCHHHhhcCCC
Confidence 7 6677788899999999999998874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=254.88 Aligned_cols=179 Identities=26% Similarity=0.366 Sum_probs=150.1
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEecCC-CEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEE-ee--
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNG-QEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC-AE-- 153 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~-~~-- 153 (266)
..+++...++++.+.|.+|+|+.||+|....+ ..||+|++-.......+.+.+|+.+|++|. |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 44566667788999999999999999995554 999999998888888899999999999997 99999999943 21
Q ss_pred -C---CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 154 -G---PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 154 -~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
. -.++|.||||.||.|-++++.+...+ |++.++++|++|+++|+.+||... ++|||||||.|||||+.+|..||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 1 24688999999999999997765544 999999999999999999999987 56999999999999999999999
Q ss_pred ecccccccCCCCC-c---------eeeeeeEEeeeeCCCcc
Q 024537 230 SDFGLARLFPGED-T---------HVNTFRISVVTWPPNMH 260 (266)
Q Consensus 230 ~DFG~a~~~~~~~-~---------~~~~~~~t~~y~aPE~~ 260 (266)
||||.|....... + .+. ...|+.|+|||||
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~-k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIE-KYTTPQYRSPEMI 227 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHH-hhCCccccChHHH
Confidence 9999997542111 1 111 1467899999997
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=236.64 Aligned_cols=167 Identities=22% Similarity=0.284 Sum_probs=142.6
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|+ ..+++.||+|++... .......+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999 457889999998754 233445677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999887733 356899999999999999999999998 99999999999999999999999999987544444445
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...||+.|+|||++.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (329)
T cd05618 155 TFCGTPNYIAPEILRGED 172 (329)
T ss_pred cccCCccccCHHHHcCCC
Confidence 567899999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=235.96 Aligned_cols=172 Identities=26% Similarity=0.308 Sum_probs=145.5
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+|.+.+.||+|+||.||+|+ ..+++.||+|++.... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47889999999999999998 4467899999987542 22334566788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|...+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 345889999999999999999999998 999999999999999999999999999865444
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
........||+.|+|||++....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~ 177 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQP 177 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCC
Confidence 44445567899999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=235.69 Aligned_cols=167 Identities=27% Similarity=0.335 Sum_probs=140.4
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHh-cCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|. ..+++.||+|.+.... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998 4568899999987542 2233455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999888843 346889999999999999999999998 99999999999999999999999999987654444455
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...||+.|+|||++.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05592 155 TFCGTPDYIAPEILKGQK 172 (316)
T ss_pred cccCCccccCHHHHcCCC
Confidence 667899999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=236.21 Aligned_cols=171 Identities=20% Similarity=0.219 Sum_probs=147.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468999999999999999998 4578999999987542 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246889999999999999999999998 999999999999999999999999999877543
Q ss_pred Cce-eeeeeEEeeeeCCCccc
Q 024537 242 DTH-VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~~-~~~~~~t~~y~aPE~~~ 261 (266)
... .....+|+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CceeeecccCCccccCHHHhc
Confidence 322 22346889999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=235.23 Aligned_cols=167 Identities=26% Similarity=0.324 Sum_probs=139.9
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHH-HHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|+ ..+++.||||++.... ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999 4578999999987542 222334555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999888743 346888999999999999999999998 99999999999999999999999999986544444445
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...||+.|+|||++....
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQP 172 (323)
T ss_pred cccCChhhcChhhhcCCC
Confidence 567899999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=236.10 Aligned_cols=171 Identities=24% Similarity=0.304 Sum_probs=145.4
Q ss_pred CccccceecccCceEEEEEEe----cCCCEEEEEeeccc----ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 157 (266)
+|++++.||+|+||+||+|+. .+++.||+|++... .....+.+..|+.++..+ .||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 36889999998643 222345677899999999 499999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988843 345889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCC-CceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGE-DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~-~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+... ........||..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCC
Confidence 5432 2333456789999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=234.77 Aligned_cols=167 Identities=26% Similarity=0.312 Sum_probs=138.9
Q ss_pred ceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHH-HHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999994 578899999986542 222334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999877732 346888899999999999999999998 99999999999999999999999999986544444445
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...||+.|+|||++....
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEP 172 (321)
T ss_pred cccCCcccCCHHHhcCCC
Confidence 567899999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=235.36 Aligned_cols=166 Identities=26% Similarity=0.331 Sum_probs=139.5
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHH-HHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|. ..+++.||+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999998 457899999998654 1222344555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+. ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99988773 3356889999999999999999999998 99999999999999999999999999986544444445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++...
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQ 171 (325)
T ss_pred cccCChhhCCHHHHcCC
Confidence 56789999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=234.68 Aligned_cols=166 Identities=25% Similarity=0.278 Sum_probs=143.3
Q ss_pred ceecccCceEEEEEEe----cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 92 NQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
+.||+|+||.||+++. .+++.||+|++.... ......+..|+.++.+++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999873 368899999987542 2233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+.+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999888843 346899999999999999999999998 9999999999999999999999999998765554445
Q ss_pred eeeeEEeeeeCCCccccC
Q 024537 246 NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~e 263 (266)
....|++.|+|||++...
T Consensus 156 ~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred ecccCChhhcCHHHHcCC
Confidence 566789999999988653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=235.39 Aligned_cols=166 Identities=26% Similarity=0.318 Sum_probs=141.5
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|. ..+++.||+|++... .......+..|..++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998 446889999998754 223345677888888865 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999888743 346888999999999999999999998 99999999999999999999999999987544444445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++...
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (321)
T cd05591 155 TFCGTPDYIAPEILQEL 171 (321)
T ss_pred ccccCccccCHHHHcCC
Confidence 56789999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=235.63 Aligned_cols=166 Identities=26% Similarity=0.352 Sum_probs=141.4
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|+ ..+++.||+|++... .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998 457899999998754 223345677888888776 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999888743 346889999999999999999999998 99999999999999999999999999986543344445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++...
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (320)
T cd05590 155 TFCGTPDYIAPEILQEM 171 (320)
T ss_pred ccccCccccCHHHHcCC
Confidence 56789999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=234.96 Aligned_cols=167 Identities=23% Similarity=0.293 Sum_probs=143.2
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|. ..+++.||+|++.... ......+..|+.++.++ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998 4578899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999887732 346899999999999999999999998 99999999999999999999999999986544444445
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...||+.|+|||++.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~ 172 (327)
T cd05617 155 TFCGTPNYIAPEILRGEE 172 (327)
T ss_pred cccCCcccCCHHHHCCCC
Confidence 668999999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-34 Score=236.08 Aligned_cols=167 Identities=28% Similarity=0.448 Sum_probs=153.9
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
|.++++||+|+||.||+|. ...|+.+|||.+.... +++++..|+.||+++..|++|++||.|.....+|||||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 7889999999999999998 6689999999988754 357889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
|++.+.++. ++.++.+.++..++...+.||+|||... -||||||..|||++.+|..||+|||.|..+.+...+.+
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999954 4568999999999999999999999987 89999999999999999999999999999988777788
Q ss_pred eeeEEeeeeCCCccc
Q 024537 247 TFRISVVTWPPNMHC 261 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~ 261 (266)
+..||++|+|||++.
T Consensus 188 TVIGTPFWMAPEVI~ 202 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIE 202 (502)
T ss_pred ccccCcccccHHHHH
Confidence 889999999999873
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=234.84 Aligned_cols=166 Identities=25% Similarity=0.307 Sum_probs=138.3
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHH-HHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEV-KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|+ ..+++.||+|++.... ......+..|. .+++.+.||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999998 4467899999987542 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|..++.. ...+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+..........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999988843 345788888999999999999999998 99999999999999999999999999987544444455
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++...
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQ 171 (325)
T ss_pred cccCCccccCHHHHcCC
Confidence 66799999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=242.20 Aligned_cols=171 Identities=27% Similarity=0.363 Sum_probs=149.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-C-----CCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-H-----KNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~ 157 (266)
..+|.+++.||+|+||+|.+|. ..+++.||||+++.... ...+...|+.+|..|+ | -|+|+++++|...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3479999999999999999999 56799999999976543 4467788999999997 3 4899999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC--CeEEeccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL--NPKISDFGLA 235 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~--~~kl~DFG~a 235 (266)
|||+|++ ..+|.+++..+ ...+++...++.++.||+.||.+||..+ |||+|||||||||...+ .+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999 77999999654 4467999999999999999999999998 99999999999997643 6999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..... ...++..+.+|+|||++.+-+
T Consensus 339 c~~~q---~vytYiQSRfYRAPEVILGlp 364 (586)
T KOG0667|consen 339 CFESQ---RVYTYIQSRFYRAPEVILGLP 364 (586)
T ss_pred cccCC---cceeeeeccccccchhhccCC
Confidence 98643 344778999999999998755
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=235.02 Aligned_cols=172 Identities=25% Similarity=0.318 Sum_probs=145.6
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+|++.+.||+|+||+||+|. ..+++.||+|++... .......+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36778999999999999998 457899999998754 2233456778888888886 577888999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999888843 346889999999999999999999998 999999999999999999999999999876444
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
........||+.|+|||++....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~ 177 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQP 177 (323)
T ss_pred CccccCccCCccccCHHHHcCCC
Confidence 44444567899999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=244.56 Aligned_cols=174 Identities=16% Similarity=0.217 Sum_probs=149.0
Q ss_pred CccccceecccCceEEEEEEe-cC-CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.|.+.+.||+|+||.||+|.. .+ +..||+|.+..........+..|+.+++.++||||+++++.+..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999983 34 6788999876666555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 165 PNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 165 ~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
++|+|.+.+... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 22346888999999999999999999998 99999999999999999999999999997754321
Q ss_pred --eeeeeeEEeeeeCCCccccC
Q 024537 244 --HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 --~~~~~~~t~~y~aPE~~~~e 263 (266)
......||+.|+|||++...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~ 246 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK 246 (478)
T ss_pred cccccccCCCccccCHhHhCCC
Confidence 23445789999999988654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=233.49 Aligned_cols=173 Identities=24% Similarity=0.349 Sum_probs=149.3
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..++|++++.||+|+||.||+|+ ..++..||+|.+... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 35789999999999999999999 457889999998765 3334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999843 345888999999999999999999863 2999999999999999999999999999876433
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. .....++..|+|||++.+.
T Consensus 158 ~--~~~~~g~~~y~aPE~~~~~ 177 (331)
T cd06649 158 M--ANSFVGTRSYMSPERLQGT 177 (331)
T ss_pred c--cccCCCCcCcCCHhHhcCC
Confidence 2 2345689999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=239.66 Aligned_cols=168 Identities=23% Similarity=0.290 Sum_probs=143.0
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
....|++++.||+|+||.||+|. ..+++.||+|.... ..+.+|+.++++++||||+++++++..+...++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34679999999999999999998 55789999997532 346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC-
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE- 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~- 241 (266)
++ +++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 164 ~~-~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RY-KTDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cC-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99 4678777733 346889999999999999999999998 999999999999999999999999999764322
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
........||+.|+|||++....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~ 259 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDP 259 (391)
T ss_pred ccccccccCccCCCChhhhcCCC
Confidence 22334457999999999987653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=229.93 Aligned_cols=173 Identities=21% Similarity=0.329 Sum_probs=146.0
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4689999999999999999994 468899999987542 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++++.+..+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765442 2346889999999999999999999998 9999999999999999999999999998875332
Q ss_pred -ceeeeeeEEeeeeCCCccccCC
Q 024537 243 -THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 243 -~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.......++..|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~ 177 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAP 177 (287)
T ss_pred cccccccccccccCCcHHHcCCC
Confidence 2223456889999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=234.36 Aligned_cols=171 Identities=21% Similarity=0.211 Sum_probs=145.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||+||++. ..+++.||+|++... .......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368899999999999999998 446788999998643 2223345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998532 346888999999999999999999998 999999999999999999999999999876433
Q ss_pred Cc-eeeeeeEEeeeeCCCccc
Q 024537 242 DT-HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~-~~~~~~~t~~y~aPE~~~ 261 (266)
.. ......||+.|+|||++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CcceecccccCccccCHHHHh
Confidence 22 223357899999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=227.98 Aligned_cols=167 Identities=27% Similarity=0.376 Sum_probs=143.0
Q ss_pred ecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||+|+||+||+|. ..+++.||+|.+.... ....+.+..|+.+++.++||||+++.+++..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999998 4578999999986542 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeee
Q 024537 170 DYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248 (266)
Q Consensus 170 ~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 248 (266)
...+... .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 8777432 23456899999999999999999999998 9999999999999999999999999998776554444456
Q ss_pred eEEeeeeCCCccccC
Q 024537 249 RISVVTWPPNMHCMD 263 (266)
Q Consensus 249 ~~t~~y~aPE~~~~e 263 (266)
.|++.|+|||++...
T Consensus 158 ~g~~~y~aPE~~~~~ 172 (280)
T cd05608 158 AGTPGFMAPELLQGE 172 (280)
T ss_pred CCCcCccCHHHhcCC
Confidence 788999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=231.61 Aligned_cols=166 Identities=27% Similarity=0.350 Sum_probs=140.3
Q ss_pred ceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHh-cCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|.. .+++.||||++.... ......+..|..++.. ++||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 468899999987542 2233556677878775 5899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999988843 346888999999999999999999998 99999999999999999999999999986543344445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||..|+|||++.+.
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (316)
T cd05619 155 TFCGTPDYIAPEILLGQ 171 (316)
T ss_pred eecCCccccCHHHHcCC
Confidence 66789999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=232.31 Aligned_cols=166 Identities=27% Similarity=0.329 Sum_probs=140.1
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHh-cCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|. ..+++.||+|.+.... .........|..++.. +.||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999 4578999999987542 2234556678888765 4899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999888843 346888999999999999999999998 99999999999999999999999999986433334445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++.+.
T Consensus 155 ~~~gt~~y~aPE~~~~~ 171 (316)
T cd05620 155 TFCGTPDYIAPEILQGL 171 (316)
T ss_pred ccCCCcCccCHHHHcCC
Confidence 66789999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=232.99 Aligned_cols=163 Identities=23% Similarity=0.306 Sum_probs=137.9
Q ss_pred ecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc---CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 94 iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
||+|+||+||+|+ ..+++.||||++.... .........|..++... .||||+++++.+..++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998 4578999999986532 22234455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999888743 356889999999999999999999998 99999999999999999999999999987544444445
Q ss_pred eeeEEeeeeCCCcccc
Q 024537 247 TFRISVVTWPPNMHCM 262 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~ 262 (266)
...||..|+|||++..
T Consensus 155 ~~~gt~~y~aPE~~~~ 170 (330)
T cd05586 155 TFCGTTEYLAPEVLLD 170 (330)
T ss_pred CccCCccccCHHHHcC
Confidence 6689999999998864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=210.42 Aligned_cols=171 Identities=24% Similarity=0.427 Sum_probs=149.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.+|...++||+|.||+||+|+ +.+++.||+|.++.+.. ..-....+|+.+++.+.|.|||+++++...++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 357778899999999999999 67899999999986532 223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|| ..+|..+.. .-++.++...++.++.|++.||.|+|+.+ ++||||||.|+||+.+|++|++|||+|+.++-+.
T Consensus 82 ~c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred Hh-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 99 557766653 34567899999999999999999999998 9999999999999999999999999999998777
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.-.+....|.+|+||.++-+
T Consensus 156 rcysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred EeeeceeeeeeccCcceeee
Confidence 66677788999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=232.53 Aligned_cols=172 Identities=24% Similarity=0.357 Sum_probs=148.0
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..++|++.+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 457899999999999999999994 47889999988764 3334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++..+..
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999998843 34578889999999999999999985 5 99999999999999999999999999987643
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. .....++..|+|||++.+.
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~ 177 (333)
T cd06650 157 SM--ANSFVGTRSYMSPERLQGT 177 (333)
T ss_pred hc--cccCCCCccccCHHHhcCC
Confidence 32 2344688899999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=223.89 Aligned_cols=171 Identities=24% Similarity=0.389 Sum_probs=149.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|++..........+.+|+.++.+++||||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 3569999999999999999999 457889999998766544556778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999988843 346889999999999999999999998 99999999999999999999999999987754433
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
......++..|+|||.+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccCccccCccccCHhHcc
Confidence 334557888999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=225.48 Aligned_cols=169 Identities=27% Similarity=0.384 Sum_probs=147.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--------hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP 155 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 155 (266)
+.|.-.+.||.|..++|.++. ..+|+++|+|++.... ....+.-..|+.||+++ .||+|+.+.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 457778899999999999987 6789999999986431 11234566899999998 5999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.+++|+|.|+.|.|.++|. ..-.+++.....|+.|+.+|++|||.++ ||||||||+|||++++.++||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999994 3457899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
..+.. ..+....+|||.|.|||.+.
T Consensus 171 ~~l~~-GekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 171 CQLEP-GEKLRELCGTPGYLAPETIK 195 (411)
T ss_pred eccCC-chhHHHhcCCCcccChhhee
Confidence 98864 44567779999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=233.14 Aligned_cols=186 Identities=24% Similarity=0.341 Sum_probs=149.8
Q ss_pred CCCCCCCccccchhhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHH--hcCCCC
Q 024537 66 GSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLL--KIQHKN 143 (266)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~n 143 (266)
+||+.+....+..+++ .....+.+.||+|.||+||+|+| .|+.||||++....+. ...+|.+|.+ .|+|+|
T Consensus 194 tSGSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHEN 266 (513)
T ss_pred cCCCCCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccch
Confidence 3444454444444444 34577889999999999999999 6889999999766443 3345666655 569999
Q ss_pred ceeEEeEEeeCC----cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEeCCC
Q 024537 144 LVTLFGCCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-----EAPARIIHRDI 214 (266)
Q Consensus 144 Iv~l~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-----~~~~~iiHrDl 214 (266)
|+.+++.-..+. .+|||++|.+.|||.++|.. ..++....++++..++.||++||. +|++.|.||||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999999876553 36999999999999999943 468889999999999999999995 57778999999
Q ss_pred CCCceEEcCCCCeEEecccccccCCCCC----ceeeeeeEEeeeeCCCcccc
Q 024537 215 KASNILLDEQLNPKISDFGLARLFPGED----THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 215 Kp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~ 262 (266)
|..|||+.+++++.|+|+|+|.....+. ...+...||..|+|||++-.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999999999999999998876553 23455689999999999853
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=230.08 Aligned_cols=166 Identities=28% Similarity=0.361 Sum_probs=141.6
Q ss_pred ceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|.. .+++.||||++... .......+..|+.++..+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999984 46889999998754 223345677888898887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|...+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999888743 346899999999999999999999998 99999999999999999999999999986543344445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...|++.|+|||++.+.
T Consensus 155 ~~~g~~~y~aPE~~~~~ 171 (318)
T cd05570 155 TFCGTPDYIAPEILSYQ 171 (318)
T ss_pred ceecCccccCHHHhcCC
Confidence 56789999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=235.01 Aligned_cols=166 Identities=26% Similarity=0.376 Sum_probs=141.6
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
+.||.|-||+||-|. ..+|+.||||++.+. ......++.+|+.||+++.||.||.+...|++++.+++|||.+ .|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 789999999999998 568999999998654 2333367889999999999999999999999999999999999 556
Q ss_pred HHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC---CCeEEecccccccCCCCCcee
Q 024537 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~---~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+.+.+... ..+++++...+.++.||+.||.|||.++ |+|+||||+|||+... -.+||||||+||.++.. +..
T Consensus 649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFR 723 (888)
T KOG4236|consen 649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFR 723 (888)
T ss_pred HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh-hhh
Confidence 55665443 3467899999999999999999999999 9999999999999654 45999999999988654 445
Q ss_pred eeeeEEeeeeCCCccccC
Q 024537 246 NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~e 263 (266)
.+..||+.|.|||++...
T Consensus 724 rsVVGTPAYLaPEVLrnk 741 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNK 741 (888)
T ss_pred hhhcCCccccCHHHHhhc
Confidence 566899999999998764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=249.27 Aligned_cols=174 Identities=22% Similarity=0.363 Sum_probs=157.3
Q ss_pred hcCccccceecccCceEEEEEEecC-CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.+.|.++..||.|+||.||+|.... +-.-|.|.+...+...++.++-|+.||..+.||+||+++++|..++.+||+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3458889999999999999999544 444567888888888899999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
|.||-++..+.+ -...+.+.++..+++|+++||.|||++. |||||||+.|||++-+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 999999888754 3567999999999999999999999998 99999999999999999999999999998877777
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
...+|.|||.|+|||+++-|
T Consensus 186 kRDsFIGTPYWMAPEVvmCE 205 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCE 205 (1187)
T ss_pred hhccccCCcccccchheeec
Confidence 88899999999999998644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=235.26 Aligned_cols=179 Identities=30% Similarity=0.402 Sum_probs=145.9
Q ss_pred HHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeEEee
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE 153 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 153 (266)
....++|++.+.||+|+||.||+|.+ .++..||||++.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456799999999999999999963 245689999986542 33446788999999999 89999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCC-------------------------------------------------------
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTK------------------------------------------------------- 178 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 178 (266)
++..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999988854211
Q ss_pred -----------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 179 -----------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 179 -----------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788889999999999999999998 999999999999999999999999999876543
Q ss_pred Ccee--eeeeEEeeeeCCCccccC
Q 024537 242 DTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
.... ....++..|+|||++...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~ 291 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNC 291 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCC
Confidence 3211 122345579999988654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=227.54 Aligned_cols=171 Identities=26% Similarity=0.443 Sum_probs=144.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|.+.+.||+|+||.||+|+ ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 569999999999999999998 4478899999987543 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++ +|.+.+... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 965 777776332 345788899999999999999999998 99999999999999999999999999987654444
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLG 178 (309)
T ss_pred ccccccccccccCCHHHhC
Confidence 4444567889999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=224.49 Aligned_cols=172 Identities=28% Similarity=0.358 Sum_probs=145.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.|++.+.||+|+||.||++. ..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47888999999999999998 45789999999865422 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+.+... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998887432 3346899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
. .....|+..|+|||++...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd05605 157 T-IRGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred c-cccccCCCCccCcHHhcCC
Confidence 2 2344688999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=231.52 Aligned_cols=169 Identities=23% Similarity=0.372 Sum_probs=140.3
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKM 158 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 158 (266)
+|++.+.||+|+||.||+|+ ..+++.||||++... .......+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 48889999999999999998 557899999998643 2233456889999999999999999999886432 479
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+ +++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 568888773 2346889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 239 PGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
..... ......+|..|+|||++..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc
Confidence 33221 1233468899999998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=259.40 Aligned_cols=180 Identities=22% Similarity=0.234 Sum_probs=159.8
Q ss_pred chhhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecc---cChhhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV---DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 77 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
..+.+.+..++|.+++.||+|+||.|.+++ ..+++.||+|++++ .......-|..|-.+|.--+.+-|+.++-+|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 456677788999999999999999999999 67899999999876 24445567899999999999999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
++.++|+||||++||+|-.++.. ...+++..++.|+..|+.||.-||+.| +|||||||+|||||..|.+||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999843 237999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCC-CceeeeeeEEeeeeCCCcccc
Q 024537 233 GLARLFPGE-DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 233 G~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|.|-.+..+ .-..+...|||.|.+||+++.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHh
Confidence 999887644 344556689999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=234.25 Aligned_cols=180 Identities=31% Similarity=0.420 Sum_probs=146.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
+....++|++.+.||+|+||.||+|++ .++..||+|.+... .......+.+|+.+++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 345566799999999999999999873 13357999998754 333456788999999999 8999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcC-------------------------------------------------------
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKT------------------------------------------------------- 177 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 177 (266)
..+..++||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999885321
Q ss_pred ------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce-
Q 024537 178 ------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH- 244 (266)
Q Consensus 178 ------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 244 (266)
....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 1124788889999999999999999998 999999999999999999999999999876433221
Q ss_pred -eeeeeEEeeeeCCCccccC
Q 024537 245 -VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 -~~~~~~t~~y~aPE~~~~e 263 (266)
..+..++..|+|||++...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~ 289 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC 289 (374)
T ss_pred eccCCCCccceeCHHHhcCC
Confidence 1122344579999987543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=222.51 Aligned_cols=171 Identities=23% Similarity=0.399 Sum_probs=149.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 3568889999999999999998 457899999998776555556778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998843 346889999999999999999999998 99999999999999999999999999987654443
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
......++..|+|||++.
T Consensus 162 ~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccccCcccccChhhhc
Confidence 344557889999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=240.43 Aligned_cols=178 Identities=23% Similarity=0.269 Sum_probs=149.0
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC----
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP---- 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 155 (266)
...++|.+.+.||+|+||+||+|+ ..+++.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345689999999999999999998 567999999998654 3444567889999999999999999998876433
Q ss_pred ----cEEEEEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 156 ----EKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 2689999999999999886432 2356889999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCC--CceeeeeeEEeeeeCCCccccC
Q 024537 231 DFGLARLFPGE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 231 DFG~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|||+++.+... .....+..||+.|+|||++...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence 99999876433 1223455789999999998754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=221.14 Aligned_cols=174 Identities=26% Similarity=0.353 Sum_probs=144.5
Q ss_pred hcCccccceecccCceEEEEEEec----CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456899999999999999999742 45689999987653 3334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999888432 346889999999999999999999998 9999999999999999999999999887643
Q ss_pred CCCc-eeeeeeEEeeeeCCCccccC
Q 024537 240 GEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYH 183 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhC
Confidence 2211 11122345789999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=221.29 Aligned_cols=172 Identities=25% Similarity=0.391 Sum_probs=151.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.+.|++++.||.|+||.||+|.. .+++.||+|.+..........+..|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 35699999999999999999984 46899999999877766677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998877432 346889999999999999999999998 99999999999999999999999999987654444
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
......++..|+|||++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred ccceecCCccccCceeec
Confidence 445567888999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=222.35 Aligned_cols=172 Identities=25% Similarity=0.404 Sum_probs=152.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||.|+||.||+|.. .++..||+|.+..........+..|+.++++++||||+++++.+..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45699999999999999999984 46899999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|..++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999888432 346899999999999999999999998 99999999999999999999999999987655544
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
......+++.|+|||++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred ccceeecchhhcCHHHHh
Confidence 445567888999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=220.04 Aligned_cols=170 Identities=25% Similarity=0.395 Sum_probs=149.3
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.|++.+.||+|+||.||+|.. .++..+++|.+..........+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 478889999999999999994 4678899999877666666788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 9999887743 2346889999999999999999999998 9999999999999999999999999998765544444
Q ss_pred eeeeEEeeeeCCCccc
Q 024537 246 NTFRISVVTWPPNMHC 261 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~ 261 (266)
....++..|+|||++.
T Consensus 161 ~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 161 DSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccccCHhhcc
Confidence 5567889999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=241.54 Aligned_cols=170 Identities=28% Similarity=0.403 Sum_probs=147.1
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------cEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------EKML 159 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 159 (266)
|..-+.||+|+||.||+++ ..+|+.||||.++.. .....+....|+++|++++|||||++.+.=.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455779999999999999 678999999998764 3444567779999999999999999998765543 4589
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc--CCC--CeEEeccccc
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQL--NPKISDFGLA 235 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~--~~~--~~kl~DFG~a 235 (266)
|||||.||+|...+.+..+..++++.+.+.++..++.||.|||++| |+||||||.||++- .+| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888889999999999999999999999998 99999999999983 333 3699999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
+.+.+.. ...++.||..|.+||+.-
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHh
Confidence 9987555 667789999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=220.41 Aligned_cols=176 Identities=32% Similarity=0.482 Sum_probs=152.5
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
...+|++++.||.|+||.||+|...++..+|+|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568999999999999999999777899999999877665567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998543 3456889999999999999999999998 99999999999999999999999999988754433
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++...
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~ 179 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHG 179 (261)
T ss_pred cccCCCCceEecCHHHHccC
Confidence 33333456789999987543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=236.26 Aligned_cols=170 Identities=22% Similarity=0.367 Sum_probs=137.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--------
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-------- 154 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------- 154 (266)
...+|++.+.||+|+||+||+|. ..+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 34679999999999999999998 45789999998864422 234699999999999999999987532
Q ss_pred CcEEEEEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDF 232 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DF 232 (266)
..+++||||+++ ++..++.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236789999965 66665533 223457899999999999999999999998 99999999999998665 6999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+|+.+...... ....+|+.|+|||++.+
T Consensus 216 Gla~~~~~~~~~-~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 216 GSAKNLLAGQRS-VSYICSRFYRAPELMLG 244 (440)
T ss_pred ccchhccCCCCc-ccCCCCcCccCHHHhcC
Confidence 999977543322 34568899999998754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=247.81 Aligned_cols=175 Identities=21% Similarity=0.299 Sum_probs=145.9
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999984 46899999998754 2233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcC--------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 162 EYLPNKSLDYFIFDKT--------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
||++|++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234566778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCC------------------ceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGED------------------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~------------------~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|+...... .......||+.|+|||++.+.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~ 206 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV 206 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence 998762111 111224689999999998654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=221.75 Aligned_cols=172 Identities=24% Similarity=0.457 Sum_probs=138.2
Q ss_pred cCccccceecccCceEEEEEEe--cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhc---CCCCceeEEeEEe-----e
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCA-----E 153 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~-----~ 153 (266)
++|++++.||+|+||+||+|+. .+++.||+|.+.... ......+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3689999999999999999984 346789999886542 22223455677777665 6999999999885 2
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
....++||||+. ++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999995 6888887432 2345889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+++..... .......+++.|+|||++...
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 184 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQS 184 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCC
Confidence 99876543 233445789999999988543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=231.92 Aligned_cols=181 Identities=25% Similarity=0.347 Sum_probs=147.1
Q ss_pred hHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcC-CCCceeEEeEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~ 151 (266)
.+....+.|.+++.||+|+||.||+|... .+..||||++... .....+.+.+|+.+++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 44555778999999999999999999742 2347999998754 3333467889999999996 99999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcC------------------------------------------------------
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKT------------------------------------------------------ 177 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 177 (266)
...+..++||||+++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998875421
Q ss_pred ---------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 178 ---------------------------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 178 ---------------------------------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 0124778888999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
||++.++.+||+|||+++.+...... .....++..|+|||++.+.
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 314 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN 314 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC
Confidence 99999999999999999876433221 1222356679999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=216.72 Aligned_cols=172 Identities=26% Similarity=0.456 Sum_probs=144.6
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45888999999999999999987778899998764432 23578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999888432 235889999999999999999999998 9999999999999999999999999998764332211
Q ss_pred -eeeeEEeeeeCCCccccC
Q 024537 246 -NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 -~~~~~t~~y~aPE~~~~e 263 (266)
....++..|+|||++...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred cCCCCCchhhCChhhcccC
Confidence 122344579999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=217.69 Aligned_cols=175 Identities=21% Similarity=0.352 Sum_probs=149.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|+ ..+++.||||.+... .......+.+|+.+++.++||||+++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 568999999999999999998 457899999987542 3344456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875322 2345788899999999999999999998 99999999999999999999999999998765
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........++..|+|||.+...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~ 181 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred hhHHHhcCCCCccccChhhhccC
Confidence 44444455688899999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=226.39 Aligned_cols=168 Identities=23% Similarity=0.277 Sum_probs=141.2
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.....|++++.||+|+||.||+|.. .++..||+|+.... ....|+.++++++||||+++++++..++..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3446799999999999999999994 46788999975432 2346899999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|++. ++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9994 577777743 3456899999999999999999999998 999999999999999999999999999864322
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ......||..|+|||++...
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~ 231 (357)
T PHA03209 211 P-AFLGLAGTVETNAPEVLARD 231 (357)
T ss_pred c-ccccccccccccCCeecCCC
Confidence 2 22345789999999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=234.18 Aligned_cols=172 Identities=24% Similarity=0.331 Sum_probs=148.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--------hhHHHHHHHHHHHHhcC---CCCceeEEeEEee
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQ---HKNLVTLFGCCAE 153 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 153 (266)
.+|..++.+|+|+||.||.|. +.+...|+||.+.+... ..+..+-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 348889999999999999998 55778899998865411 11234567999999997 9999999999999
Q ss_pred CCcEEEEEecc-CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 154 GPEKMLVYEYL-PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 154 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
++++||+||.. +|.+|.+++. ....+++.++..|++|++.|+++||++| |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 4678888883 3356999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
|.|....+. .-..|+||..|+|||++.++.+
T Consensus 715 gsaa~~ksg--pfd~f~gtv~~aapevl~g~~y 745 (772)
T KOG1152|consen 715 GSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKY 745 (772)
T ss_pred cchhhhcCC--CcceeeeeccccchhhhCCCcc
Confidence 999987533 3468899999999999999865
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=226.94 Aligned_cols=170 Identities=28% Similarity=0.365 Sum_probs=140.7
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----- 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 155 (266)
..++|++.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999998 457899999998643 3334466789999999999999999999987543
Q ss_pred -cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
..++||||+.+ ++...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999965 5555542 24778889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++...... ......+|+.|+|||++.+.
T Consensus 170 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 197 (359)
T cd07876 170 ARTACTNF-MMTPYVVTRYYRAPEVILGM 197 (359)
T ss_pred ccccccCc-cCCCCcccCCCCCchhccCC
Confidence 98754332 22344788999999998664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=214.36 Aligned_cols=173 Identities=25% Similarity=0.341 Sum_probs=149.4
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+|++.+.||+|+||.||++. ..+++.||+|.+... .....+.+..|+.+++.++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47889999999999999998 457899999998643 3444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999998887432 3446788999999999999999999998 999999999999999999999999999877655444
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~ 175 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENM 175 (255)
T ss_pred cccccCCccccCHHHHccC
Confidence 4455788899999987554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=218.44 Aligned_cols=172 Identities=26% Similarity=0.435 Sum_probs=145.0
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478899999999999999984 578999999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
++ ++|.+++........+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 96 578777754333467899999999999999999999998 99999999999999999999999999987644433
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLG 175 (285)
T ss_pred cccCCcccccccChHHhcC
Confidence 3333456888999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=216.51 Aligned_cols=175 Identities=26% Similarity=0.452 Sum_probs=148.2
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|+++++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3567999999999999999999977888999998765433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999988543 3456888899999999999999999998 99999999999999999999999999988754321
Q ss_pred e-eeeeeEEeeeeCCCccccC
Q 024537 244 H-VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~-~~~~~~t~~y~aPE~~~~e 263 (266)
. .....++..|+|||++...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFG 179 (261)
T ss_pred eccCCCccceecCCHHHhccC
Confidence 1 1222356679999987543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=219.48 Aligned_cols=168 Identities=32% Similarity=0.511 Sum_probs=146.3
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhH--HHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL--REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
|++++.||+|+||+||+|. ..+++.||+|++........ ....+|+.+++.++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999 44677899999987754432 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|.+++. ....+++..+..++.|++.||.+||+++ |+|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999985 3356899999999999999999999998 999999999999999999999999999865444455
Q ss_pred eeeeeEEeeeeCCCccc
Q 024537 245 VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~ 261 (266)
.....++..|+|||++.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp BSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccccccc
Confidence 55667888999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=220.37 Aligned_cols=171 Identities=28% Similarity=0.462 Sum_probs=144.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5699999999999999999984 478899999987542 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 5887777432 345788999999999999999999998 99999999999999999999999999987654443
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLG 178 (301)
T ss_pred cccccceeecccCcHHHhC
Confidence 3344467889999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=229.28 Aligned_cols=169 Identities=26% Similarity=0.382 Sum_probs=141.7
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKM 158 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 158 (266)
+|++.+.||+|+||+||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47788999999999999998 457999999998643 2334467889999999999999999999998876 789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+. ++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999995 57777663 3356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 239 PGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
.... .......++..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcC
Confidence 4332 22223357888999998765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=214.35 Aligned_cols=174 Identities=25% Similarity=0.418 Sum_probs=152.4
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||.|+||.||+|.. .+++.+++|.+..........+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35799999999999999999984 46789999999876555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887432 246889999999999999999999998 99999999999999999999999999988765443
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred ccccccCCccccCchhhccc
Confidence 34455678889999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=220.30 Aligned_cols=171 Identities=25% Similarity=0.423 Sum_probs=149.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.+|++.+.||+|+||.||+|. ..+++.||+|.+..........+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 579999999999999999998 4578999999988765555577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999998832 34788899999999999999999998 999999999999999999999999999876544433
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....+++.|+|||++...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~ 191 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRK 191 (296)
T ss_pred cCcccCCccccCHHHHcCC
Confidence 3445688899999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=217.69 Aligned_cols=171 Identities=27% Similarity=0.357 Sum_probs=144.8
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
|+..+.||+|+||+||+|. ..+++.||+|.+.... ......+.+|+.+++.++|+||+.+++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677899999999999998 4578999999986542 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999998887532 2346899999999999999999999998 99999999999999999999999999987643322
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
.....|+..|+|||++...
T Consensus 158 -~~~~~g~~~~~aPE~~~~~ 176 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQ 176 (285)
T ss_pred -ccCCCCCcCccChHHhcCC
Confidence 2334688999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=221.48 Aligned_cols=173 Identities=25% Similarity=0.481 Sum_probs=142.1
Q ss_pred hcCccccceecccCceEEEEEEe-cCCC----EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..+|++.+.||+|+||.||+|.+ .++. .||+|.+... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 45699999999999999999984 3343 3899998754 334456788999999999999999999998764 578
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999988542 345788899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcee--eeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
....... ....++..|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~ 186 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHR 186 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccC
Confidence 5443221 112335679999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=218.63 Aligned_cols=169 Identities=30% Similarity=0.379 Sum_probs=147.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.+++++.||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468899999999999999998 4478999999986542 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999988843 356889999999999999999999998 999999999999999999999999999887544
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.....+++.|+|||.+...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSK 173 (290)
T ss_pred ---CCCCCCCccccChhhhcCC
Confidence 2344688899999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=217.16 Aligned_cols=165 Identities=27% Similarity=0.358 Sum_probs=138.7
Q ss_pred ecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||+|+||.||+++ ..+|+.||+|.+..+. ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998 4579999999986432 11223456799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..... .....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~ 155 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA 155 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-eeccC
Confidence 8887432 3345888999999999999999999998 99999999999999999999999999987754332 22346
Q ss_pred EEeeeeCCCccccC
Q 024537 250 ISVVTWPPNMHCMD 263 (266)
Q Consensus 250 ~t~~y~aPE~~~~e 263 (266)
++..|+|||++...
T Consensus 156 ~~~~y~aPE~~~~~ 169 (277)
T cd05607 156 GTNGYMAPEILKEE 169 (277)
T ss_pred CCCCccCHHHHccC
Confidence 78899999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=220.22 Aligned_cols=172 Identities=25% Similarity=0.421 Sum_probs=150.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..+|++++.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3579999999999999999998 457999999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999988732 34788899999999999999999998 99999999999999999999999999987655444
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......+++.|+|||++...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~ 190 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRK 190 (297)
T ss_pred CcCcccCCccccCHHHHcCC
Confidence 33445688899999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=212.83 Aligned_cols=172 Identities=21% Similarity=0.333 Sum_probs=150.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++++.||.|+||.||.++ ..+++.+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 48889999999999999998 557899999987654 344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 456889999999999999999999998 99999999999999999999999999988755544
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+++.|.|||++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG 175 (256)
T ss_pred cccccCCCccccCHhhcCC
Confidence 4455678899999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=217.23 Aligned_cols=178 Identities=24% Similarity=0.389 Sum_probs=144.5
Q ss_pred HhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
+..++|++.+.||+|+||.||+|... .+..||+|.+... .......+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34677999999999999999998742 3567999988643 2334456889999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCC-------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTK-------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999998854221 124577888999999999999999998 99999999999999999999
Q ss_pred EecccccccCCCCCceee--eeeEEeeeeCCCccccC
Q 024537 229 ISDFGLARLFPGEDTHVN--TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~~~--~~~~t~~y~aPE~~~~e 263 (266)
|+|||+++.+........ ...++..|+|||++...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence 999999987643322111 12345679999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=214.13 Aligned_cols=175 Identities=27% Similarity=0.432 Sum_probs=147.2
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|++.+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4567899999999999999999977778899999875432 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++.+.....
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985432 356899999999999999999999998 99999999999999999999999999988753321
Q ss_pred e-eeeeeEEeeeeCCCccccC
Q 024537 244 H-VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~-~~~~~~t~~y~aPE~~~~e 263 (266)
. ......+..|+|||++...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred cccCCCcCceeccCccccccC
Confidence 1 1111234579999987653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=219.59 Aligned_cols=169 Identities=27% Similarity=0.372 Sum_probs=145.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||+|+||.||++. ..++..+|+|.+... .......+.+|+.++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368999999999999999998 457888999988755 333446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++.. ...+++..+..++.|++.||.|||++ + ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999843 25688899999999999999999984 6 9999999999999999999999999998764332
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
...+.++..|+|||++.+
T Consensus 155 --~~~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQG 172 (308)
T ss_pred --cccCCCCcCccChhHhcC
Confidence 234578889999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=215.74 Aligned_cols=174 Identities=29% Similarity=0.495 Sum_probs=144.2
Q ss_pred hcCccccceecccCceEEEEEEe-----cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 157 (266)
...|++.+.||+|+||.||+|.. .++..||+|.+..........+.+|+.++++++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35688999999999999999973 3578999999887766666788999999999999999999998754 3468
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999988432 245889999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCceee---eeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHVN---TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~~---~~~~t~~y~aPE~~~~e 263 (266)
......... ...++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTES 186 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccC
Confidence 754332111 11234469999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=225.33 Aligned_cols=167 Identities=28% Similarity=0.415 Sum_probs=141.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------C
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 155 (266)
.++|++++.||.|+||+||+|. ..+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4679999999999999999998 4578899999987542 22345677899999999999999999988643 3
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..+++++++ +++|..++. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468999988 888887762 346899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+...... ....+|..|+|||++.+
T Consensus 166 ~~~~~~~---~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 166 RQADDEM---TGYVATRWYRAPEIMLN 189 (343)
T ss_pred eecCCCc---CCccccccccCchHhcC
Confidence 8765432 34578999999998765
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=212.21 Aligned_cols=173 Identities=26% Similarity=0.423 Sum_probs=150.6
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|.+.+.||+|+||.||+|. ..+++.|++|.+... .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47788999999999999998 457899999998654 344567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998543 2456889999999999999999999998 99999999999999999999999999998765544
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......+++.|+|||++...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred hhhccccCccccCHHHhcCC
Confidence 44555788899999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=236.14 Aligned_cols=171 Identities=24% Similarity=0.386 Sum_probs=143.5
Q ss_pred cccceecccCceEEEEEE-ecCCCEEEEEeeccc----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc--EEEEE
Q 024537 89 SDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE--KMLVY 161 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lv~ 161 (266)
+....||+|+|-+||+|. -.+|-+||--.++.. .....++|..|+.+|+.|+||||+++|++|.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 556789999999999998 346778875444322 44556889999999999999999999999998766 77899
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~ 240 (266)
|++..|+|..++.+ .+.+....++.|++||+.||.|||++. ++|||||||-+||+|+. .|.|||+|+|+|+....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999843 456888999999999999999999998 46999999999999975 58899999999998754
Q ss_pred CCceeeeeeEEeeeeCCCccccCCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
... ....|||.||||||+--+.|
T Consensus 199 s~a--ksvIGTPEFMAPEmYEE~Yn 221 (632)
T KOG0584|consen 199 SHA--KSVIGTPEFMAPEMYEENYN 221 (632)
T ss_pred ccc--ceeccCccccChHHHhhhcc
Confidence 433 34689999999999864443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=228.12 Aligned_cols=176 Identities=28% Similarity=0.346 Sum_probs=153.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..+.|..-+.||+|+||.||-|+ ..+|+.||.|.+.++. +......++|-.+|.+++.+.||.+-.+|++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34668888999999999999998 5689999999886542 2223456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||..|.||+|...|.+.. +..+++..++.++.+|+.||++||..+ ||+|||||+|||+|+.|.++|+|+|+|..++
T Consensus 263 VLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999988885543 368999999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
...... .-.||..|||||++.+|-
T Consensus 339 ~g~~~~-~rvGT~GYMAPEvl~ne~ 362 (591)
T KOG0986|consen 339 EGKPIR-GRVGTVGYMAPEVLQNEV 362 (591)
T ss_pred CCCccc-cccCcccccCHHHHcCCc
Confidence 554433 338999999999998874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=213.71 Aligned_cols=174 Identities=28% Similarity=0.477 Sum_probs=145.4
Q ss_pred hcCccccceecccCceEEEEEEec----CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.+.||+|+||+||+|.+. +...||||.+.... ......+..|+.++.+++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 456899999999999999999853 24579999887543 3344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998432 236889999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCceeee--eeEEeeeeCCCccccC
Q 024537 240 GEDTHVNT--FRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~--~~~t~~y~aPE~~~~e 263 (266)
.......+ ..++..|+|||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~ 183 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYR 183 (266)
T ss_pred ccccceeccCCCCCccccChhhhccC
Confidence 33222222 2334679999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=216.95 Aligned_cols=171 Identities=29% Similarity=0.376 Sum_probs=144.6
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+..|+.+++.++|++|+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6778899999999999998 4578999999886542 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999998887432 2346889999999999999999999998 99999999999999999999999999987643322
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
.....|+..|+|||++...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred -ccCCCCCccccChHHHcCC
Confidence 2234688999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=215.68 Aligned_cols=175 Identities=30% Similarity=0.495 Sum_probs=144.5
Q ss_pred cCccccceecccCceEEEEEEe-----cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
+.|++.+.||+|+||+||+|.+ .++..||+|.+... .......+.+|+.++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688899999999999999973 24578999998754 33444678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCC--------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 160 VYEYLPNKSLDYFIFDKTK--------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853221 234788889999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 226 NPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
.+||+|||+++...... .......++..|+|||++.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccC
Confidence 99999999998764322 112233456679999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=214.88 Aligned_cols=165 Identities=24% Similarity=0.384 Sum_probs=142.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+|++.+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 57888999999999999998 457899999998755 3334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999985432 3678888999999999999999998 9999999999999999999999999998764332
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 150 AKTYVGTNAYMAPERISGE 168 (279)
T ss_pred ccCCCCChhhcCceeecCC
Confidence 2345788999999988653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=234.88 Aligned_cols=169 Identities=28% Similarity=0.411 Sum_probs=150.7
Q ss_pred ceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHH
Q 024537 92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~ 170 (266)
-.||+|.||+||-|+ ..+...+|||.+..+.....+-+.+|+.+-++++|.|||+++|.+.+++.+-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 359999999999999 5567789999998777766778889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeEEecccccccCCCCCceeeeee
Q 024537 171 YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 171 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
++++.+-..-.-.+..+-.+.+||++||.|||++. |||||||-+|+|++ ..|.+||+|||.++++.+-...+.+|+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 99976544334477888899999999999999998 99999999999996 478899999999999987777888999
Q ss_pred EEeeeeCCCccccC
Q 024537 250 ISVVTWPPNMHCMD 263 (266)
Q Consensus 250 ~t~~y~aPE~~~~e 263 (266)
||..|||||++-..
T Consensus 738 GTLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQG 751 (1226)
T ss_pred cchhhhChHhhccC
Confidence 99999999998543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=215.56 Aligned_cols=173 Identities=29% Similarity=0.447 Sum_probs=146.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC------Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG------PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~~ 156 (266)
.+.|++.+.||+|+||.||+|. ..+++.||+|.+..... ....+..|+.++.++ +||||+++++.+... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4568889999999999999998 45688999999875533 235677899999998 699999999998753 45
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|++|||+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 79999999999999988542 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.............++..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred ecccccccCCcccccccccCHhHhcc
Confidence 76544444556678999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=217.34 Aligned_cols=172 Identities=26% Similarity=0.406 Sum_probs=146.9
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++++.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3688999999999999999995 47899999988754 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988885433334789999999999999999999974 6 9999999999999999999999999998764433
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
. ....++..|+|||++..
T Consensus 158 ~--~~~~~~~~y~aPE~~~~ 175 (286)
T cd06622 158 A--KTNIGCQSYMAPERIKS 175 (286)
T ss_pred c--ccCCCccCccCcchhcC
Confidence 2 23357778999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=227.33 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=141.9
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHh--cCCCCceeEEeEEeeCC----cEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEGP----EKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~l 159 (266)
...++++.||+|.||.||+|.+ +++.||||++..... +.+.+|-.|... +.|+||++++++-.... .+||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3456678899999999999998 569999999875433 567777777664 68999999999887665 7899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc------CCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE------APARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~------~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
|++|.+.|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||..|||+.+++++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 34689999999999999999999973 24569999999999999999999999999
Q ss_pred ccccCCCC--CceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|..+... ....-...||..|||||++-+-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 99887533 2233335899999999998653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=218.31 Aligned_cols=173 Identities=25% Similarity=0.406 Sum_probs=143.2
Q ss_pred cCccccceecccCceEEEEEE-ec--C--CCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CCcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MP--N--GQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~--~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 157 (266)
..|+....||+|.||.||+|. .. + .+.+|||+++... ........+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 458999999999999999995 22 2 3479999987652 2223556789999999999999999999988 7889
Q ss_pred EEEEeccCCCCHHHHHhh--cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC----CCeEEec
Q 024537 158 MLVYEYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ----LNPKISD 231 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~----~~~kl~D 231 (266)
|+++||.+. +|+..++- ......++...++.|+.||++|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 67677642 233457889999999999999999999999 9999999999999877 8999999
Q ss_pred ccccccCCCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 232 FGLARLFPGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 232 FG~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
||+||.+.++-. ..+....|.+|+|||++.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG 213 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG 213 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcc
Confidence 999999876533 3345577999999999865
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=226.30 Aligned_cols=169 Identities=24% Similarity=0.340 Sum_probs=142.1
Q ss_pred HhhcCccccceecccCceEEEEEEe---cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM---PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
....+|++++.||+|+||.||+|.. ..+..||+|.+... ....+|+.+++.++||||+++++++...+..++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3456799999999999999999973 24578999987643 234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||++. ++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+|+.+.
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 67777772 3356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCc--eeeeeeEEeeeeCCCccccC
Q 024537 240 GEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......||+.|+|||++...
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~ 262 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALD 262 (392)
T ss_pred cccccccccccccccCccCHhHhcCC
Confidence 3322 22345689999999998754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=215.13 Aligned_cols=175 Identities=33% Similarity=0.553 Sum_probs=144.7
Q ss_pred cCccccceecccCceEEEEEEecC-C-----CEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPN-G-----QEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
++|++++.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468899999999999999998432 2 579999887543 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 159 LVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854321 145788899999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 226 NPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
.++|+|||+++...... .......+++.|+|||++...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG 201 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence 99999999998754322 112233557789999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=213.56 Aligned_cols=175 Identities=29% Similarity=0.457 Sum_probs=146.3
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..+.|++++.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34567999999999999999999977889999999875443 2357889999999999999999999874 567899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999888543 3456888999999999999999999998 9999999999999999999999999998775322
Q ss_pred -ceeeeeeEEeeeeCCCccccC
Q 024537 243 -THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 -~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......++..|+|||++...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred cccccCCcccccccCHHHhccC
Confidence 222223456689999987543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=211.38 Aligned_cols=175 Identities=22% Similarity=0.371 Sum_probs=150.4
Q ss_pred cCccccceecccCceEEEEEEec-CCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999954 8999999988642 2333567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|..++... .....+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888542 22345889999999999999999999998 99999999999999999999999999987755
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........++..|.|||++...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~ 181 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred CCcccceecCCccccCHHHhccC
Confidence 44444455788899999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=239.16 Aligned_cols=170 Identities=24% Similarity=0.340 Sum_probs=148.4
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|.+++.||+|+||.||+|.. .+++.||||++... .......+..|+.++..++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 36799999999999999999994 47899999998754 233346788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+.+++|..++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999998843 345788999999999999999999998 99999999999999999999999999998766
Q ss_pred CCceeeeeeEEeeeeCCCcc
Q 024537 241 EDTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~ 260 (266)
.........+|+.|.+||..
T Consensus 157 ~~~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 157 RELNMMDILTTPSMAKPKND 176 (669)
T ss_pred CcccccccccCccccCcccc
Confidence 55555566788889998854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=212.67 Aligned_cols=174 Identities=28% Similarity=0.455 Sum_probs=144.6
Q ss_pred hcCccccceecccCceEEEEEEec-C---CCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..+|++.+.||+|+||.||+|... + +..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356889999999999999999842 2 3379999886542 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999998533 346788999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCceeee---eeEEeeeeCCCccccC
Q 024537 240 GEDTHVNT---FRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~---~~~t~~y~aPE~~~~e 263 (266)
.......+ ..++..|+|||++...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~ 184 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYR 184 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccC
Confidence 44332221 1224579999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-31 Score=226.56 Aligned_cols=176 Identities=26% Similarity=0.308 Sum_probs=153.3
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 158 (266)
...+|.++..||+|+||.|.+|. ..+.+.||||+++++ ...+.+--+.|-.+|+... -|.+++++..|++-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34568889999999999999997 557788999999876 3333444556777777664 678999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+.||+|-..+. .-+.+.+..+..++..|+-||-|||++| ||+||||.+||+++.+|.+||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999987773 3456888899999999999999999999 999999999999999999999999999987
Q ss_pred CCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.-+...+.+++|||.|.|||+++.+++
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPY 527 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPY 527 (683)
T ss_pred ccCCcceeeecCCCcccccceEEeccc
Confidence 667778899999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=219.51 Aligned_cols=166 Identities=24% Similarity=0.384 Sum_probs=133.6
Q ss_pred cceecccCceEEEEEEec---CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEEEEeccC
Q 024537 91 LNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVYEYLP 165 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 165 (266)
..+||+|+||+||+|+.. +++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999843 567899999865432 2456789999999999999999999864 456799999994
Q ss_pred CCCHHHHHhhcC------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE----cCCCCeEEeccccc
Q 024537 166 NKSLDYFIFDKT------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLA 235 (266)
Q Consensus 166 ~~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill----~~~~~~kl~DFG~a 235 (266)
++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +..+.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57777764221 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred ccCCCCC---ceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGED---THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.+.... .......+|+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcC
Confidence 8775432 22334578899999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=212.15 Aligned_cols=175 Identities=26% Similarity=0.361 Sum_probs=146.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.+++.....||+|+||.||+|. ..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 3444455689999999999998 456788999998877666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++.........++..+..++.|++.||.|||+++ |+||||||+||+++. .+.++|+|||++..+....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999999998854322222377888899999999999999998 999999999999976 6789999999998775444
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......++..|+|||++..
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred CccccCCCCccccChhhhcc
Confidence 33444567889999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=211.63 Aligned_cols=172 Identities=27% Similarity=0.456 Sum_probs=145.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-----hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
++|++.+.||+|+||.||.|. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468899999999999999998 4578999999886432 2234567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988843 245788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCCcee---eeeeEEeeeeCCCccccC
Q 024537 240 GEDTHV---NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~---~~~~~t~~y~aPE~~~~e 263 (266)
...... ....++..|+|||++...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGE 182 (263)
T ss_pred ccccccccccCCCcCccccCcceeccC
Confidence 332211 234577889999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=224.51 Aligned_cols=170 Identities=26% Similarity=0.351 Sum_probs=141.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----- 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 155 (266)
..++|++.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 35689999999999999999998 457899999998753 3334467788999999999999999999986543
Q ss_pred -cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
..++||||+++ ++...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999965 5655552 24788889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++...... ......+|..|+|||++.+.
T Consensus 166 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 193 (355)
T cd07874 166 ARTAGTSF-MMTPYVVTRYYRAPEVILGM 193 (355)
T ss_pred cccCCCcc-ccCCccccCCccCHHHHcCC
Confidence 98764332 22345789999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=215.19 Aligned_cols=176 Identities=28% Similarity=0.486 Sum_probs=147.1
Q ss_pred hcCccccceecccCceEEEEEEe------cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45688999999999999999973 234568999987666666678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcC----------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 159 LVYEYLPNKSLDYFIFDKT----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885322 1235899999999999999999999998 99999999999999999999
Q ss_pred EecccccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 229 ISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
|+|||+++........ .....++..|+|||++...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 197 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 197 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence 9999999876433211 1122346689999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=215.40 Aligned_cols=171 Identities=24% Similarity=0.395 Sum_probs=145.8
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999985 468999999886542 2223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++++++..++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988877763 2345899999999999999999999998 9999999999999999999999999999876554
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred ccccCcccccccCCHHHHhC
Confidence 33334467888999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=216.99 Aligned_cols=171 Identities=24% Similarity=0.435 Sum_probs=150.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.+|++.+.||.|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 469999999999999999998 4678999999987665555577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999988732 35889999999999999999999998 999999999999999999999999999877554443
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~ 190 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRK 190 (296)
T ss_pred CCCcCCCccccCcchhcCC
Confidence 3445678899999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=214.07 Aligned_cols=174 Identities=22% Similarity=0.370 Sum_probs=149.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|. ..+++.||||.+... .......+.+|+.+++.+.||||+++++.+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999999 568999999987643 2334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885322 2346889999999999999999999998 99999999999999999999999999988755
Q ss_pred CCceeeeeeEEeeeeCCCcccc
Q 024537 241 EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.........++..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~ 180 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred CCcccccccCCcCccCHHHhcC
Confidence 4444445578889999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=215.47 Aligned_cols=177 Identities=24% Similarity=0.375 Sum_probs=143.2
Q ss_pred HhhcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
+..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998632 24589999876543 233456788999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCC-------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTK-------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
..++||||+++|+|.+++..... ....++..+..++.|++.||.|||+++ |+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999854221 133566788899999999999999998 99999999999999999999
Q ss_pred EecccccccCCCCCce--eeeeeEEeeeeCCCcccc
Q 024537 229 ISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~ 262 (266)
|+|||+++.+...... .....++..|+|||++..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 9999999876432211 111234567999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=215.59 Aligned_cols=171 Identities=27% Similarity=0.454 Sum_probs=136.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhc---CCCCceeEEeEEee-----CC
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAE-----GP 155 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 155 (266)
+|++.+.||+|+||+||+|+ ..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48889999999999999998 4578999999887542 11123455677766655 79999999998864 24
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..+++||++. ++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999996 4787777432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+.+...... ....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~ 182 (288)
T cd07863 156 RIYSCQMAL-TPVVVTLWYRAPEVLLQS 182 (288)
T ss_pred ccccCcccC-CCccccccccCchHhhCC
Confidence 877543322 234678899999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=215.34 Aligned_cols=172 Identities=27% Similarity=0.440 Sum_probs=143.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|.+.+.||+|+||.||+|. ..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 3579999999999999999998 457899999998755322 22356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+. +++.+.+... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 995 6666665322 245778888899999999999999998 9999999999999999999999999998764443
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCCCCccccccccCCceeec
Confidence 33344467889999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=212.85 Aligned_cols=172 Identities=28% Similarity=0.459 Sum_probs=143.2
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35888999999999999999977777899998864432 23467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988533 236889999999999999999999998 9999999999999999999999999998764332111
Q ss_pred -eeeeEEeeeeCCCccccC
Q 024537 246 -NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 -~~~~~t~~y~aPE~~~~e 263 (266)
....++..|+|||++...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~ 176 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYS 176 (256)
T ss_pred cCCCCCCccccCHHHhccC
Confidence 111233469999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=212.85 Aligned_cols=171 Identities=29% Similarity=0.478 Sum_probs=144.1
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
++|++.+.||+|+||+||+|.+.++..+|+|.+..... ....+.+|+.++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45888999999999999999976777899998875433 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999988542 236889999999999999999999998 9999999999999999999999999998764432211
Q ss_pred -eeeeEEeeeeCCCcccc
Q 024537 246 -NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 246 -~~~~~t~~y~aPE~~~~ 262 (266)
....++..|+|||++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~ 175 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY 175 (256)
T ss_pred cCCCccChhhCCHHHHhc
Confidence 11234567999998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=216.24 Aligned_cols=161 Identities=18% Similarity=0.290 Sum_probs=137.8
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChh---hHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEEEEEecc
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ---GLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLVYEYL 164 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~ 164 (266)
..||+|++|.||+|.+ +|+.||||.+...... ..+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 7899999998754322 24678899999999999999999999877 35689999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
++|+|.+++.. ...+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 34688899999999999999999985 6 8899999999999999999999999998764432
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
....++..|+|||++..
T Consensus 178 --~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLND 194 (283)
T ss_pred --ccccCcccccCHHHhhh
Confidence 23357889999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=222.23 Aligned_cols=178 Identities=29% Similarity=0.423 Sum_probs=143.4
Q ss_pred HhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG 154 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 154 (266)
+..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4456799999999999999999963 135789999987542 33446678899999999 799999999988654
Q ss_pred -CcEEEEEeccCCCCHHHHHhhcCC-------------------------------------------------------
Q 024537 155 -PEKMLVYEYLPNKSLDYFIFDKTK------------------------------------------------------- 178 (266)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 178 (266)
...+++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999988853211
Q ss_pred ---CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEee
Q 024537 179 ---SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVV 253 (266)
Q Consensus 179 ---~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~ 253 (266)
...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++.+..... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 126789999999999999999999998 99999999999999999999999999987643321 1222345667
Q ss_pred eeCCCccccC
Q 024537 254 TWPPNMHCMD 263 (266)
Q Consensus 254 y~aPE~~~~e 263 (266)
|+|||++...
T Consensus 241 y~aPE~~~~~ 250 (337)
T cd05054 241 WMAPESIFDK 250 (337)
T ss_pred ccCcHHhcCC
Confidence 9999987554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=213.82 Aligned_cols=173 Identities=25% Similarity=0.502 Sum_probs=144.1
Q ss_pred cCccccceecccCceEEEEEEe-----cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 157 (266)
..|++++.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.+.||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478899999999999999973 35788999998754 344456788999999999999999999998875 568
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999988432 235889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCce---eeeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTH---VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~---~~~~~~t~~y~aPE~~~~e 263 (266)
+...... .....++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 187 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQS 187 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccC
Confidence 7543321 1234556679999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=214.18 Aligned_cols=176 Identities=28% Similarity=0.497 Sum_probs=145.9
Q ss_pred hcCccccceecccCceEEEEEEec------CCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.+.|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999742 3578999998765433 456888999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcC-----------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 158 MLVYEYLPNKSLDYFIFDKT-----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 1245788899999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+++.+..... ......+++.|+|||++...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR 199 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccC
Confidence 99999999986533221 11222346789999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=225.98 Aligned_cols=180 Identities=24% Similarity=0.382 Sum_probs=146.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcC-CCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 152 (266)
+.+..++|.+.+.||+|+||.||+|++. .++.||+|++.... ......+..|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888999999999999999853 34689999997542 333457889999999997 999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcC-------------------------------------------------------
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKT------------------------------------------------------- 177 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 177 (266)
..+..++||||+++|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999985421
Q ss_pred ----------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 178 ----------------------------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 178 ----------------------------------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124677788899999999999999998 999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
|||++.++.+||+|||+++.+..... ......++..|+|||++...
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence 99999999999999999987543221 11223456789999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=242.93 Aligned_cols=181 Identities=21% Similarity=0.302 Sum_probs=146.8
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--C
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--P 155 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~ 155 (266)
.....++|++++.||+|+||+||+|. ..++..||+|.+... .......+..|+.+++.+.|||||+++++|... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34455789999999999999999999 456788999988754 334456788999999999999999999998654 5
Q ss_pred cEEEEEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCC----CCeEeCCCCCCceEEcC-------
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAP----ARIIHRDIKASNILLDE------- 223 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~----~~iiHrDlKp~Nill~~------- 223 (266)
.+||||||+++++|..++.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999885422 23468999999999999999999998541 23999999999999964
Q ss_pred ----------CCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 224 ----------QLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 224 ----------~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+.+||+|||+++.+.... ......||+.|+|||++..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhc
Confidence 2348999999998764332 2234578999999999854
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=221.86 Aligned_cols=178 Identities=28% Similarity=0.401 Sum_probs=142.6
Q ss_pred HhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG 154 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 154 (266)
...++|++.+.||+|+||+||+|.+ .+++.||||++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456799999999999999999973 356789999987643 33346788999999999 689999999988654
Q ss_pred -CcEEEEEeccCCCCHHHHHhhcCC-------------------------------------------------------
Q 024537 155 -PEKMLVYEYLPNKSLDYFIFDKTK------------------------------------------------------- 178 (266)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 178 (266)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999998854210
Q ss_pred ---------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc--eeee
Q 024537 179 ---------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNT 247 (266)
Q Consensus 179 ---------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~ 247 (266)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 123678888999999999999999998 99999999999999999999999999987643322 1122
Q ss_pred eeEEeeeeCCCccccC
Q 024537 248 FRISVVTWPPNMHCMD 263 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e 263 (266)
..++..|+|||++...
T Consensus 241 ~~~~~~y~aPE~~~~~ 256 (343)
T cd05103 241 ARLPLKWMAPETIFDR 256 (343)
T ss_pred CCCCcceECcHHhcCC
Confidence 2345679999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=214.95 Aligned_cols=171 Identities=28% Similarity=0.469 Sum_probs=142.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5799999999999999999984 4789999999865422 2224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+.+ +|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 888877432 246889999999999999999999998 99999999999999999999999999976533222
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred cccccccccccCCcHHhhc
Confidence 2223346788999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=229.66 Aligned_cols=167 Identities=23% Similarity=0.255 Sum_probs=141.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
...|.+.+.||+|+||.||+|.. .+++.||||.... ..+.+|+.++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 44699999999999999999994 4688999996432 2356899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+. ++|..++.. ....+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 678777643 2346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred --eeeeeeEEeeeeCCCccccC
Q 024537 244 --HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 --~~~~~~~t~~y~aPE~~~~e 263 (266)
......||..|+|||++.+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~ 337 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD 337 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC
Confidence 12234689999999998654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=215.24 Aligned_cols=179 Identities=25% Similarity=0.340 Sum_probs=147.3
Q ss_pred hHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe-----
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA----- 152 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~----- 152 (266)
.+....++|++.+.||+|+||.||+|. ..+++.+|+|++...... ...+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 344456789999999999999999998 457889999987643222 25677899999999 6999999999874
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
.++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999887532 23346888999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
||+++.+...........++..|+|||++..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhch
Confidence 9999877544433344568889999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=224.66 Aligned_cols=174 Identities=21% Similarity=0.320 Sum_probs=152.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh--hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.-|.+.+.||+|.|.+|-+|+ .=+|..||||++.+.... ....+.+|+..|+.++|||||++|.+......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 447888999999999999998 348999999999765332 34578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE-cCCCCeEEecccccccCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill-~~~~~~kl~DFG~a~~~~~~ 241 (266)
+-.+|+|.+++... ...+.+..+.+|+.||+.|+.|+|... +|||||||+|+.+ .+-|.|||.|||++..+.+
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 99999999999654 346889999999999999999999988 9999999999876 4568899999999988753
Q ss_pred CceeeeeeEEeeeeCCCccccCCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.....+++|+..|-|||++.++.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsY 195 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSY 195 (864)
T ss_pred cchhhcccchhhccCchhhhcCcc
Confidence 456788899999999999988754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=209.20 Aligned_cols=173 Identities=23% Similarity=0.337 Sum_probs=147.2
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-CcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-PEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e 162 (266)
.|++.+.||+|++|.||++. ..+++.||+|++... .....+.+.+|+.++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48889999999999999998 456889999998654 234456688899999999999999999988754 45789999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+.+... ....+++.+++.++.|++.|+.|||+++ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888543 3346899999999999999999999998 9999999999999999999999999998876554
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+++.|+|||++...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~ 177 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNK 177 (257)
T ss_pred CccccccCCcCccChhHhcCC
Confidence 444556788899999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=208.36 Aligned_cols=167 Identities=27% Similarity=0.400 Sum_probs=137.9
Q ss_pred ceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999984 57899999987644 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce--eee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--VNT 247 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~~ 247 (266)
.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988432 345889999999999999999999998 999999999999999999999999999865432111 011
Q ss_pred eeEEeeeeCCCccccC
Q 024537 248 FRISVVTWPPNMHCMD 263 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e 263 (266)
...+..|+|||.+...
T Consensus 156 ~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 156 KQIPVKWTAPEALNYG 171 (252)
T ss_pred CCCceeecCchhhcCC
Confidence 1224569999987543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=217.63 Aligned_cols=169 Identities=26% Similarity=0.419 Sum_probs=147.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.|.....||+|+||.||++. ..++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 35556779999999999998 45788999999876665566778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..+.......
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999888732 35788999999999999999999998 9999999999999999999999999998765544444
Q ss_pred eeeeEEeeeeCCCcccc
Q 024537 246 NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~ 262 (266)
....++..|+|||++..
T Consensus 176 ~~~~~~~~y~aPE~~~~ 192 (292)
T cd06658 176 KSLVGTPYWMAPEVISR 192 (292)
T ss_pred ceeecCccccCHHHHcc
Confidence 55678889999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=215.62 Aligned_cols=179 Identities=27% Similarity=0.427 Sum_probs=146.8
Q ss_pred HHhhcCccccceecccCceEEEEEEe--------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
.+..++|.+.+.||+|+||.||+|+. .++..||+|.+... .......+.+|+.++..+ .||||+++++.+
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 45567799999999999999999963 12457999988654 234456788999999999 899999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
...+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 999999999999999999999865321 235788889999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
|+++.++.+||+|||+++.+...... .....++..|+|||++.+.
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 214 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence 99999999999999999877543322 1222345679999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=216.31 Aligned_cols=179 Identities=29% Similarity=0.424 Sum_probs=145.4
Q ss_pred HHhhcCccccceecccCceEEEEEEec--------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
++..++|.+.+.||+|+||.||+|... +...+|+|.+... .......+..|+.++..+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 334467999999999999999999732 2346999998754 234456788899999999 799999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
...+..|+||||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 999999999999999999999865321 135888999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCceeee--eeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTHVNT--FRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~~~~--~~~t~~y~aPE~~~~e 263 (266)
|+++.++.+||+|||+++.+........+ ..++..|+|||++.+.
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC
Confidence 99999999999999999876432211111 1234679999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=222.98 Aligned_cols=169 Identities=25% Similarity=0.343 Sum_probs=140.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------C
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 155 (266)
.++|++.+.||+|+||.||+|. ...++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4679999999999999999998 457889999998753 233346678899999999999999999988644 3
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..|+||||+++ ++...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999965 6666652 24778889999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+...... ......+|..|+|||++.+.
T Consensus 174 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 200 (364)
T cd07875 174 RTAGTSF-MMTPYVVTRYYRAPEVILGM 200 (364)
T ss_pred cccCCCC-cccCCcccCCcCCHHHHhCC
Confidence 8764332 22345789999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=235.67 Aligned_cols=223 Identities=22% Similarity=0.231 Sum_probs=172.6
Q ss_pred CCCCCCCcccchhhhhhhhheeceeeeccCCCCCCCCCccccCCCCCCCCccccchhhHHHhhcCccccceecccCceEE
Q 024537 23 HNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPV 102 (266)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~V 102 (266)
+...-.+..|+.+|.+.+..+.-...+..... ...........+....-.+...+++.+..||-|+||.|
T Consensus 367 ~~gv~cl~lDresF~~liG~l~~l~ek~~~D~----------~r~A~~~~~~~~~~e~a~v~l~dl~~iaTLGvGgFGRV 436 (732)
T KOG0614|consen 367 APGVECLTLDRESFKKLIGDLEELKEKDYGDE----------ERRASVVIKEDFAEEFAQVKLSDLKRIATLGVGGFGRV 436 (732)
T ss_pred CCCceEEEecHHHHHHhcccHHHhhhhhccch----------hhhhhhHHHHHHHhhhcccchhhhhhhhhcccCccceE
Confidence 33455788889898888877765432111000 00000000111111122334456778899999999999
Q ss_pred EEEEecCC-CEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCC
Q 024537 103 YRGLMPNG-QEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178 (266)
Q Consensus 103 ~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 178 (266)
-++..... ..+|+|++++. .....+.+..|-.||..++.|.||++|.+|.+.+.+||.||-|-||.++..+++
T Consensus 437 ELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd--- 513 (732)
T KOG0614|consen 437 ELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD--- 513 (732)
T ss_pred EEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh---
Confidence 99985332 34888888765 444557888999999999999999999999999999999999999999999954
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCC
Q 024537 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPN 258 (266)
Q Consensus 179 ~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE 258 (266)
.+.++...++.++..+++|++|||++| ||+|||||+|++++.+|.+||.|||+|+.+... .++.+|+|||.|.|||
T Consensus 514 Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPE 589 (732)
T KOG0614|consen 514 RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPE 589 (732)
T ss_pred cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-CceeeecCCcccccch
Confidence 356888999999999999999999999 999999999999999999999999999998754 4567999999999999
Q ss_pred cccc
Q 024537 259 MHCM 262 (266)
Q Consensus 259 ~~~~ 262 (266)
++.+
T Consensus 590 IILn 593 (732)
T KOG0614|consen 590 IILN 593 (732)
T ss_pred hhhc
Confidence 9864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=214.28 Aligned_cols=180 Identities=28% Similarity=0.425 Sum_probs=147.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
+++..++|++.+.||+|+||.||++.+. ....+|+|.+... .......+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4555677999999999999999999843 2367999988754 333446688999999999 7999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhc-------------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCce
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI 219 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Ni 219 (266)
.++..+++|||+++++|..++... .....+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999998542 22356889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEecccccccCCCCCcee--eeeeEEeeeeCCCccccC
Q 024537 220 LLDEQLNPKISDFGLARLFPGEDTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 220 ll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
|++.++.+||+|||+++.+....... ....++..|+|||++...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 209 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence 99999999999999998765432211 111234579999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=231.32 Aligned_cols=178 Identities=28% Similarity=0.430 Sum_probs=158.0
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEee-----C
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE-----G 154 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~ 154 (266)
....+-|++.+.||.|.+|.||+++ ..+++..|||+.......+ +++..|..+++.. .|||++.++++|.. +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3345668999999999999999999 6689999999987664443 5667888898887 59999999999864 4
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+.+|||||||.||+..+++.... +.++.|..+..|+..++.|+.+||.+. ++|||+|-.|||++.++.|||+|||+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 67899999999999999996544 788999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+..+........++.||+.|+|||+++-+.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeeccc
Confidence 999988888889999999999999998664
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=212.64 Aligned_cols=177 Identities=24% Similarity=0.402 Sum_probs=146.2
Q ss_pred HhhcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
+..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34567999999999999999999843 24689999987553 334457889999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCC-------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTK-------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 99999999999999999854321 234678899999999999999999998 99999999999999999999
Q ss_pred EecccccccCCCCCc--eeeeeeEEeeeeCCCcccc
Q 024537 229 ISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 229 l~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
|+|||+++.+..... ......++..|+|||++..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc
Confidence 999999987643321 1223345678999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=211.10 Aligned_cols=176 Identities=29% Similarity=0.466 Sum_probs=148.0
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..++|.+.+.||+|+||.||+|...++..||||.+..... ....+.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678999999999999999999977778899999875433 23578899999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.+....
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999998543 3346889999999999999999999998 9999999999999999999999999998765321
Q ss_pred c-eeeeeeEEeeeeCCCccccC
Q 024537 243 T-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~-~~~~~~~t~~y~aPE~~~~e 263 (266)
. ......++..|+|||.+.+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYG 179 (261)
T ss_pred hhhhhccCCCccccCHHHhccC
Confidence 1 11122345679999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=215.79 Aligned_cols=164 Identities=26% Similarity=0.349 Sum_probs=142.8
Q ss_pred cceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
.+.||+|+|+.|--|. ..+|.+||||++.+...-...++.+|++++.+.+ |+||++++.+|+++..+|+|||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999998 7799999999998876666788999999999985 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEecccccccCC--C---
Q 024537 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLFP--G--- 240 (266)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG~a~~~~--~--- 240 (266)
|...+.+ ...+.+.++.++..+|+.||.|||.+| |.||||||+|||...... ||||||.++..+. .
T Consensus 163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9888843 456899999999999999999999999 999999999999976544 7999999886542 1
Q ss_pred --CCceeeeeeEEeeeeCCCcc
Q 024537 241 --EDTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 241 --~~~~~~~~~~t~~y~aPE~~ 260 (266)
......+++|+..|||||+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCCccccCcccchhhcchhHH
Confidence 12345667888999999985
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=211.15 Aligned_cols=173 Identities=26% Similarity=0.460 Sum_probs=144.8
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
...|.+.+.||+|+||.||+|. ..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4458888999999999999998 4468899999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999988542 2346888999999999999999999998 99999999999999999999999999987754322
Q ss_pred ee-eeeeEEeeeeCCCcccc
Q 024537 244 HV-NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~-~~~~~t~~y~aPE~~~~ 262 (266)
.. ....++..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~ 179 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAY 179 (263)
T ss_pred eccCCCCCccccCCHHHhcc
Confidence 11 11123557999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=211.42 Aligned_cols=173 Identities=26% Similarity=0.421 Sum_probs=142.8
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|++.+.||+|+||.||+|.+.++..||+|++..... ....+..|+.+++.++||||+++++.+. .+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 3456999999999999999999876667899999875432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.++.+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999998542 2345788999999999999999999998 99999999999999999999999999987643322
Q ss_pred e-eeeeeEEeeeeCCCcccc
Q 024537 244 H-VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~-~~~~~~t~~y~aPE~~~~ 262 (266)
. .....++..|+|||++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~ 177 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALY 177 (262)
T ss_pred ccccCCcccceecCHhHhcc
Confidence 1 112345667999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=213.17 Aligned_cols=175 Identities=26% Similarity=0.422 Sum_probs=144.9
Q ss_pred hcCccccceecccCceEEEEEEecC-----------------CCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCcee
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN-----------------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVT 146 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 146 (266)
.++|++++.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4579999999999999999987432 2468999987653 344567889999999999999999
Q ss_pred EEeEEeeCCcEEEEEeccCCCCHHHHHhhcC--------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT--------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 147 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
+++++..++..+++||++++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1126889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCcccc
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
|+++.++.++|+|||+++....... ......++..|+|||++..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 9999999999999999987643321 1122345668999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=211.52 Aligned_cols=167 Identities=27% Similarity=0.401 Sum_probs=134.1
Q ss_pred ceecccCceEEEEEEec---CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||+||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 35999999999999743 23568888776442 333456789999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC--CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce-
Q 024537 168 SLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH- 244 (266)
Q Consensus 168 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 244 (266)
+|.+++..... ....++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865322 233567788899999999999999998 999999999999999999999999999765332211
Q ss_pred -eeeeeEEeeeeCCCccc
Q 024537 245 -VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 245 -~~~~~~t~~y~aPE~~~ 261 (266)
.....++..|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 158 TKDCHAVPLRWLAPELVE 175 (269)
T ss_pred ccCCCCCcccccCHHHHh
Confidence 11223456799999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=214.72 Aligned_cols=175 Identities=26% Similarity=0.427 Sum_probs=143.7
Q ss_pred cCccccceecccCceEEEEEEec------CCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778899999999999999842 257899999875533 33466889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 159 LVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
+++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999884321 1235788889999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 226 NPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
.+||+|||+++....... ......+++.|+|||++...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence 999999999987643321 12233456789999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=210.63 Aligned_cols=173 Identities=28% Similarity=0.460 Sum_probs=143.9
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 4567999999999999999999977888899999876433 2356889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999988542 3346889999999999999999999998 99999999999999999999999999987643321
Q ss_pred -eeeeeeEEeeeeCCCcccc
Q 024537 244 -HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 -~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALY 177 (260)
T ss_pred ccccCCCCCccccChHHHhc
Confidence 1112234567999998754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=214.49 Aligned_cols=169 Identities=28% Similarity=0.445 Sum_probs=145.0
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccChh-----hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ-----GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+|++.+.||+|+||.||+|.. .+++.||||.+...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999984 47899999998755322 234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+ +++|..++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 89999988432 236899999999999999999999998 99999999999999999999999999988765
Q ss_pred CCceeeeeeEEeeeeCCCccc
Q 024537 241 EDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~ 261 (266)
.........++..|.|||++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~ 175 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLF 175 (298)
T ss_pred CCccccccccceeeeCHHHHh
Confidence 544444445678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=209.68 Aligned_cols=172 Identities=26% Similarity=0.423 Sum_probs=143.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 157 (266)
.+|++.+.||+|+||.||.|. ..++..||||.+... .......+.+|+.+++++.||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468899999999999999998 456899999987533 123356788899999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999888432 34788889999999999999999998 99999999999999999999999999986
Q ss_pred CCCC---CceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGE---DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~---~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ........++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGE 184 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCC
Confidence 5422 1122334578899999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=211.33 Aligned_cols=171 Identities=29% Similarity=0.457 Sum_probs=150.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||.|+||.||+|. ..+++.||+|.+.... ......+.+|+.+++.++|+||+++++.+.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 368889999999999999999 4478999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999988843 26889999999999999999999998 99999999999999999999999999998865544
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
....+.++..|+|||++...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~ 173 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQS 173 (274)
T ss_pred ccccccCCccccChhhhccC
Confidence 44556788899999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=208.24 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=146.1
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|++.+.||.|+||.||+|.. .++.||+|.+..... ...++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 346788999999999999999986 478999999876644 457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999985432 236899999999999999999999998 99999999999999999999999999988743322
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
....+..|+|||++..
T Consensus 158 ---~~~~~~~~~ape~~~~ 173 (256)
T cd05039 158 ---SGKLPVKWTAPEALRE 173 (256)
T ss_pred ---cCCCcccccCchhhcC
Confidence 2234567999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=216.30 Aligned_cols=171 Identities=24% Similarity=0.432 Sum_probs=143.3
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999994 578999999986542 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
++ ++|.+.+... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5776666332 346899999999999999999999998 99999999999999999999999999987654433
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred CcCCCccccCCcChHHHhCC
Confidence 33344678899999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=211.74 Aligned_cols=172 Identities=26% Similarity=0.469 Sum_probs=145.6
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+|++.+.||.|++|.||+|.. .++..||||.+..... .....+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488899999999999999995 4789999999876532 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 75 78777755444456899999999999999999999998 999999999999999999999999999876544333
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
.....++..|+|||++..
T Consensus 157 ~~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLG 174 (284)
T ss_pred cccccccccccChHHhcC
Confidence 334456788999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=209.24 Aligned_cols=171 Identities=27% Similarity=0.451 Sum_probs=145.1
Q ss_pred CccccceecccCceEEEEEEecCCCEEEEEeecccC------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999997788999999886442 22345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998432 45788999999999999999999998 99999999999999999999999999986532
Q ss_pred C------CceeeeeeEEeeeeCCCccccC
Q 024537 241 E------DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~------~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ........++..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 183 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINES 183 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCC
Confidence 1 1112234578889999998654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=236.53 Aligned_cols=179 Identities=30% Similarity=0.497 Sum_probs=149.5
Q ss_pred HHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
.+...+.+..+.||+|+||+||+|+. .+...||||.++..... ...+|.+|++++..++|||||+|+|++..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 44455677789999999999999973 23567999999876544 678899999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcC-------C----CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKT-------K----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~-------~----~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~ 223 (266)
+..+||+|||..|+|.++|+... . ...++..+.+.|+.||+.||+||-+.. +|||||-.+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996421 1 223888999999999999999999988 999999999999999
Q ss_pred CCCeEEecccccccCCCCC-ceee-eeeEEeeeeCCCccccC
Q 024537 224 QLNPKISDFGLARLFPGED-THVN-TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 224 ~~~~kl~DFG~a~~~~~~~-~~~~-~~~~t~~y~aPE~~~~e 263 (266)
+..|||+|||++|-+.+.+ .+.. .-.-.+.|||||-|...
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~ 680 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG 680 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence 9999999999999764433 2222 12346789999987643
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=213.35 Aligned_cols=175 Identities=23% Similarity=0.391 Sum_probs=142.4
Q ss_pred hcCccccceecccCceEEEEEEecC---------------CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN---------------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~ 148 (266)
.++|++.+.||+|+||.||+|+... ...||+|.+... .......+.+|+.++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4579999999999999999987432 235899998754 333456788999999999999999999
Q ss_pred eEEeeCCcEEEEEeccCCCCHHHHHhhcC---------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCce
Q 024537 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKT---------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI 219 (266)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Ni 219 (266)
+++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885421 1124678889999999999999999998 99999999999
Q ss_pred EEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCcccc
Q 024537 220 LLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 220 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
+++.++.+||+|||+++.+..... ......++..|+|||++..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc
Confidence 999999999999999987643221 1112234568999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=211.36 Aligned_cols=173 Identities=25% Similarity=0.458 Sum_probs=141.7
Q ss_pred hcCccccceecccCceEEEEEEe-cCCC----EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|++.+.||+|+||+||+|.+ .++. .||+|.+... .......+.+|+.++..+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45688999999999999999984 3454 4899998754 33345678899999999999999999999875 4578
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999888432 346889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCCceee--eeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVN--TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~--~~~~t~~y~aPE~~~~e 263 (266)
........ ...++..|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHR 186 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccC
Confidence 54332211 12345679999987543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=209.34 Aligned_cols=167 Identities=30% Similarity=0.418 Sum_probs=136.3
Q ss_pred ceecccCceEEEEEEec---CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999743 34679999887653 333456888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC--CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce-
Q 024537 168 SLDYFIFDKT--KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH- 244 (266)
Q Consensus 168 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 244 (266)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985432 2234567778889999999999999998 999999999999999999999999999765433221
Q ss_pred -eeeeeEEeeeeCCCccc
Q 024537 245 -VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 245 -~~~~~~t~~y~aPE~~~ 261 (266)
.....++..|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 158 TPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cCCCcCCcccccCHhHhc
Confidence 11234567899999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=215.10 Aligned_cols=179 Identities=29% Similarity=0.417 Sum_probs=145.3
Q ss_pred HHhhcCccccceecccCceEEEEEEec--------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
....++|.+.+.||+|+||.||+|... ....+|+|.+... .......+..|+.+++++ .||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567899999999999999999731 2457899988754 334456788999999999 699999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
...+..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||++| |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999986532 1235888999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCcee--eeeeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
||++.++.+||+|||+++......... ....++..|+|||++...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence 999999999999999998765332211 112234579999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=208.96 Aligned_cols=161 Identities=24% Similarity=0.401 Sum_probs=135.1
Q ss_pred ceecccCceEEEEEEecC-------------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 92 NQLGHGGFGPVYRGLMPN-------------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 2258889877665555567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC-------eEEec
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-------PKISD 231 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~-------~kl~D 231 (266)
+||||+++++|..++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2346889999999999999999999998 999999999999987664 89999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
||++....... ...++..|+|||.+.
T Consensus 156 ~g~~~~~~~~~----~~~~~~~y~aPE~~~ 181 (262)
T cd05077 156 PGIPITVLSRQ----ECVERIPWIAPECVE 181 (262)
T ss_pred CCCCccccCcc----cccccccccChhhhc
Confidence 99998764332 235678899999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=207.74 Aligned_cols=172 Identities=28% Similarity=0.440 Sum_probs=150.4
Q ss_pred hcCccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||.|+||.||+|.+. +++.|++|.+..... ...+.+|+.++++++||||+++++.+..+...|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 467999999999999999999954 478999999875533 57889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999998843 2356899999999999999999999998 99999999999999999999999999998765543
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~ 174 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEI 174 (256)
T ss_pred ccccccCCccccCHHHHhcC
Confidence 44445678899999987553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=239.51 Aligned_cols=177 Identities=31% Similarity=0.460 Sum_probs=143.0
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee------
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------ 153 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------ 153 (266)
..-..+|+.++.||+|+||.||+++ .-||+.||||++... +......+.+|+.++++|+|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4455679999999999999999999 448999999999876 34445678899999999999999999875521
Q ss_pred --------------------------------------------------------------------------------
Q 024537 154 -------------------------------------------------------------------------------- 153 (266)
Q Consensus 154 -------------------------------------------------------------------------------- 153 (266)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHH
Q 024537 154 -------------------------G--------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200 (266)
Q Consensus 154 -------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~y 200 (266)
+ -.+||.||||+..++.+++..+.... .....++++.+|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12478899998888888774432211 457788999999999999
Q ss_pred HhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC------------------CCCceeeeeeEEeeeeCCCcccc
Q 024537 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP------------------GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 201 LH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~------------------~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|++| ||||||||.||+++.++.|||+|||+|.... ..........||..|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 11224456689999999999876
Q ss_pred C
Q 024537 263 D 263 (266)
Q Consensus 263 e 263 (266)
.
T Consensus 790 ~ 790 (1351)
T KOG1035|consen 790 T 790 (1351)
T ss_pred c
Confidence 4
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=213.94 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=146.4
Q ss_pred cCccccceecccCceEEEEEEec-CCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36889999999999999999954 68999999876542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++++++..+... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999988877632 335889999999999999999999998 9999999999999999999999999998875544
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
.......++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred cccCcccceeeccCcHHhcc
Confidence 44444567889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=211.68 Aligned_cols=174 Identities=29% Similarity=0.432 Sum_probs=142.5
Q ss_pred CccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 23578888876543 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcC---------------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 160 VYEYLPNKSLDYFIFDKT---------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
+|||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235788999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
||+++++.+||+|||+++.+..... ......++..|+|||++...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 9999999999999999987643322 11222456689999987554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=209.65 Aligned_cols=171 Identities=24% Similarity=0.420 Sum_probs=144.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
+|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+..|+.++++++|+||+++++.+.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999998 5678999999986432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLF 238 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~ 238 (266)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 246888999999999999999999998 99999999999998776 5999999999887
Q ss_pred CCCCce----eeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTH----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~----~~~~~~t~~y~aPE~~~~e 263 (266)
...... .....++..|+|||++.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccC
Confidence 544221 1234577889999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=208.86 Aligned_cols=170 Identities=31% Similarity=0.496 Sum_probs=143.5
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccCh---------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
+|.+...||+|+||.||+|. ..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 37788999999999999998 44688999998864321 123567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||||+++++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999998843 346788899999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCC------ceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGED------THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~------~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+.... .....+.++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhcc
Confidence 775221 11223457888999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=216.10 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=146.4
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
|.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++..+.||||+++++.+..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 4445679999999999998 457899999998765544556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|..++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.+........
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999887632 45789999999999999999999998 99999999999999999999999999987765544445
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...++..|+|||++...
T Consensus 176 ~~~~~~~y~aPE~~~~~ 192 (297)
T cd06659 176 SLVGTPYWMAPEVISRT 192 (297)
T ss_pred ceecCccccCHHHHccC
Confidence 56788999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=208.62 Aligned_cols=174 Identities=24% Similarity=0.354 Sum_probs=145.1
Q ss_pred cCccccceecccCceEEEEEEec------CCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
++|++++.||+|+||.||+|+.. +.+.|++|.+...... ....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56889999999999999999843 3467999988655433 4567889999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHhhcCCC------CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKS------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543321 25899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCC-CceeeeeeEEeeeeCCCcccc
Q 024537 233 GLARLFPGE-DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 233 G~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+++..... ........++..|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc
Confidence 999754322 222233456778999998643
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=211.00 Aligned_cols=177 Identities=27% Similarity=0.443 Sum_probs=146.6
Q ss_pred hcCccccceecccCceEEEEEEe------cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..+|...++||+|+||.||+|.. .++..+|+|.+..........+.+|+.+++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35678889999999999999963 245689999887766666678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCC------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 159 LVYEYLPNKSLDYFIFDKTK------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999854321 135788999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCce--eeeeeEEeeeeCCCccccCC
Q 024537 227 PKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e~ 264 (266)
+||+|||+++........ .....+++.|+|||++....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 999999999865432211 11223467899999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=207.50 Aligned_cols=164 Identities=26% Similarity=0.477 Sum_probs=134.4
Q ss_pred eecccCceEEEEEEec---CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 93 QLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999743 45579999987653 333466889999999999999999999886 457899999999999
Q ss_pred HHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeee
Q 024537 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248 (266)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 248 (266)
|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.+..........
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988843 2346899999999999999999999998 9999999999999999999999999998765443221111
Q ss_pred ---eEEeeeeCCCcccc
Q 024537 249 ---RISVVTWPPNMHCM 262 (266)
Q Consensus 249 ---~~t~~y~aPE~~~~ 262 (266)
.++..|+|||++..
T Consensus 156 ~~~~~~~~y~aPE~~~~ 172 (257)
T cd05115 156 SAGKWPLKWYAPECINF 172 (257)
T ss_pred CCCCCCcccCCHHHHcc
Confidence 22467999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=239.78 Aligned_cols=178 Identities=33% Similarity=0.507 Sum_probs=148.5
Q ss_pred hhcCccccceecccCceEEEEEEec--CCC----EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP--NGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
...+.+.++.||+|+||.||.|... ++. .||||.+... +......|.+|..+|+.++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3456677899999999999999843 343 4899988766 56667899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcC----CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
.+|++|||++|+|..+|++.. ....+.....+.++.||+.|+.||++++ +|||||..+|+|++....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999997541 2456888999999999999999999998 999999999999999999999999
Q ss_pred cccccC-CCCCceeeee-eEEeeeeCCCccccCC
Q 024537 233 GLARLF-PGEDTHVNTF-RISVVTWPPNMHCMDI 264 (266)
Q Consensus 233 G~a~~~-~~~~~~~~~~-~~t~~y~aPE~~~~e~ 264 (266)
|+|+-+ ..+-...... .-...|||||.+...+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i 880 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI 880 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence 999944 3332222222 2346899999887544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=215.87 Aligned_cols=180 Identities=28% Similarity=0.415 Sum_probs=145.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEec--------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGC 150 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 150 (266)
+++...+|++.+.||+|+||.||+|... .+..||+|.+... .......+.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4455567999999999999999999731 1236899988754 334456788999999999 79999999999
Q ss_pred EeeCCcEEEEEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 151 CAEGPEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
+..++..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999986432 1235788889999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCCCceeee--eeEEeeeeCCCccccC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGEDTHVNT--FRISVVTWPPNMHCMD 263 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~--~~~t~~y~aPE~~~~e 263 (266)
|||++.++.+||+|||+++.+......... ..++..|+|||++...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC
Confidence 999999999999999999876443221111 2234579999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=229.74 Aligned_cols=175 Identities=21% Similarity=0.311 Sum_probs=134.7
Q ss_pred hhcCccccceecccCceEEEEEEec--CCCEEEEE------------------eecccChhhHHHHHHHHHHHHhcCCCC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVK------------------KLSVDSRQGLREFTNEVKLLLKIQHKN 143 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 143 (266)
..++|++++.||+|+||+||+|... ++...++| .+. ........+.+|+.+|+.++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 4578999999999999999998732 22222222 111 11223456789999999999999
Q ss_pred ceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCC--CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE
Q 024537 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221 (266)
Q Consensus 144 Iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill 221 (266)
|+++++++..++..|+|++++. +++..++..... ........+..|+.||+.||.|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 566665532211 122345667889999999999999998 9999999999999
Q ss_pred cCCCCeEEecccccccCCCCC-ceeeeeeEEeeeeCCCccccC
Q 024537 222 DEQLNPKISDFGLARLFPGED-THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 222 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~e 263 (266)
+.++.+||+|||+|+.+.... .......||..|+|||++.+.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD 343 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC
Confidence 999999999999998875432 222345789999999998764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=210.71 Aligned_cols=175 Identities=26% Similarity=0.462 Sum_probs=146.2
Q ss_pred cCccccceecccCceEEEEEEec------CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.+|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999732 345689999877666656778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 160 VYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1234789999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
++|+|||+++....... ......++..|+|||++...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 200 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 200 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccC
Confidence 99999999986643321 11223456789999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=210.58 Aligned_cols=176 Identities=28% Similarity=0.428 Sum_probs=146.9
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEee------
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE------ 153 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------ 153 (266)
....+.|++.+.||.|+||.||+|. ..+++.||+|++..... ....+..|+.++.++ +|+||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 3345679999999999999999999 45788999999865533 335678899999988 69999999999853
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
.+..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 45679999999999999988542 3345788889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
++..............++..|+|||++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 195 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCc
Confidence 99876544334445678899999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=210.08 Aligned_cols=170 Identities=27% Similarity=0.411 Sum_probs=146.7
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488899999999999999984 578999999987653 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+ +++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999888433 256899999999999999999999998 99999999999999999999999999988754431
Q ss_pred -eeeeeeEEeeeeCCCcccc
Q 024537 244 -HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 -~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYG 174 (286)
T ss_pred CccccccCcccccCceeeec
Confidence 2234467889999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=210.65 Aligned_cols=171 Identities=29% Similarity=0.468 Sum_probs=139.0
Q ss_pred cCccccceecccCceEEEEEEe-cCCC----EEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
++|++++.||+|+||+||+|.+ .++. .+++|.+.... ......+..|+.++..+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 5688899999999999999985 3444 47788775442 333466778888999999999999999875 455789
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998532 346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCc--eeeeeeEEeeeeCCCcccc
Q 024537 240 GEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
.... ......++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~ 185 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF 185 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc
Confidence 3321 1223345668999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=221.80 Aligned_cols=177 Identities=25% Similarity=0.423 Sum_probs=149.2
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhh-HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.+...+...+.++||+|-||.|-+|....+..||||.++...... ...|..|+++|.+++||||++++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 455667788899999999999999997678999999998775444 4789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|+||+++|+|.+++....... ........|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||++|-+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999996543222 455666779999999999999988 9999999999999999999999999999653
Q ss_pred -CCCceee-eeeEEeeeeCCCccc
Q 024537 240 -GEDTHVN-TFRISVVTWPPNMHC 261 (266)
Q Consensus 240 -~~~~~~~-~~~~t~~y~aPE~~~ 261 (266)
++..+.. ...-...|+|||-+-
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHH
Confidence 3333222 234456899999764
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=213.80 Aligned_cols=175 Identities=30% Similarity=0.442 Sum_probs=141.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCC--EEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.+.||+|+||.||+|.+ .++. .+|+|.+... .......+.+|+.++.++ +||||+++++++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46789999999999999999984 3454 4577776543 334456788899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 160 VYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985432 1235789999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+++....... .....++..|+|||++...
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 198 (303)
T cd05088 163 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYS 198 (303)
T ss_pred EEeCccccCcccchhhh-cccCCCcccccCHHHHhcc
Confidence 99999999975422111 1112345679999987544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=216.89 Aligned_cols=168 Identities=20% Similarity=0.245 Sum_probs=131.6
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEec--CCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCcee-EEeE
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVT-LFGC 150 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~ 150 (266)
.+.....+.|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|+.+|++++|+||+. ++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556778999999999999999999843 5777899986532 1223456889999999999999985 443
Q ss_pred EeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCC-CCCceEEcCCCCeEE
Q 024537 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI-KASNILLDEQLNPKI 229 (266)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDl-Kp~Nill~~~~~~kl 229 (266)
.+..|+||||++|++|.. . .. .. ...++.|++.||.|||+.| |+|||| ||+|||++.++.+||
T Consensus 90 ---~~~~~LVmE~~~G~~L~~-~---~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHL-A---RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ---cCCcEEEEEccCCCCHHH-h---Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 246799999999999962 2 11 11 1357889999999999998 999999 999999999999999
Q ss_pred ecccccccCCCCCce--------eeeeeEEeeeeCCCccccC
Q 024537 230 SDFGLARLFPGEDTH--------VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 230 ~DFG~a~~~~~~~~~--------~~~~~~t~~y~aPE~~~~e 263 (266)
+|||+|+.+...... ..+..++..|++||++.++
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999977543311 1244567789999999876
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=212.01 Aligned_cols=172 Identities=27% Similarity=0.403 Sum_probs=144.8
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 160 (266)
++|++.+.||.|+||.||+|.. .+++.+|+|.++.... .....+.+|+.++.+++||||+++++++..+ +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688999999999999999995 4688999999875432 2233567899999999999999999999877 889999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+. ++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 5888887432 236899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........++..|+|||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred CccccccccccccccCchhhcCC
Confidence 54333445678889999987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=207.62 Aligned_cols=175 Identities=24% Similarity=0.398 Sum_probs=146.0
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..++|++.+.||+|+||.||+|....+..+|+|.+..... ....+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45677999999999999999999976778899998875432 34678899999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++..+.+||+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999998543 3456788889999999999999999998 9999999999999999999999999998764322
Q ss_pred c-eeeeeeEEeeeeCCCccccC
Q 024537 243 T-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~-~~~~~~~t~~y~aPE~~~~e 263 (266)
. ......++..|+|||++...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~ 178 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFG 178 (260)
T ss_pred cccccCCcccccccCHhHhccC
Confidence 1 11122345679999988643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=212.88 Aligned_cols=166 Identities=25% Similarity=0.387 Sum_probs=132.8
Q ss_pred cceecccCceEEEEEEec---CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEEEEeccC
Q 024537 91 LNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVYEYLP 165 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 165 (266)
..+||+|+||+||+|... ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999843 457899998865432 2456789999999999999999999854 456799999985
Q ss_pred CCCHHHHHhhc------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE----cCCCCeEEeccccc
Q 024537 166 NKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLA 235 (266)
Q Consensus 166 ~~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill----~~~~~~kl~DFG~a 235 (266)
++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4676665321 12235888999999999999999999998 9999999999999 55678999999999
Q ss_pred ccCCCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
+.+..... ......+|+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcC
Confidence 87754322 2334578899999998864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=212.48 Aligned_cols=170 Identities=26% Similarity=0.434 Sum_probs=148.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
++|++.+.||+|+||.||++. ..++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 579999999999999999998 4578899999987655555577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999988842 34778899999999999999999998 999999999999999999999999999877555444
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
.....++..|+|||++..
T Consensus 172 ~~~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR 189 (293)
T ss_pred cccccCChhhcCchhhcc
Confidence 445568888999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=210.39 Aligned_cols=161 Identities=22% Similarity=0.318 Sum_probs=133.1
Q ss_pred eecccCceEEEEEEecC-------------------------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeE
Q 024537 93 QLGHGGFGPVYRGLMPN-------------------------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 147 (266)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999987311 13588998876555555678889999999999999999
Q ss_pred EeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC--
Q 024537 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-- 225 (266)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-- 225 (266)
++++..++..++||||+++++|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999888843 2346888999999999999999999998 99999999999997644
Q ss_pred -----CeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 226 -----NPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 226 -----~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+|++|||++........ ..++..|+|||.+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~aPe~~~~ 194 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREE----RVERIPWIAPECVPG 194 (274)
T ss_pred cCccceeeecCCccccccccccc----cccCCcccCchhhcC
Confidence 379999999876533222 246678999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=210.62 Aligned_cols=180 Identities=27% Similarity=0.348 Sum_probs=148.4
Q ss_pred hhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC--
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG-- 154 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-- 154 (266)
..+....++|.+.+.||+|+||.||+|. ..+++.+|+|.+...... ...+..|+.++.++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3444456789999999999999999998 457899999998654322 35667899999998 799999999998754
Q ss_pred ---CcEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 155 ---PEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 155 ---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3579999999999999887532 23456889999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 231 DFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|||+++.+...........++..|+|||++..
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcC
Confidence 99999876544333344567889999998753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=207.10 Aligned_cols=173 Identities=25% Similarity=0.432 Sum_probs=140.4
Q ss_pred ccccceecccCceEEEEEEec-C---CCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-----
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----- 156 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 156 (266)
|++.+.||+|+||.||+|... + +..||+|++... .......+..|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999842 2 368999998754 33445678899999999999999999998876554
Q ss_pred -EEEEEeccCCCCHHHHHhhcC---CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 157 -KMLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 157 -~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
.+++|||+++++|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999988875422 2246889999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 233 GLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 233 G~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
|+++.+...... .....++..|+|||++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 190 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC
Confidence 999876433221 1112345679999987654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=206.08 Aligned_cols=169 Identities=31% Similarity=0.529 Sum_probs=144.2
Q ss_pred ceecccCceEEEEEEec-C---CCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|... . +..|++|.+...... ....+..|+.++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999854 3 789999998765433 367888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCC------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 167 KSLDYFIFDKTK------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 167 ~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
++|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999854311 367899999999999999999999998 99999999999999999999999999998765
Q ss_pred CC--ceeeeeeEEeeeeCCCccccC
Q 024537 241 ED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. .......++..|+|||++...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC
Confidence 43 222334567889999987653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=207.14 Aligned_cols=161 Identities=24% Similarity=0.422 Sum_probs=134.6
Q ss_pred ceecccCceEEEEEEecC-C----------CEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 92 NQLGHGGFGPVYRGLMPN-G----------QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 369999999999998543 3 25778877655433 5778899999999999999999999988 778999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-------CeEEeccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-------NPKISDFG 233 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-------~~kl~DFG 233 (266)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885432 26888999999999999999999998 99999999999999887 79999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+++..... ....++..|+|||++...
T Consensus 154 ~a~~~~~~----~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 154 IPITVLSR----EERVERIPWIAPECIRNG 179 (259)
T ss_pred cccccccc----cccccCCCccChhhhcCC
Confidence 99876542 223466789999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=207.62 Aligned_cols=174 Identities=26% Similarity=0.410 Sum_probs=143.0
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..++|.+.+.||+|+||.||+|.+..+..+|+|.+..... ..+.+.+|+.+++.+.|||++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 3456889999999999999999976777899998765432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999988543 2345788999999999999999999998 99999999999999999999999999987643221
Q ss_pred -eeeeeeEEeeeeCCCccccC
Q 024537 244 -HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 -~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||.+...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~ 178 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred cccCCCccchhhCCHHHhccC
Confidence 11223456779999987543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=225.11 Aligned_cols=171 Identities=20% Similarity=0.223 Sum_probs=136.0
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC------CCceeEEeEEeeC
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH------KNLVTLFGCCAEG 154 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~~~ 154 (266)
....++|++++.||+|+||+||+|. ..+++.||||++..... .......|+.+++.+.| ++++.+++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3445789999999999999999998 45688999999864322 22345567777777654 4588999988765
Q ss_pred -CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCC-------
Q 024537 155 -PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQL------- 225 (266)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~------- 225 (266)
+..++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 5688999988 7788887743 3468899999999999999999998 47 99999999999998765
Q ss_pred ---------CeEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 226 ---------NPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 226 ---------~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.+||+|||++...... .....||+.|+|||++.+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcC
Confidence 4999999998754322 2345789999999998654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=206.33 Aligned_cols=173 Identities=22% Similarity=0.322 Sum_probs=148.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||++. ..+++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 48889999999999999998 557899999998643 233446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+.+... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998888432 2345788999999999999999999998 99999999999999999999999999988755443
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~ 176 (256)
T cd08218 157 LARTCIGTPYYLSPEICENR 176 (256)
T ss_pred hhhhccCCccccCHHHhCCC
Confidence 33344678889999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=204.61 Aligned_cols=166 Identities=28% Similarity=0.439 Sum_probs=138.5
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~ 170 (266)
+.||+|+||.||+|...++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999997788999999987553 333456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee-eeee
Q 024537 171 YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV-NTFR 249 (266)
Q Consensus 171 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~ 249 (266)
+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 887432 345789999999999999999999998 9999999999999999999999999997654322111 1123
Q ss_pred EEeeeeCCCcccc
Q 024537 250 ISVVTWPPNMHCM 262 (266)
Q Consensus 250 ~t~~y~aPE~~~~ 262 (266)
++..|+|||++..
T Consensus 156 ~~~~y~aPE~~~~ 168 (250)
T cd05085 156 IPIKWTAPEALNY 168 (250)
T ss_pred CcccccCHHHhcc
Confidence 3557999998754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=212.44 Aligned_cols=179 Identities=28% Similarity=0.388 Sum_probs=147.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
+....++|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++++ +||||+++++.+.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 344556799999999999999999973 13457999988754 233456788999999999 7999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
..+..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999988532 2234899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 233 GLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 233 G~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
|+++.+...... .....++..|+|||++...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 218 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccC
Confidence 999876543321 1122456779999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=208.90 Aligned_cols=178 Identities=25% Similarity=0.402 Sum_probs=146.0
Q ss_pred HhhcCccccceecccCceEEEEEEecC-----CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 155 (266)
+..++|++.+.||+|+||.||+|.+.. +..|++|++... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345779999999999999999998544 688999988654 34445678899999999999999999998766 46
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCC-----CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKS-----SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
..++++||+++++|.+++...... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999988543222 46889999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCcee--eeeeEEeeeeCCCccccC
Q 024537 231 DFGLARLFPGEDTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 231 DFG~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
|||+++.+....... ....++..|+|||++...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 194 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence 999998764332211 122345679999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=205.16 Aligned_cols=172 Identities=29% Similarity=0.418 Sum_probs=151.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||+|++|.||+|.. .+++.|++|++..... .....+..|+.++..++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3688899999999999999984 4699999999876643 4457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998433 568999999999999999999999 98 9999999999999999999999999999876555
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......++..|.|||++...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred CcccceeecccccCHhhhCCC
Confidence 544456788899999987665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=213.32 Aligned_cols=172 Identities=27% Similarity=0.399 Sum_probs=141.3
Q ss_pred CccccceecccCceEEEEEEe-c--CCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-P--NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKM 158 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 158 (266)
.|.+.+.||+|+||.||+|.. . ++..||+|.+.... ....+.+.+|+.++..++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 378889999999999999994 3 58899999987632 33346678899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHhhcC--CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC----CCCeEEecc
Q 024537 159 LVYEYLPNKSLDYFIFDKT--KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE----QLNPKISDF 232 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~----~~~~kl~DF 232 (266)
+||||+++ ++.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6666653322 2236889999999999999999999998 999999999999999 899999999
Q ss_pred cccccCCCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 233 GLARLFPGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 233 G~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
|+++.+..... ......++..|+|||++.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC
Confidence 99987643322 2233467888999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=210.39 Aligned_cols=170 Identities=22% Similarity=0.251 Sum_probs=141.6
Q ss_pred hcCcccc-ceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEee----CCcE
Q 024537 85 TNFFSDL-NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE----GPEK 157 (266)
Q Consensus 85 ~~~y~~~-~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 157 (266)
.++|.+. ++||-|-.|.|..|. ..+++.+|+|++... ....+|+++-... .|||||.++++|.. .+.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556553 679999999999998 678999999988644 2334788876665 59999999999864 3456
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEecccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGL 234 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~ 234 (266)
.+|||.|+||.|..-+.++ ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8899999999999888543 4567999999999999999999999998 999999999999964 45699999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|+.-.. .....+++.|+.|.|||++.+|-
T Consensus 211 AK~t~~-~~~L~TPc~TPyYvaPevlg~eK 239 (400)
T KOG0604|consen 211 AKETQE-PGDLMTPCFTPYYVAPEVLGPEK 239 (400)
T ss_pred ccccCC-CccccCCcccccccCHHHhCchh
Confidence 997643 44567889999999999998873
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=210.43 Aligned_cols=175 Identities=30% Similarity=0.446 Sum_probs=140.9
Q ss_pred cCccccceecccCceEEEEEEec-CCC--EEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 160 (266)
++|++.+.||+|+||+||+|... ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 56889999999999999999853 343 4688887643 334456788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCe
Q 024537 161 YEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~ 227 (266)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1135888999999999999999999998 9999999999999999999
Q ss_pred EEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 228 KISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||+|||++......... .....+..|+|||++....
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~ 194 (297)
T cd05089 159 KIADFGLSRGEEVYVKK-TMGRLPVRWMAIESLNYSV 194 (297)
T ss_pred EECCcCCCccccceecc-CCCCcCccccCchhhccCC
Confidence 99999999754221111 1112345699999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=213.20 Aligned_cols=174 Identities=26% Similarity=0.322 Sum_probs=146.9
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+..|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999984 4689999999876532 24567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998843 23457899999999999999999999998 999999999999999999999999999765322
Q ss_pred Cc-----------------------------eeeeeeEEeeeeCCCccccC
Q 024537 242 DT-----------------------------HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~-----------------------------~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ....+.|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 207 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence 11 11234578889999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=205.89 Aligned_cols=175 Identities=29% Similarity=0.437 Sum_probs=149.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||.|+||+||+|. ..++..+|+|++.... ......+.+|+.+++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468999999999999999998 4578899999986542 23557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999854433356899999999999999999999998 99999999999999999999999999987754432
Q ss_pred e----eeeeeEEeeeeCCCccccC
Q 024537 244 H----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~----~~~~~~t~~y~aPE~~~~e 263 (266)
. .....++..|+|||++...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccccCChhhcChHHHccc
Confidence 2 1334578889999987643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=208.20 Aligned_cols=171 Identities=27% Similarity=0.478 Sum_probs=147.6
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+.||||+++++.+.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3578889999999999999984 468899999987553 44456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ..+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988732 35788899999999999999999998 99999999999999999999999999988765443
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|.|||++...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~ 176 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQS 176 (277)
T ss_pred ccccccCcccccCHhHhccC
Confidence 33445677889999987553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=208.57 Aligned_cols=169 Identities=29% Similarity=0.517 Sum_probs=147.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.|++.+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+.+++.+. |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47888999999999999999 457899999998754 3344567888999999986 999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 26889999999999999999999998 999999999999999999999999999887655
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
........++..|+|||++..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITE 175 (277)
T ss_pred ccccccccCCcceeCHHHhcc
Confidence 544455578889999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=205.69 Aligned_cols=170 Identities=30% Similarity=0.457 Sum_probs=146.0
Q ss_pred CccccceecccCceEEEEEEec-CCCEEEEEeecccC-----hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+|+..+.||+|+||+||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999954 78999999886543 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 245788999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......++..|+|||.+...
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~ 176 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQ 176 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCC
Confidence 43 22345678889999987543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=207.35 Aligned_cols=175 Identities=30% Similarity=0.426 Sum_probs=148.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCC------c
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP------E 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------~ 156 (266)
.++|++.+.||+|+||.||+|.. .+++.|++|.+...... ...+.+|+.+++++ .|+||+++++.+.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 47899999999999999999995 46789999998765443 36788999999999 6999999999997654 4
Q ss_pred EEEEEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence 899999999999998875422 2457889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..............++..|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACD 188 (275)
T ss_pred eecccchhhhcCccccccccCHhHhccc
Confidence 8765544444556788899999988643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=206.35 Aligned_cols=171 Identities=27% Similarity=0.450 Sum_probs=147.6
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488889999999999999984 4789999999876543 3567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345788899999999999999999998 99999999999999999999999999988754433
Q ss_pred eee----eeeEEeeeeCCCccccC
Q 024537 244 HVN----TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~----~~~~t~~y~aPE~~~~e 263 (266)
... ...++..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred cccccccCCcCCcCccChhhccCC
Confidence 221 34677899999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=211.66 Aligned_cols=170 Identities=29% Similarity=0.493 Sum_probs=147.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.|+..+.||+|+||.||+|. ..++..||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 47778899999999999998 4568899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|.+++. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999988873 245788999999999999999999998 999999999999999999999999999887654444
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred hhcccCcccccCHHHhCcC
Confidence 4455678899999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=198.70 Aligned_cols=186 Identities=22% Similarity=0.352 Sum_probs=153.3
Q ss_pred chhhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHH-hcCCCCceeEEeEEee
Q 024537 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLL-KIQHKNLVTLFGCCAE 153 (266)
Q Consensus 77 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~ 153 (266)
..+.+++..+....+..||+|++|+|-+-+ ..+|...|+|.+... ..+...+.++|+++.. ...+|.+|.+||.+..
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 444567777777788999999999999888 668999999999765 3444467778888765 4579999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
.+.+||.||.| ..+|+.+..+. ..+..+++..+-+|+..++.||.|||++- .+||||+||+||||+.+|.||||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 99999999999 66887766442 44567999999999999999999999974 5999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCccccCCCC
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCMDICQ 266 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~~~ 266 (266)
|++..+.+.-..+ .-.|...|+|||.+-+|.-|
T Consensus 194 GIsG~L~dSiAkt-~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 194 GISGYLVDSIAKT-MDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred ccceeehhhhHHH-HhcCCCccCChhhcCcccCc
Confidence 9999876543332 12577899999999988643
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=206.62 Aligned_cols=172 Identities=24% Similarity=0.437 Sum_probs=136.8
Q ss_pred cccceecccCceEEEEEEecC-CC--EEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------CcE
Q 024537 89 SDLNQLGHGGFGPVYRGLMPN-GQ--EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------PEK 157 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 157 (266)
.+.+.||+|+||.||+|.+.. +. .||+|.++.. .....+.+..|+.+++.++||||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999998543 33 6899988654 344567788999999999999999999987432 246
Q ss_pred EEEEeccCCCCHHHHHhhcC---CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+++|||+++++|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999988774321 2345889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
++.+...... .....+++.|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 189 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR 189 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC
Confidence 9976533211 1122345679999987654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=213.29 Aligned_cols=169 Identities=18% Similarity=0.222 Sum_probs=139.1
Q ss_pred ccceeccc--CceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 90 DLNQLGHG--GFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 90 ~~~~iG~G--~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
++++||+| +|++||++. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 689999998 5689999999987542 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc-
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT- 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 243 (266)
++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 345889999999999999999999998 99999999999999999999999987654322111
Q ss_pred ------eeeeeeEEeeeeCCCcccc
Q 024537 244 ------HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ------~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccccccceecccChHHhhc
Confidence 0112245677999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=207.88 Aligned_cols=169 Identities=28% Similarity=0.475 Sum_probs=146.0
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
-|++.+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++.+..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477889999999999999984 578899999876543 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++++|..++. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..+......
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 9999988873 235789999999999999999999998 999999999999999999999999999877554433
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
.....++..|+|||++..
T Consensus 158 ~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred hccccCCccccChhhhcc
Confidence 444567888999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=205.84 Aligned_cols=172 Identities=27% Similarity=0.457 Sum_probs=142.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 157 (266)
.+|+..+.||+|+||.||+|. ..++..||+|++... .......+.+|+.++++++||||+++++.+... +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468899999999999999998 457899999988643 123345688899999999999999999998753 567
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++++||+++++|.+.+.. ...+++...+.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988843 235788899999999999999999998 99999999999999999999999999986
Q ss_pred CCCC---CceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGE---DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~---~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+... ........++..|+|||.+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGE 184 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCC
Confidence 6432 1222334578889999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=210.58 Aligned_cols=171 Identities=20% Similarity=0.272 Sum_probs=142.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999998 4568899999887553 233456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 246888999999999999999999998 999999999999999999999999998742100
Q ss_pred C---------------ceeeeeeEEeeeeCCCcccc
Q 024537 242 D---------------THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~---------------~~~~~~~~t~~y~aPE~~~~ 262 (266)
. .......++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccC
Confidence 0 00112346778999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=206.67 Aligned_cols=166 Identities=22% Similarity=0.362 Sum_probs=134.4
Q ss_pred eecccCceEEEEEEecCC---CEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 93 QLGHGGFGPVYRGLMPNG---QEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999974333 346677766543 3445678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCC-CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC--cee
Q 024537 169 LDYFIFDKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED--THV 245 (266)
Q Consensus 169 L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~ 245 (266)
|.+++..... ....++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9998864322 234667778899999999999999998 9999999999999999999999999986532211 122
Q ss_pred eeeeEEeeeeCCCccc
Q 024537 246 NTFRISVVTWPPNMHC 261 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~ 261 (266)
....++..|+|||++.
T Consensus 159 ~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 159 DDKCVPLRWLAPELVG 174 (268)
T ss_pred cCCcCcccccCchhcc
Confidence 3446778899999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=206.29 Aligned_cols=173 Identities=27% Similarity=0.485 Sum_probs=142.6
Q ss_pred cCccccceecccCceEEEEEEec-CC---CEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP-NG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+.|++.+.||+|+||.||+|... ++ ..||||.+... .......+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45888999999999999999843 33 36999998754 344457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999888432 346889999999999999999999998 99999999999999999999999999987643
Q ss_pred CCce---eeeee--EEeeeeCCCccccC
Q 024537 241 EDTH---VNTFR--ISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~---~~~~~--~t~~y~aPE~~~~e 263 (266)
.... ..... .+..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccC
Confidence 2211 11111 13479999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=208.56 Aligned_cols=169 Identities=30% Similarity=0.471 Sum_probs=138.8
Q ss_pred ccccceecccCceEEEEEE-----ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-----MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML 159 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 159 (266)
|++++.||+|+||+||++. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4889999999999998865 2367889999987653 23446788999999999999999999988654 35789
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999988843 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCce---eeeeeEEeeeeCCCccccC
Q 024537 240 GEDTH---VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~---~~~~~~t~~y~aPE~~~~e 263 (266)
..... .....++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhccc
Confidence 43221 1112345679999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=209.73 Aligned_cols=172 Identities=26% Similarity=0.396 Sum_probs=146.2
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688999999999999999984 46889999988654 23334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++++.+..+.. ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998877765552 2345889999999999999999999998 9999999999999999999999999998876543
Q ss_pred c-eeeeeeEEeeeeCCCccccC
Q 024537 243 T-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~-~~~~~~~t~~y~aPE~~~~e 263 (266)
. ....+.++..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred cccccCcccccCCcCCchhcCC
Confidence 2 23345678889999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=204.65 Aligned_cols=174 Identities=23% Similarity=0.393 Sum_probs=147.5
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~ 161 (266)
+|++++.||.|+||.||+|. ..++..||+|.+... .....+.+..|+.+++.++||||+++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999998 457889999988654 34445678899999999999999999998764 34579999
Q ss_pred eccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH-----EEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 162 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH-----~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
||+++++|.+++... .....+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999888543 22457899999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..............++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~ 185 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHM 185 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCC
Confidence 9876555434556788999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=210.17 Aligned_cols=170 Identities=36% Similarity=0.569 Sum_probs=138.8
Q ss_pred ccceecccCceEEEEEEec-----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 90 DLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+.+.||.|+||.||+|.+. .+..|+||.+... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999965 3578999999654 344468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++|+|.+++... ....+++..+..|+.|++.||.|||+++ ++|+||+++|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2456899999999999999999999998 99999999999999999999999999988733222
Q ss_pred e--eeeeeEEeeeeCCCccccC
Q 024537 244 H--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~--~~~~~~t~~y~aPE~~~~e 263 (266)
. .........|+|||.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~ 180 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG 180 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS
T ss_pred cccccccccccccccccccccc
Confidence 1 1222456679999987654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=207.97 Aligned_cols=172 Identities=22% Similarity=0.358 Sum_probs=140.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHH-HHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKL-LLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|+||.||+|. ..+++.||+|++.... ......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468899999999999999998 4579999999987542 2223345556654 666789999999999999999999999
Q ss_pred ccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 163 YLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 163 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|++ ++|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 6787776442 2335789999999999999999999997 7 99999999999999999999999999987643
Q ss_pred CCceeeeeeEEeeeeCCCcccc
Q 024537 241 EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.... ....++..|+|||++.+
T Consensus 157 ~~~~-~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 157 SVAK-TIDAGCKPYMAPERINP 177 (283)
T ss_pred cccc-ccccCCccccChhhcCC
Confidence 3221 22357788999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=206.48 Aligned_cols=173 Identities=27% Similarity=0.514 Sum_probs=143.2
Q ss_pred hcCccccceecccCceEEEEEEec-CCC---EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ---EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|+..+.||+|+||.||+|... ++. .+|+|.+... .......+..|+.++..++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456888999999999999999843 333 7999998765 34445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999988432 356889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCceeee---eeEEeeeeCCCcccc
Q 024537 240 GEDTHVNT---FRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~---~~~t~~y~aPE~~~~ 262 (266)
........ ...+..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc
Confidence 33221111 112346999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=206.78 Aligned_cols=172 Identities=24% Similarity=0.471 Sum_probs=141.8
Q ss_pred hcCccccceecccCceEEEEEEec-CCC----EEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..+|++.+.||+|+||+||+|.+. ++. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 456889999999999999999843 333 58999876553 3445678899999999999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999988432 345889999999999999999999998 999999999999999999999999999887
Q ss_pred CCCCceeee--eeEEeeeeCCCcccc
Q 024537 239 PGEDTHVNT--FRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~~~~~--~~~t~~y~aPE~~~~ 262 (266)
......... ..++..|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc
Confidence 543322111 122457999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=210.78 Aligned_cols=174 Identities=22% Similarity=0.371 Sum_probs=141.7
Q ss_pred hcCccccceecccCceEEEEEEec-----------------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCcee
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-----------------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~ 146 (266)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456999999999999999998532 2446899998754 3334567889999999999999999
Q ss_pred EEeEEeeCCcEEEEEeccCCCCHHHHHhhcCC--------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK--------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 147 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
+++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998854321 124777889999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCce--eeeeeEEeeeeCCCccc
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~ 261 (266)
||++.++.++|+|||+++.+...... .....++..|++||+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 99999999999999999876433211 11223356789998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=230.18 Aligned_cols=175 Identities=26% Similarity=0.442 Sum_probs=149.5
Q ss_pred HhhcCccccceecccCceEEEEEEec-C---CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
+.....++.+.||.|.||.|++|+++ . ...||||.++.. ..+....|+.|+.||.+++||||++|.|+......+
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 33455677899999999999999943 2 357999999876 455667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.||+|||++|+|+.+|+.+. +.+.+.+...+++.|+.||+||-+.+ +|||||-++|||++.+-.+|++|||++|.
T Consensus 706 MIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999996543 55888999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCceeeeeeE---EeeeeCCCcccc
Q 024537 238 FPGEDTHVNTFRI---SVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~~~~~---t~~y~aPE~~~~ 262 (266)
+.++.....+..| ...|.|||.|+-
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~ 808 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAY 808 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhh
Confidence 8655422222222 457999999864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=205.35 Aligned_cols=169 Identities=28% Similarity=0.428 Sum_probs=141.8
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEe-eCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA-EGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||.||++.. .+..||+|.+..... ...+.+|+.++++++|+|++++++++. .++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 45789999999999999999986 478899998865433 356889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 9999999988543 2345888999999999999999999998 99999999999999999999999999987643322
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
...++..|+|||++..+
T Consensus 158 ---~~~~~~~y~aPE~~~~~ 174 (256)
T cd05082 158 ---TGKLPVKWTAPEALREK 174 (256)
T ss_pred ---CCccceeecCHHHHccC
Confidence 23456689999987553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=205.25 Aligned_cols=180 Identities=27% Similarity=0.313 Sum_probs=154.4
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG----- 154 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 154 (266)
+.+..++|.+.+.||+|+|+-||++. ..++..||+|++........+..++|++..++++|||++++++....+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34556789999999999999999998 778999999999988888888999999999999999999999876543
Q ss_pred CcEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
...|++++|...|+|.+.+... .++..+++.+++.|+.++++||++||+..+ +++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEecc
Confidence 3489999999999999888653 344479999999999999999999999874 69999999999999999999999999
Q ss_pred ccccCCCC---------CceeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGE---------DTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~---------~~~~~~~~~t~~y~aPE~~~ 261 (266)
.++...-. -.......+|..|+|||++.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 99865311 12233457899999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=209.29 Aligned_cols=173 Identities=24% Similarity=0.363 Sum_probs=141.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCc-----
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPE----- 156 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 156 (266)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999994 478999999876542 222356778999999995 6999999999987666
Q ss_pred EEEEEeccCCCCHHHHHhhcCC--CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEeccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFG 233 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG 233 (266)
.|+||||+++ +|..++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 78777754322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+++.+...........+++.|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhC
Confidence 99876544333333356788999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=204.88 Aligned_cols=172 Identities=27% Similarity=0.451 Sum_probs=143.5
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 157 (266)
.+|.+.+.||+|+||.||+|. ..+++.||+|.+... .......+.+|+.++++++||||+++++.+.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468899999999999999998 457899999987532 223446788999999999999999999998764 457
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988843 234788899999999999999999998 99999999999999999999999999987
Q ss_pred CCCC---CceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGE---DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~---~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ........++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCC
Confidence 6432 1122334678899999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=203.95 Aligned_cols=164 Identities=28% Similarity=0.441 Sum_probs=135.1
Q ss_pred eecccCceEEEEEEe---cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 93 QLGHGGFGPVYRGLM---PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+||+|+||.||+|.+ .++..+|+|++.... ....+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999963 367899999986542 334567889999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee-
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN- 246 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~- 246 (266)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||.||+++.++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 346889999999999999999999998 99999999999999999999999999987754432211
Q ss_pred --eeeEEeeeeCCCccccC
Q 024537 247 --TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 --~~~~t~~y~aPE~~~~e 263 (266)
...++..|+|||++...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYY 173 (257)
T ss_pred cCCCCCCccccCHhHhccC
Confidence 11224689999987543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=211.33 Aligned_cols=178 Identities=21% Similarity=0.288 Sum_probs=158.6
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.+..++|.+++.||+|+|.+|..++ ..+.+.||+|++++. ...++.-++.|-.+..+. +||.+|-+...|+++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 3456789999999999999999999 667889999998753 445566677888888766 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+++|.||++||+|-..+ ...+.++++.++.+...|+-||.|||++| ||+||||.+|+|++..|.+||+|+|+++
T Consensus 326 lffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 99999999999996655 45678999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccCCC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
.--.+...+++|+|||-|.|||++.+|-+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhccccc
Confidence 88777788899999999999999998854
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=209.87 Aligned_cols=170 Identities=23% Similarity=0.351 Sum_probs=145.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++++.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3568899999999999999998 4468899999876543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999888743 34688999999999999999999974 6 999999999999999999999999999765332
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
. .....++..|+|||++..
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQG 176 (284)
T ss_pred c--cCccccCcccCCHHHHcc
Confidence 2 234568889999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-28 Score=207.09 Aligned_cols=170 Identities=25% Similarity=0.393 Sum_probs=147.3
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
|...+.||+|++|.||++. ..+++.+++|++..........+.+|+.+++.+.||||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4556789999999999998 457899999998766555556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++...........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999988843 45888999999999999999999998 99999999999999999999999999987655443334
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
...++..|+|||++....
T Consensus 174 ~~~~~~~y~aPE~~~~~~ 191 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP 191 (285)
T ss_pred cccCCccccCHHHhcCCC
Confidence 456888999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=206.09 Aligned_cols=171 Identities=26% Similarity=0.391 Sum_probs=144.0
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC----------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS----------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
+|.+.+.||.|+||.||+|. ..+++.||+|.+.... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999998 4578999999875421 112346778999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988432 46888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
+...... .......++..|+|||++..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccc
Confidence 8764321 122344678899999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=208.87 Aligned_cols=171 Identities=25% Similarity=0.427 Sum_probs=144.1
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|+.++.||.|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999984 578999999886542 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6787777432 3456889999999999999999999998 99999999999999999999999999987654433
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||++.+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred ccccccccccccCCeEEec
Confidence 3334456788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=209.31 Aligned_cols=177 Identities=30% Similarity=0.504 Sum_probs=144.8
Q ss_pred hhcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567999999999999999999842 46789999987543 3334668899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcC-------------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 157 KMLVYEYLPNKSLDYFIFDKT-------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
.+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999985321 1134778889999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
||+++.++.++|+|||+++.+..... .......+..|+|||++...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 99999999999999999986543321 11122345679999986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=206.91 Aligned_cols=175 Identities=31% Similarity=0.438 Sum_probs=142.1
Q ss_pred hcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456899999999999999999853 45688999886543 33345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCC----CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---CeEEe
Q 024537 158 MLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKIS 230 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl~ 230 (266)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998854321 135889999999999999999999998 99999999999998765 58999
Q ss_pred cccccccCCCCCcee--eeeeEEeeeeCCCcccc
Q 024537 231 DFGLARLFPGEDTHV--NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 231 DFG~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~ 262 (266)
|||+++.+....... .....+..|+|||++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence 999998774322111 11122457999998754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=203.96 Aligned_cols=171 Identities=25% Similarity=0.500 Sum_probs=143.3
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.+|++.+.||+|+||.||+|.+.++..+|+|.+...... ...+..|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468889999999999999999766889999988654322 3567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce-
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH- 244 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~- 244 (266)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888432 245788999999999999999999998 999999999999999999999999999876433211
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
.....++..|+|||++..
T Consensus 158 ~~~~~~~~~~~aPe~~~~ 175 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF 175 (256)
T ss_pred cCCCccchhhcCHhHhcc
Confidence 112234567999998764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=203.98 Aligned_cols=167 Identities=31% Similarity=0.469 Sum_probs=140.0
Q ss_pred ceecccCceEEEEEEecC--C--CEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLMPN--G--QEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|++|.||+|.+.+ + ..||||.+..... .....+..|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998532 3 3689999887655 556788999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce--
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-- 244 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~-- 244 (266)
++|.+.+..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998855332 56899999999999999999999998 999999999999999999999999999987543221
Q ss_pred -eeeeeEEeeeeCCCccccC
Q 024537 245 -VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 -~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~ 175 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTR 175 (257)
T ss_pred cccCCCCCceecCHHHhccc
Confidence 1123456789999987543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=207.90 Aligned_cols=170 Identities=25% Similarity=0.299 Sum_probs=143.6
Q ss_pred CccccceecccCceEEEEEEe----cCCCEEEEEeecccC----hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 157 (266)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999984 368899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999988843 245788899999999999999999998 99999999999999999999999999987
Q ss_pred CCCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.... .......++..|+|||++..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred cccccccccccccCCcccCChhhccC
Confidence 64332 22234567889999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=207.53 Aligned_cols=170 Identities=28% Similarity=0.387 Sum_probs=147.3
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+|++.+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++.+..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488899999999999999994 468999999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+.+++|...+... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999888432 46889999999999999999999998 9999999999999999999999999998775443
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~ 174 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQ 174 (258)
T ss_pred -cccccCCChhhcCHHHHccc
Confidence 22344678889999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=207.15 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=147.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+.||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3578889999999999999984 478999999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885432 568889999999999999999999 88 9999999999999999999999999998764333
Q ss_pred ceeeeeeEEeeeeCCCccccCC
Q 024537 243 THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... ..++..|+|||++.+..
T Consensus 156 ~~~--~~~~~~y~~PE~~~~~~ 175 (265)
T cd06605 156 AKT--FVGTSSYMAPERIQGND 175 (265)
T ss_pred hhc--ccCChhccCHHHHcCCC
Confidence 222 56788999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=201.29 Aligned_cols=171 Identities=30% Similarity=0.450 Sum_probs=149.8
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|++|.||+|.. .+++.|++|.+..... .....+.+|+.++.+++|||++++++++..++..+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999984 4688999999876643 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988432 56899999999999999999999998 99999999999999999999999999998865554
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||.....
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred cccccccchhhcCHhhhcCC
Confidence 44456788899999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=206.71 Aligned_cols=172 Identities=25% Similarity=0.392 Sum_probs=141.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++.+.||+|++|+||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5689999999999999999984 4789999998865422 233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGE 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~~ 241 (266)
|++ +++...+... ....+++..+..++.||+.||+|||+++ ++|+||||+||+++. ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 5776666332 2334678888899999999999999998 999999999999985 456899999999876544
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
........++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred ccccccCceeecccCHHHHhC
Confidence 333334467889999998754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=203.54 Aligned_cols=167 Identities=29% Similarity=0.450 Sum_probs=140.3
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
++|++.+.||+|+||.||++.. +++.||+|.+..... ...+.+|+.++..++||||+++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999875 678899999865432 35788999999999999999999998764 4799999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998543 2345888999999999999999999998 9999999999999999999999999998653321
Q ss_pred eeeeEEeeeeCCCccccC
Q 024537 246 NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~e 263 (266)
.....+..|+|||++...
T Consensus 155 ~~~~~~~~y~~pe~~~~~ 172 (254)
T cd05083 155 DNSKLPVKWTAPEALKHK 172 (254)
T ss_pred CCCCCCceecCHHHhccC
Confidence 122345679999987643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=205.00 Aligned_cols=172 Identities=24% Similarity=0.350 Sum_probs=141.4
Q ss_pred hcCccccceecccCceEEEEEEecC----CCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.+++.+.||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998432 3468999887654 4455688999999999999999999998875 55789
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 335889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCceee-eeeEEeeeeCCCcccc
Q 024537 240 GEDTHVN-TFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~-~~~~t~~y~aPE~~~~ 262 (266)
....... ...++..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF 182 (270)
T ss_pred cccceecCCCCccccccChhhhcc
Confidence 4422111 1223457999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=209.85 Aligned_cols=172 Identities=31% Similarity=0.464 Sum_probs=142.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 159 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4679999999999999999999 45789999999865422 1123456799999999999999999998765 56899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 5787777432 256899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..........++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CccCCCCcccccccccChhhhcC
Confidence 54333333345778999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=207.06 Aligned_cols=162 Identities=23% Similarity=0.405 Sum_probs=136.1
Q ss_pred ceecccCceEEEEEEec-C-------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 92 NQLGHGGFGPVYRGLMP-N-------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+.||.|+||.||+|... . ...||+|.+........+.+.+|+.+++.+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999742 2 234888887665555557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC--------eEEeccccc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--------PKISDFGLA 235 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~--------~kl~DFG~a 235 (266)
+++|+|..++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998432 236888999999999999999999998 999999999999987765 699999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
...... ....++..|+|||++..
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 156 ITVLPK----EILLERIPWVPPECIEN 178 (258)
T ss_pred cccCCc----hhccccCCccCchhccC
Confidence 766432 23467788999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=200.96 Aligned_cols=167 Identities=31% Similarity=0.481 Sum_probs=139.7
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~ 170 (266)
+.||+|+||.||+|...+++.||+|++..... .....+.+|+.+++++.||||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999965699999998876533 34567889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee--ee
Q 024537 171 YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN--TF 248 (266)
Q Consensus 171 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~--~~ 248 (266)
+++... ...+++..+..++.+++.||.|||+++ ++||||||+||+++.++.++|+|||+++.......... ..
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 888432 345788899999999999999999998 99999999999999999999999999987642221111 12
Q ss_pred eEEeeeeCCCccccC
Q 024537 249 RISVVTWPPNMHCMD 263 (266)
Q Consensus 249 ~~t~~y~aPE~~~~e 263 (266)
..+..|+|||++...
T Consensus 156 ~~~~~y~~PE~~~~~ 170 (251)
T cd05041 156 QIPIKWTAPEALNYG 170 (251)
T ss_pred cceeccCChHhhccC
Confidence 335679999987543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=202.37 Aligned_cols=171 Identities=32% Similarity=0.528 Sum_probs=143.0
Q ss_pred ccccceecccCceEEEEEEec-C----CCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-N----GQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+++.+.||.|+||.||+|.+. . +..||+|.+...... ....+..|+.++..++|+||+++++.+...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356788999999999999853 3 388999998765433 5678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999884322 122899999999999999999999998 999999999999999999999999999877544
Q ss_pred Cceee-eeeEEeeeeCCCcccc
Q 024537 242 DTHVN-TFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~-~~~~t~~y~aPE~~~~ 262 (266)
..... ...++..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~ 178 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD 178 (258)
T ss_pred cccccccCCCcccccChHHhcc
Confidence 22211 1236678999998744
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=204.49 Aligned_cols=172 Identities=28% Similarity=0.490 Sum_probs=142.9
Q ss_pred cCccccceecccCceEEEEEEec-----CCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 157 (266)
..|++.+.||+|+||.||+|.+. +++.||||.+...... ....+.+|+.+++.+.||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45788899999999999999843 3689999998766443 45778999999999999999999999877 5578
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998432 235889999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCceee---eeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVN---TFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~---~~~~t~~y~aPE~~~~ 262 (266)
......... ...++..|+|||++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc
Confidence 763322111 1133456999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=201.03 Aligned_cols=172 Identities=25% Similarity=0.399 Sum_probs=145.7
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||+|. ..+++.+|+|.+... .......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 48889999999999999998 457889999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345889999999999999999999998 99999999999998654 57999999998775433
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
. .....++..|+|||++...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08220 157 K-AYTVVGTPCYISPELCEGK 176 (256)
T ss_pred c-ccccccCCcccCchhccCC
Confidence 2 2234678899999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=205.57 Aligned_cols=166 Identities=28% Similarity=0.380 Sum_probs=139.7
Q ss_pred ecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||+|+||+||+|. ..+++.||+|.+.... ......+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998 4578999999986542 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 98885432 246889999999999999999999998 999999999999999999999999999876432 2223345
Q ss_pred EEeeeeCCCccccCC
Q 024537 250 ISVVTWPPNMHCMDI 264 (266)
Q Consensus 250 ~t~~y~aPE~~~~e~ 264 (266)
++..|+|||++.+..
T Consensus 156 ~~~~y~~PE~~~~~~ 170 (277)
T cd05577 156 GTPGYMAPEVLQGEV 170 (277)
T ss_pred CCCCcCCHHHhcCCC
Confidence 677899999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=198.94 Aligned_cols=174 Identities=24% Similarity=0.379 Sum_probs=151.2
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|.+.+.||.|+||.||++.. .+++.||+|++.... ......+..|+.+++.++|||++++.+.+...+..++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 478889999999999999994 468999999987653 24556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+.+.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885432 2367899999999999999999999998 9999999999999999999999999998876654
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+++.|+|||.+...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~ 178 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNK 178 (258)
T ss_pred ceecceeeeecccChhHhccC
Confidence 444556788999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=207.62 Aligned_cols=173 Identities=27% Similarity=0.533 Sum_probs=139.8
Q ss_pred hcCccccceecccCceEEEEEEe-cCCC----EEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|+..+.||+|+||.||+|.+ .++. .||+|.+.... ......+.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35688889999999999999984 3444 57888876543 33344678999999999999999999998754 467
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999888432 345788899999999999999999998 999999999999999999999999999877
Q ss_pred CCCCce--eeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
...... .....++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYR 186 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccC
Confidence 543321 1122345689999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=206.33 Aligned_cols=166 Identities=26% Similarity=0.391 Sum_probs=143.8
Q ss_pred ccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 90 DLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
....||+|+||.||++. ..+++.||||++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 34679999999999998 45789999999876555555678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeee
Q 024537 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248 (266)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 248 (266)
|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..........
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 988763 235788999999999999999999998 9999999999999999999999999998775544333445
Q ss_pred eEEeeeeCCCcccc
Q 024537 249 RISVVTWPPNMHCM 262 (266)
Q Consensus 249 ~~t~~y~aPE~~~~ 262 (266)
.++..|+|||++..
T Consensus 177 ~~~~~y~~pE~~~~ 190 (292)
T cd06657 177 VGTPYWMAPELISR 190 (292)
T ss_pred ccCccccCHHHhcC
Confidence 67888999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=202.24 Aligned_cols=173 Identities=24% Similarity=0.369 Sum_probs=146.5
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|.+.+.||+|+||.||+|. ..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47889999999999999999 4468899999986542 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC-eEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~-~kl~DFG~a~~~~~~~ 242 (266)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999888542 2345789999999999999999999998 999999999999998864 6999999998876554
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......++..|+|||++...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~ 177 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNR 177 (257)
T ss_pred ccccccCCCccccCHHHHcCC
Confidence 444455688899999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=211.10 Aligned_cols=170 Identities=27% Similarity=0.362 Sum_probs=140.9
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------ 154 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 154 (266)
..++|++.+.||+|+||.||+|. ..+++.||||.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 34779999999999999999998 457899999998643 333345677899999999999999999998644
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34799999995 577776622 2788889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++....... .....++..|+|||++.+.
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 192 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGM 192 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCC
Confidence 987654332 2344678899999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=203.32 Aligned_cols=173 Identities=28% Similarity=0.452 Sum_probs=149.7
Q ss_pred hcCccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.+.|++.+.||+|+||.||+|... ++..|++|.+..... ....+.+|+.+++.++|+||+++++.+..++..++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456888899999999999999954 688999999876544 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.... ..+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++........
T Consensus 97 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 97 MDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999985432 36899999999999999999999998 99999999999999999999999999987654433
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++...
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~ 191 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRK 191 (286)
T ss_pred hhccccCCcccCCHhHhcCC
Confidence 33444577889999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=201.21 Aligned_cols=162 Identities=25% Similarity=0.301 Sum_probs=139.5
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999994 468999999987542 23346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 998843 245888999999999999999999998 9999999999999999999999999999875543 223346
Q ss_pred EEeeeeCCCcccc
Q 024537 250 ISVVTWPPNMHCM 262 (266)
Q Consensus 250 ~t~~y~aPE~~~~ 262 (266)
++..|+|||++..
T Consensus 154 ~~~~~~~PE~~~~ 166 (262)
T cd05572 154 GTPEYVAPEIILN 166 (262)
T ss_pred CCcCccChhHhcC
Confidence 7888999998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=205.92 Aligned_cols=174 Identities=29% Similarity=0.451 Sum_probs=142.3
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC----
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP---- 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 155 (266)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999994 468999999987542 222345678999999999999999999987654
Q ss_pred ------cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 156 ------EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 156 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
..++|+||+++ ++..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 66666532 2346899999999999999999999998 999999999999999999999
Q ss_pred ecccccccCCCCCc-eeeeeeEEeeeeCCCcccc
Q 024537 230 SDFGLARLFPGEDT-HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 230 ~DFG~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 262 (266)
+|||++..+..... ......++..|+|||++.+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcC
Confidence 99999987754332 1122345778999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=196.34 Aligned_cols=171 Identities=31% Similarity=0.505 Sum_probs=149.9
Q ss_pred CccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
+|...+.||+|++|.||++... +++.+++|++..........+.+|+.+++.++|+||+++++.+..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999954 788999999977655556788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 154 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-R 154 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-c
Confidence 99999988432 256899999999999999999999988 99999999999999999999999999988765442 3
Q ss_pred eeeeEEeeeeCCCccccC
Q 024537 246 NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~e 263 (266)
....++..|+|||++...
T Consensus 155 ~~~~~~~~~~~PE~~~~~ 172 (253)
T cd05122 155 NTMVGTPYWMAPEVINGK 172 (253)
T ss_pred cceecCCcccCHHHHcCC
Confidence 455788899999987654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=201.02 Aligned_cols=167 Identities=31% Similarity=0.482 Sum_probs=134.6
Q ss_pred eecccCceEEEEEEec-CCC--EEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 93 QLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
.||+|+||.||+|... ++. .+++|.+... .......+.+|+.++.++ .||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999853 444 4688887643 344456788999999999 7999999999999999999999999999
Q ss_pred CHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 168 SLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 168 ~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999985422 1235788999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+......... .....+..|+|||++...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~y~apE~~~~~ 186 (270)
T cd05047 159 SRGQEVYVKK-TMGRLPVRWMAIESLNYS 186 (270)
T ss_pred ccccchhhhc-cCCCCccccCChHHHccC
Confidence 9643221111 112335579999987543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=199.32 Aligned_cols=164 Identities=30% Similarity=0.514 Sum_probs=134.3
Q ss_pred ceecccCceEEEEEEec-C---CCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|.+. . +..||+|.+..... .....+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999732 2 26899999876543 34567889999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998432 36889999999999999999999998 99999999999999999999999999987644332211
Q ss_pred e---eeEEeeeeCCCcccc
Q 024537 247 T---FRISVVTWPPNMHCM 262 (266)
Q Consensus 247 ~---~~~t~~y~aPE~~~~ 262 (266)
. ..++..|+|||++..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY 172 (257)
T ss_pred cccCccccccccCHHHhcC
Confidence 1 122357999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=205.87 Aligned_cols=173 Identities=27% Similarity=0.461 Sum_probs=139.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35699999999999999999984 578999999886442 222234568999999999999999999987654
Q ss_pred --cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 156 --EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
..++||||+. +++...+.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 3499999995 577777632 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc----eeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGEDT----HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~e 263 (266)
++..+..... ......++..|+|||++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 9987643321 11233567789999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=240.22 Aligned_cols=172 Identities=28% Similarity=0.403 Sum_probs=149.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.-+|+....||.|.||.||-|. ..+|...|+|-++.. .......+.+|..++..++|||+|+++|+=...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3457778889999999999999 668999999987643 3344566779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||++|+|.+++ ..++..++.....+..|++.|+.|||..| ||||||||.||+++.+|.+|++|||.|..+.+.
T Consensus 1314 EyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999998 33455777788889999999999999999 999999999999999999999999999988644
Q ss_pred C----ceeeeeeEEeeeeCCCcccc
Q 024537 242 D----THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~----~~~~~~~~t~~y~aPE~~~~ 262 (266)
. ..+....||+-|||||++.+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcc
Confidence 2 34556789999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=202.20 Aligned_cols=162 Identities=24% Similarity=0.272 Sum_probs=132.4
Q ss_pred eecccCceEEEEEE-ecCCCEEEEEeecccCh---hhHHHHHHHHH---HHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---QGLREFTNEVK---LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 93 ~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.||+|+||.||+|. ..+++.||+|.+..... .....+..|.. ++....||+|+++++.+..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999998 45689999998865421 11122333433 4445679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
|++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999888742 346899999999999999999999998 99999999999999999999999999987643332
Q ss_pred eeeeEEeeeeCCCcccc
Q 024537 246 NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~ 262 (266)
....|+..|+|||++..
T Consensus 153 ~~~~~~~~y~aPE~~~~ 169 (278)
T cd05606 153 HASVGTHGYMAPEVLQK 169 (278)
T ss_pred cCcCCCcCCcCcHHhcC
Confidence 23468899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=202.99 Aligned_cols=162 Identities=24% Similarity=0.285 Sum_probs=131.6
Q ss_pred eecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHH---HhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLL---LKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
.||+|+||.||++.. .+++.||+|.+.... ......+.+|..++ ....||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999984 568999999886542 11112233444333 33479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999888843 345899999999999999999999998 99999999999999999999999999986643322
Q ss_pred eeeeEEeeeeCCCcccc
Q 024537 246 NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~ 262 (266)
....++..|+|||++..
T Consensus 153 ~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 153 HASVGTHGYMAPEVLQK 169 (279)
T ss_pred cCcCCCcCccCHHHhcC
Confidence 23468899999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=199.58 Aligned_cols=166 Identities=27% Similarity=0.425 Sum_probs=132.9
Q ss_pred ceecccCceEEEEEEec----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEe-eCCcEEEEEeccC
Q 024537 92 NQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA-EGPEKMLVYEYLP 165 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~~~ 165 (266)
+.||+|+||.||+|.+. ....||+|.+... .......+..|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999842 2457999988543 3445577889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc--
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT-- 243 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~-- 243 (266)
+++|.+++... .....+..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998532 234567778889999999999999998 99999999999999999999999999986543221
Q ss_pred --eeeeeeEEeeeeCCCcccc
Q 024537 244 --HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 --~~~~~~~t~~y~aPE~~~~ 262 (266)
......++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred ecccccCcCCccccChhHhcc
Confidence 1112234667999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=210.55 Aligned_cols=171 Identities=25% Similarity=0.441 Sum_probs=143.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 156 (266)
.++|++.+.||+|+||+||+|. ..+++.||||.+... .......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3569999999999999999998 557899999988653 223345677899999999999999999988654 34
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 68877773 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.............++..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccCCCcccccccccccCccChHHHhc
Confidence 87554334445578889999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=202.64 Aligned_cols=170 Identities=25% Similarity=0.431 Sum_probs=142.2
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
|++.+.||.|++|.||+|. ..+|..||+|++.... ......+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6778999999999999998 4579999999987543 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+ ++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++.+......
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 4 6888887432 2246899999999999999999999998 999999999999999999999999999876433322
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
.....++..|+|||++..
T Consensus 156 ~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 156 YTHEVVTLWYRAPEILLG 173 (283)
T ss_pred cCccccccCCCCCceeec
Confidence 233356788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=207.33 Aligned_cols=179 Identities=25% Similarity=0.355 Sum_probs=144.6
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHH-HhcCCCCceeEEeEEeeCCcE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLL-LKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.....++.+.+..||.|+||+|++-. .+.|+.+|||+++... .....+++.|.+.. +.-+.||||++||+...++..
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 44555677778999999999999988 6789999999998664 35557788888765 455799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhh--cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 158 MLVYEYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
||.||+| ..+|+.+... ......+++.-+-.|....+.||.||-..- .|||||+||+|||++..|.+||||||++
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccch
Confidence 9999999 6677665422 123456888888888888999999998753 5999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..+.+.-..+. -.|...|+|||-+.+.
T Consensus 216 GqLv~SiAkT~-daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 216 GQLVDSIAKTV-DAGCRPYMAPERIDPS 242 (361)
T ss_pred HhHHHHHHhhh-ccCCccccChhccCCc
Confidence 87754433322 2578899999988764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=199.85 Aligned_cols=173 Identities=24% Similarity=0.416 Sum_probs=143.8
Q ss_pred CccccceecccCceEEEEEEec--CCCEEEEEeeccc----------ChhhHHHHHHHHHHHHh-cCCCCceeEEeEEee
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVD----------SRQGLREFTNEVKLLLK-IQHKNLVTLFGCCAE 153 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~--~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 153 (266)
.|++.+.||+|+||.||+|... .++.+|+|.+... .......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3788899999999999999954 4788999987532 22234567788888865 799999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
++..+++|||+++++|.+++.. ......+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999888743 2234568889999999999999999996 56 99999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
||++....... ......++..|+|||++...
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~ 188 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNE 188 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCC
Confidence 99998765443 33455688899999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=204.00 Aligned_cols=166 Identities=33% Similarity=0.496 Sum_probs=140.9
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++.+++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588899999999999999984 47899999988643 2333456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+. +++.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5666665322 345889999999999999999999998 999999999999999999999999999876433
Q ss_pred CceeeeeeEEeeeeCCCccc
Q 024537 242 DTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~ 261 (266)
. ...++..|+|||++.
T Consensus 169 ~----~~~~~~~y~aPE~~~ 184 (307)
T cd06607 169 N----SFVGTPYWMAPEVIL 184 (307)
T ss_pred C----CccCCccccCceeee
Confidence 2 345778899999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=211.52 Aligned_cols=172 Identities=25% Similarity=0.391 Sum_probs=143.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh-------hHHHHHHHHHHHHhcCCCCceeEEeEEee-CCc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-------GLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPE 156 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 156 (266)
++|-.+.+||+|+|+.||+|. +...+.||+|+-..+..+ ..+...+|..|-+.|.||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 357888999999999999998 556788999986544221 12456789999999999999999999975 467
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEeccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFG 233 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG 233 (266)
+|-|+|||+|.+|+.+|. ....+++.+++.|+.||+.||.||.... ++|||=||||.|||+.. .|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999998883 4467999999999999999999999987 56999999999999954 5679999999
Q ss_pred ccccCCCCCc-------eeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGEDT-------HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~ 261 (266)
+++.+.++.. -++.+.||.+|.|||.+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 9998865532 245668899999999753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=203.63 Aligned_cols=171 Identities=27% Similarity=0.389 Sum_probs=146.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 160 (266)
++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+..|+.++.++. ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688999999999999999984 47999999998653 2233456788999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||++++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CC--------------------ceeeeeeEEeeeeCCCcccc
Q 024537 241 ED--------------------THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~--------------------~~~~~~~~t~~y~aPE~~~~ 262 (266)
.. .....+.++..|+|||+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 33 22234456788999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=208.43 Aligned_cols=168 Identities=28% Similarity=0.440 Sum_probs=141.6
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----- 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 155 (266)
..++|++++.||+|+||.||+|. ..++..||||++... .......+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 35679999999999999999998 557899999998643 2333456789999999999999999999987654
Q ss_pred -cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
..++||||+ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 788887773 246889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+....... ....++..|+|||++.+
T Consensus 165 ~~~~~~~~---~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 165 ARQTDSEM---TGYVVTRWYRAPEVILN 189 (343)
T ss_pred ccccccCc---cccccCCcccCHHHHhC
Confidence 98764332 23467888999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=203.53 Aligned_cols=173 Identities=26% Similarity=0.371 Sum_probs=140.5
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|+..+.||+|+||.||++. ..+++.||+|.+.... ......+..|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 456778899999999999998 4578999999987542 334467889999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHHhh--cCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|+. +++.++... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||+++.+.
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 455544321 12235689999999999999999999975 6 9999999999999999999999999998765
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ....++..|+|||++...
T Consensus 160 ~~~~~-~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 160 DSIAK-TRDAGCRPYMAPERIDPS 182 (288)
T ss_pred cCCcc-ccccCccCccCHHHhccc
Confidence 44322 223578889999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=200.78 Aligned_cols=164 Identities=25% Similarity=0.345 Sum_probs=140.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||.|+||.||+|... +++.|++|.+..... .....+.+|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999954 589999999875533 4456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc------
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT------ 243 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~------ 243 (266)
.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988432 36899999999999999999999998 99999999999999999999999999987543311
Q ss_pred --eeeeeeEEeeeeCCCccccC
Q 024537 244 --HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 --~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||+....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~ 176 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQ 176 (265)
T ss_pred cccccCcccCccccCHHHhcCC
Confidence 22334577789999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=207.70 Aligned_cols=170 Identities=26% Similarity=0.435 Sum_probs=139.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~ 157 (266)
.++|++.+.||+|+||.||+|. ..+++.||||.+... .......+..|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 3679999999999999999998 557899999998643 2333456788999999999999999999876543 47
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++|+||+. +++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999995 57766662 346889999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
...... ......++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhC
Confidence 643321 1123467888999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=209.27 Aligned_cols=170 Identities=23% Similarity=0.412 Sum_probs=141.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 158 (266)
++|++.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999998 5579999999987542 2334567789999999999999999998763 34679
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68888773 2345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc----eeeeeeEEeeeeCCCcccc
Q 024537 239 PGEDT----HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~----~~~~~~~t~~y~aPE~~~~ 262 (266)
..... ......++..|+|||++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcC
Confidence 43221 1223467888999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=200.59 Aligned_cols=172 Identities=26% Similarity=0.352 Sum_probs=143.6
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 161 (266)
++|...+.||.|++|.||+|.. .+++.+|+|.+.... ......+.+|+.+++.++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3588889999999999999994 578899999987543 23456788999999999999999999998654 4689999
Q ss_pred eccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23456888899999999999999999998 99999999999999999999999999987643
Q ss_pred CCceeeeeeEEeeeeCCCcccc
Q 024537 241 EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
... ....++..|.|||.+..
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQG 177 (287)
T ss_pred ccc--ccccCCccccCHHHhcC
Confidence 322 23456788999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=202.78 Aligned_cols=165 Identities=35% Similarity=0.522 Sum_probs=140.1
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.|...+.||+|+||.||+|. ..++..||+|.+... .......+..|+.+++.++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 37788999999999999998 457899999998643 22334578889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+.+ ++.+.+.. ....+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9964 67666632 2345889999999999999999999998 999999999999999999999999999865432
Q ss_pred ceeeeeeEEeeeeCCCccc
Q 024537 243 THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~ 261 (266)
....++..|+|||++.
T Consensus 179 ---~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 179 ---NSFVGTPYWMAPEVIL 194 (317)
T ss_pred ---ccccCCccccChhhhh
Confidence 2346788899999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=199.71 Aligned_cols=169 Identities=28% Similarity=0.462 Sum_probs=141.4
Q ss_pred ccccceecccCceEEEEEEec-CCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEEEEe
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVYE 162 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 162 (266)
|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.+++++.|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999854 68899999997653 33345678899999999999999999999988 88999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++ ++|..++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 4887777432 246899999999999999999999998 9999999999999999999999999998775443
Q ss_pred c-eeeeeeEEeeeeCCCcccc
Q 024537 243 T-HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~-~~~~~~~t~~y~aPE~~~~ 262 (266)
. ......++..|+|||++.+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred cccccccccccccCCceeeEc
Confidence 1 1122245778999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=198.01 Aligned_cols=173 Identities=26% Similarity=0.425 Sum_probs=137.6
Q ss_pred ccccceecccCceEEEEEEec----CCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999742 4688999998754 3344567889999999999999999999886542
Q ss_pred cEEEEEeccCCCCHHHHHhhcC---CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
..++++||+++++|..++.... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999988764321 2235788899999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 233 GLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 233 G~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
|+++....... ......+++.|++||.+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN 190 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence 99987643321 11222345678999987544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=205.53 Aligned_cols=170 Identities=24% Similarity=0.339 Sum_probs=138.9
Q ss_pred cCcc-ccceecccCceEEEEEE-ecCCCEEEEEeecccChhh--------------HHHHHHHHHHHHhcCCCCceeEEe
Q 024537 86 NFFS-DLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG--------------LREFTNEVKLLLKIQHKNLVTLFG 149 (266)
Q Consensus 86 ~~y~-~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 149 (266)
++|. +.+.||.|+||+||+|. ..+++.||||.+....... ...+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4564 45779999999999998 4578999999886542211 124678999999999999999999
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
++..++..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 688888732 345888999999999999999999998 999999999999999999999
Q ss_pred ecccccccCCC--------------CCceeeeeeEEeeeeCCCcccc
Q 024537 230 SDFGLARLFPG--------------EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 230 ~DFG~a~~~~~--------------~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|||+++.... .........++..|+|||++.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhccc
Confidence 99999987651 1112223346778999998754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=198.90 Aligned_cols=174 Identities=24% Similarity=0.383 Sum_probs=143.4
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 160 (266)
..++.+.+..||.|+.|+||+++ ..+|..+|||.+... +.....+++..+.++.+.. +|.||+.+|+|..+..+++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 34556678889999999999999 557899999999765 5556678888888876664 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||.| ..-+..++. ....++++..+-++...++.||.||-++. .|||||+||+|||+|+.|++||||||++.++.+
T Consensus 170 MelM-s~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELM-STCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9998 444555553 23356888888889999999999998875 599999999999999999999999999988765
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
....... .|.+.|+|||-+-++
T Consensus 245 SkAhtrs-AGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 245 SKAHTRS-AGCAAYMAPERIDPP 266 (391)
T ss_pred ccccccc-cCCccccCccccCCC
Confidence 5443332 688899999988775
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=194.17 Aligned_cols=171 Identities=28% Similarity=0.440 Sum_probs=148.2
Q ss_pred CccccceecccCceEEEEEEec-CCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVY 161 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 161 (266)
+|...+.||+|++|.||+|... +++.|++|.+.... ......+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999954 78999999987654 24457788999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|++++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998433 27899999999999999999999998 999999999999999999999999999987655
Q ss_pred Cc--eeeeeeEEeeeeCCCccccC
Q 024537 242 DT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......++..|.|||.+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred cccccccCCCCCccccCHhhhcCC
Confidence 43 13345688899999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=206.75 Aligned_cols=167 Identities=27% Similarity=0.413 Sum_probs=138.1
Q ss_pred cccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cEEEE
Q 024537 89 SDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKMLV 160 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv 160 (266)
+--+.||.|+||+||.+. -++|+.||+|++..- +....+++.+|+++|.-++|.|++..++..+... .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 334779999999999998 558999999988643 3334467889999999999999999999887653 35788
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
+|+| ..+|...+ .....++...++-+++||++||+|||+.+ |+||||||.|+|++.++.+||||||+|+....
T Consensus 136 TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8988 55776666 34467888899999999999999999998 99999999999999999999999999998865
Q ss_pred CCc-eeeeeeEEeeeeCCCcccc
Q 024537 241 EDT-HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~-~~~~~~~t~~y~aPE~~~~ 262 (266)
++. .+.....|..|+|||++++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG 231 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG 231 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc
Confidence 543 3333456788999999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=206.38 Aligned_cols=170 Identities=27% Similarity=0.433 Sum_probs=144.4
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-----cEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKM 158 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 158 (266)
+|++.+.||.|+||.||+|.. .+++.||||++.... ....+.+..|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 488899999999999999995 458999999987643 344567889999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
++|||++ ++|..++.. ...+++..+..++.|++.||.|||+.| |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 578777732 337899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC---ceeeeeeEEeeeeCCCccccC
Q 024537 239 PGED---THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~---~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... .......++..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred cccccccccccccccccCcCCceeeecc
Confidence 5543 223344678889999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=196.54 Aligned_cols=162 Identities=25% Similarity=0.310 Sum_probs=133.7
Q ss_pred ceecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHH-HhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLL-LKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..++ ....|+||+++++.+..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999984 5689999999865422 2223344555444 455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----K 151 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc----c
Confidence 999998843 245888999999999999999999998 999999999999999999999999999875432 2
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...++..|+|||++.+.
T Consensus 152 ~~~~~~~y~~pe~~~~~ 168 (260)
T cd05611 152 KFVGTPDYLAPETILGV 168 (260)
T ss_pred cCCCCcCccChhhhcCC
Confidence 34577889999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=205.19 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=142.1
Q ss_pred hHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-- 154 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-- 154 (266)
.+....++|.+.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 344556889999999999999999998 5578999999987532 22345677899999999999999999988643
Q ss_pred ----CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 155 ----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 155 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
...+++++++ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence 3467888887 889987763 235889999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 231 DFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|||+++...... ....++..|+|||.+.+
T Consensus 163 dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 163 DFGLARHTDDEM---TGYVATRWYRAPEIMLN 191 (345)
T ss_pred cccccccccccc---cccccCCCccCHHHHhC
Confidence 999998754322 23467888999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=200.68 Aligned_cols=170 Identities=25% Similarity=0.315 Sum_probs=142.4
Q ss_pred CccccceecccCceEEEEEEe----cCCCEEEEEeecccC----hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 157 (266)
+|++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999873 357889999886432 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888743 345888999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc-eeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDT-HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~-~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... ......++..|+|||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred cccccccccccccCCccccCHHHhcC
Confidence 644322 2233457889999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=197.36 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=146.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+|++.+.||+|+||.||++. ..+++.+|+|.+... .......+..|+.+++.++|+||+++++.+......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47889999999999999998 557889999998754 234456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999998875422 2356888999999999999999999998 9999999999999999999999999998876542
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ....++..|+|||.+...
T Consensus 158 ~--~~~~~~~~~~~Pe~~~~~ 176 (256)
T cd08530 158 A--KTQIGTPHYMAPEVWKGR 176 (256)
T ss_pred c--ccccCCccccCHHHHCCC
Confidence 2 234578889999987543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=198.60 Aligned_cols=166 Identities=22% Similarity=0.291 Sum_probs=136.2
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeC--CcEEEEEe
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG--PEKMLVYE 162 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e 162 (266)
|++.+.||+|+||.||+|. ..+++.||+|++.... .........|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6778999999999999998 5578999999886542 222233457888888885 99999999999987 88999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|++ +++.+.+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 5777776432 246899999999999999999999998 999999999999999 999999999998775433
Q ss_pred ceeeeeeEEeeeeCCCccc
Q 024537 243 THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~ 261 (266)
.. ....++..|+|||++.
T Consensus 154 ~~-~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 154 PY-TEYISTRWYRAPECLL 171 (282)
T ss_pred Cc-CCCCCCcccCChhHhh
Confidence 22 2345788899999764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=196.24 Aligned_cols=165 Identities=19% Similarity=0.260 Sum_probs=135.2
Q ss_pred hcCcccccee--cccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQL--GHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~i--G~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.+ |+|+||.||++. ..++..+|+|.+........ |+.....+ +||||+++++.+..++..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3567777776 999999999998 55788999999865422211 22222222 699999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~ 239 (266)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999999999998432 37899999999999999999999998 99999999999999988 99999999998765
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... ...++..|+|||++....
T Consensus 162 ~~~----~~~~~~~y~aPE~~~~~~ 182 (267)
T PHA03390 162 TPS----CYDGTLDYFSPEKIKGHN 182 (267)
T ss_pred CCc----cCCCCCcccChhhhcCCC
Confidence 432 336788999999986543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=204.73 Aligned_cols=169 Identities=26% Similarity=0.440 Sum_probs=139.7
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC--CcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG--PEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~~ 158 (266)
.++|++.+.||+|+||.||+|.. .+++.+|+|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 46799999999999999999984 46889999988542 233345677899999999 999999999998654 3579
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 588877732 26788888999999999999999998 999999999999999999999999999876
Q ss_pred CCCCc-----eeeeeeEEeeeeCCCccc
Q 024537 239 PGEDT-----HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 239 ~~~~~-----~~~~~~~t~~y~aPE~~~ 261 (266)
..... ....+.++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred ccccccccCcchhcccccccccCceeee
Confidence 44321 223456788899999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=212.18 Aligned_cols=175 Identities=25% Similarity=0.466 Sum_probs=144.8
Q ss_pred hHHHhhcCccccceecccCceEEEEEEecC---CC--EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPN---GQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
..++........++||+|-||.||+|...+ |+ .||||.-+.+ .....+.|+.|+.+|++++||||++++|++.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344445556667899999999999998432 33 4788887775 44556889999999999999999999999985
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
...|||||+++.|.|..+|.. +...++......++.||+.||.|||++. +|||||-.+|||+....-|||+|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 568999999999999999943 3456888889999999999999999998 9999999999999999899999999
Q ss_pred ccccCCCCCce-eeeeeEEeeeeCCCcc
Q 024537 234 LARLFPGEDTH-VNTFRISVVTWPPNMH 260 (266)
Q Consensus 234 ~a~~~~~~~~~-~~~~~~t~~y~aPE~~ 260 (266)
++|.+..+... .+.-.-..-|+|||-+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESI 564 (974)
T ss_pred hhhhccccchhhccccccceeecCcccc
Confidence 99998766432 2332345679999975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=202.16 Aligned_cols=168 Identities=22% Similarity=0.316 Sum_probs=136.2
Q ss_pred ceeccc--CceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHG--GFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G--~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
..||+| +||+||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 899999998 458999999998754 333456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce--
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-- 244 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~-- 244 (266)
+++.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999988543 2345889999999999999999999998 999999999999999999999999866433211111
Q ss_pred -----eeeeeEEeeeeCCCccccC
Q 024537 245 -----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 -----~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccccccccccCccCccChhhhcCC
Confidence 0111245569999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=197.68 Aligned_cols=168 Identities=31% Similarity=0.448 Sum_probs=136.5
Q ss_pred eecccCceEEEEEEecC-------CCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 93 QLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.||+|+||.||+|...+ +..+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998432 2579999876543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC----CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-----CeEEeccccc
Q 024537 165 PNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-----NPKISDFGLA 235 (266)
Q Consensus 165 ~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-----~~kl~DFG~a 235 (266)
++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999985422 2235788999999999999999999998 99999999999999877 8999999999
Q ss_pred ccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
+....... ......++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccC
Confidence 86643221 11122345679999987643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=212.36 Aligned_cols=148 Identities=23% Similarity=0.374 Sum_probs=131.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
..-|..++.||-|+||+|.++++ .+...||.|.+++.. +.....+..|.+||.....+-||+||-.|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34477789999999999999984 456789999887653 33345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
|+|++||++-.+| .+.+-|++..++.++..+..|+++.|..| +|||||||+|||||.+|.+||+|||+|.-+
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999998888 44567899999999999999999999999 999999999999999999999999999654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=201.28 Aligned_cols=172 Identities=32% Similarity=0.495 Sum_probs=138.2
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh--hHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+|+.+++.++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4679999999999999999999 457899999988654221 2235678999999999999999999875433
Q ss_pred --cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 156 --EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 156 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
..++||||+.+ ++...+.. ....+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999964 66665532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCce-----------eeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGEDTH-----------VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~ 262 (266)
+++........ .....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 99876432211 122356778999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=201.40 Aligned_cols=168 Identities=30% Similarity=0.452 Sum_probs=140.4
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l 159 (266)
..++|++++.||.|+||.||+|. ..+++.||+|++... .......+..|+.++..++||||+++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 46789999999999999999998 558999999987543 22334667789999999999999999999876 457899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
++||+ +++|..++. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++...
T Consensus 88 v~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 88 VTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred Eeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 99998 668887773 235778888899999999999999998 9999999999999999999999999998653
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.. .....++..|+|||.+..
T Consensus 160 ~~---~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 160 PQ---MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CC---cCCCcccccccCceeeec
Confidence 32 223457788999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=198.07 Aligned_cols=164 Identities=34% Similarity=0.486 Sum_probs=139.0
Q ss_pred ccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
|...+.||+|+||+||+|.. .+++.|++|++... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999984 57889999998643 233345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+. +++.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 567666632 2346889999999999999999999998 999999999999999999999999999754322
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
....++..|+|||++.
T Consensus 175 --~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 175 --NSFVGTPYWMAPEVIL 190 (313)
T ss_pred --CCccccccccChhhcc
Confidence 3456888999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=201.92 Aligned_cols=168 Identities=25% Similarity=0.372 Sum_probs=136.0
Q ss_pred CccccceecccCceEEEEEEec-C--CCEEEEEeeccc--ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC----Cc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-N--GQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG----PE 156 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 156 (266)
+|++.+.||+|+||.||+|... + +..||+|++... .......+..|+.+++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999943 4 789999988643 222345677899999999 599999999975432 45
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.+++++++. ++|.+.+. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999985 68887773 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc----eeeeeeEEeeeeCCCccc
Q 024537 237 LFPGEDT----HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 237 ~~~~~~~----~~~~~~~t~~y~aPE~~~ 261 (266)
.+..... ......++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHh
Confidence 7643221 123346788999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=200.27 Aligned_cols=174 Identities=20% Similarity=0.250 Sum_probs=127.5
Q ss_pred HhhcCccccceecccCceEEEEEEecC----CCEEEEEeecccChhh-H----------HHHHHHHHHHHhcCCCCceeE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQG-L----------REFTNEVKLLLKIQHKNLVTL 147 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~nIv~l 147 (266)
+..+.|++.+.||+|+||+||+|...+ +..+|+|+........ . .....+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345679999999999999999998543 4566777544332111 0 112233344566789999999
Q ss_pred EeEEeeCC----cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC
Q 024537 148 FGCCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223 (266)
Q Consensus 148 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~ 223 (266)
++.+.... ..++++|++ ..++.+++.. ....++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99776543 347788887 4466655522 233567888999999999999999998 999999999999999
Q ss_pred CCCeEEecccccccCCCCC-------ceeeeeeEEeeeeCCCccccC
Q 024537 224 QLNPKISDFGLARLFPGED-------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 224 ~~~~kl~DFG~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~e 263 (266)
++.++|+|||+|+.+.... .......||+.|+|||+..+.
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~ 208 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA 208 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC
Confidence 9999999999998764221 112334689999999987654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=198.01 Aligned_cols=170 Identities=26% Similarity=0.448 Sum_probs=143.3
Q ss_pred ccccceecccCceEEEEEEe-cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
|++.+.||.|++|.||+|.. .+++.+++|.+..... .....+..|+.+++.++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999984 4789999999875532 23467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++ ++.+.+... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 65 777776432 256889999999999999999999998 999999999999999999999999999887654422
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
.....++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred ccCccCcccccCcHHHhcC
Confidence 2334567789999987653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=192.99 Aligned_cols=164 Identities=29% Similarity=0.351 Sum_probs=141.2
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 94 iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
||+|+||.||++.. .+++.||+|.+..... .....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999984 4689999999875532 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 249 (266)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 998843 235889999999999999999999988 99999999999999999999999999988755433334556
Q ss_pred EEeeeeCCCccccC
Q 024537 250 ISVVTWPPNMHCMD 263 (266)
Q Consensus 250 ~t~~y~aPE~~~~e 263 (266)
++..|+|||+....
T Consensus 155 ~~~~~~~Pe~~~~~ 168 (250)
T cd05123 155 GTPEYLAPEVLLGK 168 (250)
T ss_pred CCccccChHHhCCC
Confidence 78899999987543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=197.98 Aligned_cols=174 Identities=22% Similarity=0.373 Sum_probs=140.9
Q ss_pred HhhcCccccceecccCceEEEEEEec-CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 159 (266)
...++|++.+.||+|+||.||+|.+. +++.||||.+.... ......+..|+.++.+.. ||||+++++++.++...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34567899999999999999999954 48999999987542 233455667777666664 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+|||+. +++..++... ...+++..+..++.|++.||.|||+. + |+||||+|+||+++.++.+||+|||++..+
T Consensus 92 v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999984 5776666332 24788899999999999999999974 6 999999999999999999999999999877
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
....... ...++..|+|||++.++
T Consensus 166 ~~~~~~~-~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 166 VDSKAKT-RSAGCAAYMAPERIDPP 189 (296)
T ss_pred cCCCccc-CCCCCccccCHhhcCCC
Confidence 5433222 23467789999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=196.91 Aligned_cols=168 Identities=28% Similarity=0.409 Sum_probs=140.1
Q ss_pred ccccceecccCceEEEEEEec-CCCEEEEEeecccCh-hhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEecc
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
|.+.+.||+|+||+||+|... +++.|+||++..... .......+|+..++++. ||||+++++.+..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999954 578999998865422 22234457899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+++|.+.+.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788888774332 346899999999999999999999998 99999999999999999999999999987654322
Q ss_pred eeeeeEEeeeeCCCccc
Q 024537 245 VNTFRISVVTWPPNMHC 261 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~ 261 (266)
.....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 155 YTDYVSTRWYRAPEILL 171 (283)
T ss_pred cCCCCCcccccCceeee
Confidence 22345788899999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=209.88 Aligned_cols=176 Identities=23% Similarity=0.296 Sum_probs=132.2
Q ss_pred hhcCccccceecccCceEEEEEEe-----------------cCCCEEEEEeecccChhhHHH--------------HHHH
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-----------------PNGQEIAVKKLSVDSRQGLRE--------------FTNE 132 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 132 (266)
..++|.+.++||+|+||+||+|.. ..++.||||++........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999963 235679999987553322222 3346
Q ss_pred HHHHHhcCCCCc-----eeEEeEEee--------CCcEEEEEeccCCCCHHHHHhhcCC---------------------
Q 024537 133 VKLLLKIQHKNL-----VTLFGCCAE--------GPEKMLVYEYLPNKSLDYFIFDKTK--------------------- 178 (266)
Q Consensus 133 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------- 178 (266)
+.++.+++|.++ +++++++.. .+..|+||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777643 3568999999999999998853211
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee-eeeeEEeeeeCC
Q 024537 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV-NTFRISVVTWPP 257 (266)
Q Consensus 179 ~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~t~~y~aP 257 (266)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......... ....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123467788899999999999999998 9999999999999999999999999997654322111 111347889999
Q ss_pred Ccccc
Q 024537 258 NMHCM 262 (266)
Q Consensus 258 E~~~~ 262 (266)
|++..
T Consensus 380 E~l~~ 384 (507)
T PLN03224 380 EELVM 384 (507)
T ss_pred hhhcC
Confidence 99863
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=197.21 Aligned_cols=170 Identities=28% Similarity=0.441 Sum_probs=144.1
Q ss_pred ccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
|++.+.||+|.||.||+|.. .+++.||+|.+.... ......+..|+.+++.++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999994 468999999987653 333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+ ++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58988885432 46889999999999999999999998 999999999999999999999999999887654433
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
......+..|+|||++...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred cCccccCcCcCChHHhcCC
Confidence 3344556789999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=212.49 Aligned_cols=182 Identities=25% Similarity=0.450 Sum_probs=153.4
Q ss_pred chhhHHHhhcCccccceecccCceEEEEEEecC-CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 77 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
....+++...+.....+||-|-||.||.|.|.. .-.||||.++-+.. ..++|+.|+.+|+.+.|||+|+++|+|..+.
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 345566667777788999999999999999653 56799998875543 4589999999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.+|||+|||.+|+|.++|++- ....++.-..+.++.||..||+||..++ +|||||-.+|+|+.++..||++|||++
T Consensus 337 PFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999653 3345666778889999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeee-eeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNT-FRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~-~~~t~~y~aPE~~~~e 263 (266)
+++..+...... -...+-|.|||-++..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyN 441 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYN 441 (1157)
T ss_pred hhhcCCceecccCccCcccccCccccccc
Confidence 999776543211 1335579999988764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=203.88 Aligned_cols=170 Identities=25% Similarity=0.450 Sum_probs=138.8
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC---------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--------- 154 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------- 154 (266)
..+|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3679999999999999999998 457899999998776555567788999999999999999999876554
Q ss_pred -----CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeE
Q 024537 155 -----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPK 228 (266)
Q Consensus 155 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~k 228 (266)
...++||||++ ++|..++. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999996 58877763 235889999999999999999999998 999999999999975 55689
Q ss_pred EecccccccCCCCCce---eeeeeEEeeeeCCCcccc
Q 024537 229 ISDFGLARLFPGEDTH---VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~---~~~~~~t~~y~aPE~~~~ 262 (266)
|+|||+++.+...... .....++..|+|||++..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 9999999876432211 112246778999997643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=207.45 Aligned_cols=175 Identities=24% Similarity=0.279 Sum_probs=147.1
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 157 (266)
+.+....|+++++||.|+.+.||++...+.+.||+|++... ....+..+.+|+.+|.+|+ |.+|++++++-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34455679999999999999999999878889999987654 4455788999999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
|||||+- ..+|...|.++. ..++...++.|-.|++.|+.++|..| |||.||||.|+|+-. |.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999986 678988885543 22332367788999999999999999 999999999999965 6899999999999
Q ss_pred CCCCCceee--eeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVN--TFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~--~~~~t~~y~aPE~~~~ 262 (266)
+..+.+... +-.||+-|++||.+..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~ 535 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTD 535 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhh
Confidence 987765432 3478999999998753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-29 Score=202.25 Aligned_cols=173 Identities=26% Similarity=0.501 Sum_probs=139.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEee--------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-------- 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 153 (266)
.+.|+.+.+||+|.||.||+|+ ..+++.||+|++.... ...-...++|+++|..+.|+|++.++..+..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3457778999999999999999 5678889999876532 2222345789999999999999998887643
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
...+|+|+.+|+ -+|.-++. ....+++..++..++.++..||.|+|.+. |+|||+||+|+||+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 234799999995 46777773 23357999999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCC----ceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGED----THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|+.+.... ........|.+|++||.+.++
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~ 203 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD 203 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcc
Confidence 998774332 122233568899999998765
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=198.62 Aligned_cols=169 Identities=18% Similarity=0.168 Sum_probs=135.9
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+.+.+|.|+++.|+++.. +++.||||++... .......+..|+.+++.++||||+++++++...+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555555444 7899999998754 3445678899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc----
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT---- 243 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~---- 243 (266)
+|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998543 2345888999999999999999999998 99999999999999999999999999976532211
Q ss_pred ---eeeeeeEEeeeeCCCccccC
Q 024537 244 ---HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ---~~~~~~~t~~y~aPE~~~~e 263 (266)
......++..|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred cccccccccccccccCHHHhcCC
Confidence 12233466789999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=200.81 Aligned_cols=166 Identities=29% Similarity=0.453 Sum_probs=137.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|.+.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3679999999999999999998 457899999998653 2222356788999999999999999999987543
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..++|+||+. .++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4689999995 4665544 235888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+...... ....++..|+|||++..
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 165 RHADAEM---TGYVVTRWYRAPEVILN 188 (342)
T ss_pred cCCCCCC---CCceeeecccChhhhcC
Confidence 8764322 23467889999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=195.12 Aligned_cols=172 Identities=26% Similarity=0.342 Sum_probs=140.1
Q ss_pred CccccceecccCceEEEEEEec-CCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+|.+.+.||+|+||.||++... .+..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888899999999999999843 3445555554421 122234566799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 23457899999999999999999999998 999999999999975 569999999998875
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..........++..|+|||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~ 179 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKH 179 (260)
T ss_pred CCcccccCCCCCcCccCHHHHcc
Confidence 54444455678889999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=197.54 Aligned_cols=166 Identities=34% Similarity=0.511 Sum_probs=140.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..|+..+.||+|+||.||+|+ ..+++.+|+|.+... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347778899999999999999 457889999988642 3334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 5776666332 345788999999999999999999998 999999999999999999999999999876433
Q ss_pred CceeeeeeEEeeeeCCCccc
Q 024537 242 DTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~ 261 (266)
....++..|+|||++.
T Consensus 169 ----~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 ----NXFVGTPYWMAPEVIL 184 (308)
T ss_pred ----ccccCCccccCHHHHh
Confidence 2346788999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=195.71 Aligned_cols=178 Identities=20% Similarity=0.221 Sum_probs=146.0
Q ss_pred cchhhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC--C----CceeEE
Q 024537 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--K----NLVTLF 148 (266)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~ 148 (266)
+.+.......++|+++..+|+|.||.|-.+. ...+..||||+++.-. ...+...-|+.+|+++.+ | .+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 3444445557889999999999999999998 3457899999986432 334566789999999942 2 478888
Q ss_pred eEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-----
Q 024537 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE----- 223 (266)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~----- 223 (266)
++|.-.++.|||+|.+ |.++.+++.. ....+++...+..|+.|++.+++|||+.+ ++|.||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 9999999999999999 8899999943 34568999999999999999999999998 999999999999932
Q ss_pred ---------------CCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 224 ---------------QLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 224 ---------------~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+..++|+|||.|+...... ++...|..|+|||++.+
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILG 283 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheec
Confidence 2348999999999865444 45678999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=191.76 Aligned_cols=169 Identities=28% Similarity=0.461 Sum_probs=137.5
Q ss_pred ccccceecccCceEEEEEEec-CCCEEEEEeecccCh--hhHHHHHHHHHHHHhc---CCCCceeEEeEEeeCCc-----
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR--QGLREFTNEVKLLLKI---QHKNLVTLFGCCAEGPE----- 156 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 156 (266)
|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++.++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999954 589999999874422 2234556787777665 59999999999998877
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.+++|||+. ++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 4788777432 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+..... .....++..|+|||++.+
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 156 IYSFEMA-LTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred eccCCcc-cccccccccccChHHhcc
Confidence 8754322 223356788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-28 Score=218.83 Aligned_cols=172 Identities=25% Similarity=0.403 Sum_probs=158.5
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
..++|+.+..+|.|.||.||+|+ ...++..|+|.++......+..+++|+-+++..+||||+.+++.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34679999999999999999999 66899999999998887788888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
||.||+|++.. .....+++.++..+.+..+.||+|||++| -+|||||-.|||+++.|.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999998876 34567889999999999999999999999 8999999999999999999999999999998777
Q ss_pred ceeeeeeEEeeeeCCCccc
Q 024537 243 THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~ 261 (266)
.+...|.||+.|+|||+-+
T Consensus 167 ~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhcccCCccccchhHHH
Confidence 7778899999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=201.63 Aligned_cols=167 Identities=29% Similarity=0.447 Sum_probs=141.4
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----- 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 156 (266)
.++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.+++++.||||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46799999999999999999994 46889999988643 22334567789999999999999999998876654
Q ss_pred -EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 157 -KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 157 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 6799888732 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
...... .....++..|+|||++..
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 166 RHTDDE---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccccc---ccCCcccccccCHHHHhC
Confidence 876433 233467788999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=210.90 Aligned_cols=169 Identities=30% Similarity=0.453 Sum_probs=141.6
Q ss_pred ccccceecccCceEEEEEEec--CCC--EEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP--NGQ--EIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.+..++||+|+||+|++|.|. .|+ .||||.+...... ....|++|+.+|.+|+|||+++|||+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 445688999999999999874 333 6899999876443 56889999999999999999999999987 67889999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
+++.|+|.+.|+. .....+.....-.|+.||+.||.||.+++ +|||||-.+|+|+-..-+|||+|||+.|-++.-.
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999966 34456778888899999999999999998 9999999999999999999999999999886544
Q ss_pred cee---eeeeEEeeeeCCCccc
Q 024537 243 THV---NTFRISVVTWPPNMHC 261 (266)
Q Consensus 243 ~~~---~~~~~t~~y~aPE~~~ 261 (266)
..+ ........|||||-+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred cceEecCCCcCcccccCHhHhc
Confidence 332 1112234699999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=187.03 Aligned_cols=153 Identities=19% Similarity=0.168 Sum_probs=128.2
Q ss_pred cCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhh
Q 024537 97 GGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175 (266)
Q Consensus 97 G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 175 (266)
|.||.||+|+ ..+++.||+|.+..... +..|...+....||||+++++++...+..++||||+++++|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999 55789999999876432 23455555566799999999999999999999999999999988843
Q ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeee
Q 024537 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTW 255 (266)
Q Consensus 176 ~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~ 255 (266)
. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++++|||++....... ....++..|+
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~ 149 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYC 149 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcccc
Confidence 2 35889999999999999999999998 9999999999999999999999999987764332 2334567799
Q ss_pred CCCccccC
Q 024537 256 PPNMHCMD 263 (266)
Q Consensus 256 aPE~~~~e 263 (266)
|||++...
T Consensus 150 aPE~~~~~ 157 (237)
T cd05576 150 APEVGGIS 157 (237)
T ss_pred CCcccCCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=181.68 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=108.9
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChh--h------------------------HHHHHHHHHHHHhcCCCCc
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ--G------------------------LREFTNEVKLLLKIQHKNL 144 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nI 144 (266)
...||+|+||.||+|...+|+.||||+++..... . ......|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999768999999998754211 0 0122359999999988776
Q ss_pred eeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeCCCCCCceEEcC
Q 024537 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL-HEEAPARIIHRDIKASNILLDE 223 (266)
Q Consensus 145 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yL-H~~~~~~iiHrDlKp~Nill~~ 223 (266)
........ ...+|||||++|+++..... ....+++..+..++.|++.+|.|| |+.| |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 22389999998877654432 234688899999999999999999 6888 99999999999998
Q ss_pred CCCeEEecccccccCCC
Q 024537 224 QLNPKISDFGLARLFPG 240 (266)
Q Consensus 224 ~~~~kl~DFG~a~~~~~ 240 (266)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=176.58 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=111.9
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChh---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ---------------------G-----LREFTNEVKLLLKIQHKNL 144 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nI 144 (266)
.+.||+|+||+||+|...+|+.||||++...... . ...+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999668999999998754210 0 1223578999999999988
Q ss_pred eeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcC
Q 024537 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDE 223 (266)
Q Consensus 145 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~ 223 (266)
.....+... ..++||||++|+++..... ....++......++.|++.++.+||+ .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 2489999998875533321 12356778889999999999999999 88 99999999999999
Q ss_pred CCCeEEecccccccCCCC
Q 024537 224 QLNPKISDFGLARLFPGE 241 (266)
Q Consensus 224 ~~~~kl~DFG~a~~~~~~ 241 (266)
++.++|+|||+|+....+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 789999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=207.11 Aligned_cols=170 Identities=22% Similarity=0.229 Sum_probs=120.0
Q ss_pred hhcCccccceecccCceEEEEEEe-cC----CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeE------Ee
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PN----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC------CA 152 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 152 (266)
..++|++.+.||+|+||.||+|+. .+ +..||||++...... +....| .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999994 45 789999987643221 111111 1122222223222222 24
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCC-----------------CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKS-----------------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK 215 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlK 215 (266)
.+...++||||+.+++|.+++...... .......+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888532110 01123345678999999999999998 9999999
Q ss_pred CCceEEcC-CCCeEEecccccccCCCC-CceeeeeeEEeeeeCCCcc
Q 024537 216 ASNILLDE-QLNPKISDFGLARLFPGE-DTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 216 p~Nill~~-~~~~kl~DFG~a~~~~~~-~~~~~~~~~t~~y~aPE~~ 260 (266)
|+|||++. ++.+||+|||+|+.+... ......+.+++.|+|||.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 99999986 578999999999866432 2233456788999999965
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=215.48 Aligned_cols=163 Identities=25% Similarity=0.445 Sum_probs=134.6
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
..|...+.||+|+||.||+|.. .++..||||++...... ...|+.++++++|||||++++++.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577778999999999999984 68899999988644322 124688999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++|+|.+++. .++|..+..|+.|++.||+|||.....+|+||||||+||+++.++..++. ||.+.......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~-- 836 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT-- 836 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC--
Confidence 9999999983 37889999999999999999995433449999999999999998888776 77665543222
Q ss_pred eeeeeEEeeeeCCCccccC
Q 024537 245 VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e 263 (266)
...+++.|+|||++...
T Consensus 837 --~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 837 --KCFISSAYVAPETRETK 853 (968)
T ss_pred --CccccccccCcccccCC
Confidence 22578899999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=182.95 Aligned_cols=167 Identities=22% Similarity=0.316 Sum_probs=141.6
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..-.|++.++||+|+||+++.|. +-+++.||||.-..++.. .++..|....+.|. .++|..+|-+..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34579999999999999999998 568999999987655443 56778888888885 799999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-----CeEEecccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-----NPKISDFGLAR 236 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-----~~kl~DFG~a~ 236 (266)
|++ |.+|.++. ...++.++...+..++.|++.-++|+|++. +|+|||||+|+||...+ .+.|+|||+|+
T Consensus 104 dLL-GPSLEDLF--D~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLF--DLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHH--HHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999 99999987 345678999999999999999999999998 99999999999996543 48999999999
Q ss_pred cCCCCCce-------eeeeeEEeeeeCCC
Q 024537 237 LFPGEDTH-------VNTFRISVVTWPPN 258 (266)
Q Consensus 237 ~~~~~~~~-------~~~~~~t~~y~aPE 258 (266)
.+.++.+. -....||..||+=.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSIN 206 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSIN 206 (449)
T ss_pred hhcCccccccCccccccccccceeeeEee
Confidence 88655432 23447888888743
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=194.31 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=157.7
Q ss_pred cccchhhHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC------CCCcee
Q 024537 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ------HKNLVT 146 (266)
Q Consensus 74 ~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~ 146 (266)
.+|.+.-.++..++|.+....|+|-|++|.+|. ...|..||||++..+.... ..-+.|+.||++|+ --++++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHH
Confidence 456777788888999999999999999999998 4468899999998775543 44567999999996 458999
Q ss_pred EEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-C
Q 024537 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-L 225 (266)
Q Consensus 147 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~ 225 (266)
++..|...+++|||+|.+ ..+|.++|.....+..+....+..|+.|+.-||..|-..| |+|.||||+|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence 999999999999999988 7799999988777888999999999999999999999988 9999999999999875 4
Q ss_pred CeEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 226 NPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.+||||||.|-..... .+..+..+.+|.|||+|.+-+
T Consensus 575 iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~ 611 (752)
T KOG0670|consen 575 ILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLP 611 (752)
T ss_pred eeeeccCccccccccc--cccHHHHHHhccCcceeecCc
Confidence 5799999999877432 334456677999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=173.33 Aligned_cols=167 Identities=31% Similarity=0.454 Sum_probs=144.2
Q ss_pred ccccceecccCceEEEEEEec-CCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
|.+.+.||.|++|.||+|... +++.+|+|.+...... ....+..|+..+..++|+|++++++.+...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556789999999999999954 4889999999876544 56788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCC-cCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC-c
Q 024537 166 NKSLDYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED-T 243 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~-~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 243 (266)
+++|.+++... .. +++..+..++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999988432 22 788999999999999999999998 9999999999999999999999999999875442 1
Q ss_pred eeeeeeEEeeeeCCCcc
Q 024537 244 HVNTFRISVVTWPPNMH 260 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~ 260 (266)
......++..|++||++
T Consensus 155 ~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 155 LLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccceeccCCcCCHhHh
Confidence 22344677789999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=177.48 Aligned_cols=165 Identities=21% Similarity=0.418 Sum_probs=137.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCC--cEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP--EKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv 160 (266)
.++|++.+++|+|.+++||.|. ..+.+.++||+++.-.. ..+.+|+.||..|. ||||+++++...++. ...+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999998 55788999999875433 45678999999997 999999999998764 46899
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~ 239 (266)
+|++.+.+...+. ..++...+..++.+++.||.|+|+.| |+|||+||.|++||... .++|+|+|+|.++-
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988886665 34667788999999999999999999 99999999999998754 58999999998874
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.. ...+....+..|-.||++..
T Consensus 185 p~-~eYnVRVASRyfKGPELLVd 206 (338)
T KOG0668|consen 185 PG-KEYNVRVASRYFKGPELLVD 206 (338)
T ss_pred CC-ceeeeeeehhhcCCchheee
Confidence 33 33444466778889998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=196.12 Aligned_cols=165 Identities=26% Similarity=0.338 Sum_probs=137.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHh-cCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.+.|.+...+|.|+|++|-.+. ..+++..++|++..... ...+|+.++.. -+||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4668888899999999999988 66889999999976622 23357755544 479999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE-cCCCCeEEecccccccCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill-~~~~~~kl~DFG~a~~~~~~ 241 (266)
.+.|+.+.+-+... +....++..|+.+|+.|+.|||++| ||||||||+|||+ +..++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998886666322 2223677789999999999999999 9999999999999 68999999999999988655
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..+++.|-.|+|||++...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~ 488 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQ 488 (612)
T ss_pred ---hcccchhhcccChhhhccC
Confidence 5567889999999998743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=173.56 Aligned_cols=170 Identities=24% Similarity=0.329 Sum_probs=140.3
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC-CCceeEEeEEeeCCcEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv 160 (266)
+..+.|.++++||.|+||.+|.|. ..+|+.||||.-..+... .++.-|..+...|++ ..|..+..++.+.....+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345779999999999999999998 678999999987654332 467789999999974 7888888888889999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEeccccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARL 237 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a~~ 237 (266)
|+++ |.+|.++.. ...+.++...++..+-|++.-++|+|.++ +|||||||+|+|+.- ...+.|+|||+|+.
T Consensus 90 MdLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999 999999883 44567889999999999999999999999 999999999999954 34589999999988
Q ss_pred CCCCCc-------eeeeeeEEeeeeCCCcc
Q 024537 238 FPGEDT-------HVNTFRISVVTWPPNMH 260 (266)
Q Consensus 238 ~~~~~~-------~~~~~~~t~~y~aPE~~ 260 (266)
+.+..+ ......||..|++=...
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh 193 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAH 193 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhh
Confidence 743322 23345789999875443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-23 Score=166.68 Aligned_cols=165 Identities=33% Similarity=0.551 Sum_probs=141.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHH
Q 024537 94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY 171 (266)
Q Consensus 94 iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~ 171 (266)
||+|++|.||++... +++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999954 4899999998866442 34678899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCCCCceeeeeeE
Q 024537 172 FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRI 250 (266)
Q Consensus 172 ~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~ 250 (266)
++.... ..+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. .+.++|+|||.+..............+
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 884321 46888999999999999999999998 999999999999999 899999999999887554322334467
Q ss_pred EeeeeCCCccccC
Q 024537 251 SVVTWPPNMHCMD 263 (266)
Q Consensus 251 t~~y~aPE~~~~e 263 (266)
...|++||++...
T Consensus 156 ~~~~~~pe~~~~~ 168 (215)
T cd00180 156 TPAYMAPEVLLGK 168 (215)
T ss_pred CCCccChhHhccc
Confidence 7889999987653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=178.51 Aligned_cols=165 Identities=19% Similarity=0.370 Sum_probs=132.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeE-EeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGC-CAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lv~ 161 (266)
.+.|.+.+.||+|.||.+.+|+ ..+...+++|.+...... ...|.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3569999999999999999999 556788999988765333 46788888765555 48999987765 78888889999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC--CCCeEEecccccccCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFP 239 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~~ 239 (266)
||++.|+|.+-+ ...++.+...+.++.|+++|+.|||+++ +||||||.+||||-. .-.|||||||.++..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999996555 3466888999999999999999999998 999999999999943 3469999999998764
Q ss_pred CCCceeeeeeEEeeeeCCCcc
Q 024537 240 GEDTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~ 260 (266)
.. +....-+-.|.+||+.
T Consensus 175 ~t---V~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 175 TT---VKYLEYVNNYHAPELC 192 (378)
T ss_pred ce---ehhhhhhcccCCcHHH
Confidence 32 2222344568888864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=197.92 Aligned_cols=180 Identities=26% Similarity=0.386 Sum_probs=147.6
Q ss_pred hHHHhhcCccccceecccCceEEEEEEec--------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEe
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFG 149 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~ 149 (266)
.+++..++.++.+.||+|+||.||+|... ....||||.++.. .....+.+..|+.+|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666667777889999999999999721 1457899998754 335567899999999998 5999999999
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcC-----C------C--CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCC
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKT-----K------S--SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA 216 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~------~--~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp 216 (266)
++...+..++|+||+..|+|..+++... . . ..+.....+.++.||+.|++||.+.. +|||||-+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996543 0 0 13888999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEecccccccCCCCCceeee-ee--EEeeeeCCCcccc
Q 024537 217 SNILLDEQLNPKISDFGLARLFPGEDTHVNT-FR--ISVVTWPPNMHCM 262 (266)
Q Consensus 217 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~-~~--~t~~y~aPE~~~~ 262 (266)
+|||+..+..+||+|||+|+........... -. -...|+|||-+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 9999999999999999999976554433211 11 2446999998865
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=200.23 Aligned_cols=167 Identities=27% Similarity=0.452 Sum_probs=138.8
Q ss_pred ccccceecccCceEEEEEEe-cCC----CEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-PNG----QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+..++||+|+||+||+|.| +.+ -+||||++... ..+...++++|+.+|..++|||++++++++.... .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568899999999999984 334 36899988655 4445678999999999999999999999998766 78899
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
+|++.|.|.++++.. ...+.....+.|..||+.||.|||.+. ++||||-.+|||+.....+||.|||+|+.+..+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999653 346777889999999999999999988 999999999999999999999999999999887
Q ss_pred CceeeeeeE--EeeeeCCCcc
Q 024537 242 DTHVNTFRI--SVVTWPPNMH 260 (266)
Q Consensus 242 ~~~~~~~~~--t~~y~aPE~~ 260 (266)
........| .+.|+|-|.+
T Consensus 852 ~~ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred cccccccccccCcHHHHHHHh
Confidence 766555433 2235555544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=168.24 Aligned_cols=136 Identities=18% Similarity=0.300 Sum_probs=106.2
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-----CCCCceeEEeEEeeCC---cE-EEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-----QHKNLVTLFGCCAEGP---EK-MLVY 161 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~-~lv~ 161 (266)
.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. .+ .+|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 3334444 79988765444557789999999999 5799999999999873 43 4789
Q ss_pred ec--cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHH-HHHhhcCCCCeEeCCCCCCceEEcCC----CCeEEec-cc
Q 024537 162 EY--LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL-LYLHEEAPARIIHRDIKASNILLDEQ----LNPKISD-FG 233 (266)
Q Consensus 162 e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al-~yLH~~~~~~iiHrDlKp~Nill~~~----~~~kl~D-FG 233 (266)
|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++.. ..++|+| ||
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 557999999943 235554 35677888777 9999999 9999999999999743 3799999 55
Q ss_pred cccc
Q 024537 234 LARL 237 (266)
Q Consensus 234 ~a~~ 237 (266)
.+..
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 5544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=196.00 Aligned_cols=168 Identities=28% Similarity=0.354 Sum_probs=133.1
Q ss_pred ccccceecccCce-EEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 88 FSDLNQLGHGGFG-PVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 88 y~~~~~iG~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
|.-.+.+|.|+.| .||+|.. .++.||||++..... .-..+|+..|+.- .|||||++++.-.+....||.+|+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445779999975 4689988 688999998865433 3456899999887 5999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCC-cCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CC--CeEEecccccccCC
Q 024537 166 NKSLDYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QL--NPKISDFGLARLFP 239 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~-~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~--~~kl~DFG~a~~~~ 239 (266)
..+|.+++........ ...-..+.+..|++.||++||+.+ ||||||||.||||+. ++ .++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7799999854211111 111334667899999999999988 999999999999976 34 58999999999986
Q ss_pred CCC---ceeeeeeEEeeeeCCCccccC
Q 024537 240 GED---THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~---~~~~~~~~t~~y~aPE~~~~e 263 (266)
... ...++..||-.|.|||++..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcc
Confidence 553 345566889999999999765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=177.97 Aligned_cols=166 Identities=29% Similarity=0.409 Sum_probs=136.5
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------c
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------E 156 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~ 156 (266)
.+|.-+..+|.|+- .|..|- .-.+++||+|++... .....++..+|..++..++|+||++++.+|.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45777888999887 555554 336889999987543 3334567789999999999999999999997543 4
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+|+|||+| ..+|..++. ..++-..+..++.|++.|++|||+.| |+||||||+||++..++.+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 69999999 678888774 34667888999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.-..+ -.......|..|.|||++++
T Consensus 167 ~e~~~-~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 167 TEDTD-FMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred ccCcc-cccCchhheeeccCchheec
Confidence 76444 24455678889999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=180.33 Aligned_cols=171 Identities=25% Similarity=0.322 Sum_probs=137.6
Q ss_pred CccccceecccCceEEEEEEecC--CCEEEEEeecccChhhHHHHHHHHHHHHhcCC----CCceeEEeEE-eeCCcEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMPN--GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH----KNLVTLFGCC-AEGPEKML 159 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 159 (266)
+|++.+.||+|+||.||.|.... ...+|+|............+..|+.++..+.. +++..+++.+ ..+...||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999544 35788888765433322266788999888873 6899999999 57788999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-----CCeEEecccc
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-----LNPKISDFGL 234 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-----~~~kl~DFG~ 234 (266)
||+.+ |.+|.++..... ...++...+..++.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 999999874433 678999999999999999999999999 9999999999999765 3599999999
Q ss_pred cc--cCCCCC--------ceeeeeeEEeeeeCCCcccc
Q 024537 235 AR--LFPGED--------THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 235 a~--~~~~~~--------~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+ .+.... .....++||..|+++....+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 99 432221 11245679999999986543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=168.56 Aligned_cols=157 Identities=29% Similarity=0.420 Sum_probs=135.7
Q ss_pred CceEEEEEEec-CCCEEEEEeecccChhh-HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhh
Q 024537 98 GFGPVYRGLMP-NGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175 (266)
Q Consensus 98 ~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 175 (266)
+||.||+|... +++.+|+|++....... ...+.+|+..+++++|+||+++++.+......++++|++++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999954 58999999987664433 57888999999999999999999999999999999999999999998843
Q ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeee
Q 024537 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTW 255 (266)
Q Consensus 176 ~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~ 255 (266)
. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|.
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 2 23888999999999999999999998 9999999999999999999999999999876543 223446778899
Q ss_pred CCCccc
Q 024537 256 PPNMHC 261 (266)
Q Consensus 256 aPE~~~ 261 (266)
|||...
T Consensus 154 ~pE~~~ 159 (244)
T smart00220 154 APEVLL 159 (244)
T ss_pred CHHHHc
Confidence 999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=162.70 Aligned_cols=146 Identities=17% Similarity=0.162 Sum_probs=112.4
Q ss_pred cCccccceecccCceEEEEEE--ecCCCEEEEEeecccChh------------------------hHHHHHHHHHHHHhc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL--MPNGQEIAVKKLSVDSRQ------------------------GLREFTNEVKLLLKI 139 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 139 (266)
..|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 568999999998754210 012356799999999
Q ss_pred CCCC--ceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 140 QHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 140 ~H~n--Iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
.+.. +.+++.. ...++||||++|.++..... ....+....+..++.|++.++.+||+.| +|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7533 3344432 23589999999988765431 2234555667889999999999999986 4999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++ ++.++|+|||.|.....+
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCc
Confidence 99999 789999999999876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=157.16 Aligned_cols=135 Identities=19% Similarity=0.257 Sum_probs=113.4
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccCh--------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
+.||+|++|.||+|.+ ++..+++|+...... .....+.+|+.++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997653311 1124577899999999999998877777777888999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
++|++|.+++... .+ ....++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887321 11 67789999999999999998 99999999999999 788999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=158.46 Aligned_cols=142 Identities=11% Similarity=0.120 Sum_probs=115.5
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccCh---hhHHH------HHHHHHHHHhcCCCCceeEEeEEe
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR---QGLRE------FTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
....++|+..+.||.|+||.||++.. ++..+|||.+..... ..... +.+|+..+.++.||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44568899999999999999999765 577899999875422 11122 578999999999999999998866
Q ss_pred eC--------CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC
Q 024537 153 EG--------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 153 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~ 224 (266)
.. +..+++|||++|.+|.++. .+++ ....+++.+|..||+.| ++|||+||.||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 3578999999999997763 1222 23558999999999999 9999999999999998
Q ss_pred CCeEEecccccccCC
Q 024537 225 LNPKISDFGLARLFP 239 (266)
Q Consensus 225 ~~~kl~DFG~a~~~~ 239 (266)
+ ++|+|||..+...
T Consensus 172 g-i~liDfg~~~~~~ 185 (232)
T PRK10359 172 G-LRIIDLSGKRCTA 185 (232)
T ss_pred C-EEEEECCCccccc
Confidence 8 9999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=169.38 Aligned_cols=135 Identities=28% Similarity=0.389 Sum_probs=113.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC--------CCCceeEEeEEee--
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--------HKNLVTLFGCCAE-- 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~~-- 153 (266)
..+|.+.++||.|.|++||+|. ..+.+.||+|+++.. ....+..+.||.+|++++ ...||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999998 556788999998654 333467789999999984 3479999999975
Q ss_pred --CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC
Q 024537 154 --GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 154 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~ 224 (266)
+.++|||+|++ |.+|..++. +...+.++...++.|++||+.||.|||.+. +|||.||||+|||+...
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~-~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIK-YSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHH-HhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45789999999 888888874 445678999999999999999999999975 59999999999999654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=153.25 Aligned_cols=140 Identities=20% Similarity=0.183 Sum_probs=110.0
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChh----------------------hHHHHHHHHHHHHhcCCCC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ----------------------GLREFTNEVKLLLKIQHKN 143 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n 143 (266)
..|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|..++..+.+++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 348888999999999999999778999999987643210 0123567888999888774
Q ss_pred --ceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE
Q 024537 144 --LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221 (266)
Q Consensus 144 --Iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill 221 (266)
+...++ ....++||||++|++|..+.. . .....++.+++.++.++|+.+ |+|+||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---L------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc---c------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 444443 245589999999999865431 0 234568889999999999998 9999999999999
Q ss_pred cCCCCeEEecccccccCCCC
Q 024537 222 DEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 222 ~~~~~~kl~DFG~a~~~~~~ 241 (266)
+.++.++|+|||+|.....+
T Consensus 159 ~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cCCCcEEEEECCccccCCCc
Confidence 99999999999999776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=152.86 Aligned_cols=132 Identities=23% Similarity=0.321 Sum_probs=107.7
Q ss_pred eecccCceEEEEEEecCCCEEEEEeecccC----h----hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDS----R----QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.||+|+||.||+|.+ ++..|++|...... . .....+.+|+.++..+.++++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 67889999865321 1 12356778999999999887766655666677789999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988773211 0 67899999999999998 99999999999999 7899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-20 Score=158.11 Aligned_cols=170 Identities=31% Similarity=0.449 Sum_probs=143.2
Q ss_pred ccccceecccCceEEEEEEecCCCEEEEEeecccChh---hHHHHHHHHHHHHhcCCC-CceeEEeEEeeCCcEEEEEec
Q 024537 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ---GLREFTNEVKLLLKIQHK-NLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~ 163 (266)
|.+.+.||.|+||.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999865 78899988765322 357788999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~~~~ 242 (266)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866633211136888999999999999999999999 99999999999999988 69999999998765443
Q ss_pred c------eeeeeeEEeeeeCCCcccc
Q 024537 243 T------HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~------~~~~~~~t~~y~aPE~~~~ 262 (266)
. ......++..|++||.+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccccccCCHHHhcC
Confidence 2 3466789999999998865
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=149.68 Aligned_cols=132 Identities=20% Similarity=0.142 Sum_probs=105.8
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeecccChhh----HHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEecc
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+...|++|.||+||.+.- .+..++.+.+....... ...+.+|+.+|+++. +++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 67788877776553321 225789999999995 5889999886 4469999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCC-CCCceEEcCCCCeEEecccccccCC
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI-KASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDl-Kp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
.|.+|...+. . . ...++.|++.+|+++|+.| |+|||| ||+|||++.++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~---~------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP---R------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh---h------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9998864431 0 1 1346789999999999999 999999 7999999999999999999998654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=172.92 Aligned_cols=138 Identities=21% Similarity=0.254 Sum_probs=111.8
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEee-ccc-C------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL-SVD-S------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
..|...+.||+|+||+||+|.+... .+++|+. ... . ....+.+.+|+.++..++|++++....++..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456678999999999999987443 3444432 211 1 11235678999999999999999888888777788
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988873 34678999999999999998 9999999999999 577899999999987
Q ss_pred CC
Q 024537 238 FP 239 (266)
Q Consensus 238 ~~ 239 (266)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 53
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=162.94 Aligned_cols=145 Identities=26% Similarity=0.476 Sum_probs=126.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEe-c---CCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCC
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM-P---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP 155 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 155 (266)
+....+.|.++++||+|+|++||+|.. . ..+.||+|.+...+.. ..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 455567799999999999999999983 2 4678999998766554 46789999999985 899999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEecccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGL 234 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~ 234 (266)
.+.+||||++.....++++ .++...+..++..++.||.++|.+| ||||||||.|+|.+.. +.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988873 3567889999999999999999999 9999999999999864 4579999999
Q ss_pred cc
Q 024537 235 AR 236 (266)
Q Consensus 235 a~ 236 (266)
|.
T Consensus 180 A~ 181 (418)
T KOG1167|consen 180 AQ 181 (418)
T ss_pred HH
Confidence 97
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=142.50 Aligned_cols=137 Identities=19% Similarity=0.199 Sum_probs=98.3
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChh--hHHH----------------------HHHHHHHHHhcCCCC--c
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ--GLRE----------------------FTNEVKLLLKIQHKN--L 144 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--I 144 (266)
.+.||+|+||+||+|...+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999768999999987653211 1111 134556666654432 4
Q ss_pred eeEEeEEeeCCcEEEEEeccCCCCHHH-HHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEc
Q 024537 145 VTLFGCCAEGPEKMLVYEYLPNKSLDY-FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLD 222 (266)
Q Consensus 145 v~l~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~ 222 (266)
.+.++. ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 24589999999854321 11110 011 5567889999999999999 88 99999999999999
Q ss_pred CCCCeEEecccccccCCC
Q 024537 223 EQLNPKISDFGLARLFPG 240 (266)
Q Consensus 223 ~~~~~kl~DFG~a~~~~~ 240 (266)
++.++|+|||.|.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.1e-18 Score=131.68 Aligned_cols=136 Identities=19% Similarity=0.176 Sum_probs=113.0
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC--CCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
+++.||.|.++.||++...+ ..+++|....... ...+..|+.++..+.+ .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999744 7899999865543 3567889999999976 58999999988888899999999887
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
.+..+ +......++.+++.++.+||.....+++|+|++|+||+++..+.++++|||.++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77432 44566678899999999999853234999999999999999889999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-17 Score=139.90 Aligned_cols=136 Identities=17% Similarity=0.197 Sum_probs=104.1
Q ss_pred ceec-ccCceEEEEEEecCCCEEEEEeecccC-------------hhhHHHHHHHHHHHHhcCCCCc--eeEEeEEeeCC
Q 024537 92 NQLG-HGGFGPVYRGLMPNGQEIAVKKLSVDS-------------RQGLREFTNEVKLLLKIQHKNL--VTLFGCCAEGP 155 (266)
Q Consensus 92 ~~iG-~G~fg~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~ 155 (266)
..|| .|+.|+||.+.. .+..++||++.... ......+.+|+.++..+.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 788889998876 47789999875321 1123457789999999998875 66776644332
Q ss_pred c----EEEEEeccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 156 E----KMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 156 ~----~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.| |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688888732 234443 3568999999999999 9999999999999998899999
Q ss_pred cccccccCC
Q 024537 231 DFGLARLFP 239 (266)
Q Consensus 231 DFG~a~~~~ 239 (266)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=167.31 Aligned_cols=174 Identities=21% Similarity=0.221 Sum_probs=135.1
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~ 157 (266)
.++....|.+-+.||+|+||.||+|...+|+.||+|+-+........-. .+++.+|+ -+.|..+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 4555667889999999999999999966799999999776655432211 12233333 35666777777778888
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-------CCCeEEe
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-------QLNPKIS 230 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-------~~~~kl~ 230 (266)
++|+||.+.|+|.++++ ..+.+++..+..++.|++.-++.||..+ |||+||||+|+||.. ...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999994 5678999999999999999999999999 999999999999942 3358999
Q ss_pred cccccccCC--CCCceeeeeeEEeeeeCCCccccC
Q 024537 231 DFGLARLFP--GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 231 DFG~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|||-+--+. .+...-...++|-.+-.+||+.+-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence 999995331 223444555677778888887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-18 Score=161.69 Aligned_cols=169 Identities=22% Similarity=0.261 Sum_probs=131.4
Q ss_pred cccceecccCceEEEEEE-ecCCCEEEEEeec-----ccChhh-HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 89 SDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-----VDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.....+|.|++|.|+.+. ....+..+.|.+. ...... ...+..|..+-..+.|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 446789999999888776 3344445555433 112221 222667888888899999988888777766666669
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||++ +|..++.. ...+...++-.++.|++.|+.|||+.| |.|||+||+|++++.+|.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99888833 245777888889999999999999999 999999999999999999999999999876433
Q ss_pred --C--ceeeeeeEEeeeeCCCccccCC
Q 024537 242 --D--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 --~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ......+|+-.|.|||++.+..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ 500 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKE 500 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccc
Confidence 2 4556678999999999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-18 Score=165.91 Aligned_cols=120 Identities=13% Similarity=0.109 Sum_probs=87.4
Q ss_pred cCC-CCceeEEeEE-------eeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024537 139 IQH-KNLVTLFGCC-------AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210 (266)
Q Consensus 139 l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~ii 210 (266)
++| +||++++++| .....++.++|++ +++|.+++.. ....+++..++.++.||+.||.|||++| |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 344 5777788877 2234567788887 6799999843 2356899999999999999999999999 99
Q ss_pred eCCCCCCceEEcC-------------------CCCeEEecccccccCCCCC----------------ceeeeeeEEeeee
Q 024537 211 HRDIKASNILLDE-------------------QLNPKISDFGLARLFPGED----------------THVNTFRISVVTW 255 (266)
Q Consensus 211 HrDlKp~Nill~~-------------------~~~~kl~DFG~a~~~~~~~----------------~~~~~~~~t~~y~ 255 (266)
||||||+||||+. ++.+||+|||+++...... .......+|+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456777777776432100 0001124678899
Q ss_pred CCCccccCC
Q 024537 256 PPNMHCMDI 264 (266)
Q Consensus 256 aPE~~~~e~ 264 (266)
|||++....
T Consensus 183 APE~~~~~~ 191 (793)
T PLN00181 183 SPEEDNGSS 191 (793)
T ss_pred ChhhhccCC
Confidence 999986543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-17 Score=144.37 Aligned_cols=183 Identities=25% Similarity=0.321 Sum_probs=144.7
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEecC------CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEE
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 151 (266)
..+.+...+++....+.+|.||.||.|.|.+ .+.|-+|.++.. +.-....+..|...+..+.|||+..+.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3456666778888899999999999997643 345566766544 444556788999999999999999999998
Q ss_pred eeC-CcEEEEEeccCCCCHHHHHh-----hcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 152 AEG-PEKMLVYEYLPNKSLDYFIF-----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 152 ~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
.++ +..+.++.++.-|+|..++. +....+.++.-+...++.|++.|++|||..+ |||.||-.+|.+|++.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 765 45688899999999999997 4444566778888999999999999999999 99999999999999999
Q ss_pred CeEEecccccccC-CCCCce-eeeeeEEeeeeCCCccccCC
Q 024537 226 NPKISDFGLARLF-PGEDTH-VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 226 ~~kl~DFG~a~~~-~~~~~~-~~~~~~t~~y~aPE~~~~e~ 264 (266)
.|||+|=.++|-+ +.+-.- -+...-...|++||.+..+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ 474 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH 474 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh
Confidence 9999999999865 333111 11112345799999887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.3e-16 Score=139.54 Aligned_cols=141 Identities=20% Similarity=0.261 Sum_probs=98.2
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhHH----------------------------------------HHHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR----------------------------------------EFTN 131 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 131 (266)
+.||.|++|+||+|++.+|+.||||+.+........ .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999889999999998654211100 1334
Q ss_pred HHHHHHhc----CCCCceeEEeEE-eeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHH-HHHHHhhcC
Q 024537 132 EVKLLLKI----QHKNLVTLFGCC-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR-GLLYLHEEA 205 (266)
Q Consensus 132 E~~~l~~l----~H~nIv~l~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~-al~yLH~~~ 205 (266)
|+..+.++ .+.+-+.+-..+ ......++||||++|++|.++...... ..+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 55544444 233223333333 223456999999999999877632211 122 2345555555 467889888
Q ss_pred CCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 206 ~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
++|+|++|.||+++.++.++++|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999988753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-17 Score=151.19 Aligned_cols=158 Identities=23% Similarity=0.221 Sum_probs=131.7
Q ss_pred ecccCceEEEEEEe----cCCCEEEEEeecccChh--hHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 94 LGHGGFGPVYRGLM----PNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 94 iG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+|+|+||.|++++. ..+..||+|..+..... .......|..++..++ ||.+|++...++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998763 34677898887654211 1124556888888887 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
|.+...+ .....+.+.....+...++-|++++|+.+ |++||+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9986655 34456777778888889999999999999 999999999999999999999999999987544433
Q ss_pred eeeEEeeeeCCCccc
Q 024537 247 TFRISVVTWPPNMHC 261 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~ 261 (266)
+||..|+|||++.
T Consensus 154 --cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN 166 (612)
T ss_pred --ccchhhhhhHhhh
Confidence 8999999999987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-15 Score=138.48 Aligned_cols=145 Identities=17% Similarity=0.192 Sum_probs=93.5
Q ss_pred cCccccceecccCceEEEEEEecC-CCEEEEEeecccChhh----------------------------------HHHHH
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQG----------------------------------LREFT 130 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~~~ 130 (266)
..|.. +.||.|++|+||+|+..+ |+.||||+....-... .+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999766 9999999987542110 11122
Q ss_pred HHHHH------HHhc----CCCCceeEEeEEee-CCcEEEEEeccCCCCHHHHHhhcCCC---CCcCHHHHHHHHHHHHH
Q 024537 131 NEVKL------LLKI----QHKNLVTLFGCCAE-GPEKMLVYEYLPNKSLDYFIFDKTKS---SSLDWTTRYRIVMGVAR 196 (266)
Q Consensus 131 ~E~~~------l~~l----~H~nIv~l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~ 196 (266)
+|++. +.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.++-.....+ ..+....+..++.|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 33333 3333 13333333333322 34567999999999997653111111 1233333444445544
Q ss_pred HHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEecccccccCCCC
Q 024537 197 GLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFGLARLFPGE 241 (266)
Q Consensus 197 al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG~a~~~~~~ 241 (266)
..| ++|+|+||.||+++.++ .++++|||++..+...
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 356 99999999999999888 8999999999887543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=114.33 Aligned_cols=132 Identities=18% Similarity=0.144 Sum_probs=97.0
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCce-eEEeEEeeCCcEEEEEeccCCCCH
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
++.|+.|.++.||++.. .+..|++|........ ...+..|+.+++.+...+++ +++... ....++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46788999999999986 4778999987654321 23456899999888655544 455443 2345899999999877
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA--PARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~--~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
... .. ....++.+++.+|..||+.+ +..++|+|++|.||+++ ++.++++|||.|..-
T Consensus 79 ~~~--------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTE--------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 432 01 11235678999999999987 22359999999999999 668999999999753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7e-15 Score=127.51 Aligned_cols=115 Identities=19% Similarity=0.308 Sum_probs=84.1
Q ss_pred CCCCceeEEeEEee---------------------------CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHH
Q 024537 140 QHKNLVTLFGCCAE---------------------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192 (266)
Q Consensus 140 ~H~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 192 (266)
.|||||++.++|.+ +...|+||.-. ..+|..++-. ...+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 49999999998853 23457888766 4577777632 3345566777899
Q ss_pred HHHHHHHHHhhcCCCCeEeCCCCCCceEEc--CCC--CeEEecccccccCCC------CCceeeeeeEEeeeeCCCcccc
Q 024537 193 GVARGLLYLHEEAPARIIHRDIKASNILLD--EQL--NPKISDFGLARLFPG------EDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 193 qi~~al~yLH~~~~~~iiHrDlKp~Nill~--~~~--~~kl~DFG~a~~~~~------~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+++|+.|||..| |.|||+|.+|||+. +++ .+.|+|||+|-.-.. ..+.....-|+.-.+|||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 333 378999999843321 1233334467778899998643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.5e-13 Score=107.34 Aligned_cols=138 Identities=14% Similarity=0.094 Sum_probs=98.5
Q ss_pred cceecccCceEEEEEEecC-------CCEEEEEeecccC-----h-----------------hhHHHH----HHHHHHHH
Q 024537 91 LNQLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDS-----R-----------------QGLREF----TNEVKLLL 137 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-----~-----------------~~~~~~----~~E~~~l~ 137 (266)
...||.|.-+.||.|...+ +..+|||+.+... . .....+ ..|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998432 4799999775320 0 011222 37899998
Q ss_pred hcCC--CCceeEEeEEeeCCcEEEEEeccCCCCHHH-HHhhcCCCCCcCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeCC
Q 024537 138 KIQH--KNLVTLFGCCAEGPEKMLVYEYLPNKSLDY-FIFDKTKSSSLDWTTRYRIVMGVARGLLYL-HEEAPARIIHRD 213 (266)
Q Consensus 138 ~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~al~yL-H~~~~~~iiHrD 213 (266)
++.- -++.+.+++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |..+ |||+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 8853 455666654 45689999997653321 121 12344456667789999999999 8888 99999
Q ss_pred CCCCceEEcCCCCeEEecccccccCCC
Q 024537 214 IKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 214 lKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|++.|||++. +.+.|+|||-|.....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999974 6799999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.1e-14 Score=119.01 Aligned_cols=166 Identities=24% Similarity=0.411 Sum_probs=127.6
Q ss_pred ccccceecccCceEEEEEEecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccC
Q 024537 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
..++-+|.+...|+.|+|+|+ |..+++|++.... ....+.|..|.-.|+-+.||||+.+++.+..+.+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 334567888999999999994 5567778877652 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe--cccccccCCCCCc
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS--DFGLARLFPGEDT 243 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~--DFG~a~~~~~~~~ 243 (266)
.|+|+.++++. .+..++..++.+++.++++|+.|||+..+. |.---|....++||++.+.+|. |--++-.- .
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfqe---~- 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQE---V- 344 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeeec---c-
Confidence 99999999653 345678889999999999999999998732 4444678888999999887664 32222111 1
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
.....+.|++||.+...
T Consensus 345 ---gr~y~pawmspealqrk 361 (448)
T KOG0195|consen 345 ---GRAYSPAWMSPEALQRK 361 (448)
T ss_pred ---ccccCcccCCHHHHhcC
Confidence 11345789999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.46 E-value=2e-13 Score=116.55 Aligned_cols=166 Identities=20% Similarity=0.320 Sum_probs=102.1
Q ss_pred ccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcC----------CCCceeEEeEEe-
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQ----------HKNLVTLFGCCA- 152 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~nIv~l~~~~~- 152 (266)
+...+.||.|+|+.||.+.. .+++.+|+|++.... ....+.+.+|.-....+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 45578899999999999994 568999999886543 223455666554444332 222332233221
Q ss_pred --------eC---C-----cEEEEEeccCCCCHHHHHh---hcCCC-CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 024537 153 --------EG---P-----EKMLVYEYLPNKSLDYFIF---DKTKS-SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212 (266)
Q Consensus 153 --------~~---~-----~~~lv~e~~~~~~L~~~l~---~~~~~-~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHr 212 (266)
.. . +.+++|+-+ .++|.+++. ..... ..+.....+.+..|++..+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 235677777 667877753 22111 22333444566689999999999999 9999
Q ss_pred CCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcc
Q 024537 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 213 DlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~ 260 (266)
||||+|++++.+|.++|+||+.....+.. ......+..|.|||+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELE 214 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhh
Confidence 99999999999999999999988875432 2212345678888864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-12 Score=100.53 Aligned_cols=144 Identities=23% Similarity=0.302 Sum_probs=109.7
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeeccc--------ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--------SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+..|-+|+-+.|+++.+ .|+...||.-..+ ..-...+..+|+.+|.++.--.|..-.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467788999999999988 6787777753322 1222456778999999987667766666777888889999
Q ss_pred eccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEeccccccc
Q 024537 162 EYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARL 237 (266)
Q Consensus 162 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG~a~~ 237 (266)
||++| .++.+++.........++ .....+.+|-+.+.-||+++ |||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~-~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDE-GLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccch-hHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 467777755443333332 33677888999999999999 999999999999976654 58999999965
Q ss_pred C
Q 024537 238 F 238 (266)
Q Consensus 238 ~ 238 (266)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.9e-12 Score=100.04 Aligned_cols=132 Identities=21% Similarity=0.271 Sum_probs=100.8
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeeccc--------ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--------SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
..+++|+-+.+|.+.+- |..+++|.-..+ ..-..++-.+|+.++.++.--.|...+=++.+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999763 445666643222 111234567899999998766666666667778888999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
++|..|.+.+... ...++..+-.-+.-||..| |+|+||.++||++...+ +.++|||++..-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888432 1345667777888999999 99999999999998765 999999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-12 Score=105.53 Aligned_cols=143 Identities=17% Similarity=0.245 Sum_probs=106.7
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCC--CCceeEEeEEeeC---CcEEEEEeccC
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQH--KNLVTLFGCCAEG---PEKMLVYEYLP 165 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~---~~~~lv~e~~~ 165 (266)
+.|+.|.++.||++...+|+.+++|....... .....+..|+.+++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999876668999998765432 133567889999999875 3456777776654 36689999999
Q ss_pred CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 024537 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA---------------------------------------- 205 (266)
Q Consensus 166 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~---------------------------------------- 205 (266)
|.++...+. ...+++.....++.+++.+|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988765431 024566666677777777777777421
Q ss_pred -------------CCCeEeCCCCCCceEEcC--CCCeEEecccccccC
Q 024537 206 -------------PARIIHRDIKASNILLDE--QLNPKISDFGLARLF 238 (266)
Q Consensus 206 -------------~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~ 238 (266)
+..++|+|+.|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 234799999999999998 566899999999753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-14 Score=134.14 Aligned_cols=166 Identities=19% Similarity=0.220 Sum_probs=125.4
Q ss_pred CccccceecccCceEEEEEEecCCCEEEEEeecccC-h---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-R---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+|...+.||.+.|=+|.+|+.+.|. |+||++-+.. . ....+.+.|++ ...+++||++.+.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666789999999999999987776 8899875442 2 23344455565 666789999999988888888899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc--CCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL--FPG 240 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~--~~~ 240 (266)
|. .-+|.+.+.. ..-+..-+.+.|+.|++.||.-+|..| |+|+|||.+||||+..+-+.|+||..-+- ++.
T Consensus 102 yv-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YV-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HH-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 98 5678777732 234566777889999999999999999 99999999999999999999999976653 333
Q ss_pred CCcee-----eeeeEEeeeeCCCccc
Q 024537 241 EDTHV-----NTFRISVVTWPPNMHC 261 (266)
Q Consensus 241 ~~~~~-----~~~~~t~~y~aPE~~~ 261 (266)
++... +|-+-..=|.|||-.-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhh
Confidence 32211 1212233589999654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.4e-14 Score=132.74 Aligned_cols=173 Identities=25% Similarity=0.297 Sum_probs=136.1
Q ss_pred cCccccceecccCceEEEEEEec--CCCEEEEEeecccC--hhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 160 (266)
..|.+.+.||+|+|+.|-.+... ....+|.|.+.... .........|..+-..+. |+|++.+++....+...+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34777888999999999988743 34456666665442 333344556777777777 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHh-hcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH-EEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLF 238 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH-~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~ 238 (266)
+++..|+++...+.. ......+....-.++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999777631 11114566677789999999999999 877 99999999999999999 9999999999887
Q ss_pred CC---CCceeeeeeE-EeeeeCCCcccc
Q 024537 239 PG---EDTHVNTFRI-SVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~---~~~~~~~~~~-t~~y~aPE~~~~ 262 (266)
.. ........+| ++.|.|||...+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc
Confidence 54 2334445577 889999999876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=117.69 Aligned_cols=174 Identities=20% Similarity=0.175 Sum_probs=134.5
Q ss_pred HhhcCccccceecc--cCceEEEEEEe---cCCCEEEEEeec--ccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeC
Q 024537 83 VATNFFSDLNQLGH--GGFGPVYRGLM---PNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG 154 (266)
Q Consensus 83 ~~~~~y~~~~~iG~--G~fg~V~~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 154 (266)
.....+.+...+|. |.+|.||.+.. .++..+|+|.-+ .........-.+|+....++. |+|.++.+..|...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 33455777888999 99999999874 467889998743 222222233346676666664 99999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHH----HHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEE
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR----GLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKI 229 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~----al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl 229 (266)
+..++-+|++ +.++..+.. ....-++...++.++.+... ||.++|+.+ ++|-|+||+||++..+ ..+++
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred Ccceeeeccc-cchhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 9999999999 577776663 33445777888888888888 999999998 9999999999999998 88999
Q ss_pred ecccccccCCCCCceeeee-----eEEeeeeCCCcccc
Q 024537 230 SDFGLARLFPGEDTHVNTF-----RISVVTWPPNMHCM 262 (266)
Q Consensus 230 ~DFG~a~~~~~~~~~~~~~-----~~t~~y~aPE~~~~ 262 (266)
+|||+...+....-.-... .+...|++||...+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 9999999886543111111 57789999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.6e-12 Score=101.63 Aligned_cols=80 Identities=23% Similarity=0.197 Sum_probs=67.2
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
|+|.+++... ...+++..++.|+.|++.||.|||+.+ ||+|||++.++.+|+ ||+++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~--- 64 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQS--- 64 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccC---
Confidence 6788888432 356999999999999999999999975 999999999999999 999987654322
Q ss_pred eeeEEeeeeCCCccccCC
Q 024537 247 TFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e~ 264 (266)
.||+.|+|||++..+.
T Consensus 65 --~g~~~y~aPE~~~~~~ 80 (176)
T smart00750 65 --RVDPYFMAPEVIQGQS 80 (176)
T ss_pred --CCcccccChHHhcCCC
Confidence 5889999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.1e-13 Score=118.32 Aligned_cols=171 Identities=18% Similarity=0.185 Sum_probs=114.6
Q ss_pred ccccceecccCceEEEEEEec-C---CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEe-------EEe----
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG-------CCA---- 152 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~-------~~~---- 152 (266)
+.+.+..+..+++.+...... + ...++-+....+..........++..+.-..|-+..-+.+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 344555666666666655421 1 2344444443333122222333444443333333322222 111
Q ss_pred -eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 153 -EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 153 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
.....||.|++|...+|.+++..+......++...+.++.|++.|++| ++ .+|||+||.||++..+..+||+|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 123578999999999999999766666678888999999999999999 77 99999999999999999999999
Q ss_pred ccccccCCCCC------ceeeeeeEEeeeeCCCccccCC
Q 024537 232 FGLARLFPGED------THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 232 FG~a~~~~~~~------~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||+........ .....-.||..|++||.+.++-
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~ 438 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ 438 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh
Confidence 99998775444 1223347899999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-12 Score=120.53 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=92.4
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
...+|..++.|..|+||.||.++ ..+-+++|+|+-+ ++... .+ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~lil----Rn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNLIL----RN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-cchhh----hc---cccccCCccee-----------------
Confidence 35678889999999999999998 4467788985432 21110 01 33333344433
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+-..++ ...+.++... +.+++|||+.| |+|||+||+|.+|+.-|.+|+.|||+.+...-..
T Consensus 136 ----gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333333 2223333322 67899999999 9999999999999999999999999997642100
Q ss_pred ---------------ceeeeeeEEeeeeCCCccccC
Q 024537 243 ---------------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ---------------~~~~~~~~t~~y~aPE~~~~e 263 (266)
-.....+||+.|.|||++-.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq 233 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ 233 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence 011233899999999998654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-11 Score=112.43 Aligned_cols=123 Identities=28% Similarity=0.488 Sum_probs=101.7
Q ss_pred HHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCe-EeCCC
Q 024537 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI-IHRDI 214 (266)
Q Consensus 136 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~i-iHrDl 214 (266)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++++.||.|||... | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 3568899999999999999999999999999999999954 4567888888889999999999999865 4 89999
Q ss_pred CCCceEEcCCCCeEEecccccccCCCC--CceeeeeeEEeeeeCCCccccC
Q 024537 215 KASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 215 Kp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++.|.+++....+||+|||+....... ........-...|.|||+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 999999999999999999999887431 1111111233468999999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.3e-10 Score=95.38 Aligned_cols=141 Identities=16% Similarity=0.128 Sum_probs=98.3
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChh-----------hHHHHHHHHHHHHhcCCCCc--eeEEeEEee-----
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ-----------GLREFTNEVKLLLKIQHKNL--VTLFGCCAE----- 153 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~----- 153 (266)
+.+-......|+++.+ +|+.|.||........ ....+.+|...+..+..-+| +..+.++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444445666656 6788999976433211 01136788888888753333 334444433
Q ss_pred CCcEEEEEeccCCC-CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-------CC
Q 024537 154 GPEKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-------QL 225 (266)
Q Consensus 154 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-------~~ 225 (266)
....++|||++++. +|.+++.... ....+......++.+++..+.-||+.| |+|+|+++.|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23478999999876 7888874321 234455667789999999999999999 999999999999975 46
Q ss_pred CeEEeccccccc
Q 024537 226 NPKISDFGLARL 237 (266)
Q Consensus 226 ~~kl~DFG~a~~ 237 (266)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.7e-10 Score=92.05 Aligned_cols=126 Identities=23% Similarity=0.306 Sum_probs=82.5
Q ss_pred EEEEEecCCCEEEEEeecccCh--------------------------hhHHHHHHHHHHHHhcCCC--CceeEEeEEee
Q 024537 102 VYRGLMPNGQEIAVKKLSVDSR--------------------------QGLREFTNEVKLLLKIQHK--NLVTLFGCCAE 153 (266)
Q Consensus 102 V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~ 153 (266)
||.|...+|..+|||+.+.... .......+|...|.++.-- ++.+++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 8999988899999997653200 0123466899999999765 456666543
Q ss_pred CCcEEEEEeccC--CCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHH-HhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 154 GPEKMLVYEYLP--NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY-LHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 154 ~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~y-LH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++.+ .+.|+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 65565443211 1123445567777775555 57888 9999999999999987 89999
Q ss_pred cccccccCCC
Q 024537 231 DFGLARLFPG 240 (266)
Q Consensus 231 DFG~a~~~~~ 240 (266)
|||-|.....
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.4e-10 Score=102.26 Aligned_cols=125 Identities=15% Similarity=0.209 Sum_probs=100.9
Q ss_pred EecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHH
Q 024537 106 LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185 (266)
Q Consensus 106 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 185 (266)
+..++.+|.|.....+.........+-++.|+.++||||+++++.++.++..|+|+|-+.- |...+.+.. ..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~------~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG------KE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH------HH
Confidence 3667888998888776554445566778899999999999999999999999999998853 444553221 34
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 186 ~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
.+...+.||+.||.|||+.+ +++|++|..+.|+++..|..||++|.++....+
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 55567899999999998655 499999999999999999999999998866543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-10 Score=105.20 Aligned_cols=148 Identities=22% Similarity=0.220 Sum_probs=118.2
Q ss_pred hcCccccceecccCceEEEEEEe--cCCCEEEEEeecccChhhHH--HHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDSRQGLR--EFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 159 (266)
..+|..+..||.|.|+.|+.+.. .++..|++|.+......... .-..|+.+...+ .|.+++.....|......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45688889999999999999873 46889999987655322211 223466666555 59999999999988888889
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEecccccccC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARLF 238 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~a~~~ 238 (266)
-.|||.++++...+ .-...+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||++..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999886554 22345778888999999999999999988 9999999999999886 77899999999753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.5e-09 Score=88.08 Aligned_cols=136 Identities=20% Similarity=0.216 Sum_probs=95.5
Q ss_pred CccccceecccCceEEEEEEecCCCEEEEEeecccCh----------------------hhHHHHHHHHHHHHhcCCC--
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----------------------QGLREFTNEVKLLLKIQHK-- 142 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~-- 142 (266)
-+.+..+||.|.-+.||.|..+.|.++|||.=+.... -......+|..+|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3567789999999999999988999999995321100 0123456899999988644
Q ss_pred CceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc
Q 024537 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222 (266)
Q Consensus 143 nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~ 222 (266)
.+.+.+++ +.-.+|||+++|-.|...- ++....-.++..|+.-+.-+-..| |||+|+.+-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 55555443 4458999999987764321 122333344445555555555677 99999999999999
Q ss_pred CCCCeEEeccccccc
Q 024537 223 EQLNPKISDFGLARL 237 (266)
Q Consensus 223 ~~~~~kl~DFG~a~~ 237 (266)
++|.+.++||==+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999955543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.7e-09 Score=92.90 Aligned_cols=142 Identities=18% Similarity=0.282 Sum_probs=110.7
Q ss_pred CceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEEEEEeccCC-CCHHH
Q 024537 98 GFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLVYEYLPN-KSLDY 171 (266)
Q Consensus 98 ~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-~~L~~ 171 (266)
...+.|+|. ..+|..|++|++..+..........-++.++++.|+|||++..+|.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346778888 66899999999954322222233345778999999999999999873 3457899999875 56777
Q ss_pred HHhhc------------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 172 FIFDK------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 172 ~l~~~------------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+.+.. ..+...++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+..++|.-.|+...+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65432 22345788999999999999999999999 8889999999999999999998888887665
Q ss_pred CCC
Q 024537 240 GED 242 (266)
Q Consensus 240 ~~~ 242 (266)
.+.
T Consensus 445 ~d~ 447 (655)
T KOG3741|consen 445 EDP 447 (655)
T ss_pred CCC
Confidence 443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-08 Score=82.71 Aligned_cols=107 Identities=23% Similarity=0.284 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHhcCCCC--ceeEEeEEeeC----CcEEEEEeccCCC-CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHH
Q 024537 127 REFTNEVKLLLKIQHKN--LVTLFGCCAEG----PEKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199 (266)
Q Consensus 127 ~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ 199 (266)
....+|...+..+..-+ ..+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence 45667888777775333 34455555442 2358999999874 7888874321 1555667788999999999
Q ss_pred HHhhcCCCCeEeCCCCCCceEEcCCC---CeEEecccccccCC
Q 024537 200 YLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARLFP 239 (266)
Q Consensus 200 yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl~DFG~a~~~~ 239 (266)
-||+.| |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 99999999999999887 79999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-08 Score=92.73 Aligned_cols=142 Identities=17% Similarity=0.253 Sum_probs=93.1
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhH----------------------------------H------HHHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL----------------------------------R------EFTN 131 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------~------~~~~ 131 (266)
..|+.++-|+||+|++.+|+.||||+.+.+-...+ + .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999998999999998765422110 0 1233
Q ss_pred HHHHHHhcC-----CCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHH-HHHHhhcC
Q 024537 132 EVKLLLKIQ-----HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG-LLYLHEEA 205 (266)
Q Consensus 132 E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~a-l~yLH~~~ 205 (266)
|+.-+.++. .+++.--.=+++-.+...|+|||++|..+.+....+. ..++...+ +..++.+ +.-+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 444444432 3444333333344566789999999988887753222 33443332 2222222 12222245
Q ss_pred CCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 206 ~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
+.|.|..|.||+++.+|.+.+.|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-07 Score=76.54 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=98.8
Q ss_pred cccCceEEEEEEecCCCEEEEEeeccc---C---hhhHHHHHHHHHHHHhcCCCC--ceeEEeEEe--eC--CcEEEEEe
Q 024537 95 GHGGFGPVYRGLMPNGQEIAVKKLSVD---S---RQGLREFTNEVKLLLKIQHKN--LVTLFGCCA--EG--PEKMLVYE 162 (266)
Q Consensus 95 G~G~fg~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~--~~--~~~~lv~e 162 (266)
|+|+.+-|+.... .|+.+-+|+-... + +.....|.+|...+..+..-+ +.+....-. .+ -..+||+|
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 4688888888765 4457888876521 0 223467889999998885322 344442211 11 23589999
Q ss_pred ccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC--eEEecccccccC
Q 024537 163 YLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFGLARLF 238 (266)
Q Consensus 163 ~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~--~kl~DFG~a~~~ 238 (266)
-+.| .+|.+++.+. ...+.+......+..+++..+.-||+.| +.|+|+-+.||+++.++. ++++||.-++..
T Consensus 106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 7753 5787777332 2234566777789999999999999999 999999999999987677 999999888754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.8e-07 Score=76.88 Aligned_cols=141 Identities=18% Similarity=0.200 Sum_probs=85.9
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC--ceeEEeEEeeCCcEEEEEeccCCCC-
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKS- 168 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~~~- 168 (266)
.+||+|..+.||+. .+..+++|....... .....+|..++..+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 345678888765332 245678999998886443 4667777777778889999998863
Q ss_pred HHHHH--------------hh------cCCCCCcCHHHHH-HHHHH----------HHH-HHHHHhhc-CCCCeEeCCCC
Q 024537 169 LDYFI--------------FD------KTKSSSLDWTTRY-RIVMG----------VAR-GLLYLHEE-APARIIHRDIK 215 (266)
Q Consensus 169 L~~~l--------------~~------~~~~~~~~~~~~~-~i~~q----------i~~-al~yLH~~-~~~~iiHrDlK 215 (266)
+...+ .. ............. .+..+ +.. ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 0000011111100 01000 001 12222211 12347899999
Q ss_pred CCceEEcCCCCeEEecccccccC
Q 024537 216 ASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 216 p~Nill~~~~~~kl~DFG~a~~~ 238 (266)
|.||+++.++ +.|+||+.|..-
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcC
Confidence 9999999888 999999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-08 Score=87.31 Aligned_cols=97 Identities=23% Similarity=0.341 Sum_probs=81.1
Q ss_pred HHHHhcCCCCceeEEeEEeeCC-----cEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCC
Q 024537 134 KLLLKIQHKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207 (266)
Q Consensus 134 ~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~ 207 (266)
.-+-++.|.|||+++.+|.+.+ ...+++||++.|++..+|++. .....+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455667999999999997654 468899999999999999753 33346777888899999999999999987 4
Q ss_pred CeEeCCCCCCceEEcCCCCeEEec
Q 024537 208 RIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 208 ~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
+|+|+++..+-|++..+|.+||+-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred ccccCCcchhheeecCCceEEecc
Confidence 599999999999999998888853
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.7e-07 Score=75.91 Aligned_cols=139 Identities=19% Similarity=0.209 Sum_probs=91.5
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhH-------------------H-----HHHHHHHHHHhcC--CCCce
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL-------------------R-----EFTNEVKLLLKIQ--HKNLV 145 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~-----~~~~E~~~l~~l~--H~nIv 145 (266)
..|..|.-+.||+|...++..+|+|+++....... + -...|..-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 45677888999999876899999999875422110 0 1224555555543 33333
Q ss_pred eEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCC
Q 024537 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 146 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~ 224 (266)
+-+.+. ...+||||+...... ........+...+...+..++++.+.-|-. .+ +||+||..-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence 444433 247999999543110 001111223333567778888899888877 55 99999999999999 7
Q ss_pred CCeEEecccccccCCCC
Q 024537 225 LNPKISDFGLARLFPGE 241 (266)
Q Consensus 225 ~~~kl~DFG~a~~~~~~ 241 (266)
+.+.|+|||=|.....+
T Consensus 203 ~~p~iID~~QaV~~~hp 219 (268)
T COG1718 203 GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CeEEEEECccccccCCC
Confidence 89999999988766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.2e-07 Score=72.67 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=89.5
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHH---------HHHHHHHHHhcC---CCCceeEEe
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE---------FTNEVKLLLKIQ---HKNLVTLFG 149 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---H~nIv~l~~ 149 (266)
....++|+..+.+-......|.+-.. +|+.+++|..+.......+. ..+++..+..+. --.++.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34456788777777766655555444 67889999876543222121 223333333332 223333333
Q ss_pred EEe-----eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC
Q 024537 150 CCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 150 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~ 224 (266)
+.. -....+++|||++|..|.++. .+++ .+...+.+++.-||+.| +.|+|..|.|++++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 222 223457899999998885543 1222 24456778899999999 9999999999999865
Q ss_pred CCeEEeccccccc
Q 024537 225 LNPKISDFGLARL 237 (266)
Q Consensus 225 ~~~kl~DFG~a~~ 237 (266)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.7e-07 Score=73.33 Aligned_cols=144 Identities=20% Similarity=0.210 Sum_probs=82.9
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC--CceeEEeEEee---CCcEEEEEeccC
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGCCAE---GPEKMLVYEYLP 165 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~---~~~~~lv~e~~~ 165 (266)
++.|+.|..+.||++...+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999998755 68999987654 3446677888888887533 34566654332 334689999999
Q ss_pred CCCHHH----------------HHh---hc-CCCCCcCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 024537 166 NKSLDY----------------FIF---DK-TKSSSLDWTT---------RYRI------------VMGVAR-GLLYLHE 203 (266)
Q Consensus 166 ~~~L~~----------------~l~---~~-~~~~~~~~~~---------~~~i------------~~qi~~-al~yLH~ 203 (266)
|..+.. .+. .. .......... .... ...+.. .+..+..
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987776 111 11 0111111100 0000 001111 2333332
Q ss_pred ----cCCCCeEeCCCCCCceEEc-CCCCeEEeccccccc
Q 024537 204 ----EAPARIIHRDIKASNILLD-EQLNPKISDFGLARL 237 (266)
Q Consensus 204 ----~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~ 237 (266)
..+..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234499999999999999 556567999988864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.2e-06 Score=72.10 Aligned_cols=142 Identities=15% Similarity=0.106 Sum_probs=85.7
Q ss_pred eecccCc-eEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEeccCCCCHH
Q 024537 93 QLGHGGF-GPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170 (266)
Q Consensus 93 ~iG~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~ 170 (266)
.|-.|.+ ..||+.... +..+.+|+..... ...+..|+.++..+. +--+.+++.+...++..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 888998753 4678888875443 234567888888774 344667888777767789999999987775
Q ss_pred HHHh-------------------hcC-CCCCcCHH--HHHHHHH--------------------HHHHHHHHHhh----c
Q 024537 171 YFIF-------------------DKT-KSSSLDWT--TRYRIVM--------------------GVARGLLYLHE----E 204 (266)
Q Consensus 171 ~~l~-------------------~~~-~~~~~~~~--~~~~i~~--------------------qi~~al~yLH~----~ 204 (266)
.... ... ....+... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4310 000 00111100 0000000 01111222211 1
Q ss_pred CCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 205 ~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
.++.++|+|+.|.|||++.+..+.|+||+.|..-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 1234899999999999999877889999998643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.47 E-value=4e-06 Score=68.33 Aligned_cols=135 Identities=18% Similarity=0.326 Sum_probs=94.3
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccC----------------hhhHHHHHHHHHHHHhcC------CCCceeEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS----------------RQGLREFTNEVKLLLKIQ------HKNLVTLF 148 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l~ 148 (266)
...||+|+.-.||. .++.....||+..... .....+..+|+.-...+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35699999999986 4455667888876554 122355666776665555 88999999
Q ss_pred eEEeeCCcEEEEEeccCC------CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc
Q 024537 149 GCCAEGPEKMLVYEYLPN------KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222 (266)
Q Consensus 149 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~ 222 (266)
|+.+++-..-+|+|.+.+ .+|.+++. ...++. .... .+-+-..||-+.+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999888999997642 35666662 233444 3322 2334456777777 99999999999995
Q ss_pred CCC----CeEEec-ccccccC
Q 024537 223 EQL----NPKISD-FGLARLF 238 (266)
Q Consensus 223 ~~~----~~kl~D-FG~a~~~ 238 (266)
... .+.|+| ||-...+
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred ecCCCceEEEEEeCCCCcccc
Confidence 432 588999 7777654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=67.81 Aligned_cols=132 Identities=21% Similarity=0.246 Sum_probs=88.4
Q ss_pred cccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCcee-EEeEEeeCCcEEEEEeccCCC
Q 024537 89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT-LFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lv~e~~~~~ 167 (266)
.+.+.|++|.+|.||+|.| .|..+|+|+-..++.. ..+..|+++|..+.-.++.+ ++.+..+ ++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 3457899999999999999 4568899986655443 67889999999998766653 4444332 4569999998
Q ss_pred CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC-CCceEEcCCCCeEEecccccccCCC
Q 024537 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK-ASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 168 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlK-p~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
.|...-.. .+...+. .++++---|-..| |-|..|. |...++..++.+.|+||..|+.-..
T Consensus 98 ~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 98 PLGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred chhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 88665411 1223333 3444433344455 7777764 4444555555899999999985433
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.9e-06 Score=82.00 Aligned_cols=148 Identities=19% Similarity=0.306 Sum_probs=91.9
Q ss_pred cceecccCceEEEEEEecCC---CEEEEEeecccC-hhhHHHHHHHHHHHHhcC-CCCc--eeEEeEEeeC---CcEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNG---QEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNL--VTLFGCCAEG---PEKMLV 160 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lv 160 (266)
++.|+.|.+..+|+....++ ..+++|+..... ......+.+|..+|+.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999875443 467888765432 122346779999999985 6665 7777777654 467999
Q ss_pred EeccCCCCHHH--------------------HH---hhcCC--------CCC--cCHHHHHHHHHH--------------
Q 024537 161 YEYLPNKSLDY--------------------FI---FDKTK--------SSS--LDWTTRYRIVMG-------------- 193 (266)
Q Consensus 161 ~e~~~~~~L~~--------------------~l---~~~~~--------~~~--~~~~~~~~i~~q-------------- 193 (266)
|||++|..+.+ .+ +.... ..+ ....++..|..+
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 01 11000 000 101122222111
Q ss_pred -HHHHHHHHhhcCC--------CCeEeCCCCCCceEEcCC-CC-eEEecccccccC
Q 024537 194 -VARGLLYLHEEAP--------ARIIHRDIKASNILLDEQ-LN-PKISDFGLARLF 238 (266)
Q Consensus 194 -i~~al~yLH~~~~--------~~iiHrDlKp~Nill~~~-~~-~kl~DFG~a~~~ 238 (266)
+...+.+|..+-| ..+||+|+++.|||++.+ +. .-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2234567754332 239999999999999853 33 579999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=79.52 Aligned_cols=142 Identities=16% Similarity=0.181 Sum_probs=88.0
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhh-------------------------------HHH------HHHHHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-------------------------------LRE------FTNEVK 134 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~E~~ 134 (266)
+.||.-+.|+|++|+..+|+.||||+-+..-... .+. |.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999998899999999765431111 011 233333
Q ss_pred HHH----hcCCCC---ceeEEeEEe-eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCC
Q 024537 135 LLL----KIQHKN---LVTLFGCCA-EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206 (266)
Q Consensus 135 ~l~----~l~H~n---Iv~l~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~ 206 (266)
-.. .+.|-+ -|.+=.++. -.....|+||||+|..+.++-.-. ...++...+..-+.++.. +-|=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~--~qIf~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYL--EQIFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 222 223445 111222222 224568999999998776664322 234554443333222221 1222345
Q ss_pred CCeEeCCCCCCceEEcC----CCCeEEecccccccCCC
Q 024537 207 ARIIHRDIKASNILLDE----QLNPKISDFGLARLFPG 240 (266)
Q Consensus 207 ~~iiHrDlKp~Nill~~----~~~~kl~DFG~a~~~~~ 240 (266)
++|.|-.|.||++.. ++.+.+.|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 66799999999988753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-06 Score=69.68 Aligned_cols=105 Identities=21% Similarity=0.222 Sum_probs=81.9
Q ss_pred HHHHHHHHhcCC-CCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 024537 130 TNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208 (266)
Q Consensus 130 ~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~ 208 (266)
.+|.-+++.+++ +++.+++|++-. ++|+|+...+++......-..-...+|..+.+|+.++++.+++++......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 699999999943 678899987765321100011234689999999999999999999855445
Q ss_pred eEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 209 IIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 209 iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+.-.|++|+|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 788999999999999999999999888654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.4e-05 Score=63.62 Aligned_cols=125 Identities=25% Similarity=0.391 Sum_probs=88.5
Q ss_pred cCccccceecccCc-eEEEEEEecCCCEEEEEeecc---cCh------------------hhHHHHHHHHHHHHhcC---
Q 024537 86 NFFSDLNQLGHGGF-GPVYRGLMPNGQEIAVKKLSV---DSR------------------QGLREFTNEVKLLLKIQ--- 140 (266)
Q Consensus 86 ~~y~~~~~iG~G~f-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 140 (266)
.+++.++.||.|.- |.||++.. +|+.||+|.+.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77899999999999 99999987 678999999321 100 11234778888777664
Q ss_pred CCCc--eeEEeEEeeC------------------CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHH
Q 024537 141 HKNL--VTLFGCCAEG------------------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200 (266)
Q Consensus 141 H~nI--v~l~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~y 200 (266)
+.++ |+++|+..-. ....||-||++... .+... -+.++.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence 5566 8999987322 01246777665432 12222 34566777889
Q ss_pred HhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 201 LH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
+|..| |+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999985 3489999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=66.17 Aligned_cols=72 Identities=19% Similarity=0.331 Sum_probs=44.3
Q ss_pred ceecccCce-EEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC---CceeEEeEEeeC---CcEEEEEecc
Q 024537 92 NQLGHGGFG-PVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK---NLVTLFGCCAEG---PEKMLVYEYL 164 (266)
Q Consensus 92 ~~iG~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~---~~~~lv~e~~ 164 (266)
+.|+.|+.. .||+. +..+++|...... ....+..|..++..+... -+.+++...... +..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766654 58875 2357777654322 234678899999877532 344444443332 2358899999
Q ss_pred CCCCH
Q 024537 165 PNKSL 169 (266)
Q Consensus 165 ~~~~L 169 (266)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.3e-05 Score=65.83 Aligned_cols=77 Identities=13% Similarity=0.095 Sum_probs=55.7
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC---CCceeEEeEEee---CCcEEEEEec
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH---KNLVTLFGCCAE---GPEKMLVYEY 163 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~---~~~~~lv~e~ 163 (266)
..+.||.|..+.||.....++ .+.+|..+... ....+..|...|+.+.- ..+.++++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356799999999999875455 46667743311 22477889999988853 367788887754 3668999999
Q ss_pred cCCCCH
Q 024537 164 LPNKSL 169 (266)
Q Consensus 164 ~~~~~L 169 (266)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 988654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.9e-05 Score=64.77 Aligned_cols=143 Identities=15% Similarity=0.239 Sum_probs=81.6
Q ss_pred cceecccCceEEEEEEecC--CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCCcEEEEEeccCCC
Q 024537 91 LNQLGHGGFGPVYRGLMPN--GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
++.|..|-...+|++...+ ++.|++|+........ -....|+.++..+...+ .++++..+. -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788889999987653 6789999765432221 12346888888885333 344544432 24899999886
Q ss_pred CHHHH-------H----------hhcCCC--------CCcC-HHHHHHHHH----------------------HHHHHHH
Q 024537 168 SLDYF-------I----------FDKTKS--------SSLD-WTTRYRIVM----------------------GVARGLL 199 (266)
Q Consensus 168 ~L~~~-------l----------~~~~~~--------~~~~-~~~~~~i~~----------------------qi~~al~ 199 (266)
++... + +..... .... +..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 0 000000 0111 112111111 1111112
Q ss_pred HH----hhc-CCCCeEeCCCCCCceEEcC-CCCeEEecccccccC
Q 024537 200 YL----HEE-APARIIHRDIKASNILLDE-QLNPKISDFGLARLF 238 (266)
Q Consensus 200 yL----H~~-~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~ 238 (266)
.| -.. .+..++|+|+.+.|||++. ++.+.|+||..|..-
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 22 111 2234899999999999998 578999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-07 Score=84.94 Aligned_cols=159 Identities=16% Similarity=0.059 Sum_probs=112.7
Q ss_pred ccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCCcEEEEEeccCC
Q 024537 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+....-+++|+++++++.+-...+....+.+... ....-++++|.+++||| .+..++.+..++..+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 5556778899999999988433344445555433 33446889999999999 77778888888899999999987
Q ss_pred C-CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee
Q 024537 167 K-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 167 ~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 245 (266)
+ +..... ......+...+...+.+.-.++++++|+.- -+|+| ||+..+ +..+..||+.+..+.... ..
T Consensus 319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 7 221111 011112333444555666778899999864 48998 777766 578999999998886554 45
Q ss_pred eeeeEEeeeeCCCcccc
Q 024537 246 NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~ 262 (266)
.++.+++.+.|||+...
T Consensus 388 ~t~~~~~~~~~pev~~~ 404 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQE 404 (829)
T ss_pred ccCCCCCCCCCchhhcc
Confidence 67788999999997643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.1e-07 Score=86.97 Aligned_cols=147 Identities=16% Similarity=0.200 Sum_probs=104.7
Q ss_pred hhcCccccceecccCceEEEEEEec-CCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..+.+.+.+.+..|+++.++.+... .|...++|..... .....+....+-.++-...+|.+++....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777788999999999988732 3433344432211 11122333344445444567888877777777788999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+++|..+++|...++.. ...+..-...+...+..+++|||+.. ++|||++|.|+|+..++..++.|||+..
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 99999999998888433 23444445556667889999999976 8999999999999999999999998543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.1e-05 Score=65.68 Aligned_cols=139 Identities=16% Similarity=0.099 Sum_probs=77.6
Q ss_pred ecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEEeccCCCCHHHH
Q 024537 94 LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYLPNKSLDYF 172 (266)
Q Consensus 94 iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~~~L~~~ 172 (266)
+..|-.+.+|+... +++.+++|..........-....|..+++.+....+ .+++.... -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45688889998874 567888887554322210124578888888864333 33443332 3789999988665321
Q ss_pred --------------H---hhc-CCCCCcCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCCeEeCCCCCCce
Q 024537 173 --------------I---FDK-TKSSSLDWT-TRYRIVMGV---------ARGLLYLHEE-----APARIIHRDIKASNI 219 (266)
Q Consensus 173 --------------l---~~~-~~~~~~~~~-~~~~i~~qi---------~~al~yLH~~-----~~~~iiHrDlKp~Ni 219 (266)
+ +.. .....++.. .+..+..++ ...+..+-.. .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 110 011112211 111111111 1112222111 122489999999999
Q ss_pred EEcCCCCeEEecccccccC
Q 024537 220 LLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 220 ll~~~~~~kl~DFG~a~~~ 238 (266)
+++.++ +.|+||..|..-
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999877 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.0004 Score=62.58 Aligned_cols=76 Identities=17% Similarity=0.188 Sum_probs=53.7
Q ss_pred cceecccCceEEEEEEecCC-CEEEEEeeccc-----C--hhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNG-QEIAVKKLSVD-----S--RQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~l 159 (266)
.+.||.|.+..||++...+| +.|+||.-... . .-..++...|...|..+. -..+.+++.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999997666 58999985311 1 123456777888888763 2456677776 3456789
Q ss_pred EEeccCCCC
Q 024537 160 VYEYLPNKS 168 (266)
Q Consensus 160 v~e~~~~~~ 168 (266)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00041 Score=59.97 Aligned_cols=143 Identities=15% Similarity=0.159 Sum_probs=83.9
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC--ceeEEeE------EeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGC------CAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lv~e 162 (266)
.+.|..|....+|+... ++..+++|+.... ....+..|+.++..+...+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 46677788889999875 3457888987642 2245566787777774322 4444432 233456789999
Q ss_pred ccCCCCHHH----HH----------hhcC---CC-----CCcCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 024537 163 YLPNKSLDY----FI----------FDKT---KS-----SSLDWTTRY----------RIVMGVARGLLYLHE----EAP 206 (266)
Q Consensus 163 ~~~~~~L~~----~l----------~~~~---~~-----~~~~~~~~~----------~i~~qi~~al~yLH~----~~~ 206 (266)
+++|..+.. .. +... .. ....|.... .....+..++.++-. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866422 10 0000 00 001111100 011113334455443 112
Q ss_pred CCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 207 ARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 207 ~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
..++|+|+.|.||+++.++.+.|+||+.|..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0008 Score=58.88 Aligned_cols=143 Identities=15% Similarity=0.187 Sum_probs=75.6
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC--CceeEEeE------EeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGC------CAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~------~~~~~~~~lv~e 162 (266)
.+.|+.|....+|+....+| .+++|+...... ..+..|+.++..|... .+.+.+.. ....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35577787789999875444 688898762222 2333455555554311 13333321 223456789999
Q ss_pred ccCCCCHH-----------HHH---hhcCCC--------CCcCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 024537 163 YLPNKSLD-----------YFI---FDKTKS--------SSLDW-TTRYR------------IVMG-VARGLLYLHEE-- 204 (266)
Q Consensus 163 ~~~~~~L~-----------~~l---~~~~~~--------~~~~~-~~~~~------------i~~q-i~~al~yLH~~-- 204 (266)
+++|..+. ..+ +..... ..+.+ ..... ...+ +...++.+-..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 111 110000 01111 11110 0111 11112222211
Q ss_pred --CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 205 --~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
-+..+||+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 133499999999999999765568999999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00097 Score=58.13 Aligned_cols=144 Identities=16% Similarity=0.185 Sum_probs=80.7
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC--CceeEEeEE------eeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGCC------AEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~------~~~~~~~lv~e 162 (266)
.+.++.|....+|+....++ .+++|+...... ...+..|+.++..|... .+.+++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789998875444 678887654321 13344566666666322 234444321 12456789999
Q ss_pred ccCCCCHH----H-------HH---hhcCCC----C-----CcCHHHHH------------HHHHHHHHHHHHHhh----
Q 024537 163 YLPNKSLD----Y-------FI---FDKTKS----S-----SLDWTTRY------------RIVMGVARGLLYLHE---- 203 (266)
Q Consensus 163 ~~~~~~L~----~-------~l---~~~~~~----~-----~~~~~~~~------------~i~~qi~~al~yLH~---- 203 (266)
|++|..+. . .+ +..... . .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 01 110000 0 00111100 001122334555532
Q ss_pred cCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 204 ~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.-+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123499999999999999887778999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00033 Score=61.80 Aligned_cols=142 Identities=19% Similarity=0.212 Sum_probs=96.3
Q ss_pred cccceecccCceEEEEEEecCCCEEEEEeeccc-----Chh-------------------hH--HHHHHHHHHHHhcCCC
Q 024537 89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD-----SRQ-------------------GL--REFTNEVKLLLKIQHK 142 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~-----~~~-------------------~~--~~~~~E~~~l~~l~H~ 142 (266)
.+..+|..|.-+-||.|...+|..+|||+++.+ ... .. -....|+.-|.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445778889999999999889999999987543 000 00 0123566667777655
Q ss_pred CceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc
Q 024537 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222 (266)
Q Consensus 143 nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~ 222 (266)
.|....-... ....|||+|+...... ....+...++...+..+-.|++.-|.-|.... ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 5443222222 2347999999533221 11233445777778888888888888887765 599999999999996
Q ss_pred CCCCeEEecccccccC
Q 024537 223 EQLNPKISDFGLARLF 238 (266)
Q Consensus 223 ~~~~~kl~DFG~a~~~ 238 (266)
. |.+.|+|-+=+...
T Consensus 300 d-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEH 314 (520)
T ss_pred C-CEEEEEEccccccC
Confidence 5 57999998766543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0011 Score=57.53 Aligned_cols=142 Identities=20% Similarity=0.329 Sum_probs=82.8
Q ss_pred ceecccCceEEEEEEecC-------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEEec
Q 024537 92 NQLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~ 163 (266)
+.|..|-...+|+....+ ++.|++|+....... ......|..++..+...++ .+++..+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667778999987544 578999987654322 2345678888887753333 345555532 368999
Q ss_pred cCCCCHHHH--------------H---hhcCCCC------CcC--HHHHHH--------------------------HHH
Q 024537 164 LPNKSLDYF--------------I---FDKTKSS------SLD--WTTRYR--------------------------IVM 192 (266)
Q Consensus 164 ~~~~~L~~~--------------l---~~~~~~~------~~~--~~~~~~--------------------------i~~ 192 (266)
++|..+... + +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888665321 0 0100000 000 111111 111
Q ss_pred HHHHHHHHHhh------cCCCCeEeCCCCCCceEEcCC----CCeEEecccccccC
Q 024537 193 GVARGLLYLHE------EAPARIIHRDIKASNILLDEQ----LNPKISDFGLARLF 238 (266)
Q Consensus 193 qi~~al~yLH~------~~~~~iiHrDlKp~Nill~~~----~~~kl~DFG~a~~~ 238 (266)
.+...+.++-. ..+..++|+|+.|.|||++.+ +.+.++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22222334432 123458999999999999884 78999999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00013 Score=63.32 Aligned_cols=133 Identities=18% Similarity=0.160 Sum_probs=88.7
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeeccc---------Ch---------hh----HHHHHHHHHHHHhcC-CC
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---------SR---------QG----LREFTNEVKLLLKIQ-HK 142 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~---------~~---------~~----~~~~~~E~~~l~~l~-H~ 142 (266)
.-+.+.++||-|.-+-||.+-...|++.++|.=+.. .. .+ .-....|...|+.|. |-
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 347788999999999999999888999999843211 00 01 112456888888874 22
Q ss_pred -CceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE
Q 024537 143 -NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221 (266)
Q Consensus 143 -nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill 221 (266)
-+.+.++ -+.-++|||++.|-.|...- ...+.+. +...+..-+.-|-..| +||+|..--||++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 2233333 34558999999888775432 1112222 2233333345556667 9999999999999
Q ss_pred cCCCCeEEecccc
Q 024537 222 DEQLNPKISDFGL 234 (266)
Q Consensus 222 ~~~~~~kl~DFG~ 234 (266)
++++.++++||==
T Consensus 236 ~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQ 248 (465)
T ss_pred ecCCCEEEeechH
Confidence 9999999999943
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0015 Score=58.01 Aligned_cols=143 Identities=16% Similarity=0.205 Sum_probs=81.8
Q ss_pred cceecccCceEEEEEEecC-----CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCce-eEEeEEeeCCcEEEEEecc
Q 024537 91 LNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~ 164 (266)
+..|-.|-...+|++...+ ++.|++|+........+. ..+|..+++.+.--++. ++++.+.. + .|++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 3456558888999987432 367899887654332222 25788888888644443 45565533 2 578998
Q ss_pred CCCCHHHH-----------------HhhcC-CCC--CcCHHHHHHHHHHH-----------------HHHHHHH----hh
Q 024537 165 PNKSLDYF-----------------IFDKT-KSS--SLDWTTRYRIVMGV-----------------ARGLLYL----HE 203 (266)
Q Consensus 165 ~~~~L~~~-----------------l~~~~-~~~--~~~~~~~~~i~~qi-----------------~~al~yL----H~ 203 (266)
++.++... ++... ... ...+..+..+..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665321 00100 001 11122232332211 1112222 11
Q ss_pred -cCCCCeEeCCCCCCceEEcC-CCCeEEecccccccC
Q 024537 204 -EAPARIIHRDIKASNILLDE-QLNPKISDFGLARLF 238 (266)
Q Consensus 204 -~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~ 238 (266)
..+..++|+|+++.|||+++ ++.+.++||..|..-
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11234899999999999986 467999999999764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0026 Score=54.73 Aligned_cols=31 Identities=26% Similarity=0.475 Sum_probs=26.2
Q ss_pred CeEeCCCCCCceEEcCCCC-eEEecccccccC
Q 024537 208 RIIHRDIKASNILLDEQLN-PKISDFGLARLF 238 (266)
Q Consensus 208 ~iiHrDlKp~Nill~~~~~-~kl~DFG~a~~~ 238 (266)
.++|+|+.|.|||++.++. .-|+||+.|..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0029 Score=55.30 Aligned_cols=147 Identities=18% Similarity=0.278 Sum_probs=80.4
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeecc--cChhhHHHHHHHHHHHHhcCC--CCceeEEeEEeeCC--cEEEEEec
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGP--EKMLVYEY 163 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~--~~~lv~e~ 163 (266)
+++.+-.|..-.+|.... +++.+++. ... ..........+|..+++.+.- .-+...++.+.++. ..|.||++
T Consensus 29 ~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 344454454445555443 36778877 321 223334555678888887743 22334455555544 66999999
Q ss_pred cCCCCHH------------------HHHhh----c-------CCCCCcCHHHHHHHHHH--------------HHHHHHH
Q 024537 164 LPNKSLD------------------YFIFD----K-------TKSSSLDWTTRYRIVMG--------------VARGLLY 200 (266)
Q Consensus 164 ~~~~~L~------------------~~l~~----~-------~~~~~~~~~~~~~i~~q--------------i~~al~y 200 (266)
++|..+. ++|.. . .........++..+..+ ...-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9873221 11110 0 00000011111111111 1222345
Q ss_pred Hhhc-----CCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 201 LHEE-----APARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 201 LH~~-----~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
|..+ ++..++|+|+.+.||+++...-+=+.||+++..-
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5443 3356999999999999999888999999999764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0038 Score=56.09 Aligned_cols=163 Identities=13% Similarity=0.098 Sum_probs=100.7
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEE------eeCC-cEEEEE
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC------AEGP-EKMLVY 161 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------~~~~-~~~lv~ 161 (266)
..+.||+|+-+.+|-.-.- ...+.|+..........+ .+..|... .||-+..-+.+- .... ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3577999999999964321 123457766554432222 22233333 455433211111 1122 256777
Q ss_pred eccCCCC-HHHHHhh---cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 162 EYLPNKS-LDYFIFD---KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 162 e~~~~~~-L~~~l~~---~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
..+++.. +..+++. +.......|...++.++.++.+.+-||..| .+=+|+.++|+|+++++.|.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8776642 2333322 222335778999999999999999999999 88899999999999999999988443333
Q ss_pred CCCCCceeeeeeEEeeeeCCCccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
-.+.. -...+.|...|.|||.=.
T Consensus 167 ~~ng~-~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 167 NANGT-LHLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccCCc-eEecccCccccCCHHHhc
Confidence 22222 233456788899999643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0064 Score=52.57 Aligned_cols=75 Identities=19% Similarity=0.236 Sum_probs=48.3
Q ss_pred cccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEEEEeccC
Q 024537 89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLP 165 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~ 165 (266)
+..+.|+.|....+|+.. .+++.+.||.-... ....|..|..-|+.|. --.+.+++++....+..++||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345778889999999987 57888999987622 2245677888888773 4457789999888888899999987
Q ss_pred CC
Q 024537 166 NK 167 (266)
Q Consensus 166 ~~ 167 (266)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0083 Score=53.30 Aligned_cols=72 Identities=18% Similarity=0.213 Sum_probs=46.4
Q ss_pred eecccCceEEEEEEecCC-CEEEEEeecc-------cChhhHHHHHHHHHHHHhcC--CCC-ceeEEeEEeeCCcEEEEE
Q 024537 93 QLGHGGFGPVYRGLMPNG-QEIAVKKLSV-------DSRQGLREFTNEVKLLLKIQ--HKN-LVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~n-Iv~l~~~~~~~~~~~lv~ 161 (266)
.||.|....||++..+++ +.|+||.-.. +-.-...+..-|...|+... -|. +.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999996544 6899996431 11223455567777776653 343 4444433 345567999
Q ss_pred eccCC
Q 024537 162 EYLPN 166 (266)
Q Consensus 162 e~~~~ 166 (266)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.049 Score=47.26 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=25.4
Q ss_pred CeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 208 ~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4899999999999988 6789999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.038 Score=50.03 Aligned_cols=73 Identities=12% Similarity=0.156 Sum_probs=49.5
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecc-----cCh--hhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-----DSR--QGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~-----~~~--~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv 160 (266)
.+.||.|....||+... .+..|+||.-.. ... -...+-..|...|+.+. -..+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 56799999999999876 455799997651 110 12334445666666553 247777888776 456889
Q ss_pred EeccCC
Q 024537 161 YEYLPN 166 (266)
Q Consensus 161 ~e~~~~ 166 (266)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.021 Score=50.41 Aligned_cols=142 Identities=12% Similarity=0.236 Sum_probs=78.6
Q ss_pred ceecccCceEEEEEEecC----CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCce-eEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.|..|-...+|+....+ +..|++|+........+ ...+|..+++.+..-++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557778899886432 23788888755433221 224688888888655553 5565553 22 58888876
Q ss_pred CCHHH-------HH----------hhcC-CCC--CcCHHHHHHHHHHH----------------------HHHHH----H
Q 024537 167 KSLDY-------FI----------FDKT-KSS--SLDWTTRYRIVMGV----------------------ARGLL----Y 200 (266)
Q Consensus 167 ~~L~~-------~l----------~~~~-~~~--~~~~~~~~~i~~qi----------------------~~al~----y 200 (266)
..+.. .+ +... ... .-.+..+..+..++ ..-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 01 0100 001 11122222222221 11111 1
Q ss_pred Hhh-cCCCCeEeCCCCCCceEEcC-CCCeEEecccccccC
Q 024537 201 LHE-EAPARIIHRDIKASNILLDE-QLNPKISDFGLARLF 238 (266)
Q Consensus 201 LH~-~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~ 238 (266)
+.. ..+.-++|.|+-+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 111 11233789999999999975 468999999998654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.012 Score=52.21 Aligned_cols=72 Identities=21% Similarity=0.230 Sum_probs=54.7
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..|++|++. |+.+... ....++++..++.+.+.-+.-+..+- +.=|||+.-.||||+ +|+|-|+||-+|
T Consensus 300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 457788876 6666311 23456788888888777666666553 588999999999999 999999999999
Q ss_pred ccC
Q 024537 236 RLF 238 (266)
Q Consensus 236 ~~~ 238 (266)
|.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 954
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.14 Score=45.08 Aligned_cols=71 Identities=11% Similarity=0.112 Sum_probs=42.9
Q ss_pred cCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC--ceeEE---e--EEeeCCcEEEEEeccCCCC
Q 024537 97 GGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLF---G--CCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 97 G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~---~--~~~~~~~~~lv~e~~~~~~ 168 (266)
+.-..||+....++..+++|+..... .....+..|+..+..|.-.. ++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567999887678889999875332 23355667887777663211 22211 1 1223456778999987754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.033 Score=46.22 Aligned_cols=103 Identities=15% Similarity=0.128 Sum_probs=66.9
Q ss_pred EEEEEeecccChh-hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHH
Q 024537 112 EIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190 (266)
Q Consensus 112 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i 190 (266)
+..+|++...... ...-+.++..+++++. .|+++..- ..-.+-+++|.|-.... .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 3456666544322 3345677888888875 67777632 33456789999843222 00 111
Q ss_pred HHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 191 ~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
+..=+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.-
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 221246677788654 35999999999999999999999996543
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.13 Score=52.24 Aligned_cols=31 Identities=39% Similarity=0.502 Sum_probs=26.0
Q ss_pred CCeEeCCCCCCceEEcCCC--CeE-Eeccccccc
Q 024537 207 ARIIHRDIKASNILLDEQL--NPK-ISDFGLARL 237 (266)
Q Consensus 207 ~~iiHrDlKp~Nill~~~~--~~k-l~DFG~a~~ 237 (266)
..+||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999875 454 999999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.0035 Score=59.14 Aligned_cols=73 Identities=19% Similarity=0.308 Sum_probs=53.3
Q ss_pred HHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC--------ceeee-eeEEeeeeCCCccc
Q 024537 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED--------THVNT-FRISVVTWPPNMHC 261 (266)
Q Consensus 191 ~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~--------~~~~~-~~~t~~y~aPE~~~ 261 (266)
+.++++|+.|+|..- .+||++|.|++|.++..+.+||+-|+++.-..+.. ..... ..-..-|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344559999999764 59999999999999999999999999987654411 11111 12244689999887
Q ss_pred cCCC
Q 024537 262 MDIC 265 (266)
Q Consensus 262 ~e~~ 265 (266)
...|
T Consensus 183 ~~~~ 186 (700)
T KOG2137|consen 183 GTTN 186 (700)
T ss_pred cccc
Confidence 6554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.14 Score=44.71 Aligned_cols=30 Identities=23% Similarity=0.357 Sum_probs=27.6
Q ss_pred CeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 208 ~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999998999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.063 Score=44.75 Aligned_cols=76 Identities=25% Similarity=0.287 Sum_probs=52.4
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
.+.+.-|.--..|.... ...++-+|.- .......|..|+.-|..|. --++.+++.+..+.++.|+||||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34455555555565544 4567888863 3344456777887776664 456788999999999999999999875
Q ss_pred CHH
Q 024537 168 SLD 170 (266)
Q Consensus 168 ~L~ 170 (266)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.089 Score=46.40 Aligned_cols=141 Identities=23% Similarity=0.359 Sum_probs=78.9
Q ss_pred eecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC------ceeEEeE----EeeCCcEEEEEe
Q 024537 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN------LVTLFGC----CAEGPEKMLVYE 162 (266)
Q Consensus 93 ~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~----~~~~~~~~lv~e 162 (266)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..|.-+.-.. +..+-|- ...+...+-+.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456788888766665 88888765 22345566777777663211 2222221 222236678899
Q ss_pred ccCCCCHHH-H--------------HhhcCCC---------CCcCHH----HH---------HHHHHHHHHHHHHHhhc-
Q 024537 163 YLPNKSLDY-F--------------IFDKTKS---------SSLDWT----TR---------YRIVMGVARGLLYLHEE- 204 (266)
Q Consensus 163 ~~~~~~L~~-~--------------l~~~~~~---------~~~~~~----~~---------~~i~~qi~~al~yLH~~- 204 (266)
|++|..+.. . ++....+ ....|. .. .....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998877762 1 0000000 011221 00 01122333344444432
Q ss_pred ---CC---CCeEeCCCCCCceEEcCCCC-eEEeccccccc
Q 024537 205 ---AP---ARIIHRDIKASNILLDEQLN-PKISDFGLARL 237 (266)
Q Consensus 205 ---~~---~~iiHrDlKp~Nill~~~~~-~kl~DFG~a~~ 237 (266)
-+ ..+||.|+-|.||+++.+.. +.++|||-|..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 11 22899999999999999874 89999998864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.062 Score=48.47 Aligned_cols=74 Identities=15% Similarity=0.204 Sum_probs=48.5
Q ss_pred cceecccCceEEEEEEec-CCCEEEEEeec----cc--ChhhHHHHHHHHHHHHhcC--CCC-ceeEEeEEeeCCcEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLS----VD--SRQGLREFTNEVKLLLKIQ--HKN-LVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~-~~~~vavK~~~----~~--~~~~~~~~~~E~~~l~~l~--H~n-Iv~l~~~~~~~~~~~lv 160 (266)
.+.||-|.-..||++... .++.|+||.-. .. -.-..++..-|...|+... -|. +.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 467999999999999864 35789999642 11 1223456667888887663 353 4445443 34556788
Q ss_pred EeccCC
Q 024537 161 YEYLPN 166 (266)
Q Consensus 161 ~e~~~~ 166 (266)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.17 Score=46.52 Aligned_cols=75 Identities=12% Similarity=0.155 Sum_probs=46.8
Q ss_pred ccceecccCceEEEEEEecC---------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCce-eEEeEEeeCCcEEE
Q 024537 90 DLNQLGHGGFGPVYRGLMPN---------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKML 159 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~l 159 (266)
.++.|..|-.-.+|++...+ ++.|.+++.-.....-. ....|..+++.+...+|. ++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 34667667788889887432 45788887755433222 234678787777654554 4555553 256
Q ss_pred EEeccCCCCH
Q 024537 160 VYEYLPNKSL 169 (266)
Q Consensus 160 v~e~~~~~~L 169 (266)
|.||++|..|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899987643
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.088 Score=44.63 Aligned_cols=78 Identities=18% Similarity=0.147 Sum_probs=54.1
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc-CCCCHH
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL-PNKSLD 170 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~-~~~~L~ 170 (266)
..+..|..+.|+.++..+|.+.++|+.........+ ......|+..+-...|++++.-. ..-.|++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E--~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHE--ARGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhh--hhHHhHhheeCCCCceeeecccc--ccchhhhhhccCCCchh
Confidence 345679999999999889999999987654322111 11225588888888899988763 3457888888 455676
Q ss_pred HHH
Q 024537 171 YFI 173 (266)
Q Consensus 171 ~~l 173 (266)
++.
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.023 Score=49.72 Aligned_cols=53 Identities=21% Similarity=0.287 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCC------------------CeEEeccccccc
Q 024537 185 TTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQL------------------NPKISDFGLARL 237 (266)
Q Consensus 185 ~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~------------------~~kl~DFG~a~~ 237 (266)
.-++.++.|++--.-.+.. .+....+|-||||+|||+-+.. .++|-||.+++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3455677777654323322 2234599999999999994332 267788888764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.0066 Score=55.51 Aligned_cols=74 Identities=24% Similarity=0.380 Sum_probs=59.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
.....++|+....+|.|+||+|+.+.. .++..+|||++.... .....+..+|..-+..+.|++|+++...|...
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 344557789999999999999999984 356689999987653 44456778899999999999999988887653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.23 Score=44.79 Aligned_cols=75 Identities=13% Similarity=0.287 Sum_probs=44.6
Q ss_pred cceecccCceEEEEEEecCC--CE-----EEEEeecccChhhHHHHHHHHHHHHhcCCCCce-eEEeEEeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNG--QE-----IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e 162 (266)
++.|..|-...+|++...++ .. |.++......... -.-..|+.+++.+...++. ++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 35565688899999875432 22 3333321111111 1224688899988755554 56666643 69999
Q ss_pred ccCCCCHH
Q 024537 163 YLPNKSLD 170 (266)
Q Consensus 163 ~~~~~~L~ 170 (266)
|++|..+.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.029 Score=49.37 Aligned_cols=51 Identities=27% Similarity=0.437 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHH--Hhhc-CCCCeEeCCCCCCceEEcCC------------------CCeEEecccccccC
Q 024537 186 TRYRIVMGVARGLLY--LHEE-APARIIHRDIKASNILLDEQ------------------LNPKISDFGLARLF 238 (266)
Q Consensus 186 ~~~~i~~qi~~al~y--LH~~-~~~~iiHrDlKp~Nill~~~------------------~~~kl~DFG~a~~~ 238 (266)
-++.++.|++ |-| +... +....+|-||||+|||+-+. -.++|-||.+++.-
T Consensus 276 YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3455666664 445 3222 23459999999999999432 23688899888653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 266 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-98
Identities = 81/174 (46%), Positives = 113/174 (64%), Gaps = 2/174 (1%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL-REFTNEVK 134
F LR LQVA++ FS+ N LG GGFG VY+G + +G +AVK+L + QG +F EV+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMG 193
++ H+NL+ L G C E++LVY Y+ N S+ + ++ +S LDW R RI +G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
ARGL YLH+ +IIHRD+KA+NILLDE+ + DFGLA+L +DTHV T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-95
Identities = 74/197 (37%), Positives = 107/197 (54%), Gaps = 15/197 (7%)
Query: 62 EDADGSGADSWNLFFDLRTLQVATNFFSD------LNQLGHGGFGPVYRGLMPNGQEIAV 115
E+ +D+ F L+ TN F + N++G GGFG VY+G + N +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 116 KKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY 171
KKL+ + + + ++F E+K++ K QH+NLV L G ++G + LVY Y+PN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 172 FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
+ + L W R +I G A G+ +LHE IHRDIK++NILLDE KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 232 FGLARLFP-GEDTHVNT 247
FGLAR T + +
Sbjct: 177 FGLARASEKFAQTVMTS 193
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-91
Identities = 73/200 (36%), Positives = 112/200 (56%), Gaps = 5/200 (2%)
Query: 50 SLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN 109
S + + + L L+ ATN F +GHG FG VY+G++ +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 110 GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169
G ++A+K+ + +S QG+ EF E++ L +H +LV+L G C E E +L+Y+Y+ N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 170 DYFIFDKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
++ + S+ W R I +G ARGL YLH A IIHRD+K+ NILLDE PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 229 ISDFGLARLFPGED-THVNT 247
I+DFG+++ D TH++T
Sbjct: 180 ITDFGISKKGTELDQTHLST 199
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-62
Identities = 54/199 (27%), Positives = 81/199 (40%), Gaps = 22/199 (11%)
Query: 60 SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
SG D L + L G FG V++ + +AVK
Sbjct: 3 HHHHHHSSGVD-----LGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFP 56
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVYEYLPNKSLDYFIFD 175
+ +Q + EV L ++H+N++ G G + L+ + SL F+
Sbjct: 57 IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113
Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA-------RIIHRDIKASNILLDEQLNPK 228
K++ + W I +ARGL YLHE+ P I HRDIK+ N+LL L
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 229 ISDFGLARLFPGEDTHVNT 247
I+DFGLA F + +T
Sbjct: 172 IADFGLALKFEAGKSAGDT 190
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-52
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 17/178 (9%)
Query: 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEV 133
+ + + L +G G +G VY+G + + + +AVK S +RQ +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NI 58
Query: 134 KLLLKIQHKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
+ ++H N+ E +LV EY PN SL ++ T DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 189 RIVMGVARGLLYLHEEAPAR------IIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
R+ V RGL YLH E P I HRD+ + N+L+ ISDFGL+ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-50
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 7/155 (4%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
+ DL ++G G FG V+R +G ++AVK L + + EF EV ++ +++H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N+V G + P +V EYL SL + LD R + VA+G+ YLH
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
P I+HR++K+ N+L+D++ K+ DFGL+RL
Sbjct: 155 NRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-48
Identities = 57/165 (34%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNEVKLLLKIQ 140
F++L +G GGFG VYR G E+AVK D Q + E KL ++
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N++ L G C + P LV E+ L+ + K + + +ARG+ Y
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNY 120
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP--------KISDFGLARL 237
LH+EA IIHRD+K+SNIL+ +++ KI+DFGLAR
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-47
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
+ ++ +G G FG V + +++A+K++ +S + F E++ L ++ H N+
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L+G C LV EY SL + + ++G+ YLH
Sbjct: 64 VKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 205 APARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDT 243
P +IHRD+K N+LL KI DFG A T
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-47
Identities = 47/172 (27%), Positives = 90/172 (52%), Gaps = 21/172 (12%)
Query: 88 FSDL---NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG-------LREFTNEVKLL 136
+++ Q+G GGFG V++G L+ + +A+K L + +G +EF EV ++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
+ H N+V L+G P +V E++P L + + DK + W+ + R+++ +A
Sbjct: 78 SNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIAL 133
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQ-----LNPKISDFGLARLFPGEDT 243
G+ Y+ + P I+HRD+++ NI L + K++DFGL++ +
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-47
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
F L +L G +++G G +I VK L V S + R+F E L H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 143 NLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
N++ + G C P L+ ++P SL + + + +D + + + +ARG+ +
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
LH P I + + ++++DE + +IS + F
Sbjct: 127 LHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-45
Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 9/176 (5%)
Query: 88 FSDL---NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
SDL LG G FG + G+ + +K+L + R F EVK++ ++H N
Sbjct: 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
++ G + + EY+ +L I K+ S W+ R +A G+ YLH
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
IIHRD+ + N L+ E N ++DFGLARL E T R
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-42
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 19/174 (10%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL--LLKIQHKNLVTLF 148
L +G G +G V+RG G+ +AVK S + + + E +L + ++H+N++
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 149 GCCAEGPEK----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
L+ Y SL ++ + ++LD + RIV+ +A GL +LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 205 APAR-----IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVV 253
I HRD+K+ NIL+ + I+D GLA + ++ V
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-41
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
+ ++G G FG VY+G +G ++AVK L+V + Q L+ F NEV +L K +H
Sbjct: 23 DGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N++ G P+ +V ++ SL + + + + I ARG+ YLH
Sbjct: 81 NILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH 137
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+ IIHRD+K++NI L E KI DFGLA
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 59 ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL 118
+S GSG + +Q+ + Q+G G +G V+ G G+++AVK
Sbjct: 17 QSQSSGSGSGLPLLVQRTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF 68
Query: 119 SVDSRQGLREFTNEVK--LLLKIQHKNLVTLFGCCAEG----PEKMLVYEYLPNKSLDYF 172
+ E + + ++H+N++ +G + L+ +Y N SL +
Sbjct: 69 F---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125
Query: 173 IFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR-----IIHRDIKASNILLDEQLNP 227
+ KS++LD + ++ GL +LH E + I HRD+K+ NIL+ +
Sbjct: 126 L----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181
Query: 228 KISDFGLARLFPGEDTHVNTFRISVV 253
I+D GLA F + V+ + V
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRV 207
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 14/178 (7%)
Query: 88 FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHK 142
F L +G G FG VY G +G E+A++ + + D+ L+ F EV + +H+
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N+V G C P ++ ++L + + LD +I + +G+ YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-WPPNM 259
+ I+H+D+K+ N+ D I+DFGL + ++ + W ++
Sbjct: 148 AKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 28/220 (12%)
Query: 48 KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL---NQLGHGGFGPVYR 104
+ + G + D SG+ S RT+ + +G G FG V+R
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTI------ARTIVLQESIGKGRFGEVWR 60
Query: 105 GLMPNGQEIAVKKLSVDSRQGLREFTNE--VKLLLKIQHKNLVTLFGCC----AEGPEKM 158
G G+E+AVK S + R + E + + ++H+N++ +
Sbjct: 61 GKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR-----IIHRD 213
LV +Y + SL ++ ++ ++ + A GL +LH E I HRD
Sbjct: 117 LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 214 IKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVV 253
+K+ NIL+ + I+D GLA ++ V
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 91 LNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
Q+G G FG V+ G + + +AVK +F E ++L + H N+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G C + +V E + F+ +T+ + L T ++V A G+ YL +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
IHRD+ A N L+ E+ KISDFG++R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 91 LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
++QLG G FG V G +AVK+L R+F E+++L + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
G + LV EYLP+ L F+ + + LD + + +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
R +HRD+ A NIL++ + + KI+DFGLA+L P +
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-34
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 68 GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDS 122
G+D F+ R L+ L QLG G FG V G+ +AVKKL +
Sbjct: 1 GSDPTQ--FEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 51
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSS 180
+ LR+F E+++L +QH N+V G C + L+ EYLP SL ++ +
Sbjct: 52 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKE 109
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
+D + + +G+ YL + R IHRD+ NIL++ + KI DFGL ++ P
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 241 ED 242
+
Sbjct: 167 DK 168
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-34
Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+ LG G FG VY+G +P G++ +A+K+L S + +E +E ++ + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
L G C L+ + +P L ++ + ++ + +A+G+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
R++HRD+ A N+L+ + KI+DFGLA+L E+ +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 91 LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
L QLG G FG V G+ +AVKKL + + LR+F E+++L +QH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
G C + L+ EYLP SL ++ + +D + + +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ R IHRD+ NIL++ + KI DFGL ++ P
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 91 LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+ LG G FG V G+++AVK L + + + E+++L + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 145 VTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
V G C E L+ E+LP+ SL ++ + ++ + + + + +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ +HRD+ A N+L++ + KI DFGL + +
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 93 QLGHGGFGPVYRGL--MPNGQEI--AVKKL---SVDSRQGLREFTNEVKLLLKIQHKNLV 145
+LG G FG V RG P+G+ + AVK L + + + +F EV + + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L+G P +V E P SL + + T R + VA G+ YL +
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
R IHRD+ A N+LL + KI DFGL R P D
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +G G FG V G G ++AVK + D+ + F E ++ +++H NLV L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 151 C-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
E +V EY+ SL ++ + +S L + + V + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
+HRD+ A N+L+ E K+SDFGL +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +G G FG V G G ++AVK + D+ + F E ++ +++H NLV L G
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 151 C-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
E +V EY+ SL ++ + +S L + + V + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
+HRD+ A N+L+ E K+SDFGL +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 93 QLGHGGFGPVYRG-LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+LG G FG V +G ++I A+K L + E E +++ ++ + +V L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G C MLV E L F+ K + + ++ V+ G+ YL E+
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HRD+ A N+LL + KISDFGL++ +D
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-32
Identities = 41/163 (25%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNL 144
+ LG G FG VY+G +P G+++ A+K+L + + +E +E ++ + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
L G C L+ + +P L ++ + ++ + +A+G+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
R++HRD+ A N+L+ + KI+DFGLA+L E+ +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-32
Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 91 LNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+ LG G FG V G+ +AVK L D Q + E+ +L + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 145 VTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
+ GCC + LV EY+P SL ++ S+ + G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ IHRD+ A N+LLD KI DFGLA+ P
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-32
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+ ++G G FG V+ G N ++A+K + + +F E ++++K+ H LV L+G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C E LV E++ + L ++ +T+ T + + V G+ YL E +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD+ A N L+ E K+SDFG+ R +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+ +LG G FG V+ G ++AVK L S F E L+ ++QH+ LV L+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+ P ++ EY+ N SL F+ L + +A G+ ++ E I
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD++A+NIL+ + L+ KI+DFGLARL +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 92 NQLGHGGFGPVYRG-LMPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLV 145
LG G FG V++G +P G+ I +K + S RQ + T+ + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G C LV +YLP SL + + +L + +A+G+ YL E
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
++HR++ A N+LL +++DFG+A L P +D +
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +LG G FG V G ++AVK + S EF E + ++K+ H LV +G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C++ +V EY+ N L ++ ++ L+ + + V G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD+ A N L+D L K+SDFG+ R +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+LG G FG V+ ++AVK + S + F E ++ +QH LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+ P ++ E++ SL F+ + S +A G+ ++ + I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD++A+NIL+ L KI+DFGLAR+ +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
L +LG G FG V G ++A+K + S EF E K+++ + H+ LV L+G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
C + ++ EY+ N L ++ + + V + YL + + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD+ A N L+++Q K+SDFGL+R ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 6e-31
Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 91 LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
LG G FG VY G+ G++I AVK D + +F +E ++ + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G E P ++ E P L +++ + +SL T + + + + YL
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HRDI NIL+ K+ DFGL+R ED
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 91 LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G G V G +P +++ A+K L + + R+F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G G M+V EY+ N SLD F+ +T ++ GV G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HRD+ A N+L+D L K+SDFGL+R+ +
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-31
Identities = 41/157 (26%), Positives = 66/157 (42%), Gaps = 11/157 (7%)
Query: 91 LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G FG V++G+ P + A+K S +F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G E P ++ E L F+ + + SLD + ++ L YL +
Sbjct: 80 KLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
R +HRDI A N+L+ K+ DFGL+R
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
++LG G +G VY G +AVK L D+ + + EF E ++ +I+H NLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
C P ++ E++ +L ++ + + + + ++ + YL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
IHR++ A N L+ E K++DFGL+RL G+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 21/170 (12%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
+LG G FG V+ L+P ++ AVK L S ++F E +LL +QH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYF------------IFDKTKSSSLDWTTRYRIVM 192
V FG C EG ++V+EY+ + L+ F + L +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
VA G++YL +HRD+ N L+ + L KI DFG++R D
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
+LG G FG V+ L P ++ AVK L + ++F E +LL +QH+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIV 191
V +G C +G ++V+EY+ + L+ F + L + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+A G++YL + +HRD+ N L+ L KI DFG++R
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 21/168 (12%)
Query: 91 LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK 142
LG G F +++G+ + E+ +K L R F ++ K+ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
+LV +G C G E +LV E++ SLD ++ K + ++ + + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 203 EEAPARIIHRDIKASNILLDEQLNP--------KISDFGLARLFPGED 242
E +IH ++ A NILL + + K+SD G++ +D
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+LG G FG V+ G +A+K L + F E +++ K++H+ LV L+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+E P +V EY+ SL F L + +A G+ Y+ +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD++A+NIL+ E L K++DFGLARL +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 91 LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G FG V G +P+ +EI A+K L V + + R+F E ++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G + M+V EY+ N SLD F+ + + ++ G+A G+ YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+HRD+ A NIL++ L K+SDFGL R+
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 93 QLGHGGFGPVYRGLMPNG---QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
+LG G FG V +G + +AVK L + E E ++ ++ + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
G C MLV E L+ ++ ++ + +V V+ G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--- 136
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+HRD+ A N+LL Q KISDFGL++ ++ +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+LG G FG V+ G +A+K L + F E +++ K++H+ LV L+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+E P +V EY+ SL F L + +A G+ Y+ +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED 242
HRD++A+NIL+ E L K++DFGLARL +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 38/160 (23%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
+LG G FG VY G ++ + E A+K ++ S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------IFDKTKSSSLDWTTRYRIVMGVAR 196
+V L G ++G +++ E + L + + + + + ++ +A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
G+ YL+ + +HRD+ A N ++ E KI DFG+ R
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-30
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
++LG G +G VY G+ + AVK L D+ + + EF E ++ +I+H NLV L
Sbjct: 18 KHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G C P ++ E++ +L ++ + + + ++ + YL ++
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
IHRD+ A N L+ E K++DFGL+RL G+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-30
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 91 LNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G FG VY G + +G++I AVK L+ + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 146 TLFGCCAEG-PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+L G C ++V Y+ + L FI + ++ + + VA+G+ YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ +HRD+ A N +LDE+ K++DFGLAR
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
+ +LG FG VY+G P Q A+K L EF +E L ++QH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRI 190
+V L G + +++ Y + L F D+T S+L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
V +A G+ YL ++H+D+ N+L+ ++LN KISD GL R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 93 QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+LG G FG V +G+ M Q ++A+K L + E E +++ ++ + +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G C MLV E L F+ K + + ++ V+ G+ YL E+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HR++ A N+LL + KISDFGL++ +D
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQE----IAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
LG G FG V G + +AVK + +D S++ + EF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 145 VTLFGCCAEG-----PEKMLVYEYLPNKSLDYFI---FDKTKSSSLDWTTRYRIVMGVAR 196
+ L G C E P+ M++ ++ L ++ +T + T + ++ +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
G+ YL +HRD+ A N +L + + ++DFGL++
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 5/158 (3%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
LG G +G VY G + N IA+K++ + + E+ L ++HKN+V G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
E + E +P SL + K + T + GL YLH+ +I+HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 213 DIKASNILLDEQL-NPKISDFGLARLFPGEDTHVNTFR 249
DIK N+L++ KISDFG ++ G + TF
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 94 LGHGGFGPVYRGLMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+G G FG VY G + + A+K LS Q + F E L+ + H N++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 149 GCCAEG-PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
G ++ Y+ + L FI ++ + + VARG+ YL E+
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQ--- 143
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237
+ +HRD+ A N +LDE K++DFGLAR
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 94 LGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
+G G FG V++G+ P + A+K S +F E + + H ++V L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
G E P ++ E L F+ + + SLD + ++ L YL + R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+HRDI A N+L+ K+ DFGL+R
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 18/161 (11%)
Query: 91 LNQLGHGGFGPVYRGLMPNG----QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
LG G FG V + ++AVK L D + + EF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 145 VTLFGCCAEG------PEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYRIVMGVA 195
L G P M++ ++ + L F+ +L T R ++ +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
G+ YL IHRD+ A N +L E + ++DFGL+R
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 45/153 (29%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 91 LNQLGHGGFGPVYRGL--MPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
+G G FG VY+G+ +G++ +A+K L + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ L G ++ M++ EY+ N +LD F+ + K ++ G+A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARL 237
+HRD+ A NIL++ L K+SDFGL+R+
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 92 NQLGHGGFGPVYRG-LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVT 146
+ +G G FG V + + +G + A+K++ S+ R+F E+++L K+ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIVMG 193
L G C L EY P+ +L F + +S+L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VARG+ YL ++ + IHRD+ A NIL+ E KI+DFGL+R
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-29
Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 13/153 (8%)
Query: 91 LNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
+G G FG VY G + +G++I AVK L+ + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 146 TLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+L G C +EG ++V Y+ + L FI + ++ + + VA+G+ +L
Sbjct: 154 SLLGICLRSEGS-PLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ + +HRD+ A N +LDE+ K++DFGLAR
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 49/160 (30%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 91 LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
+ LGHG FG VY G + ++AVK L S Q +F E ++ K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI----FDKTKSSSLDWTTRYRIVMGVARGLL 199
+V G + + ++ E + L F+ ++ SSL + +A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 200 YLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLAR 236
YL E IHRDI A N LL KI DFG+AR
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 91 LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
LG G FG V + + +AVK L + S LR+ +E +L ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL---------------------DYFIFDKTKSSSL 182
++ L+G C++ +L+ EY SL + D +L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+++G+ YL A +++HRD+ A NIL+ E KISDFGL+R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
++ ++G G G VY + + GQE+A++++++ + NE+ ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V G E +V EYL SL D + +D + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
++IHRDIK+ NILL + K++DFG
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 49/160 (30%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 91 LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
+ LGHG FG VY G + ++AVK L S Q +F E ++ K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI----FDKTKSSSLDWTTRYRIVMGVARGLL 199
+V G + + ++ E + L F+ ++ SSL + +A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 200 YLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLAR 236
YL E IHRDI A N LL KI DFG+AR
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 91 LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
LG G FG V +AVK L D + + L + +E++++ I +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTR 187
HKN++ L G C + ++ EY +L +Y + ++ + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ARG+ YL A + IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 39/188 (20%), Positives = 71/188 (37%), Gaps = 17/188 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
F + LG GGFG V+ + A+K++ + +R+ RE EVK L K++H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 146 TLFGCCAEGPEKM------------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
F E + + ++L ++ + + + I +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVV 253
+A + +LH + ++HRD+K SNI K+ DFGL ++
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 254 TWPPNMHC 261
Sbjct: 184 YARHTGQV 191
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 48/174 (27%), Positives = 72/174 (41%), Gaps = 31/174 (17%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
+ +G G FG V++ L+P AVK L + S +F E L+ + + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF---------------------IFDKTKSSSL 182
+V L G CA G L++EY+ L+ F L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ I VA G+ YL E + +HRD+ N L+ E + KI+DFGL+R
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 26/169 (15%)
Query: 91 LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
LG G FG V +AVK L D + + L + +E++++ I +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTR 187
HKN++ L G C + ++ EY +L +Y + ++ + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ARG+ YL + + IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-28
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 12/160 (7%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
++G G F VY+GL E+A +L ++ + F E ++L +QH N+V +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 150 CCAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+ LV E + + +L ++ + + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 206 PARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGEDTH 244
P IIHRD+K NI + + KI D GLA L
Sbjct: 150 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
+ + +LG G FG VY+ G A K + S + L ++ E+++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L G + ++ E+ P ++D + L + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ RIIHRD+KA N+L+ + + +++DFG++
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 9/163 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLV 145
F+ L ++G G FG V++G+ + +A+K + ++ + + + E+ +L + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G + + ++ EYL S D + LD T I+ + +GL YLH E
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ IHRDIKA+N+LL E K++DFG+A NTF
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 50/168 (29%), Positives = 70/168 (41%), Gaps = 25/168 (14%)
Query: 91 LNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
LG G FG V + +AVK L + R +E+K+L+ I H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 143 NLVTLFGCC-AEGPEKMLVYEYLPNKSL-----------DYFIFDKTKSSSLDWTTRYRI 190
N+V L G C G M++ E+ +L + T + I
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 191 VMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VA+G+ +L A + IHRD+ A NILL E+ KI DFGLAR
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
++G G G V +G+++AVK + + +Q NEV ++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V ++ G E ++ E+L +L D L+ + V + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ +IHRDIK+ +ILL K+SDFG
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 22/165 (13%)
Query: 91 LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
LG G FG V ++AVK L +E+K++ + QH+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-----------DYFIFDKTKSSSLDWTTRYRIV 191
N+V L G C G +++ EY L + +S+
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
VA+G+ +L A IHRD+ A N+LL KI DFGLAR
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 9/170 (5%)
Query: 73 NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN 131
NL+F + + + + +LG GGF V + +G A+K++ +Q E
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR 75
Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKM----LVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
E + H N++ L C L+ + +L + K K + L
Sbjct: 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+++G+ RGL +H + HRD+K +NILL ++ P + D G
Sbjct: 136 ILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 48/169 (28%), Positives = 65/169 (38%), Gaps = 26/169 (15%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
LG G FG V L+ + + AVK L +E+K+L + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYR 189
N+V L G C G +++ EY L F + L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ VA+G+ +L A IHRD+ A NILL KI DFGLAR
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L +LG G +G VY+ + GQ +A+K++ V+S L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V +G + + +V EY S+ I + ++ +L I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
R IHRDIKA NILL+ + + K++DFG+A NT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 12/185 (6%)
Query: 65 DGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR- 123
SG D +++ V +S L Q+G GG V++ L Q A+K ++++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66
Query: 124 -QGLREFTNEVKLLLKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS 180
Q L + NE+ L K+Q + + L+ +V E N L+ ++ K
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-- 123
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
+D R + + +H+ I+H D+K +N L+ + K+ DFG+A
Sbjct: 124 -IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 241 EDTHV 245
+ T V
Sbjct: 179 DTTSV 183
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 16/185 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
F ++ LG G FG V + + + A+KK+ + L +EV LL + H+ +V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI---------FD--KTKSSSLDWTTRYRIVMGVA 195
+ E + + KS + +D +++ + +R+ +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTW 255
L Y+H + IIHRD+K NI +DE N KI DFGLA+ + ++
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 256 PPNMH 260
N+
Sbjct: 184 SDNLT 188
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 44/172 (25%), Positives = 68/172 (39%), Gaps = 14/172 (8%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
++ + ++G G FG V+R G + AVKK+ ++ + E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L+G EGP + E L SL I + L + GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 204 EAPARIIHRDIKASNILLDEQLNP-KISDFGLA-RLFPGEDTHVNTFRISVV 253
RI+H D+KA N+LL + + DFG A L P +
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 12/171 (7%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLL 136
+ V +S L Q+G GG V++ L Q A+K ++++ Q L + NE+ L
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 137 LKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
K+Q + + L+ +V E N L+ ++ K +D R +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNM 117
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
+ +H+ I+H D+K +N L+ + K+ DFG+A + T V
Sbjct: 118 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 164
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 10/167 (5%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
+T+++ L GGF VY + +G+E A+K+L + + R EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 138 KIQ-HKNLVTLFGCCAEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
K+ H N+V + G E+ L+ L L F+ L T +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
I R + ++H + P IIHRD+K N+LL Q K+ DFG A
Sbjct: 141 IFYQTCRAVQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSAT 186
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 53/152 (34%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHKN 143
FSDL ++GHG FG VY + N + +A+KK+S +Q ++ EV+ L K++H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ GC LV EY + D + L + G +GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+IHRD+KA NILL E K+ DFG A
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 7/161 (4%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
L ++G G FG +G++ +K++++ S + E EV +L ++H N+V
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
E +V +Y L I + K + + L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR--- 144
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+I+HRDIK+ NI L + ++ DFG+AR+
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 8/163 (4%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVT 146
++G G F VYR + +G +A+KK+ + + + E+ LL ++ H N++
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+ E E +V E L I K + + T ++ + + L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
R++HRDIK +N+ + K+ D GL R F + T ++
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
F ++ +G GGFG V++ +G+ +K++ ++ + RE VK L K+ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 147 LFGCCAEGPEKM----------------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
GC + E+ +L+ +I +K + LD +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+ +G+ Y+H + ++I+RD+K SNI L + KI DFGL +
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLV 145
+ +G G V P +++A+K+++++ Q + E E++ + + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
+ + E LV + L S+ + KS LD +T I+ V GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGL-ARLFPGEDTHVNTFRISVV 253
LH+ IHRD+KA NILL E + +I+DFG+ A L G D N R + V
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 43/174 (24%), Positives = 65/174 (37%), Gaps = 31/174 (17%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
LG G FG V + G I AVK L +E+K++ ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL------------------DYFIFDKTKSSSLDW 184
N+V L G C L++EY L + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 185 TTRYRIVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
T + VA+G+ +L +HRD+ A N+L+ KI DFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 26/169 (15%)
Query: 91 LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
LG G FG V ++AVK L D + + L + +E++++ I +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY----------FIFDKTKSSSLDWTTRYR 189
HKN++ L G C + ++ EY +L +Y + ++ + + +++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ VARG+ YL A + IHRD+ A N+L+ E KI+DFGLAR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 12/171 (7%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLL 136
+ V +S L Q+G GG V++ L Q A+K ++++ Q L + NE+ L
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 137 LKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
K+Q + + L+ +V E N L+ ++ K +D R +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNM 164
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
+ +H+ I+H D+K +N L+ + K+ DFG+A + T V
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-26
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 12/175 (6%)
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
+ + + + LG G V+RG G A+K + S + E ++L K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 140 QHKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
HKN+V LF E + L+ E+ P SL + + + + L + ++ V G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 198 LLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTF 248
+ +L E I+HR+IK NI+ D Q K++DFG AR +D +
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSL 175
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 53/181 (29%), Positives = 91/181 (50%), Gaps = 21/181 (11%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQH 141
F L +LG+G + VY+GL G +A+K++ +DS +G +RE + L+ +++H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
+N+V L+ + LV+E++ N K L+ + +GL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--P 256
+ HE +I+HRD+K N+L++++ K+ DFGLAR F G + + VVT W
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSE--VVTLWYRA 176
Query: 257 P 257
P
Sbjct: 177 P 177
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 26/182 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
F + ++G G +G VY+ G+ +A+KK+ +D+ +RE + LL ++
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELN 60
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
H N+V L + LV+E+L K D + + + + + +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGL 116
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W-- 255
+ H R++HRD+K N+L++ + K++DFGLAR F V T+ VVT W
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYR 170
Query: 256 PP 257
P
Sbjct: 171 AP 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQH 141
+ L ++G G +G VY+ G+ +A+K++ +D+ +RE + LL ++ H
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHH 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
N+V+L LV+E++ K L + + L + + + RG+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
H+ RI+HRD+K N+L++ K++DFGLAR F V ++ VVT W P
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAP 188
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVK 134
DL L+ F + +G+G +G VY+G + GQ A+K + V E E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72
Query: 135 LLLKI-QHKNLVTLFGC------CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
+L K H+N+ T +G + LV E+ S+ D + TK ++L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEW 130
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
I + RGL +LH+ ++IHRDIK N+LL E K+ DFG++ N
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 247 TF 248
TF
Sbjct: 188 TF 189
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 12/175 (6%)
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
+ + + + LG G V+RG G A+K + S + E ++L K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 140 QHKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
HKN+V LF E + L+ E+ P SL + + + + L + ++ V G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 198 LLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTF 248
+ +L E I+HR+IK NI+ D Q K++DFG AR +D +
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSL 175
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK 138
+T + +++ +G+G FG V++ + E+A+KK+ D R R E++++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRI 88
Query: 139 IQHKNLVTLFGCCAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYR 189
++H N+V L +K LV EY+P ++ ++ K L +
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIKLY 146
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGE 241
+ + R L Y+H I HRDIK N+LLD K+ DFG A+ L GE
Sbjct: 147 MYQ-LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 57/182 (31%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQH 141
+ L+ LG G F VY+ Q +A+KK+ + R ++ N E+KLL ++ H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
N++ L LV++++ L+ I K S L + ++ +GL YL
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGED-THVNTFRISVVT-W-- 255
H+ I+HRD+K +N+LLDE K++DFGLA+ F P TH VVT W
Sbjct: 129 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ------VVTRWYR 179
Query: 256 PP 257
P
Sbjct: 180 AP 181
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-24
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQH 141
+ L ++G G +G VY+ G+ A+KK+ ++ +RE + +L +++H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKH 59
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
N+V L+ +LV+E+L + L + L+ T ++ + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
H+ R++HRD+K N+L++ + KI+DFGLAR F V + +VT W P
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAP 169
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 22/179 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQH 141
+ L++LG G + VY+G +A+K++ ++ +G +RE V LL ++H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
N+VTL LV+EYL +K L ++ + ++ + + RGL Y
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
H +++HRD+K N+L++E+ K++DFGLAR T VVT W PP
Sbjct: 117 HR---QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNE--VVTLWYRPP 169
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 22/166 (13%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++D +G+G FG VY+ L +G+ +A+KK+ D R RE ++++ K+ H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 111
Query: 147 LFGCCAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
L EK LV +Y+P + ++ K + + + R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP--VIYVKLYMYQ-LFRS 168
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGE 241
L Y+H I HRDIK N+LLD K+ DFG A+ L GE
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-24
Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 16/162 (9%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGF + + A K K + + + E+ + + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVARGLLYLHEEAP 206
E + + +V E +SL + K + RY + + G YLH
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
R+IHRD+K N+ L+E L KI DFGLA +
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-24
Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
+ L ++G G +G V++ + +A+K++ +D LRE + LL +++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 59
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
HKN+V L + LV+E+ + L + + + LD + + +GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
H ++HRD+K N+L++ K+++FGLAR F G + VVT W PP
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAE--VVTLWYRPP 170
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 5e-24
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 19/175 (10%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
+ + ++G G +G V++ GQ +A+KK + + E+++L +++H NL
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L LV+EY + L + I + + + H+
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK- 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED---THVNTFRISVVT-W 255
IHRD+K NIL+ + K+ DFG ARL G V T W
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD------EVATRW 167
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-24
Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 9/177 (5%)
Query: 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTN 131
L + ++ + F +++LG G G V++ P+G +A K + ++ + +
Sbjct: 21 LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
E+++L + +V +G E + E++ SLD + K+ + ++
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 137
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ V +GL YL E+ +I+HRD+K SNIL++ + K+ DFG++ D+ N+F
Sbjct: 138 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF 190
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-24
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 8/166 (4%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
L +G G +G + +G+ + K+L + + +EV LL +++H N+V
Sbjct: 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHE- 203
+ + L V EY L I + LD R++ + L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 204 -EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ ++HRD+K +N+ LD + N K+ DFGLAR+ + + TF
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-24
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 8/160 (5%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLL 136
+ DL ++G G +G V + + P+GQ +AVK++ + ++ ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 137 LK-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMG 193
++ +V +G + + E + + S D F +I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
+ L +L E +IIHRDIK SNILLD N K+ DFG
Sbjct: 134 TVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 9e-24
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
LG GGFG V R + G+++A+K+ + RE + E++++ K+ H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EV 80
Query: 152 AEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+G +K+ L EY L ++ L ++ ++ L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 205 APARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTF 248
RIIHRD+K NI+L ++L KI D G A+ + F
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF 183
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-24
Identities = 40/162 (24%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 80 TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLL 137
+++V + + +LG G +G V + +P+GQ +AVK++ Q + ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 138 K-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMG 193
+ + VT +G + + E + + SLD F + DK ++ D + I +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ + L +LH + +IHRD+K SN+L++ K+ DFG++
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 1e-23
Identities = 30/165 (18%), Positives = 61/165 (36%), Gaps = 11/165 (6%)
Query: 77 DLRTLQVATNFFSDLNQLGHG--GFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN 131
+ + + L +G G V P G+ + V++++++ S + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRI 190
E+ + H N+V E +V ++ S D + ++ I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYI 133
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ GV + L Y+H +HR +KAS+IL+ +S
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-23
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG GGF + + A K K + + + E+ + + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVARGLLYLHEEAP 206
E + + +V E +SL + K + RY + + G YLH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN-- 134
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA 235
R+IHRD+K N+ L+E L KI DFGLA
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 8/175 (4%)
Query: 64 ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS 122
+ SG + L + Q N +L ++G G G V++ G IAVK++
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 123 -RQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS 180
++ + ++ ++LK +V FG + + E + + K
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQG 119
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
+ ++ + + + L YL E+ +IHRD+K SNILLDE+ K+ DFG++
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
+ +L +G G +G V + G+ +A+KK + + E+KLL +++H+NL
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L C + LV+E++ + LD + + LD+ + + + G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS- 142
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT-W--PP 257
IIHRDIK NIL+ + K+ DFG AR + V T W P
Sbjct: 143 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYDDEVATRWYRAP 193
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-23
Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 20/231 (8%)
Query: 22 HHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTL 81
HH+H+H+ VD + ++ + A E+ + + + F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS--- 58
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLK 138
F L++LGHG +G V++ +G+ AVK+ R + EV K
Sbjct: 59 ------FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 139 I-QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
+ QH V L EG L E SL + +SL + +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLA 169
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
L +LH + ++H D+K +NI L + K+ DFGL G
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQ 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-23
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G F VYR + G E+A+K K ++ ++ NEVK+ +++H +++ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
+ LV E N ++ ++ ++ K S + R + + G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLYLHSH---GI 133
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+HRD+ SN+LL +N KI+DFGLA T
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-23
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 30/189 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQ- 140
+ + ++G G +G VY+ +G +A+K + V + G EV LL +++
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 141 --HKNLVTLFGCCAEGPEK-----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
H N+V L CA LV+E++ ++ L ++ DK L T ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQ 128
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFRIS 251
RGL +LH I+HRD+K NIL+ K++DFGLAR++ T V
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV------ 179
Query: 252 VVT-W--PP 257
VVT W P
Sbjct: 180 VVTLWYRAP 188
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-23
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
F G G FG V G G +A+KK+ D R RE ++ L + H N+V
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQ 83
Query: 147 LFGC-CAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
L G +V EY+P ++ + + + + + R
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP--PILIKVFLFQ-LIR 140
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLAR-LFPGED 242
+ LH + + HRDIK N+L++E L K+ DFG A+ L P E
Sbjct: 141 SIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEP 187
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 35/188 (18%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
+ + +LG G +G VY+ + + +A+K++ ++ + +RE V LL ++Q
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQ 91
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
H+N++ L L++EY N K +D K+ + + + G
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSFLYQLING 144
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-----KISDFGLARLFPGEDTHVNTFRISV 252
+ + H R +HRD+K N+LL KI DFGLAR F + F +
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQFTHEI 198
Query: 253 VT-W--PP 257
+T W PP
Sbjct: 199 ITLWYRPP 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 36/191 (18%)
Query: 88 FSDLNQLGHGGFGPVYRG--LMPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKI 139
+ + ++G G +G V++ L G+ +A+K++ V + + +RE V +L +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHL 68
Query: 140 Q---HKNLVTLFGCCAEGPEK-----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
+ H N+V LF C LV+E++ ++ L ++ DK + T ++
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFR 249
+ RGL +LH R++HRD+K NIL+ K++DFGLAR++ T V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---- 179
Query: 250 ISVVT-W--PP 257
VVT W P
Sbjct: 180 --VVTLWYRAP 188
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG VY + +A+K K ++ + EV++ ++H N++ L+G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ L+ EY P ++ + + K S D + +A L Y H + R
Sbjct: 77 YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+IHRDIK N+LL KI+DFG + P
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTN--EVKLLLKIQHKN 143
+ L ++G G FG V++ GQ++A+KK+ +++ ++G T E+K+L ++H+N
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHEN 77
Query: 144 LVTLFGCCAEGPEKM--------LVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVM 192
+V L C LV+++ + L + R++
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQ 131
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRIS 251
+ GL Y+H +I+HRD+KA+N+L+ K++DFGLAR F +++ N +
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 252 VVT-W--PP 257
VVT W PP
Sbjct: 189 VVTLWYRPP 197
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 17/158 (10%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
LGHG G + M + +++AVK++ + EV+LL + +H N++ F C
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYF-CT 86
Query: 152 AEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
+ + + E +Y L+ ++ GL +LH I+
Sbjct: 87 EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS---LNIV 140
Query: 211 HRDIKASNILLDEQ-----LNPKISDFGLARLFPGEDT 243
HRD+K NIL+ + ISDFGL +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-21
Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 27/184 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKK--LSVDSRQGLREFTNEVKLLLKI-QHKN 143
F +L ++G G FG V++ + +G A+K+ + + EV + QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLH 202
+V F AE ++ EY SL I + + S +++ V RGL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 203 EEAPARIIHRDIKASNILLDE-------------------QLNPKISDFGLARLFPGEDT 243
++H DIK SNI + ++ KI D G
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 244 HVNT 247
Sbjct: 190 EEGD 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-21
Identities = 40/177 (22%), Positives = 68/177 (38%), Gaps = 33/177 (18%)
Query: 94 LGHGGFGPVYRGLMPNGQEIAVKKLS-----------------VDSRQGLREFTNEVKLL 136
L G F + + + A+KK + + +F NE++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVA 195
I+++ +T G E ++YEY+ N S+ LD I + V
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153
Query: 196 R--------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+ Y+H E I HRD+K SNIL+D+ K+SDFG + +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-21
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 94 LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG VY N +A+K K ++ + E+++ ++H N++ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
+ L+ E+ P L + + K D + +A L Y HE +
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCHER---K 134
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+IHRDIK N+L+ + KI+DFG + P
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 42/184 (22%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 93 QLGHGGFGPVYRG---LMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
++G G +G VY+ + ++ A+K++ S RE + LL +++H N+++L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 83
Query: 148 FGCCAEGPEK--MLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLLY 200
++ L+++Y + + + K + ++ + G+ Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISVVT-W 255
LH ++HRD+K +NIL+ + KI+D G ARLF + VVT W
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 256 --PP 257
P
Sbjct: 201 YRAP 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-20
Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 27/182 (14%)
Query: 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNL 144
N LG+G G V G+ +AVK++ +D E+KLL + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71
Query: 145 VTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTR----YRIVMGVARGLL 199
+ + C + + E N +L + K S + ++ +A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 200 YLHEEAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVN 246
+LH +IIHRD+K NIL+ E L ISDFGL + +
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 247 TF 248
T
Sbjct: 187 TN 188
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 50/165 (30%), Positives = 71/165 (43%), Gaps = 25/165 (15%)
Query: 92 NQLGHGGFGPVYRGLM-PNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
LG G FG V GQE AVK K V + EV+LL ++ H N++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYL 201
+ + LV E L FD+ S R+ RI+ V G+ Y+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGEL----FDEIISRK-----RFSEVDAARIIRQVLSGITYM 142
Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDT 243
H+ +I+HRD+K N+LL + N +I DFGL+ F
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 20/157 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
LG G +G V L AVK L G E++LL +++HKN++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 149 G-CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLD-WTTRY---RIVMGVARGLLYLH 202
E +KM +V EY + + D +++ G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
+ I+H+DIK N+LL KIS G+A
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 44/203 (21%), Positives = 74/203 (36%), Gaps = 48/203 (23%)
Query: 81 LQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
L+ ++ +S LG G FG V + +G+ A+KK+ D R RE + ++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVL 57
Query: 140 QHKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW------------ 184
H N++ L F + K NK S+
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 185 ----TTRYRIVMGVA-------------------RGLLYLHEEAPARIIHRDIKASNILL 221
T ++++ R + ++H I HRDIK N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 222 DEQLNP-KISDFGLAR-LFPGED 242
+ + N K+ DFG A+ L P E
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEP 197
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 6e-19
Identities = 41/197 (20%), Positives = 76/197 (38%), Gaps = 51/197 (25%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ + +G G +G V + +A+KK+ +D ++ LRE + +L ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110
Query: 141 HKNLVTLFG-CCAEGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKSSS 181
H ++V + + EK +V E L +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-------- 162
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
Y ++ G+ Y+H A I+HRD+K +N L+++ + K+ DFGLAR
Sbjct: 163 ------YNLL----VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 242 DTHVNTFRISVVTWPPN 258
+ + IS N
Sbjct: 210 ENGNSQLPISPREDDMN 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 7e-19
Identities = 43/200 (21%), Positives = 80/200 (40%), Gaps = 18/200 (9%)
Query: 52 RGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFGPVYRGL- 106
+ R G + + D D W ++ + +++ + D +LG G FG V+R
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178
Query: 107 MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
G A K + E++ + ++H LV L + E +++YE++
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 167 KSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224
L F+K + + V +GL ++HE +H D+K NI+ +
Sbjct: 239 GEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTK 291
Query: 225 LNP--KISDFGLARLF-PGE 241
+ K+ DFGL P +
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 7e-19
Identities = 34/151 (22%), Positives = 60/151 (39%), Gaps = 17/151 (11%)
Query: 94 LGHGGFGPVYRG--LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTL--F 148
+ HGG G +Y NG+ + +K L + E + L ++ H ++V + F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 149 GCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+ + Y EY+ +SL K L ++ + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS-- 200
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+++ D+K NI+L E+ K+ D G
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-19
Identities = 33/187 (17%), Positives = 55/187 (29%), Gaps = 25/187 (13%)
Query: 79 RTLQVATNFFSDLNQLGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGLREFTNE 132
Q+ + + LG G F VY N Q+ +K + T
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRI 190
++ L + + +LV E +L I + T +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-----------KISDFGLA---R 236
M + + +H+ IIH DIK N +L + D G + +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 237 LFPGEDT 243
LFP
Sbjct: 235 LFPKGTI 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 50/193 (25%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-----VDSRQGLREFTNEVKLLLKIQH 141
+++L+ +G G +G V N +A+KK+S ++ LRE +K+LL+ +H
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84
Query: 142 KNLVTLFGC-CAEGPEKM----LVYEY-------------LPNKSLDYFIFDKTKSSSLD 183
+N++ + A E+M +V + L N + YF+
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL---------- 134
Query: 184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
Y+I+ RGL Y+H A ++HRD+K SN+LL+ + KI DFGLAR+ +
Sbjct: 135 ----YQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 244 HVNTFRISVVT-W 255
H V T W
Sbjct: 184 HTGFLTEYVATRW 196
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 36/154 (23%), Positives = 61/154 (39%), Gaps = 11/154 (7%)
Query: 93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
+G G +G V + A KK+ + + F E++++ + H N++ L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
+ + LV E L + K D + V+ + Y H+ + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCHKL---NVAH 129
Query: 212 RDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
RD+K N L K+ DFGLA F PG+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-18
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 19/159 (11%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G F V R + G E A K KLS Q L E ++ K+QH N+V
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L E LV++ + L I + S D + + ++ + Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSN-- 124
Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
I+HR++K N+LL + K++DFGLA E
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK--------KLSVDSRQGLRE-FTNEVKLLLKI-QH 141
LG G V R + P +E AVK S + Q LRE EV +L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
N++ L LV++ + L DY + +K S + R ++ V +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSEKETRKIMRALLEV---ICA 139
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
LH+ I+HRD+K NILLD+ +N K++DFG + +
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE---FTNEVKLLLKIQHKN 143
LG G G V +++A++ K ++ S + E+++L K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH 202
++ + + + +V E + L FDK + L T + + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 203 EEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTF 248
E IIHRD+K N+LL +E KI+DFG +++ GE + + T
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL 301
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVT 146
+++LG GG VY ++A+K + + + L+ F EV ++ H+N+V+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+ E LV EY+ +L +I L T + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD--- 129
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR 236
RI+HRDIK NIL+D KI DFG+A+
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 31/248 (12%)
Query: 18 NHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLF-- 75
+H HHH+ +L + + + ++ ++ + +A+ + S
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62
Query: 76 ----------FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLM-PNGQEIAVKKL 118
FD R + + LG G FG V++ G ++A K +
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 119 SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
+ E NE+ ++ ++ H NL+ L+ + +LV EY+ L FD+
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRII 178
Query: 179 SSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFGL 234
S + T + + G+ ++H+ I+H D+K NIL + KI DFGL
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 235 ARLF-PGE 241
AR + P E
Sbjct: 236 ARRYKPRE 243
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 40/196 (20%), Positives = 75/196 (38%), Gaps = 51/196 (26%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ + +G G +G VY + +A+KK++ +D ++ LRE + +L +++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNRLK 83
Query: 141 HKNLVTLFG-CCAEGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKSSS 181
++ L+ + K +V E L +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-------- 135
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
Y ++ G ++HE + IIHRD+K +N LL++ + K+ DFGLAR E
Sbjct: 136 ------YNLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 242 DTHVNTFRISVVTWPP 257
+ P
Sbjct: 183 KDTNIVNDLEENEEPG 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-18
Identities = 43/220 (19%), Positives = 68/220 (30%), Gaps = 62/220 (28%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
F + +G GGFG V+ + A+K++ + +R+ RE EVK L K++H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR---------------- 189
F E P + E D S S +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 190 ----------IVMG-------------------------------VARGLLYLHEEAPAR 208
I M +A + +LH +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---G 184
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
++HRD+K SNI K+ DFGL ++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-------KLSVDSRQGLRE-FTNEVKLLLKI-QHK 142
+G G V R + G E AVK +LS + + +RE E +L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
+++TL LV++ + L DY + +K S + TR I+ + + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSEKE--TR-SIMRSLLEAVSFL 216
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGE 241
H I+HRD+K NILLD+ + ++SDFG + PGE
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 25/185 (13%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
+ DL LG GG G V+ + + +A+KK+ + LRE +K++ ++ H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68
Query: 143 NLVTLFGC-CAEGPEKMLVYEYLPNKSLDYFIFDK--------TKSSSL-DWTTRYRIVM 192
N+V +F G + L + Y + + + L + R +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMY 127
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRIS 251
+ RGL Y+H A ++HRD+K +N+ ++ E L KI DFGLAR+ +H
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 252 VVT-W 255
+VT W
Sbjct: 185 LVTKW 189
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-18
Identities = 35/170 (20%), Positives = 61/170 (35%), Gaps = 23/170 (13%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+G G F V R + GQ+ AVK K + + E + ++H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYL 201
+ +V+E++ L + I + + Y + + L Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALRYC 146
Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTF 248
H+ IIHRD+K +LL + K+ FG+A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 30/174 (17%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLK 138
+ + + +LG G +G V E A+K +S S L EV +L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL---EEVAVLKL 92
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVM 192
+ H N++ L+ + LV E L FD+ ++ I+
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM-----KFNEVDAAVIIK 143
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDT 243
V G+ YLH+ I+HRD+K N+LL ++ KI DFGL+ +F +
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-18
Identities = 43/217 (19%), Positives = 72/217 (33%), Gaps = 50/217 (23%)
Query: 73 NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGL 126
NL+F +L + +G G +G V + A+K K+ + + +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 127 REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWT 185
EV+L+ K+ H N+ L+ E + + LV E L + S+
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVY-EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 186 TRY-------------------------------------RIVMGVARGLLYLHEEAPAR 208
I+ + L YLH +
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G 188
Query: 209 IIHRDIKASNILL--DEQLNPKISDFGLARLFPGEDT 243
I HRDIK N L ++ K+ DFGL++ F +
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-18
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 18/207 (8%)
Query: 45 PCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFG 100
S G+ G D D D W + + ++V D +LG G FG
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWK-KYVPQPVEVKQGSVYDYYDILEELGSGAFG 65
Query: 101 PVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159
V+R + G+ K ++ NE+ ++ ++ H L+ L + E +L
Sbjct: 66 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKAS 217
+ E+L L FD+ + + + GL ++HE I+H DIK
Sbjct: 126 ILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 178
Query: 218 NILLDEQLNP--KISDFGLARLF-PGE 241
NI+ + + KI DFGLA P E
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDE 205
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-18
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 49/179 (27%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-----DSRQGLREFTNEVKLLLKIQH 141
F + LG G +G V P G+ +A+KK+ + + LRE +K+L +H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKH 68
Query: 142 KNLVTLFGC-CAEGPEKM----LVYEYLP--------NKSLD-----YFIFDKTKSSSLD 183
+N++T+F + E ++ E + + L YFI
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI---------- 118
Query: 184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
Y+ + R + LH + +IHRD+K SN+L++ + K+ DFGLAR+
Sbjct: 119 ----YQTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 19/159 (11%)
Query: 93 QLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
LG G FG V + QE AVK + EV+LL K+ H N++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
LF + +V E L I + + S D + V + Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKH-- 140
Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
I+HRD+K NILL ++ + KI DFGL+ F
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-18
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +G G +G V + +G+++A+KKLS + +++ RE + LL +Q
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLKHMQ 81
Query: 141 HKNLVTLF------GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
H+N++ L + LV ++ L + + +Y +V +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LVYQM 135
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
+GL Y+H A ++HRD+K N+ ++E KI DFGLAR E T
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-18
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 10/156 (6%)
Query: 93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGC 150
+LG G FG V+ +G E +K ++ D Q E E+++L + H N++ +F
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
+ +V E L + + + + +L ++ + L Y H + +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 210 IHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
+H+D+K NIL KI DFGLA LF E
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 24/172 (13%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS--VDSRQGLREFTN---------EVKLL 136
++ + G +G V G+ G +A+K++ V + + ++ E++LL
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 137 LKIQHKNLVTLFGC-CAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRI 190
H N++ L M LV E + L I + + +Y
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQY-F 139
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ + GL LHE A ++HRD+ NILL + + I DF LAR +
Sbjct: 140 MYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 9e-18
Identities = 15/176 (8%), Positives = 36/176 (20%), Gaps = 36/176 (20%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
L G V+ + ++ A+K ++ SR L ++ ++
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 150 CC--------------------------AEGPEKMLVYEYLP---NKSLDYFIFDKTKSS 180
+L+ F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ + + R L ++H N+ + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G F V R + + GQE A KLS Q L E ++ ++H N+V
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVR 74
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L +E L+++ + L I + S D + + ++ +L+ H+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA---VLHCHQM-- 129
Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTF 248
++HR++K N+LL + K++DFGLA GE F
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 19/159 (11%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+LG G F V R + G E A K KLS Q L E ++ K+QH N+V
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 92
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L E LV++ + L I + S D + + ++ + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSN-- 147
Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
I+HR++K N+LL + K++DFGLA E
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 48/166 (28%), Positives = 68/166 (40%), Gaps = 31/166 (18%)
Query: 92 NQLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
LG G FG V + QE AVK + EV+LL K+ H N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIM 84
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLL 199
LF + +V E L FD+ R+ RI+ V G+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGEL----FDEIIKRK-----RFSEHDAARIIKQVFSGIT 135
Query: 200 YLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
Y+H+ I+HRD+K NILL ++ + KI DFGL+ F
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 44/189 (23%), Positives = 73/189 (38%), Gaps = 46/189 (24%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTN----------------- 131
+G G +G V + A+K LS + R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 132 -----EVKLLLKIQHKNLVTLFGCCAEGPEK---MLVYEYLPNKSLDYFIFDKTKSSSLD 183
E+ +L K+ H N+V L + P + +V+E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 184 WTT--RY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
Y ++ G+ YLH + +IIHRDIK SN+L+ E + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 240 GEDTHVNTF 248
G D ++
Sbjct: 189 GSDALLSNT 197
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ DL +G G +G V + G ++A+KKL + +++ RE ++LL ++
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82
Query: 141 HKNLVTLFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
H+N++ L LV ++ L + K L +V +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQM 137
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
+GL Y+H A IIHRD+K N+ ++E KI DFGLAR E T
Sbjct: 138 LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 36/155 (23%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-VDSRQGLREFTNEVKLLLKIQ-HKNL 144
+ + +LG G + V+ + + N +++ VK L V ++ RE +K+L ++ N+
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKILENLRGGPNI 93
Query: 145 VTLFGCCAEGPEKMLVY--EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
+TL + + E++ N T D+ R+ + + + L Y H
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRF-YMYEILKALDYCH 147
Query: 203 EEAPARIIHRDIKASNILLD-EQLNPKISDFGLAR 236
I+HRD+K N+++D E ++ D+GLA
Sbjct: 148 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-17
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
+ + +LG G F V + G+E A K +LS R RE EV +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
+I+H N++TL + +L+ E + L F+ +K + + T + ++ G
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---G 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGE 241
+ YLH + RI H D+K NI+L ++ P K+ DFG+A G
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE---FTNEVKLLLKIQHKN 143
LG G G V +++A+K K ++ S + E+++L K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH 202
++ + + + +V E + L FDK + L T + + YLH
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 203 EEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTF 248
E IIHRD+K N+LL +E KI+DFG +++ GE + + T
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL 176
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-17
Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
LG G +G V + + +AVK + + E E+ + + H+N+V +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSS---SLDWTTRY--RIVMGVARGLLYLHEEAP 206
EG + L EY L FD+ + R+ +++ GV YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
I HRDIK N+LLDE+ N KISDFGLA +F
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-17
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 22 HHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTL 81
HH+H+H+ VD + ++ S G A+ DGS D+ + FF++
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSV-TASAAPGTASLVPDYWIDGSNRDALSDFFEVE-- 58
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ 140
++LG G VYR + A+K + + E+ +LL++
Sbjct: 59 ----------SELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLS 106
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N++ L E LV E + L I +K S D V + + Y
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAY 163
Query: 201 LHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDT 243
LHE I+HRD+K N+L KI+DFGL+++ +
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLL 137
+ ++F D LG GGFG V+ M ++ A KKL+ + R+G + E K+L
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 138 KIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VA 195
K+ + +V+L E + LV + + Y I++ + + R +
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
GL +LH+ II+RD+K N+LLD+ N +ISD GLA T +
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-17
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 18/169 (10%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
+F+ +LG G F V + G E A K + R RE EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
++ H N++TL + +L+ E + L F+ K S + T+ + ++ G
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGE 241
+ YLH + +I H D+K NI+L ++ P K+ DFGLA G
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-17
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 18/169 (10%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
+F+ +LG G F V + G E A K + R RE EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
++ H N++TL + +L+ E + L F+ K S + T+ + ++ G
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGE 241
+ YLH + +I H D+K NI+L ++ P K+ DFGLA G
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 9e-17
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +L +G G G V + +A+KKLS +++ RE + L+ +
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVN 119
Query: 141 HKNLVTLFG--CCAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
HKN+++L + E+ LV E + L I + Y ++ +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LLYQM 173
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
G+ +LH A IIHRD+K SNI++ KI DFGLAR
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 22/188 (11%), Positives = 55/188 (29%), Gaps = 38/188 (20%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVK------KLSVDSRQGLREFTNEVKLLLKIQH----- 141
LG G+ V + ++ + ++E ++LL I++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 142 --------------KNLVTLFGCCAEGPEKMLVYEYLPNKS--------LDYFIFDKTKS 179
+ + + ++ + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
SL R ++ + V R L LH ++H ++ +I+LD++ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261
Query: 240 GEDTHVNT 247
G
Sbjct: 262 GASAVSPI 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLF- 148
LG GG V+ + + +++AVK L D F E + + H +V ++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 149 -GCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
G AE P L Y EY+ +L + + + ++ + L + H+
Sbjct: 80 TGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ- 134
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR 236
IIHRD+K +NI++ K+ DFG+AR
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 34/164 (20%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+G G F V + G+E+A+K +L+ S Q L EV+++ + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 148 FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GL 198
F E + + L+ EY + FD R+ AR +
Sbjct: 80 FEVI-ETEKTLYLIMEYASGGEV----FDY-------LVAHGRMKEKEARSKFRQIVSAV 127
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGE 241
Y H++ RI+HRD+KA N+LLD +N KI+DFG + F G
Sbjct: 128 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-16
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
LG G F V+ G+ A+K + NE+ +L KI+H+N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 152 AEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
E LV + + L I ++ + D + ++ V + YLHE I+
Sbjct: 76 -ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---LVIQQVLSAVKYLHEN---GIV 128
Query: 211 HRDIKASNILL---DEQLNPKISDFGLARLFPGE 241
HRD+K N+L +E I+DFGL+++
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLFG 149
+G G + R + E AVK + R E +++LL+ QH N++TL
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHE 203
+G +V E + L DK + ++ + + + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITKTVEYLHA 134
Query: 204 EAPARIIHRDIKASNILL-DEQLNP---KISDFGLARLFPGEDTHVNTF 248
+ ++HRD+K SNIL DE NP +I DFG A+ E+ + T
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
LG G +G V + + +AVK + + E E+ + + H+N+V +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYLHE 203
EG + L EY L FD+ + + A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
I HRDIK N+LLDE+ N KISDFGLA +F
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 27/170 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +L+ +G G +G V G +AVKKLS + +++ RE ++LL ++
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 86
Query: 141 HKNLVTLFGCC--AEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIVMG 193
H+N++ L A E+ LV + L+ + K L D ++ ++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQF-LIYQ 140
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
+ RGL Y+H A IIHRD+K SN+ ++E KI DFGLAR E T
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 37/183 (20%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLS-------------VDSRQGLREFT 130
+ + +LG G +G V E A+K + + + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY- 188
NE+ LL + H N++ LF E + LV E+ L F++ + ++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FEQIINRH-----KFD 144
Query: 189 -----RIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPG 240
I+ + G+ YLH+ I+HRDIK NILL + LN KI DFGL+ F
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 241 EDT 243
+
Sbjct: 202 DYK 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ +L +G G G V + +A+KKLS +++ RE + L+ +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVN 82
Query: 141 HKNLVTLF------GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
HKN++ L E + +V E + +L I + Y ++ +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LLYQM 136
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
G+ +LH A IIHRD+K SNI++ KI DFGLAR
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 26/167 (15%)
Query: 93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGC 150
LG G F + + + Q AVK +S + E+ L + H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHEE 204
+ LV E L L F++ K + I+ + + ++H+
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV 125
Query: 205 APARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTF 248
++HRD+K N+L ++ L KI DFG ARL P ++ + T
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 32/147 (21%), Positives = 53/147 (36%), Gaps = 10/147 (6%)
Query: 94 LGHGGFGPVYRGLMPN-GQEIAVKKLSVD--SRQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
+G GG G VY + +A+K +S S R E + ++Q ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
+ + + L + + L IV + L H A
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AGA 155
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR 236
HRD+K NIL+ + DFG+A
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 46/196 (23%), Positives = 87/196 (44%), Gaps = 52/196 (26%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
+ + +LG G +G V++ + G+ +AVKK+ D+++ RE + +L ++
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELS 66
Query: 141 -HKNLVTLFGCCAEGPEKM----LVYEYLP--------NKSLD-----YFIFDKTKSSSL 182
H+N+V L + LV++Y+ L+ Y +
Sbjct: 67 GHENIVNLLNVLR--ADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV--------- 115
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
Y+++ + + YLH ++HRD+K SNILL+ + + K++DFGL+R F
Sbjct: 116 -----YQLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 243 THVNTFRISVVTWPPN 258
N +S+ N
Sbjct: 164 RVTNNIPLSINENTEN 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-16
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 27/167 (16%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG V G G ++AVK + + S + + E++ L +H +++ L+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYL 201
+ + +V EY+ L FD R+ AR + Y
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICK-------HGRVEEMEARRLFQQILSAVDYC 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
H ++HRD+K N+LLD +N KI+DFGL+ + + + T
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS 170
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 40/156 (25%), Positives = 59/156 (37%), Gaps = 23/156 (14%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
LG G V + + QE AVK + EV++L + Q H+N++ L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHEEA 205
E LV+E + S+ + +V VA L +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK- 130
Query: 206 PARIIHRDIKASNILL---DEQLNPKISDFGLARLF 238
I HRD+K NIL ++ KI DF L
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 29/200 (14%), Positives = 59/200 (29%), Gaps = 41/200 (20%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLKIQ------ 140
LG G+ V R ++E ++LL I+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 141 ----------------HKNLVTLFGCCAEGPEKMLVYEYLPNKS-----LDYFIFDKTKS 179
K ++ + + + Y +S + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
SL R ++ + V R L LH ++H ++ +I+LD++ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 240 GEDTHVNTFRISVVTWPPNM 259
D +S PP +
Sbjct: 255 -RDGARVVSSVSRGFEPPEL 273
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 41/175 (23%), Positives = 65/175 (37%), Gaps = 37/175 (21%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDS---RQGLREFTNEVKLLLKIQHKNL 144
LG G FG V+ + +E+ VK K+ D L + T E+ +L +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDK-TKSSSLDWTTRYRIVMG 193
+ + + N+ + F + LD I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ + YL + IIHRDIK NI++ E K+ DFG A TF
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-16
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 18/169 (10%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
+++ +LG G F V + G + A K + R RE EV +L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
+IQH N++TL + +L+ E + L F+ +K + + T + ++ G
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGE 241
+ YLH +I H D+K NI+L ++ P KI DFGLA G
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-16
Identities = 47/166 (28%), Positives = 68/166 (40%), Gaps = 19/166 (11%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTN---EVKLLLKIQHK--NL 144
LG GGFG VY G+ + + +A+K K + L T EV LL K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ L +L+ E P D +FD T+ +L V + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 204 EAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTF 248
++HRDIK NIL+D + K+ DFG L DT F
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDF 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-16
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 14/154 (9%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
LG G FG V+R + + + K + V E+ +L +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR--YRIVMGVARGLLYLHEEAPARII 210
E ++++E++ + F++ +S+ + R V V L +LH I
Sbjct: 72 SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 211 HRDIKASNILLDEQLNP--KISDFGLARLF-PGE 241
H DI+ NI+ + + KI +FG AR PG+
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 11/172 (6%)
Query: 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLL 137
V N F LG GGFG V + ++ A KKL + R+G NE ++L
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 138 KIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
K+ + +V+L E + + LV + L + I+ ++ + + +
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICC 297
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
GL LH E RI++RD+K NILLD+ + +ISD GLA P T +
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR 345
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 26/157 (16%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG V G G ++AVK + + S + + E++ L +H +++ L+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYL 201
+ + +V EY+ L FD R+ +R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYI-------CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
H ++HRD+K N+LLD +N KI+DFGL+ +
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 38/195 (19%), Positives = 65/195 (33%), Gaps = 41/195 (21%)
Query: 70 DSWNLFFDLRTLQVATNFFSDL-----NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR 123
S L + + +D LG G G V GQ+ A+K +
Sbjct: 8 HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDS 65
Query: 124 QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--------- 173
R+ EV + ++V + VYE + + I
Sbjct: 66 PKARQ---EVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGE 112
Query: 174 -FDK-TKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLN 226
F + + +T R I+ + + +LH I HRD+K N+L ++
Sbjct: 113 LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169
Query: 227 PKISDFGLARLFPGE 241
K++DFG A+
Sbjct: 170 LKLTDFGFAKETTQN 184
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-15
Identities = 47/168 (27%), Positives = 68/168 (40%), Gaps = 21/168 (12%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTN---EVKLLLKI----QHK 142
LG GGFG V+ G + + ++A+K + V L + EV LL K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYL 201
++ L MLV E P + D +FD T+ L V + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTF 248
H ++HRDIK NIL+D + K+ DFG L D F
Sbjct: 156 HS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-15
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG V Q++A+K + + E+ L ++H +++ L+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR-IVMGVARGLLYLHEEAPAR 208
+ ++V EY + DY I +K + + + ++ I+ + Y H +
Sbjct: 77 VITTPTDIVMVIEYAGGELFDY-IVEKKRMTEDEGRRFFQQIICAIE----YCHRH---K 128
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
I+HRD+K N+LLD+ LN KI+DFGL+ + + + T
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS 167
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH-KNLV 145
+LG G F V + + GQE A K + D R + +E+ +L + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCPRVI 92
Query: 146 TLFGCCAEGPEKM-LVYEYLPNKSL-DYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYL 201
L E ++ L+ EY + + + + S + R +I+ GV YL
Sbjct: 93 NLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY----YL 147
Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGE 241
H+ I+H D+K NILL + KI DFG++R
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 24/162 (14%)
Query: 94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
LG G G V + ++ A+K + R EV+L + ++V +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVDVY 124
Query: 152 AEGPEKM----LVYEYLPNKSLDYFIFDK-TKSSSLDWTTRY--RIVMGVARGLLYLHEE 204
+V E L L F + +T R I+ + + YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 205 APARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDT 243
I HRD+K N+L K++DFG A+ ++
Sbjct: 181 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 18/153 (11%), Positives = 43/153 (28%), Gaps = 18/153 (11%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
L G ++ L +++A+ + L+E + L +I
Sbjct: 36 LIFHGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ + ++V E++ SL +S R + +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
A + S + + + ++
Sbjct: 148 ---AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
FS +G GGFG VY + ++ A+K L + +QG NE +L + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 144 ---LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
+V + P+K+ + + + L Y + + S Y + GL
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFY--AAEIILGLE 306
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
++H +++RD+K +NILLDE + +ISD GLA F + H
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-14
Identities = 37/160 (23%), Positives = 56/160 (35%), Gaps = 36/160 (22%)
Query: 94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
LG G G V + ++ A+K + R EV+L + Q ++V +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVD-- 78
Query: 152 AEGPEKMLVYEYLPNKSLDYFI----------FDK-TKSSSLDWTTRY--RIVMGVARGL 198
VYE L I F + +T R I+ + +
Sbjct: 79 --------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 199 LYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLA 235
YLH I HRD+K N+L K++DFG A
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 9e-14
Identities = 27/230 (11%), Positives = 69/230 (30%), Gaps = 50/230 (21%)
Query: 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVK 134
+ T ++G G FG V++ + + +A+K ++++ ++ E E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 135 LLLKIQ---------HKNLVTLFGCC-------------------AEGPEKMLVYEYLPN 166
+ ++ + + L +G + +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 167 KSLDYFIF-------DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI 219
+ F ++ ++ T I+ + L R HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 220 LLDEQLNPKISDFGLARLFP----GEDTHVNTFRISVVTWPPNMHCMDIC 265
LL + K+ + G + + +S + + D+
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 36/159 (22%), Positives = 56/159 (35%), Gaps = 32/159 (20%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
+G G FG + +AVK + + RE + ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYL 201
++ EY L +++ + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGEL----YERICN-------AGRFSEDEARFFFQQLLSGVSYC 132
Query: 202 HEEAPARIIHRDIKASNILLDEQLNP--KISDFGLARLF 238
H +I HRD+K N LLD P KI DFG ++
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 16/183 (8%)
Query: 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREF 129
+ L+ +++ + F L +G G F V M ++ A+K ++ + R + F
Sbjct: 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
E +L+ + + L + + LV EY L + + + Y
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 189 --RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHV 245
IVM + +H +HRDIK NILLD + +++DFG +L
Sbjct: 168 LAEIVMA----IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 246 NTF 248
Sbjct: 221 LVA 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-12
Identities = 47/169 (27%), Positives = 69/169 (40%), Gaps = 18/169 (10%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
F LG G F V + +E A+K K + + T E ++ ++ H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARGLL 199
V L+ + EK+ Y N L K S TR+ IV L
Sbjct: 92 FVKLYFTF-QDDEKLYFGLSYAKNGEL-LKYIRKIGSFDET-CTRFYTAEIVSA----LE 144
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
YLH + IIHRD+K NILL+E ++ +I+DFG A++ E
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L +G G FG V + +++ A+K K R +R E++++ ++H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
LV L+ + E M +V + L L Y + + + + + + L YL
Sbjct: 77 LVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLF--ICELVMALDYLQ 132
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+ RIIHRD+K NILLDE + I+DF +A + P E T
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTM 174
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 41/185 (22%), Positives = 74/185 (40%), Gaps = 30/185 (16%)
Query: 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEV 133
+R L++ + + +G G FG V + +++ A+K LS + R F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
++ +V LF + + +V EY+P L ++ + Y +
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPE 167
Query: 193 GVAR--------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDT 243
AR L +H IHRD+K N+LLD+ + K++DFG ++
Sbjct: 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 244 HVNTF 248
+T
Sbjct: 225 RCDTA 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-11
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLV-TLFG 149
++G G FG +Y G + G+E+A+K V ++ L E K+ +Q + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGVGIPTIRW 72
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
C AEG ++V E L SL+ ++ SL T + + + Y+H
Sbjct: 73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHS---KNF 126
Query: 210 IHRDIKASNILLDEQLNPK---ISDFGLARLFPGEDTHV 245
IHRD+K N L+ I DFGLA+ + TH
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 36/179 (20%), Positives = 70/179 (39%), Gaps = 16/179 (8%)
Query: 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTN-EV 133
++ +++ F L +G G FG V + N ++ A+K L+ ++ E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RI 190
+L+ K + TL + + LV +Y L + + Y +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTF 248
V+ + +H+ +HRDIK NIL+D + +++DFG +L +
Sbjct: 185 VIA----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 88 FSDLNQLGHGGFGPVY---RGLMPNGQEI-AVK---KLSVDSRQGLREFT-NEVKLLLKI 139
F L LG GG+G V+ + N +I A+K K + T E +L ++
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 140 QHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVAR 196
+H +V L + K+ L+ EYL L + ++ D Y I M
Sbjct: 79 KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMA--- 133
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
L +LH++ II+RD+K NI+L+ Q + K++DFGL + + T +TF
Sbjct: 134 -LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-10
Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 20/171 (11%)
Query: 88 FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
F L LG G FG V+ Q A+K K ++ R +R E +L+++
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARG 197
H +V L + K+ L+ ++L L + K + + Y + +
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELAL----A 138
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
L +LH II+RD+K NILLDE+ + K++DFGL++ + +F
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 11/195 (5%)
Query: 59 ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI----A 114
S +D SGA+ + +V N F L LG G FG V
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 115 VKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFI 173
+KK + ++ + E ++L +H L L + +++ V EY L +F
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL-FFH 238
Query: 174 FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
+ + S D Y + L YLH E +++RD+K N++LD+ + KI+DFG
Sbjct: 239 LSRERVFSEDRARFY--GAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFG 294
Query: 234 LARLFPGEDTHVNTF 248
L + + + TF
Sbjct: 295 LCKEGIKDGATMKTF 309
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGC 150
++G G FG +Y G + +E+A+K +V ++ + E K+ +Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
EG +LV + L SL+ ++ SL T + + + ++H ++ +
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---FL 125
Query: 211 HRDIKASNILLDEQLNPK---ISDFGLARLFPGEDTHV 245
HRDIK N L+ I DFGLA+ + TH
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 25/164 (15%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGC 150
++G G FG + G + + +A+K + SR + E + ++ + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
G +V E L SL D F S + V+ +A L+ Y+H +
Sbjct: 74 GPCGKYNAMVLELL-GPSLEDLFDLCDRTFS-------LKTVLMIAIQLISRMEYVHSKN 125
Query: 206 PARIIHRDIKASNILLDEQLNPK-----ISDFGLARLFPGEDTH 244
+I+RD+K N L+ N I DF LA+ + +T
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 34/163 (20%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGC 150
++G G FG ++ G + N Q++A+K S + +E + + + ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEAP 206
EG +LV + L SL+ + + S+ + V A+ +L +HE
Sbjct: 75 GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV------KTVAMAAKQMLARVQSIHE--- 124
Query: 207 ARIIHRDIKASNILLDEQLNPK-----ISDFGLARLFPGEDTH 244
+++RDIK N L+ + + DFG+ + + T
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS----VDSRQGLREFT-NEVKLLLKIQH 141
F + LG G FG V +G A+K L V +Q E T NE ++L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ--IEHTLNEKRILQAVNF 100
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLL 199
LV L + +V EY+ + + + S Y +IV+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
YLH +I+RD+K N+L+D+Q +++DFG A+ G
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 38/179 (21%)
Query: 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV------ 145
++G GGFG +Y ++ A + V+ ++ F +E+K ++ K+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102
Query: 146 ---------TLFGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
+G + +V E L L I + + V+
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKK------STVL 154
Query: 193 GVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGEDTHV 245
+ +L Y+HE +H DIKA+N+LL + ++ +D+GL+ + H
Sbjct: 155 QLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 31/176 (17%), Positives = 59/176 (33%), Gaps = 27/176 (15%)
Query: 92 NQLGHGGFGPVYRGL---------MPNGQEIAVK----------KLSVDSRQGLREFTNE 132
+ G +Y P Q+ ++K + + R N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 133 VKLLLKIQHKNLVTLFGC-CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
K L + T G + + LV L +SL D + L + ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGEDTHV 245
+ L +LHE +H ++ A NI +D + ++ + +G A + HV
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 27/174 (15%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
F+ L LG G FG V E+ +KK V ++V+ L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVL 395
Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
L + L L C + +++ V EY+ L Y I + Y +
Sbjct: 396 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY--AAEI 451
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
A GL +L + II+RD+K N++LD + + KI+DFG+ + + TF
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 502
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 16/168 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
F L LG G FG V ++K + ++ + E ++L +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLLY 200
L L + +++ V EY L + + + + + + Y IV L Y
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA----LEY 120
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
LH +++RDIK N++LD+ + KI+DFGL + + + TF
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-09
Identities = 24/54 (44%), Positives = 32/54 (59%), Gaps = 3/54 (5%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
VA+G+ +L A + IHRD+ A NILL E+ KI DFGLAR + +V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 19/154 (12%)
Query: 92 NQLGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKI-QHKN 143
LG G FG V + +AVK L + R +E+K+L+ I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 144 LVTLFGCC-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
+V L G C G M++ E+ +L ++ + R V +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ I D+K + + S F +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 8e-09
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 31/176 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
F+ L LG G FG V E+ +KK V ++V+ L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVM 192
L + L L C + +++ V EY+ L Y I + Y I +
Sbjct: 75 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAI 132
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
G L +L + II+RD+K N++LD + + KI+DFG+ + + TF
Sbjct: 133 G----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 181
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 31/176 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
F + LG G FG V + ++ +KK + ++V+ L
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-------DDVECTMTEKRIL 77
Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
L H L LF CC + P+++ V E++ L + I K++ Y I+
Sbjct: 78 SLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIIS 135
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
L++LH++ II+RD+K N+LLD + + K++DFG+ + TF
Sbjct: 136 A----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 35/183 (19%), Positives = 63/183 (34%), Gaps = 43/183 (23%)
Query: 93 QLGHGGFGPVYRGLMPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+G GGFG +Y M + + + K+ L E+K + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF---TELKFYQRAAKPEQIQK 98
Query: 148 -----------------FGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
G + + ++ + L K S
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR------ 151
Query: 189 RIVMGVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGED 242
+ V+ ++ +L Y+HE +H DIKASN+LL+ + ++ D+GLA + E
Sbjct: 152 KTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 243 THV 245
H
Sbjct: 209 VHK 211
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 17/169 (10%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKI-QHK 142
F L +G G + V + I VKK V+ + + E + + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 143 NLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLL 199
LV L C + ++ V EY+ L + + + + + Y I + L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLA----LN 167
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
YLHE II+RD+K N+LLD + + K++D+G+ + +TF
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 13/167 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKI-QHK 142
F L +G G + V + I VKK V+ + + E + + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 143 NLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
LV L C + ++ V EY+ L + + + + + Y ++ L YL
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFY--SAEISLALNYL 126
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
HE II+RD+K N+LLD + + K++D+G+ + +TF
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 170
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 88 FSDLNQLGHGGFGPVY---RGLMPNGQEI-AVK---KLSVDSRQGLREFT-NEVKLLLKI 139
F L LG G +G V+ + + ++ A+K K ++ + E T E ++L I
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 140 QHKN-LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVA 195
+ LVTL + K+ L+ +Y+ L + + + + Y IV+
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLA-- 171
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTF 248
L +LH+ II+RDIK NILLD + ++DFGL++ F E F
Sbjct: 172 --LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 31/176 (17%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
F LG G FG V+ + A+KK V ++V+ L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-------DDVECTMVEKRVL 71
Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
L +H L +F C + E + V EYL L Y I L T Y I++
Sbjct: 72 SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIIL 129
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
G L +LH + I++RD+K NILLD+ + KI+DFG+ + D NTF
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 178
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-08
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 21/171 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS----VDSRQGLREFTNEVK--LLLKIQ 140
F L +G G FG V + AVK L + ++ + + LL ++
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVK 97
Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARG 197
H LV L + +K+ V +Y+ L Y + + + Y I
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAEIASA---- 151
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
L YLH I++RD+K NILLD Q + ++DFGL + ++ +TF
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 9e-08
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 22/158 (13%)
Query: 88 FSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLS----VDSRQGLREFT-NEVKLLLKIQ 140
F L LG G FG V+ R NG+ A+K L V +Q E T +E +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIR-SRHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVT 64
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARG 197
H ++ ++G + + ++ +Y+ L + + K++ ++ + +
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNP-VAKFYAAEVCLA---- 118
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
L YLH + II+RD+K NILLD+ + KI+DFG A
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 35/164 (21%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHK---- 142
L +G G FG V + Q +A+K RQ E+++L ++ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDN 157
Query: 143 --NLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
N++ + C + +E L + +L Y + K K +
Sbjct: 158 TMNVIHMLENFTFRNHIC-------MTFELL-SMNL-YELIKKNKFQGFSLPLVRKFAHS 208
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFGLA 235
+ + L LH+ RIIH D+K NILL +Q K+ DFG +
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 33/170 (19%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ------ 140
+ +LG G F V+ M N +A+K V + E+KLL ++
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTK 79
Query: 141 -----HKNLVTLFGC-CAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
+++ L +GP + +V+E L ++L + K + + +I
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENL-LALIKKYEHRGIPLIYVKQIS 137
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP------KISDFGLA 235
+ GL Y+H IIH DIK N+L++ +P KI+D G A
Sbjct: 138 KQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 33/167 (19%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL-SVDS--RQGLREFTNEVKLLLKIQH-- 141
+ + +G G FG V + + +A+K + + + Q EV+LL +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHD 111
Query: 142 ----KNLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
+V L C LV+E L + +L Y + T + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNL-YDLLRNTNFRGVSLNLTRKF 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFGLA 235
+ LL+L IIH D+K NILL KI DFG +
Sbjct: 163 AQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 1e-04
Identities = 41/300 (13%), Positives = 81/300 (27%), Gaps = 95/300 (31%)
Query: 1 MLRHLSHILRHPILDDQNHQHHHNHNHNLSVDEMNLKHFISNLF--PCLKTSLRGGRAAG 58
ML+ L + + D N +H+ N+ + +++ + L + L
Sbjct: 201 MLQKLLYQI------DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL------ 248
Query: 59 ESAEDADGSGADSWNL----FFDL--RTLQVATNFFSDLNQLG------------HGGFG 100
+ N F+L + L + T F + L
Sbjct: 249 ----VLL----NVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 101 PVY-RGLMPNGQEIAVKKLSVDSRQG-----------LREFTNEVKLLLKIQHKNLVTLF 148
P + L+ + + L + +R+ + L T+
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 149 GCCAEGPEKMLVYEYL-PNKSLDYF----IFDK-----TKSSSLDWT-TRYRIVMGVA-- 195
L P + F +F T SL W VM V
Sbjct: 360 ESS---------LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 196 ---RGLL---------YLHEEAPARIIHRDIKASNILLDEQLNPKISD-FGLARLFPGED 242
L+ + I+ ++K + + L+ I D + + + F +D
Sbjct: 411 LHKYSLVEKQPKESTISIPS------IYLELKV-KLENEYALHRSIVDHYNIPKTFDSDD 463
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 45/290 (15%), Positives = 94/290 (32%), Gaps = 74/290 (25%)
Query: 21 HHHNHNHNLSVDEMNLKH----------FISNLFPC--LKTSLRGGRAAGESAEDADGSG 68
HHH+H+ + E ++ F+ N F C ++ + + E + S
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILSVFEDAFVDN-FDCKDVQDMPKSILSKEE-IDHIIMSK 58
Query: 69 AD---SWNLFFDLRTLQ--VATNFFSDLNQLGHGGF----------GPV--------YRG 105
+ LF+ L + Q + F ++ ++ + F P R
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-KFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 106 LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK-MLVYEYL 164
+ N ++ K +V SR L+ + + LL+++ V + G G K + +
Sbjct: 118 RLYNDNQV-FAKYNV-SR--LQPYLKLRQALLELRPAKNVLIDGVLGSG--KTWVALDVC 171
Query: 165 PNKSL----DYFIFDKTKSSSLDWTT--RYRIVMGVARGLLYL-HEEAPARIIHRDIKAS 217
+ + D+ IF W V L L ++ P D ++
Sbjct: 172 LSYKVQCKMDFKIF---------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 218 NILLDEQLNPKISDFGLARLFPG-----ED----THVNTF----RISVVT 254
L + ++ ++ + + N F +I + T
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.63 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.75 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.65 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.44 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.61 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.14 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=325.66 Aligned_cols=172 Identities=25% Similarity=0.380 Sum_probs=156.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
..|+++++||+|+||+||+|+ ..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 569999999999999999999 4579999999997665444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+||+|.+++.. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999998843 35899999999999999999999999 999999999999999999999999999998777666
Q ss_pred eeeeeEEeeeeCCCccccCC
Q 024537 245 VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e~ 264 (266)
..+++||+.|+|||++..+.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~ 246 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLP 246 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCC
T ss_pred ccccccCcCcCCHHHHCCCC
Confidence 77889999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=326.27 Aligned_cols=176 Identities=22% Similarity=0.314 Sum_probs=151.2
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 679999999999999999999 557999999999754 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
||+||+|.+++... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998543 3456889999999999999999999999 9999999999999999999999999999886544
Q ss_pred ceeeeeeEEeeeeCCCccccCCC
Q 024537 243 THVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
....+.+||+.|+|||++.++.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y 202 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPY 202 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCC
T ss_pred ccccccCCCccccCHHHHCCCCC
Confidence 44556789999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=322.63 Aligned_cols=174 Identities=26% Similarity=0.365 Sum_probs=155.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++++.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3579999999999999999999 568999999999754 223456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||||+||+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999999543 46999999999999999999999999 99999999999999999999999999998753
Q ss_pred C--CceeeeeeEEeeeeCCCccccCC
Q 024537 241 E--DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~--~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. .....+++||+.|+|||++.++.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~ 210 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKS 210 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSC
T ss_pred CCCcccccCcccCcccCCHHHHcCCC
Confidence 3 34556789999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=326.88 Aligned_cols=172 Identities=25% Similarity=0.380 Sum_probs=157.2
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+.|+++++||+|+||+||+|+ ..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 569999999999999999999 4579999999998665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999998843 35899999999999999999999999 999999999999999999999999999998777667
Q ss_pred eeeeeEEeeeeCCCccccCC
Q 024537 245 VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e~ 264 (266)
..+++||+.|+|||++..+.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~ 323 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLP 323 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCC
T ss_pred ccccccCcCcCCHHHHCCCC
Confidence 77889999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=302.01 Aligned_cols=171 Identities=26% Similarity=0.419 Sum_probs=137.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+ ..+++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999 5579999999997542 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+ +|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899888854 356999999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ...+.+||+.|+|||++.++.
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~ 187 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKL 187 (275)
T ss_dssp ----------CTTSCHHHHSSSS
T ss_pred C-ccCCeeECcccCChhhhcCCC
Confidence 3 345678999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.53 Aligned_cols=177 Identities=21% Similarity=0.341 Sum_probs=141.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC--------
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-------- 155 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 155 (266)
++|++++.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 459999999999999999999 457999999998754 3444567899999999999999999999997654
Q ss_pred ----cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 156 ----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 156 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
.+|||||||++|+|.+++.........++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999965444345566778899999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCc------------eeeeeeEEeeeeCCCccccCCC
Q 024537 232 FGLARLFPGEDT------------HVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 232 FG~a~~~~~~~~------------~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
||+|+.+..... ...+.+||+.|+|||++.++.+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y 207 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC
Confidence 999998754322 2234579999999999987643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.81 Aligned_cols=178 Identities=28% Similarity=0.468 Sum_probs=152.2
Q ss_pred hhcCccccceecccCceEEEEEEec------CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
..++|.+.+.||+|+||+||+|++. ++..||||+++.......+.|.+|+.+|++++|||||++++++.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3467889999999999999999853 4778999999877777778899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhc----------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCe
Q 024537 158 MLVYEYLPNKSLDYFIFDK----------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~ 227 (266)
+||||||++|+|.+++... .....+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999643 23457999999999999999999999998 9999999999999999999
Q ss_pred EEecccccccCCCCCce--eeeeeEEeeeeCCCccccCC
Q 024537 228 KISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e~ 264 (266)
||+|||+|+........ .....||+.|+|||++..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC
Confidence 99999999876443322 22346899999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=309.63 Aligned_cols=176 Identities=26% Similarity=0.427 Sum_probs=148.9
Q ss_pred cCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+.+++.++||+|+||+||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44777899999999999999852 4678999998754 3334578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 159 LVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
||||||++|+|.++|..... ...+++..++.|+.||+.||+|||+++ ||||||||+|||++.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 245899999999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 226 NPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.+||+|||+|+.+.... .......||+.|+|||++..+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 223 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 223 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC
Confidence 99999999998764322 2234457899999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.14 Aligned_cols=178 Identities=28% Similarity=0.442 Sum_probs=147.2
Q ss_pred hhcCccccceecccCceEEEEEEec------CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
..++|.+.++||+|+||+||+|++. +++.||||+++.......+.|.+|+.+|++++|||||++++++.+++..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456888899999999999999853 4788999999877777778899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 158 MLVYEYLPNKSLDYFIFDKT------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
+||||||++|+|.+++.... ....+++.+++.|+.||+.||.|||+++ ||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 99999999999999986532 2246899999999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 226 NPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.+||+|||+|+.+.... .......||+.|+|||++..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC
Confidence 99999999999764332 2223456899999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=313.29 Aligned_cols=173 Identities=25% Similarity=0.262 Sum_probs=145.1
Q ss_pred cCccccceecccCceEEEEEEe----cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
++|++++.||+|+||+||+|+. .+++.||||++.... ......+.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999984 257899999987542 2223467789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||+||+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999543 46999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.......+.+||+.|+|||++.++.
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~ 202 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRG 202 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSC
T ss_pred CCCccccccccCcccCCHHHhccCC
Confidence 6666667789999999999987764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=300.25 Aligned_cols=170 Identities=25% Similarity=0.362 Sum_probs=146.2
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLV 160 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv 160 (266)
|++.++||+|+||+||+|. ..++..||+|++... .....+.+.+|+.+|++++|||||+++++|.+ ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4677889999999999999 457899999998654 34456789999999999999999999999875 3457999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~ 239 (266)
||||+||+|.+++... ..+++..++.|+.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999543 46899999999999999999999987 35999999999999974 7899999999998754
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ....+.+||+.|+|||++.+.
T Consensus 184 ~--~~~~~~~GTp~YmAPE~~~~~ 205 (290)
T 3fpq_A 184 A--SFAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp T--TSBEESCSSCCCCCGGGGGTC
T ss_pred C--CccCCcccCccccCHHHcCCC
Confidence 3 344567899999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=304.01 Aligned_cols=173 Identities=31% Similarity=0.453 Sum_probs=144.5
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
++..+++++.++||+|+||+||+|++. ..||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344567889999999999999999864 36999998744 34556789999999999999999999998764 67899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 109 VmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999853 2356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CC--CceeeeeeEEeeeeCCCcccc
Q 024537 240 GE--DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~--~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.. .....+..||+.|+|||++..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp ----------CCCCTTSCCHHHHHC
T ss_pred cCCcceeecccccCCCccCHHHhhc
Confidence 32 233456689999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=307.15 Aligned_cols=170 Identities=25% Similarity=0.355 Sum_probs=146.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.+.|++.++||+|+||+||+|+ ..+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3568888999999999999999 45799999999976432 23699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGED 242 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~~~~ 242 (266)
|+||+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999543 46999999999999999999999998 99999999999999987 59999999999875432
Q ss_pred c-----eeeeeeEEeeeeCCCccccCCC
Q 024537 243 T-----HVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 243 ~-----~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
. ...+++||+.|+|||++.++.+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y 233 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPC 233 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCC
T ss_pred cccceecCCccccCccccCHHHHCCCCC
Confidence 1 2234579999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=298.31 Aligned_cols=187 Identities=27% Similarity=0.387 Sum_probs=157.9
Q ss_pred ccchhhHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCC-CCcee
Q 024537 75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQH-KNLVT 146 (266)
Q Consensus 75 ~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H-~nIv~ 146 (266)
.++...+++..++|++.+.||+|+||+||+|.+. .++.||||.+... .....+.+.+|+.+|.++.| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 3566678888899999999999999999999843 2368999998765 34445779999999999975 89999
Q ss_pred EEeEEeeC-CcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 024537 147 LFGCCAEG-PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212 (266)
Q Consensus 147 l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHr 212 (266)
+++++..+ +.++||||||++|+|.++|..... ...+++..++.|+.||+.||+|||+++ ||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99999765 568999999999999999965321 245899999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccCC
Q 024537 213 DIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 213 DlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||||+|||++.++.+||+|||+|+.+..... ...+..||+.|+|||++..+.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~ 263 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 263 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC
Confidence 9999999999999999999999998754432 334567899999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=290.98 Aligned_cols=172 Identities=24% Similarity=0.309 Sum_probs=139.6
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC----cEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~ 161 (266)
++|.+.++||+|+||+||+|++ +|+.||||++....... ..+..|+..+.+++|||||++++++.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 68999999987554322 22335666667889999999999998764 479999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA-----PARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~-----~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
|||++|+|.+++.. ..+++..+..++.|++.||+|||++. .++||||||||+|||++.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 35899999999999999999999871 1239999999999999999999999999998
Q ss_pred cCCCCCce----eeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTH----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~----~~~~~~t~~y~aPE~~~~e 263 (266)
........ .....||+.|+|||++.++
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred cccCCCCceeeecccccccccccCHHHhccc
Confidence 87544322 2345799999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.42 Aligned_cols=172 Identities=24% Similarity=0.384 Sum_probs=147.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee------CC
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GP 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 155 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3579999999999999999999 468999999999754 34445678899999999999999999998764 36
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.+|||||||+ |+|.+++. ....+++..++.|+.||+.||.|||++| ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999995 67888883 3467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC----CceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGE----DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+.+... .....+++||+.|+|||++.+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC
Confidence 987432 3344567899999999997653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=306.80 Aligned_cols=171 Identities=23% Similarity=0.262 Sum_probs=147.1
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHH---HHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFT---NEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
..++|++++.||+|+||+||+|+ ..+|+.||||++.+.. ......+. .++.++..++|||||+++++|.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 34679999999999999999999 5579999999986532 11122233 34566777899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+|||||||+||+|..++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999543 46999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+.... ..+++||+.|+|||++..
T Consensus 341 ~~~~~~--~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 341 DFSKKK--PHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp ECSSCC--CCSCCSCGGGCCHHHHST
T ss_pred ecCCCC--CCCccCCcCccCHHHHhC
Confidence 875443 456799999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.66 Aligned_cols=169 Identities=22% Similarity=0.317 Sum_probs=144.0
Q ss_pred hhcCccccceecccCceEEEEEEe----cCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+|+.+|+.+ .|||||+++++|.+++.+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 457899999999999999999973 2467899999865533 24678899999988 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEeccccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARL 237 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~a~~ 237 (266)
+||||+++++|.+++ ..+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999888 24889999999999999999999999 9999999999999876 7899999999986
Q ss_pred CCCCC----------------------------ceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGED----------------------------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ....+.+||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 54321 123455799999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=300.85 Aligned_cols=174 Identities=21% Similarity=0.327 Sum_probs=155.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3679999999999999999999 568999999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC--CCeEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ--LNPKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~--~~~kl~DFG~a~~~~~~ 241 (266)
|+||+|.+++.. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998842 3456999999999999999999999999 9999999999999854 78999999999987644
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
....+.+||+.|+|||++.++.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~ 332 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKP 332 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCC
T ss_pred -CceeeeEECccccCHHHhCCCC
Confidence 3456678999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=270.97 Aligned_cols=183 Identities=27% Similarity=0.448 Sum_probs=145.2
Q ss_pred hHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.+.+..++|++.+.||+|+||+||+|.. +++.||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445567899999999999999999987 6889999998755 344456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++........+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999854322234899999999999999999999986 3499999999999999999999999999987
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
............||+.|+|||++.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp -------------CCTTSCHHHHTTCC
T ss_pred ccccccccccCCCCccccChhhhcCCC
Confidence 665544455668999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.89 Aligned_cols=176 Identities=21% Similarity=0.277 Sum_probs=152.8
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 157 (266)
+..++|++++.||+|+||+||+|+ ..+++.||+|++.... ......+..|..++.++ +||||+++++++.+++..
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 345679999999999999999999 4568899999987542 22334577899999877 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 129 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999888543 46899999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.........+++||+.|+|||++.++.
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~ 229 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGED 229 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCC
T ss_pred cccCCCccccccCCcccCCchhhcCCC
Confidence 655555667789999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.06 Aligned_cols=174 Identities=24% Similarity=0.286 Sum_probs=154.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++++.||+|+||+||+|+ ..+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4679999999999999999999 457999999998754 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999888543 46889999999999999999999998 99999999999999999999999999997655
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
......+.+||+.|+|||++.++.
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~ 181 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSC
T ss_pred CCCcccccccChhhCChhhhcCCC
Confidence 555667789999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=258.92 Aligned_cols=173 Identities=24% Similarity=0.416 Sum_probs=155.8
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||+||+|. ..+++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4579999999999999999998 567999999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999853 25889999999999999999999998 99999999999999999999999999998876666
Q ss_pred eeeeeeEEeeeeCCCccccCC
Q 024537 244 HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e~ 264 (266)
......||+.|+|||++.+..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSC
T ss_pred ccCCccCCcCccChhhhcCCC
Confidence 666778999999999986653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=268.26 Aligned_cols=180 Identities=27% Similarity=0.432 Sum_probs=151.3
Q ss_pred HHhhcCccccceecccCceEEEEEEe--------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
....++|++.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 44557899999999999999999984 23457999999765 344567889999999999 899999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
..++..|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 999999999999999999999865321 235889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccCC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||++.++.+||+|||+|+.+..... ......+|+.|+|||++.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 281 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC
Confidence 9999999999999999987654321 122335677899999886543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.30 Aligned_cols=175 Identities=25% Similarity=0.353 Sum_probs=146.3
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.+..++|++++.||+|+||+||+|+ ..+++.||||++... .....+.+..|..++..+ +||||+++++++.+++.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3456789999999999999999999 457899999998754 233456778999999988 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999988543 46899999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..........+.+||+.|+|||++.+
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 198 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEILQE 198 (353)
T ss_dssp CSCC---------CCGGGCCHHHHHH
T ss_pred ecccCCccccccCCCcCeEChhhcCC
Confidence 76655556677789999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.25 Aligned_cols=175 Identities=24% Similarity=0.240 Sum_probs=143.7
Q ss_pred HHhhcCccccceecccCceEEEEEEec-CCCEEEEEeeccc--ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 157 (266)
....++|+++++||+|+||+||+|+.. +++.||||++... ..........|+..+..+ .||||+++++++.+++..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 334567999999999999999999954 7999999988654 233334555666665555 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 9999999 77888887543 346999999999999999999999998 99999999999999999999999999988
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
...... .....||+.|+|||++.+.
T Consensus 207 ~~~~~~-~~~~~gt~~y~aPE~~~~~ 231 (311)
T 3p1a_A 207 LGTAGA-GEVQEGDPRYMAPELLQGS 231 (311)
T ss_dssp CC-------CCCCCGGGCCGGGGGTC
T ss_pred cccCCC-CcccCCCccccCHhHhcCC
Confidence 754432 3345689999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=265.86 Aligned_cols=172 Identities=25% Similarity=0.320 Sum_probs=133.8
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3457799999999999999999995 468899999987543 2356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a~~~ 238 (266)
||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999884 3356899999999999999999999998 999999999999975 889999999999876
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......||+.|+|||++.+.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~ 225 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGC 225 (349)
T ss_dssp ------------CGGGSCHHHHTTC
T ss_pred Cccc-ccccccCCCCccCHHHhcCC
Confidence 5432 23455789999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=266.72 Aligned_cols=174 Identities=24% Similarity=0.352 Sum_probs=152.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||+||+|. ..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 3679999999999999999998 457899999999877665667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC--CCCeEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~~~~ 241 (266)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988832 3346899999999999999999999998 999999999999974 467999999999987654
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. .....||+.|+|||++.++.
T Consensus 205 ~~-~~~~~gt~~y~aPE~~~~~~ 226 (387)
T 1kob_A 205 EI-VKVTTATAEFAAPEIVDREP 226 (387)
T ss_dssp SC-EEEECSSGGGCCHHHHTTCC
T ss_pred cc-eeeeccCCCccCchhccCCC
Confidence 33 34457899999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.87 Aligned_cols=175 Identities=28% Similarity=0.404 Sum_probs=152.8
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46799999999999999999994 57899999998777777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 456899999999999999999999999 99999999999999999999999999987754332
Q ss_pred ee--------------eeeeEEeeeeCCCccccCC
Q 024537 244 HV--------------NTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 244 ~~--------------~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ....||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 198 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCC
Confidence 21 1457899999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=260.31 Aligned_cols=176 Identities=27% Similarity=0.444 Sum_probs=146.6
Q ss_pred HhhcCccccceecccCceEEEEEEec----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
+..++|++.+.||+|+||+||+|.+. .+..||||++... .....+.+.+|+.+++.++||||+++++++..++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34567999999999999999999853 3446999999765 444557789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999843 3356899999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCceee---eeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHVN---TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~~---~~~~t~~y~aPE~~~~e 263 (266)
+........ ...+|+.|+|||++...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 229 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCC
Confidence 754432222 22345579999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=260.63 Aligned_cols=173 Identities=24% Similarity=0.393 Sum_probs=153.2
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++++.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999994 68999999998654 3445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ......||+.|+|||++.+..
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~ 189 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKK 189 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCC
T ss_pred C-ccccccCCcceeCcccccCCC
Confidence 3 345568999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=265.34 Aligned_cols=168 Identities=26% Similarity=0.377 Sum_probs=142.0
Q ss_pred cceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
.+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5789999999999998 457999999999877666677899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE--cCCCCeEEecccccccCCCCCceeee
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL--DEQLNPKISDFGLARLFPGEDTHVNT 247 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill--~~~~~~kl~DFG~a~~~~~~~~~~~~ 247 (266)
.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+..... ...
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~~~ 247 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKV 247 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-CCC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-ccc
Confidence 8887532 346889999999999999999999998 9999999999999 5677899999999998754433 334
Q ss_pred eeEEeeeeCCCccccCC
Q 024537 248 FRISVVTWPPNMHCMDI 264 (266)
Q Consensus 248 ~~~t~~y~aPE~~~~e~ 264 (266)
..||+.|+|||++..+.
T Consensus 248 ~~gt~~y~aPE~~~~~~ 264 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDF 264 (373)
T ss_dssp CCSSCTTCCHHHHTTCB
T ss_pred ccCCCcEeChhhccCCC
Confidence 46899999999886553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=263.09 Aligned_cols=176 Identities=27% Similarity=0.345 Sum_probs=152.7
Q ss_pred HHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.+..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+..|..++..+ +||||+++++++.+++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45567899999999999999999994 578999999987542 23346678899999876 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999998543 45899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..........+.+||+.|+|||++.++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 193 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQ 193 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred hcccCCCcccCCCCCcccCChhhhcCC
Confidence 765545556677899999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=261.35 Aligned_cols=173 Identities=22% Similarity=0.298 Sum_probs=153.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++++.||+|+||.||+|+. .+++.||+|++... .......+..|..++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 45799999999999999999994 57899999999754 344456788999999987 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999988543 46899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+..||+.|+|||++.++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred CCCCcccccCCCccccCccccCCC
Confidence 555556677899999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=270.56 Aligned_cols=179 Identities=20% Similarity=0.218 Sum_probs=153.4
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
...+....++|++++.||+|+||+||+|+. .+++.||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344556678899999999999999999994 4688999999865321 122347789999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999853 2356999999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGEDT-HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~ 261 (266)
+|+.+..... ......||+.|+|||++.
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHh
Confidence 9987754433 233468999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=256.28 Aligned_cols=177 Identities=21% Similarity=0.350 Sum_probs=147.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE------ 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 156 (266)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35699999999999999999995 489999999987543 3345778999999999999999999999866542
Q ss_pred ---------------------------------------------------EEEEEeccCCCCHHHHHhhcCCCCCcCHH
Q 024537 157 ---------------------------------------------------KMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185 (266)
Q Consensus 157 ---------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 185 (266)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999765544556777
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc------------eeeeeeEEee
Q 024537 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT------------HVNTFRISVV 253 (266)
Q Consensus 186 ~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~~t~~ 253 (266)
.++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 99999999999999999999999999998765421 2233468999
Q ss_pred eeCCCccccCC
Q 024537 254 TWPPNMHCMDI 264 (266)
Q Consensus 254 y~aPE~~~~e~ 264 (266)
|+|||++.+..
T Consensus 242 y~aPE~~~~~~ 252 (332)
T 3qd2_B 242 YMSPEQIHGNN 252 (332)
T ss_dssp GSCHHHHHCCC
T ss_pred ccChHHhcCCC
Confidence 99999987643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=260.38 Aligned_cols=170 Identities=29% Similarity=0.422 Sum_probs=145.2
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc----EEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----KML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~l 159 (266)
..++|++.+.||+|+||+||+|++ .++.||||++...... ......|+.++.+++||||+++++++..+.. .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 346799999999999999999987 4789999999765433 2455669999999999999999999987543 699
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc----------CCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE----------APARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~----------~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999843 3489999999999999999999998 7 999999999999999999999
Q ss_pred ecccccccCCCCCc--eeeeeeEEeeeeCCCcccc
Q 024537 230 SDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 230 ~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
+|||+|+.+..... ......||+.|+|||++.+
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred ccCCcccccccccCccccccCccCccccCHhhccc
Confidence 99999987654322 2233578999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=268.25 Aligned_cols=179 Identities=21% Similarity=0.233 Sum_probs=154.6
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
.....+..++|++++.||+|+||+||+|+. .+++.||||++.... ......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 444556678899999999999999999994 579999999987532 2223457889999999999999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..|+||||++||+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998543 246899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGEDT-HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~ 261 (266)
+|+.+..... .....+||+.|+|||++.
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHh
Confidence 9988765433 233568999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=269.36 Aligned_cols=178 Identities=22% Similarity=0.238 Sum_probs=153.0
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
+.+....++|++++.||+|+||+||+|+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34455567899999999999999999994 4789999999865321 1223477899999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeEEeeeeCCCccccC
Q 024537 235 ARLFPGEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 235 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
|+.+..... ...+.+||+.|+|||++...
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 244 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTT
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhcc
Confidence 988754432 33467899999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.99 Aligned_cols=177 Identities=25% Similarity=0.295 Sum_probs=153.1
Q ss_pred HHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.+..++|++++.||+|+||+||+|+. .+++.||||++.... ....+.+..|..++..+ .||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34457899999999999999999995 458899999987542 23356778899999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999998543 45899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..........+.+||+.|+|||++..+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (353)
T 2i0e_A 170 ENIWDGVTTKTFCGTPDYIAPEIIAYQP 197 (353)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred ccccCCcccccccCCccccChhhhcCCC
Confidence 7655555566778999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=262.22 Aligned_cols=172 Identities=27% Similarity=0.415 Sum_probs=151.9
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++++.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34679999999999999999999 4578999999986542 2335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+.||+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999998843 456999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.. ....+..||+.|+|||++..
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCC
T ss_pred CC-CceeccCCCccccCCeeecc
Confidence 43 33456789999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=253.61 Aligned_cols=173 Identities=24% Similarity=0.393 Sum_probs=147.5
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..++|++++.||+|+||+||+|+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 346799999999999999999998789999999987542 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++ +|.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99975 77777643 3356899999999999999999999998 999999999999999999999999999987655
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
........+|+.|+|||++.+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTT
T ss_pred cccccCCcccCCcCCHHHhcC
Confidence 555555678999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=251.06 Aligned_cols=172 Identities=23% Similarity=0.405 Sum_probs=148.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++++.||+|+||+||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999994 57899999998754 23334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++ ++...+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55454432 2456999999999999999999999998 9999999999999999999999999999876555
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+|+.|+|||++.+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTC
T ss_pred ccccCCccccCCcChHHHcCC
Confidence 555666789999999988653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=257.37 Aligned_cols=171 Identities=26% Similarity=0.343 Sum_probs=150.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++++.||+|+||+||+|+ ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4679999999999999999999 4579999999987542 23356778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999854 346899999999999999999999998 99999999999999999999999999998643
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ..+..||+.|+|||++..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~ 179 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKP 179 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCC
T ss_pred c---cccccCCccccCHhHhcCCC
Confidence 3 34568999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=260.70 Aligned_cols=180 Identities=28% Similarity=0.426 Sum_probs=152.2
Q ss_pred HHhhcCccccceecccCceEEEEEEec--------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
++..++|++.+.||+|+||+||+|... .+..||||++... .......+.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445678999999999999999999842 2357999998765 344557789999999999 899999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
..++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999965431 245899999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||++.++.+||+|||+|+.+.... .......+|+.|+|||++.+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC
Confidence 999999999999999998775432 2223345678899999886653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=258.81 Aligned_cols=177 Identities=20% Similarity=0.300 Sum_probs=152.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-----hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+.|++.+.||+|+||+||+|. ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4569999999999999999998 4578999999986432 113567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEecccc
Q 024537 159 LVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGL 234 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG~ 234 (266)
+||||+++++|.+.+... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777543 23346899999999999999999999998 999999999999987655 99999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.+...........||+.|+|||++..+.
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 209 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREP 209 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCC
Confidence 998866554455667999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=257.34 Aligned_cols=173 Identities=24% Similarity=0.335 Sum_probs=151.3
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh------hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.+.|++.+.||+|+||+||+|. ..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999 457999999998765321 346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG 233 (266)
++||||+++++|.+++. ....+++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999983 3456899999999999999999999998 99999999999998877 79999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+.+.... ......||+.|+|||++..+.
T Consensus 165 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 194 (361)
T 2yab_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEP 194 (361)
T ss_dssp SCEECCTTC-CCCCCCSCGGGCCHHHHTTCC
T ss_pred CceEcCCCC-ccccCCCCccEECchHHcCCC
Confidence 999875433 234557999999999987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=258.22 Aligned_cols=176 Identities=26% Similarity=0.333 Sum_probs=141.8
Q ss_pred HhhcCccccceecccCceEEEEEEe----cCCCEEEEEeecccC----hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
+..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 3456799999999999999999985 478999999987542 23345677899999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999988543 45889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.............||+.|+|||++....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMRSG 197 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTTSC
T ss_pred ccccccCCccccccCCCcCccCHhhCcCCC
Confidence 987654444445667899999999986643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=264.72 Aligned_cols=175 Identities=25% Similarity=0.292 Sum_probs=144.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHH-HHhcCCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKL-LLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|++++.||+|+||+||+|+ ..+++.||||++.... ......+..|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 45679999999999999999999 4568899999987542 2233456677776 56789999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||++||+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999988543 46889999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCceeeeeeEEeeeeCCCccccCC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
........+.+||+.|+|||++.++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQP 215 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCC
T ss_pred ccCCCccccccCCccccCHHHhCCCC
Confidence 55555566778999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=255.72 Aligned_cols=179 Identities=27% Similarity=0.428 Sum_probs=148.7
Q ss_pred HHhhcCccccceecccCceEEEEEEe--------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
.+..++|++.+.||+|+||.||+|.. .++..||||++... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34457899999999999999999985 35678999998765 344567788999999999 899999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999865321 234889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEecccccccCCCCCce--eeeeeEEeeeeCCCccccC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
||++.++.+||+|||+++........ .....+++.|+|||++...
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 234 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence 99999999999999999877544321 2223456789999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=250.80 Aligned_cols=175 Identities=26% Similarity=0.402 Sum_probs=146.9
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++++.||+|+||.||+|+ ..+++.||+|.+... .......+.+|+.++..++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35679999999999999999998 457899999998543 34445778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998543 46899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCC-ceeeeeeEEeeeeCCCccccCC
Q 024537 240 GED-THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~-~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... .......||+.|+|||++.++.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEA 188 (294)
T ss_dssp ------------CCSSCCHHHHHTCC
T ss_pred cccccccCccccCccccCHhHhcCCC
Confidence 432 2334457899999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=250.82 Aligned_cols=172 Identities=25% Similarity=0.351 Sum_probs=146.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--------------------------hhHHHHHHHHHHHH
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--------------------------QGLREFTNEVKLLL 137 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 137 (266)
.++|++.+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4679999999999999999998 45789999999865421 11356789999999
Q ss_pred hcCCCCceeEEeEEee--CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCC
Q 024537 138 KIQHKNLVTLFGCCAE--GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK 215 (266)
Q Consensus 138 ~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlK 215 (266)
.++||||+++++++.. .+..++||||+++++|.+++ ....+++..++.++.|++.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999997654 3356899999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 216 ASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 216 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|+|||++.++.+||+|||+++.+...........||+.|+|||++...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 212 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC
Confidence 999999999999999999999886665555666899999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=254.47 Aligned_cols=181 Identities=38% Similarity=0.663 Sum_probs=156.0
Q ss_pred hHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.+....++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34445688999999999999999999987899999999887666666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 160 VYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998884332 1235899999999999999999999998 999999999999999999999999999875
Q ss_pred CCC--CceeeeeeEEeeeeCCCccccC
Q 024537 239 PGE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
... ........||+.|+|||++...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 216 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKG 216 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHC
T ss_pred ccccccccccccCCCccccCHHHhcCC
Confidence 432 2223345689999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=251.73 Aligned_cols=169 Identities=25% Similarity=0.362 Sum_probs=151.7
Q ss_pred ccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999954 7999999999876655567888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCceee
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 246 (266)
++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999883 246899999999999999999999998 99999999999999999999999999998766554555
Q ss_pred eeeEEeeeeCCCccccC
Q 024537 247 TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 247 ~~~~t~~y~aPE~~~~e 263 (266)
...||+.|+|||++...
T Consensus 200 ~~~gt~~y~aPE~~~~~ 216 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRS 216 (321)
T ss_dssp CCCSCGGGCCHHHHTTC
T ss_pred cccCCccccCHhhhcCC
Confidence 66899999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=250.59 Aligned_cols=172 Identities=23% Similarity=0.309 Sum_probs=150.8
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||+||+|. ..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4679999999999999999999 45788999999876543 346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC--CCCeEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~~~~ 241 (266)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998832 2346899999999999999999999998 999999999999987 789999999999987654
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ......+|+.|+|||++..+
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTC
T ss_pred C-ccccccCChhhcCcHHhcCC
Confidence 3 34556789999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=271.31 Aligned_cols=176 Identities=24% Similarity=0.289 Sum_probs=143.1
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.+..++|++++.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 3455789999999999999999999 557999999998753 233345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
++||||+++++|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+
T Consensus 224 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999888543 468999999999999999999998 88 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.............||+.|+|||++.+.
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 324 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDN 324 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTS
T ss_pred eccCCCcccccccCCccccCHhhcCCC
Confidence 866555556677899999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=256.73 Aligned_cols=180 Identities=24% Similarity=0.270 Sum_probs=152.9
Q ss_pred cchhhHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-----CCCceeEEe
Q 024537 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----HKNLVTLFG 149 (266)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~ 149 (266)
+.........++|++++.||+|+||+||+|+. .+++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34455556678899999999999999999994 57899999998743 333456778999999986 999999999
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC------
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE------ 223 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~------ 223 (266)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 99999998543 3346899999999999999999999998 999999999999975
Q ss_pred -------------------CCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 224 -------------------QLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 224 -------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.+||+|||+|+...... ....||+.|+|||++.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCC
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcCCC
Confidence 7889999999998764433 3457899999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=265.58 Aligned_cols=175 Identities=22% Similarity=0.324 Sum_probs=152.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
..++|++.+.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35679999999999999999998 4578999999987653 33456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc---CCCCeEEeccccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARL 237 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~---~~~~~kl~DFG~a~~ 237 (266)
|||+++|+|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999888543 45899999999999999999999999 99999999999998 457899999999998
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+...........||+.|+|||++.++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDP 189 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCC
T ss_pred ecCCCceeecccCCcccCCHHHhcCCC
Confidence 876665556678999999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=257.89 Aligned_cols=170 Identities=22% Similarity=0.297 Sum_probs=150.6
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++++.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46799999999999999999994 579999999986542 23356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998543 45899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ..+..||+.|+|||++.++
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~ 213 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSK 213 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTC
T ss_pred C---cccccCCccccCHHHhcCC
Confidence 3 3456899999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=259.68 Aligned_cols=166 Identities=33% Similarity=0.518 Sum_probs=144.7
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+.|++++.||+|+||+||+|+ ..+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458999999999999999999 4688999999987542 333467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+. |++.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 5777776432 356899999999999999999999998 999999999999999999999999999876543
Q ss_pred CceeeeeeEEeeeeCCCccc
Q 024537 242 DTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~ 261 (266)
....||+.|+|||++.
T Consensus 208 ----~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp ----CCCCSCGGGCCHHHHH
T ss_pred ----CcccCCcceeCHhhhc
Confidence 2457899999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=256.69 Aligned_cols=174 Identities=24% Similarity=0.346 Sum_probs=151.0
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
..++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34679999999999999999998 457899999999754 344557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---CeEEeccccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARL 237 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl~DFG~a~~ 237 (266)
|||+++++|.+.+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998883 3356899999999999999999999998 99999999999998654 599999999988
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.... ......||+.|+|||++..+.
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~ 206 (362)
T 2bdw_A 181 VNDSE-AWHGFAGTPGYLSPEVLKKDP 206 (362)
T ss_dssp CTTCC-SCCCSCSCTTTCCHHHHTTCC
T ss_pred ecCCc-ccccCCCCccccCHHHHccCC
Confidence 76433 234567999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=253.60 Aligned_cols=186 Identities=41% Similarity=0.714 Sum_probs=159.4
Q ss_pred cccchhhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 74 ~~~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
..+...++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34677889999999999999999999999999977899999999876532 22236789999999999999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhc---CCCCeEeCCCCCCceEEcCCCCeE
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEE---APARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~---~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
.++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999986543 234589999999999999999999999 7 99999999999999999999
Q ss_pred EecccccccCCCCC-ceeeeeeEEeeeeCCCcccc
Q 024537 229 ISDFGLARLFPGED-THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 229 l~DFG~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+|||+|+...... .......||+.|+|||++..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhcc
Confidence 99999999875433 33344458999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=250.91 Aligned_cols=168 Identities=30% Similarity=0.490 Sum_probs=142.6
Q ss_pred ccccceecccCceEEEEEEe-----cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML 159 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 159 (266)
|++++.||+|+||+||+|.+ .+++.||||++.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999998863 268899999997653 34457789999999999999999999999884 56899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 24889999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCce---eeeeeEEeeeeCCCcccc
Q 024537 240 GEDTH---VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~---~~~~~~t~~y~aPE~~~~ 262 (266)
..... .....+++.|+|||++.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcC
Confidence 54321 223356677999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=261.94 Aligned_cols=179 Identities=30% Similarity=0.420 Sum_probs=148.2
Q ss_pred HHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
++..++|++.+.||+|+||+||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344577999999999999999999842 4668999998654 344456788999999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcC----CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---Ce
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NP 227 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~ 227 (266)
+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999986532 2246899999999999999999999999 99999999999999555 59
Q ss_pred EEecccccccCCCC--CceeeeeeEEeeeeCCCccccC
Q 024537 228 KISDFGLARLFPGE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 228 kl~DFG~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
||+|||+|+.+... ........+|+.|+|||++...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 261 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence 99999999854211 1222334578899999987544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.74 Aligned_cols=169 Identities=22% Similarity=0.367 Sum_probs=143.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 156 (266)
.++|++++.||+|+||+||+|+ ..+++.||||++... .......+.+|+.+++.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4679999999999999999998 457889999999753 444567889999999999999999999999876 56
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999985 699888843 356899999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCc----------------------eeeeeeEEeeeeCCCcc
Q 024537 237 LFPGEDT----------------------HVNTFRISVVTWPPNMH 260 (266)
Q Consensus 237 ~~~~~~~----------------------~~~~~~~t~~y~aPE~~ 260 (266)
....... ......||+.|+|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 8754321 23566889999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=253.82 Aligned_cols=173 Identities=28% Similarity=0.392 Sum_probs=147.6
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++++.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999994 4789999999875532 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC-
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE- 241 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~- 241 (266)
|+++++|.+++ .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 ~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGS---BTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999998887 33456999999999999999999999998 999999999999999999999999999876422
Q ss_pred -CceeeeeeEEeeeeCCCccccC
Q 024537 242 -DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 -~~~~~~~~~t~~y~aPE~~~~e 263 (266)
........||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~ 182 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRR 182 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCS
T ss_pred cccccCCCccCcCccCcHHhccC
Confidence 2223456789999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=249.02 Aligned_cols=174 Identities=24% Similarity=0.379 Sum_probs=144.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|.+.+.||+|+||+||+|. ..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 469999999999999999998 4578999999987553 33457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCC
Q 024537 164 LPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP 239 (266)
Q Consensus 164 ~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~ 239 (266)
+++++|.+.+... .....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887543 23456899999999999999999999998 9999999999999 456789999999998775
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... .....+|+.|+|||++..+
T Consensus 179 ~~~~-~~~~~~t~~y~aPE~~~~~ 201 (285)
T 3is5_A 179 SDEH-STNAAGTALYMAPEVFKRD 201 (285)
T ss_dssp ---------CTTGGGCCHHHHTTC
T ss_pred Cccc-CcCcccccCcCChHHhccC
Confidence 4432 3345788999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=249.34 Aligned_cols=171 Identities=25% Similarity=0.427 Sum_probs=144.3
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++++.||+|+||+||+|+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999987899999999875532 2236778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++ +|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 965 88888743 2356889999999999999999999998 99999999999999999999999999987755444
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+|+.|+|||++.+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp ------CCCTTCCHHHHTT
T ss_pred ccccccccccccCchheeC
Confidence 4455578999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.42 Aligned_cols=177 Identities=28% Similarity=0.418 Sum_probs=155.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+..|+.+++.++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999994 579999999986542 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCC-CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||++||+|..++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998854322 346999999999999999999999998 9999999999999999999999999999886
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..........||+.|+|||++.++.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~ 365 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEE 365 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCC
T ss_pred CCCcccccccCCccccChhhhcCCC
Confidence 6555555678999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=249.71 Aligned_cols=173 Identities=24% Similarity=0.339 Sum_probs=150.2
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3569999999999999999999 45789999999875422 1356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG 233 (266)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999983 3456899999999999999999999998 99999999999999887 79999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+.+.... ......||+.|+|||++..+.
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 193 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEP 193 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCC
Confidence 999875433 233457899999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=250.14 Aligned_cols=174 Identities=26% Similarity=0.481 Sum_probs=136.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++++.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 3579999999999999999998 4578999999987553 2234667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcC---CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|++ ++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 58888875432 2245889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
..........+|+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTT
T ss_pred CCcccCCCCcccccccCchHhhC
Confidence 55444455678999999999865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=248.74 Aligned_cols=173 Identities=28% Similarity=0.377 Sum_probs=149.6
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC--cEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv 160 (266)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 46799999999999999999994 468999999987543 333567789999999999999999999998765 77999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE----cCCCCeEEecccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLAR 236 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill----~~~~~~kl~DFG~a~ 236 (266)
|||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976554455999999999999999999999998 9999999999999 777889999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
.+...... ....||+.|+|||++.
T Consensus 165 ~~~~~~~~-~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 165 ELEDDEQF-VSLYGTEEYLHPDMYE 188 (319)
T ss_dssp ECCTTCCB-CCCCSCGGGCCHHHHH
T ss_pred ecCCCCce-eecccCCCccCHHHhh
Confidence 87654432 3457899999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=264.29 Aligned_cols=173 Identities=27% Similarity=0.387 Sum_probs=147.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh-------------hhHHHHHHHHHHHHhcCCCCceeEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-------------QGLREFTNEVKLLLKIQHKNLVTLFG 149 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~ 149 (266)
..++|++++.||+|+||+||+|. ..+++.||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35679999999999999999999 45789999999875421 23467889999999999999999999
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---C
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---N 226 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~ 226 (266)
++.+++..++||||+++++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999998888543 45899999999999999999999998 99999999999998776 6
Q ss_pred eEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+|+.+.... ......||+.|+|||++.+.
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 223 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKKK 223 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTTC
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhccC
Confidence 9999999999875543 33455799999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.40 Aligned_cols=171 Identities=25% Similarity=0.339 Sum_probs=144.3
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcC--CCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++++.||+|+||+||+|...+++.||||++... .......+.+|+.++..+. ||||+++++++..++..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34569999999999999999999777999999998654 3445678899999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 134 v~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 5688999998543 46888899999999999999999998 99999999999995 5789999999999875
Q ss_pred CCCc--eeeeeeEEeeeeCCCcccc
Q 024537 240 GEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
.... ......||+.|+|||++..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHC
T ss_pred CCCccccCCCCCcCCCccChHHhhh
Confidence 4332 2234579999999999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=254.19 Aligned_cols=185 Identities=28% Similarity=0.404 Sum_probs=154.3
Q ss_pred cchhhHHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeE
Q 024537 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTL 147 (266)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l 147 (266)
++...+++..++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45666777889999999999999999999973 24578999999764 344456789999999999 78999999
Q ss_pred EeEEeeCCc-EEEEEeccCCCCHHHHHhhcCC------------------------------------------------
Q 024537 148 FGCCAEGPE-KMLVYEYLPNKSLDYFIFDKTK------------------------------------------------ 178 (266)
Q Consensus 148 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 178 (266)
++++...+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988655 8999999999999999865322
Q ss_pred ---------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC-
Q 024537 179 ---------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED- 242 (266)
Q Consensus 179 ---------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~- 242 (266)
...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112889999999999999999999998 9999999999999999999999999998764332
Q ss_pred -ceeeeeeEEeeeeCCCccccC
Q 024537 243 -THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 -~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+|+.|+|||++.+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~ 270 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDR 270 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHC
T ss_pred chhccccCCCceeEChhhhcCC
Confidence 233455778889999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.88 Aligned_cols=170 Identities=19% Similarity=0.330 Sum_probs=133.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 156 (266)
.++|++++.||+|+||+||+|+ ..+++.||||++... .......+.+|+.+|+.++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3679999999999999999998 457899999998653 444567788999999999999999999999543 56
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+ +++|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 678888884 3356999999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCC---------------------------ceeeeeeEEeeeeCCCccc
Q 024537 237 LFPGED---------------------------THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 237 ~~~~~~---------------------------~~~~~~~~t~~y~aPE~~~ 261 (266)
.+.... .......||+.|+|||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 874322 1234457799999999763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.87 Aligned_cols=180 Identities=18% Similarity=0.159 Sum_probs=151.3
Q ss_pred hhHHHhhcCccccceecccCceEEEEEE------ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC---CCCceeEEe
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFG 149 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~ 149 (266)
..++...++|.+.+.||+|+||+||+|. ..+++.||||++..... ..+..|+.++..+. |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445566789999999999999999993 45788999999976544 35667888887776 999999999
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcC--CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC----
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKT--KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---- 223 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---- 223 (266)
++..++..++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 9999999999999999999999986422 3457999999999999999999999998 999999999999988
Q ss_pred -------CCCeEEecccccccCC--CCCceeeeeeEEeeeeCCCccccCC
Q 024537 224 -------QLNPKISDFGLARLFP--GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 224 -------~~~~kl~DFG~a~~~~--~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.+||+|||+|+.+. ..........||+.|+|||++.+..
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC
Confidence 8999999999997543 2334445567899999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=253.87 Aligned_cols=172 Identities=25% Similarity=0.373 Sum_probs=149.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||+||+|. ..+++.||||++.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3679999999999999999999 4688999999986542 12235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+ +|+|.+++... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78888887543 46899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ...+.+||+.|+|||++.+..
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~ 183 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKL 183 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSG
T ss_pred Cc-ccccccCCcCcCCHHHHcCCC
Confidence 33 334557999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.21 Aligned_cols=174 Identities=28% Similarity=0.436 Sum_probs=148.9
Q ss_pred hcCccccceecccCceEEEEEEe-----cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 157 (266)
.++|++++.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++.. .+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35699999999999999999983 4688999999988777777789999999999999999999999874 4568
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCce---eeeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTH---VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~---~~~~~~t~~y~aPE~~~~e 263 (266)
....... .....+|..|+|||++.++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDN 205 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred cccCCccceeeccCCccccccCHHHhccC
Confidence 7544322 1223466779999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.40 Aligned_cols=168 Identities=17% Similarity=0.240 Sum_probs=139.5
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccC--------hhhHHHHHHHHHHHHhcC---------CCCcee
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQ---------HKNLVT 146 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~ 146 (266)
..++|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346799999999999999999998 78999999997542 223467889999998886 777777
Q ss_pred EEeEEe-----------------e-------------CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHH
Q 024537 147 LFGCCA-----------------E-------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196 (266)
Q Consensus 147 l~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 196 (266)
+.+.+. + .+..|+||||+++|++.+.+. ...+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 766643 2 678999999999997655542 246899999999999999
Q ss_pred HHHHHh-hcCCCCeEeCCCCCCceEEcCCC--------------------CeEEecccccccCCCCCceeeeeeEEeeee
Q 024537 197 GLLYLH-EEAPARIIHRDIKASNILLDEQL--------------------NPKISDFGLARLFPGEDTHVNTFRISVVTW 255 (266)
Q Consensus 197 al~yLH-~~~~~~iiHrDlKp~Nill~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~ 255 (266)
||.||| +++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~ 244 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeeccc
Confidence 999999 898 99999999999999887 8999999999976432 347999999
Q ss_pred CCCccccCC
Q 024537 256 PPNMHCMDI 264 (266)
Q Consensus 256 aPE~~~~e~ 264 (266)
|||++.++.
T Consensus 245 aPE~~~g~~ 253 (336)
T 2vuw_A 245 DEDLFTGDG 253 (336)
T ss_dssp CSGGGCCCS
T ss_pred ChhhhcCCC
Confidence 999997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=246.20 Aligned_cols=172 Identities=23% Similarity=0.344 Sum_probs=143.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36799999999999999999995 468999999886543 333566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988873 2356899999999999999999999998 999999999999999999999999999988755
Q ss_pred CceeeeeeEEeeeeCCCcccc
Q 024537 242 DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~ 262 (266)
........+|+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp ----------GGGCCHHHHHT
T ss_pred ccccCCCcCCccccChHHHhc
Confidence 555556688999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.28 Aligned_cols=177 Identities=21% Similarity=0.249 Sum_probs=144.2
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-----ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
...++|++.+.||+|+||+||+|. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 345679999999999999999998 457889999998654 23445778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcC-------------------------------------CCCCcCHHHHHHHHHHHHHHHH
Q 024537 157 KMLVYEYLPNKSLDYFIFDKT-------------------------------------KSSSLDWTTRYRIVMGVARGLL 199 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~qi~~al~ 199 (266)
.++||||+++++|.+++.... ....+++..++.++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999884210 0123467788899999999999
Q ss_pred HHhhcCCCCeEeCCCCCCceEEcCCC--CeEEecccccccCCCCC----ceeeeeeEEeeeeCCCcccc
Q 024537 200 YLHEEAPARIIHRDIKASNILLDEQL--NPKISDFGLARLFPGED----THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 200 yLH~~~~~~iiHrDlKp~Nill~~~~--~~kl~DFG~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~ 262 (266)
|||+++ |+||||||+|||++.++ .+||+|||+|+.+.... .......||+.|+|||++..
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 999998 99999999999998776 89999999998753221 12345578999999998854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=262.40 Aligned_cols=173 Identities=25% Similarity=0.299 Sum_probs=148.4
Q ss_pred hhcCccccceecccCceEEEEEEe----cCCCEEEEEeecccC----hhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG 154 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 154 (266)
..++|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++..+ .||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346799999999999999999985 478999999986432 12234566899999999 699999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998543 35889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCC-CceeeeeeEEeeeeCCCcccc
Q 024537 235 ARLFPGE-DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 235 a~~~~~~-~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+.+... ........||+.|+|||++.+
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcC
Confidence 9876433 223344578999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=250.39 Aligned_cols=181 Identities=23% Similarity=0.343 Sum_probs=148.2
Q ss_pred hhHHHhhcCcccc-ceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcC-CCCceeEEeEEee
Q 024537 79 RTLQVATNFFSDL-NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE 153 (266)
Q Consensus 79 ~~~~~~~~~y~~~-~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 153 (266)
...+...++|.+. +.||+|+||+||+|. ..+++.||+|++.... ......+.+|+.++..+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345556678887 899999999999998 4479999999987542 233567889999999995 6999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEe
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKIS 230 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~ 230 (266)
.+..++||||+++++|.+++.. .....+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999888733 23457899999999999999999999998 999999999999988 7899999
Q ss_pred cccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 231 DFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|||+++.+..... .....||+.|+|||++....
T Consensus 177 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 209 (327)
T 3lm5_A 177 DFGMSRKIGHACE-LREIMGTPEYLAPEILNYDP 209 (327)
T ss_dssp CGGGCEEC----------CCCGGGCCHHHHTTCC
T ss_pred eCccccccCCccc-cccccCCcCccCCeeecCCC
Confidence 9999998754432 34457899999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=273.51 Aligned_cols=177 Identities=25% Similarity=0.298 Sum_probs=153.5
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 156 (266)
.+..++|++++.||+|+||+||+|+ ..+++.||||++... .....+.+..|..++..+ .||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3456789999999999999999999 457889999998754 223346678899999887 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+||||||+++|+|..++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998543 46899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..........++.||+.|+|||++..+.
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 518 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQP 518 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCC
T ss_pred ccccCCcccccccCCCcccCHhhhcCCC
Confidence 7655555567789999999999987653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=265.63 Aligned_cols=176 Identities=29% Similarity=0.376 Sum_probs=152.9
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+..++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4456799999999999999999994 579999999986542 223456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||++||+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999988543 2345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..... .....||+.|+|||++.++
T Consensus 337 ~~~~~-~~~~~GT~~Y~APEvl~~~ 360 (576)
T 2acx_A 337 PEGQT-IKGRVGTVGYMAPEVVKNE 360 (576)
T ss_dssp CTTCC-EECCCSCGGGCCHHHHTTC
T ss_pred ccCcc-ccccCCCccccCHHHHcCC
Confidence 54433 3455899999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=247.17 Aligned_cols=164 Identities=25% Similarity=0.323 Sum_probs=125.8
Q ss_pred cceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 91 LNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
.+.||+|+||+||+|.. .+++.||||++.... ...+.+|+.+++.+. ||||+++++++.+++..++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999994 578999999986542 346678999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---CeEEecccccccCCCCCcee
Q 024537 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARLFPGEDTHV 245 (266)
Q Consensus 169 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl~DFG~a~~~~~~~~~~ 245 (266)
|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.........
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9999854 356899999999999999999999998 99999999999998765 79999999999877666666
Q ss_pred eeeeEEeeeeCCCccccC
Q 024537 246 NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 ~~~~~t~~y~aPE~~~~e 263 (266)
....+|+.|+|||++...
T Consensus 167 ~~~~~t~~y~aPE~~~~~ 184 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN 184 (325)
T ss_dssp -----------------C
T ss_pred cccCCCcCccCHHHhcCC
Confidence 677889999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.58 Aligned_cols=177 Identities=29% Similarity=0.497 Sum_probs=146.1
Q ss_pred HhhcCccccceecccCceEEEEEEe-----cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--C
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--P 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~ 155 (266)
+..++|++++.||+|+||+||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3457799999999999999999983 36889999999877777778899999999999999999999998654 5
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 589999999999999998543 335899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCc---eeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDT---HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.+..... ......++..|+|||++....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCC
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence 98754322 112223556799999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=252.79 Aligned_cols=171 Identities=19% Similarity=0.208 Sum_probs=140.1
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||+||+|+. .+++.||||++...... .+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46799999999999999999994 47999999998765332 25678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC--eEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~--~kl~DFG~a~~~~~~ 241 (266)
+++++|.+++... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|||+|+.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999988543 45899999999999999999999999 999999999999987765 999999999854332
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ......||+.|+|||++.+.
T Consensus 172 ~-~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 172 S-QPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp ----------CTTSCHHHHHCS
T ss_pred C-CCCCCcCCCCcCChhhhcCC
Confidence 2 23445799999999988654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=244.33 Aligned_cols=175 Identities=26% Similarity=0.490 Sum_probs=149.7
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 345679999999999999999999878889999999765433 3578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 86 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999843 3346899999999999999999999999 9999999999999999999999999998764332
Q ss_pred -ceeeeeeEEeeeeCCCccccC
Q 024537 243 -THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 -~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~ 182 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFS 182 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHC
T ss_pred cccccCcccccccCCHHHhcCC
Confidence 112223456789999987644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=239.89 Aligned_cols=173 Identities=27% Similarity=0.419 Sum_probs=134.2
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5699999999999999999984 5799999999865421 22467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999853 2356899999999999999999999998 999999999999999999999999999987654
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
........+|+.|+|||++.+.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~ 187 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRS 187 (278)
T ss_dssp ----------------------
T ss_pred CCcceeccCCCCcCCcchhcCC
Confidence 4444556789999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=260.45 Aligned_cols=173 Identities=27% Similarity=0.424 Sum_probs=152.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999994 479999999987542 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999983 3456999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ...+.+||+.|+|||++.+..
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~ 191 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRL 191 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCC
T ss_pred cc-cccccCCCcCeEChhhccCCC
Confidence 33 344568999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=241.36 Aligned_cols=174 Identities=27% Similarity=0.440 Sum_probs=149.6
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..++|++.+.||+|+||.||+|...++..||+|++...... ...+.+|+.++..++||||+++++++..++..++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 345779999999999999999999878889999999765432 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999998543 345899999999999999999999998 9999999999999999999999999998775443
Q ss_pred ce-eeeeeEEeeeeCCCcccc
Q 024537 243 TH-VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~-~~~~~~t~~y~aPE~~~~ 262 (266)
.. .....+|+.|+|||++..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~ 179 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHY 179 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhc
Confidence 22 222244567999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=252.88 Aligned_cols=175 Identities=28% Similarity=0.459 Sum_probs=138.5
Q ss_pred hhcCccccceecccCceEEEEEEec----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3467999999999999999999853 5778999998765 3445577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999853 3346899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCceee---eeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVN---TFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~---~~~~t~~y~aPE~~~~e 263 (266)
........ ...+++.|+|||++...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp ----------------CTTSCHHHHHHC
T ss_pred ccCCccceeccCCCcCCCccChhhhccC
Confidence 54432211 12345679999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=244.87 Aligned_cols=176 Identities=26% Similarity=0.454 Sum_probs=147.4
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+..++|++++.||+|+||+||+|.+.++..||+|++...... .+.+.+|+.++..++||||+++++++..++..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4456789999999999999999999888889999999765433 357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999998542 345899999999999999999999998 999999999999999999999999999876433
Q ss_pred C-ceeeeeeEEeeeeCCCccccC
Q 024537 242 D-THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~-~~~~~~~~t~~y~aPE~~~~e 263 (266)
. .......+|+.|+|||++...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~ 196 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYS 196 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHC
T ss_pred ccccccCCccCcccCCHHHhccC
Confidence 2 111222456789999987644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=249.08 Aligned_cols=174 Identities=21% Similarity=0.343 Sum_probs=141.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE---- 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 156 (266)
.++|++.+.||+|+||.||+|+ ..+++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4679999999999999999999 468899999999764 33445678899999999999999999999876654
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999998543 46899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCC---ceeeeeeEEeeeeCCCccccCC
Q 024537 237 LFPGED---THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 237 ~~~~~~---~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.+.... .......||+.|+|||++.++.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp -----------------CCTTCCHHHHHTCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCC
Confidence 765432 2233456899999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.62 Aligned_cols=173 Identities=21% Similarity=0.288 Sum_probs=152.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999994 46889999998654 334557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988543 46889999999999999999999998 99999999999999999999999999998765
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........+|+.|+|||++...
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~ 216 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKK 216 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTS
T ss_pred CcccccccCCCccccCHHHhccC
Confidence 54445566789999999988654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=249.61 Aligned_cols=174 Identities=22% Similarity=0.355 Sum_probs=150.6
Q ss_pred HHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--------hhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
....++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++ .||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34456799999999999999999995 479999999986542 11245678999999999 799999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.| |+|+||||+|||++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999998543 46899999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
||++..+.... ......||+.|+|||++.+
T Consensus 244 fG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 244 FGFSCHLEPGE-KLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHHH
T ss_pred cCcccccCCCc-ccccCCCCCCccChhhccc
Confidence 99998876443 2345679999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=246.92 Aligned_cols=175 Identities=29% Similarity=0.506 Sum_probs=148.3
Q ss_pred hhcCccccceecccCceEEEEEEe-----cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC--c
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--E 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~ 156 (266)
..++|++++.||+|+||.||+|++ .+++.||||++........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 356699999999999999999983 368899999998776666778999999999999999999999987654 6
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999998543 346899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCcee---eeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHV---NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~---~~~~~t~~y~aPE~~~~e 263 (266)
......... ....++..|+|||++.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred hccccccccccccCCCCceeEECchhhcCC
Confidence 876543321 122456679999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=250.92 Aligned_cols=174 Identities=18% Similarity=0.229 Sum_probs=149.1
Q ss_pred hcCccccceeccc--CceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHG--GFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G--~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++++.||+| +||.||+|+. .+++.||||++... .......+.+|+.+++.++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4569999999999 9999999994 47999999998755 34445678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 2356899999999999999999999999 9999999999999999999999999987553
Q ss_pred CCCc-------eeeeeeEEeeeeCCCcccc
Q 024537 240 GEDT-------HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~-------~~~~~~~t~~y~aPE~~~~ 262 (266)
.... ......||+.|+|||++..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred cccccccccccccccccccccccCHHHHhc
Confidence 2211 1122357788999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.49 Aligned_cols=175 Identities=26% Similarity=0.473 Sum_probs=140.8
Q ss_pred hhcCccccceecccCceEEEEEEecC-----CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
..++|++.+.||+|+||+||+|.... +..||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 45678899999999999999998432 235999998765 344456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999998542 356899999999999999999999998 99999999999999999999999999988
Q ss_pred CCCCCcee---eeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHV---NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~---~~~~~t~~y~aPE~~~~e 263 (266)
+....... ....+|+.|+|||++...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYR 225 (333)
T ss_dssp --------------CCCGGGSCHHHHHSC
T ss_pred hccccccccccCCCCccccccCchhcccC
Confidence 75432211 122345679999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=248.99 Aligned_cols=182 Identities=29% Similarity=0.479 Sum_probs=152.0
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEE
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 151 (266)
..+....++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556688999999999999999999853 3478999999765 344457789999999999999999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcCC---------------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKTK---------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~ii 210 (266)
..++..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999865321 256899999999999999999999998 99
Q ss_pred eCCCCCCceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 211 HrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
||||||+|||++.++.+||+|||+++.+.... .......+|+.|+|||++...
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 99999999999999999999999998764322 222334677889999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=247.53 Aligned_cols=172 Identities=21% Similarity=0.277 Sum_probs=148.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ..+..|+.+++.+ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4679999999999999999999 468999999998755332 3577899999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC-----eEEeccccccc
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKISDFGLARL 237 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~-----~kl~DFG~a~~ 237 (266)
|+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 457999999999999999999999998 999999999999998887 99999999997
Q ss_pred CCCCCce-------eeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTH-------VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~-------~~~~~~t~~y~aPE~~~~e~ 264 (266)
+...... .....||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKE 193 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCC
Confidence 6543321 24567999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=253.81 Aligned_cols=177 Identities=26% Similarity=0.361 Sum_probs=149.5
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+.+..++|++.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++++++||||+++++++..++..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3455678999999999999999999954 7899999998754 3334456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 189 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999998543 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcee--eeeeEEeeeeCCCcccc
Q 024537 239 PGEDTHV--NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~~~--~~~~~t~~y~aPE~~~~ 262 (266)
....... ....+++.|+|||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 289 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNY 289 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhcc
Confidence 4332111 12245677999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=239.51 Aligned_cols=172 Identities=22% Similarity=0.310 Sum_probs=151.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||.||+|.. .++..||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45699999999999999999994 46789999998766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~~ 240 (266)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999998888543 45899999999999999999999999 9999999999999 7888999999999988754
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......+|+.|+|||++.+.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC
T ss_pred cc-chhccCCCCCccChHHhccc
Confidence 43 33455789999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=249.88 Aligned_cols=172 Identities=24% Similarity=0.428 Sum_probs=138.3
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
..++|++++.||+|+||+||+|+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 45679999999999999999998 55789999999875532 2245677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-----CCCCeEEeccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-----EQLNPKISDFGLA 235 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-----~~~~~kl~DFG~a 235 (266)
|||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|
T Consensus 112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99996 589888843 245899999999999999999999998 99999999999994 4455999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.+...........+|+.|+|||++.+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcC
Confidence 887655555555678999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=245.66 Aligned_cols=173 Identities=27% Similarity=0.437 Sum_probs=143.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++++.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35699999999999999999994 46899999998654 2333456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998887763 2346899999999999999999999998 999999999999999999999999999887655
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
........+|+.|+|||++.+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp ------CCCCCTTCCHHHHTTC
T ss_pred ccccCCCcCCccccCcccccCC
Confidence 5555566789999999988654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=247.81 Aligned_cols=168 Identities=25% Similarity=0.366 Sum_probs=144.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||+||+|. ..+++.||||++...... ..+|+.++.++ +||||+++++++.+++..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4569999999999999999999 457899999999765332 34688888887 79999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC----CCeEEecccccccC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ----LNPKISDFGLARLF 238 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~----~~~kl~DFG~a~~~ 238 (266)
|+++|+|.+.+.. ...+++..+..++.||+.||.|||++| |+||||||+|||+... +.+||+|||+|+.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998843 356899999999999999999999999 9999999999998543 24999999999987
Q ss_pred CCCCceeeeeeEEeeeeCCCcccc
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
........+..+|+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~ 194 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLER 194 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHH
T ss_pred cCCCCceeccCCCccccCHHHhcC
Confidence 666555567789999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=237.86 Aligned_cols=185 Identities=39% Similarity=0.605 Sum_probs=156.4
Q ss_pred ccchhhHHHhhcCcccc------ceecccCceEEEEEEecCCCEEEEEeeccc----ChhhHHHHHHHHHHHHhcCCCCc
Q 024537 75 FFDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQHKNL 144 (266)
Q Consensus 75 ~~~~~~~~~~~~~y~~~------~~iG~G~fg~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nI 144 (266)
.+....+....++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++.++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 35566666666666555 8999999999999987 6889999998653 23345678899999999999999
Q ss_pred eeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC
Q 024537 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 145 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~ 224 (266)
+++++++...+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCC
Confidence 9999999999999999999999999999865544567999999999999999999999998 9999999999999999
Q ss_pred CCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 225 LNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 225 ~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
+.+||+|||+++....... ......||+.|+|||++.++
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcCC
Confidence 9999999999987654322 22334689999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.20 Aligned_cols=180 Identities=25% Similarity=0.380 Sum_probs=148.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
+++..++|++.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.++.++ .||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 455668899999999999999999984 24568999998754 233446788999999999 8999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCC--------------------CCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKS--------------------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHr 212 (266)
.++..++||||+++++|.+++...... ..+++..++.++.|++.||.|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999653221 34789999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 213 DIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 213 DlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
||||+|||++.++.+||+|||+++.+..... ......+|+.|+|||++...
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 9999999999999999999999987644332 23344667789999987554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=238.98 Aligned_cols=173 Identities=21% Similarity=0.288 Sum_probs=151.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+++.+.||||+++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 45699999999999999999994 46889999998654 334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988443 46889999999999999999999998 99999999999999999999999999998765
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.........+|+.|+|||++...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~ 190 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKK 190 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTS
T ss_pred CccccccccCCCCcCCcchhccC
Confidence 44444556789999999988654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=252.88 Aligned_cols=173 Identities=23% Similarity=0.286 Sum_probs=146.3
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc------CCCCceeEEeEEeeCC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI------QHKNLVTLFGCCAEGP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~ 155 (266)
...++|++++.||+|+||+||+|. ..+++.||||++... ......+.+|+.+++.+ .|+||+++++++...+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 345679999999999999999998 456899999998754 33345677888888877 5779999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC--eEEeccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFG 233 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~--~kl~DFG 233 (266)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999995 6888888543 3345899999999999999999999998 999999999999999887 9999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+..... ..+..+|+.|+|||++.+..
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~ 275 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGAR 275 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBC
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCC
Confidence 99876433 23457899999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=248.69 Aligned_cols=172 Identities=25% Similarity=0.442 Sum_probs=136.9
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCC--c
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP--E 156 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 156 (266)
...++|++++.||+|+||+||+|. ..+++.||||++... .......+.+|+.++..+. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345789999999999999999998 457999999998643 4455567889999999997 999999999998654 6
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||++ ++|..++.. ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999996 688888743 35888999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCC---------------------CceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGE---------------------DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~---------------------~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+... ........||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 76321 122344578999999998865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=241.52 Aligned_cols=174 Identities=25% Similarity=0.495 Sum_probs=145.4
Q ss_pred hcCccccceecccCceEEEEEEe-----cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~ 156 (266)
.+.|++++.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45589999999999999999983 468899999987543 33456788999999999999999999999877 66
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998543 345899999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCc---eeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDT---HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~---~~~~~~~t~~y~aPE~~~~e 263 (266)
.+..... ......+|..|+|||++.+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 204 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS 204 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCC
Confidence 8765432 22234567779999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=239.37 Aligned_cols=174 Identities=28% Similarity=0.391 Sum_probs=147.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+.|.....||+|+||.||+|. ..+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345556689999999999999 4578899999998766555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-CCCeEEecccccccCCCCCc
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-~~~~kl~DFG~a~~~~~~~~ 243 (266)
++++|.+++........+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999966544456778899999999999999999998 999999999999987 88999999999998765444
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+++.|+|||++..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp --CCCCCCGGGCCHHHHHH
T ss_pred cccccCCCccccChhhhcC
Confidence 4456678999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=241.08 Aligned_cols=180 Identities=29% Similarity=0.396 Sum_probs=152.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
++...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 445567899999999999999999974 356789999997653 34457788999999999 8999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCC---------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTK---------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
.++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999865322 125899999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
|||++.++.+||+|||+++....... ......+|+.|+|||++...
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 222 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC
Confidence 99999999999999999998765432 22334567789999987554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.55 Aligned_cols=179 Identities=25% Similarity=0.446 Sum_probs=153.7
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+++..++|++.+.||+|+||+||+|.. .++..||+|++..... ..+.+.+|+.+++.++||||+++++++..++..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 4455677899999999999999999995 4588999999876543 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999998543 3456899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCc-eeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ......+++.|+|||++..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN 187 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC
T ss_pred cCCccccccCCccccCcCChhhhccC
Confidence 65432 23334566789999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=242.18 Aligned_cols=173 Identities=24% Similarity=0.337 Sum_probs=150.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChh------hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999994 57899999998754221 356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG 233 (266)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 356899999999999999999999998 99999999999999888 79999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+++....... .....||+.|+|||++....
T Consensus 165 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 194 (321)
T 2a2a_A 165 LAHEIEDGVE-FKNIFGTPEFVAPEIVNYEP 194 (321)
T ss_dssp TCEECCTTCC-CCCCCSCGGGCCHHHHTTCC
T ss_pred cceecCcccc-ccccCCCCCccCcccccCCC
Confidence 9988754432 23456899999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=246.98 Aligned_cols=173 Identities=29% Similarity=0.446 Sum_probs=143.2
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChh-----hHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ-----GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 346799999999999999999994 57899999998754221 124677999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++ +|..++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999975 78777733 3346888999999999999999999999 99999999999999999999999999998
Q ss_pred CCCCCceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+...........+|+.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred ccCCcccCCcccccccccCchHhhC
Confidence 8655555556678999999999854
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=241.89 Aligned_cols=181 Identities=29% Similarity=0.425 Sum_probs=152.1
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
.+....++|++.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 3455567899999999999999999984 24578999998764 3455678899999999999999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCC---------------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTK---------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiH 211 (266)
..+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999865332 234889999999999999999999998 999
Q ss_pred CCCCCCceEEcCCCCeEEecccccccCCCCCcee--eeeeEEeeeeCCCccccC
Q 024537 212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHV--NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 212 rDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~e 263 (266)
|||||+|||++.++.+||+|||+++......... ....+++.|+|||++...
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 227 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence 9999999999999999999999998775443322 233456779999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=251.93 Aligned_cols=174 Identities=28% Similarity=0.372 Sum_probs=149.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC--cEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv 160 (266)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 45799999999999999999994 468999999987543 333567789999999999999999999998765 67999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE----cCCCCeEEecccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLAR 236 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill----~~~~~~kl~DFG~a~ 236 (266)
|||+++++|.+++........+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999865444445999999999999999999999998 9999999999999 777789999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
....... .....||+.|+|||++..
T Consensus 165 ~~~~~~~-~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDEQ-FVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGGG-SSCSSSCCTTCCHHHHHH
T ss_pred EccCCCc-cccccCCccccCHHHhhc
Confidence 8754432 334578999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=247.20 Aligned_cols=171 Identities=28% Similarity=0.480 Sum_probs=138.2
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhh-HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|++++.||+|+||+||+|.. .+++.||||++....... ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999994 478999999987543221 12345799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
++ ++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 96 5888877443 346889999999999999999999999 99999999999999999999999999998765555
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
......+|+.|+|||++.+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp -------CGGGCCHHHHTT
T ss_pred ccccccCcccccChhhhcC
Confidence 5556678999999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=236.50 Aligned_cols=173 Identities=24% Similarity=0.363 Sum_probs=150.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4679999999999999999998 457899999998654 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG~a~~~ 238 (266)
||+++++|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998887543 45899999999999999999999998 999999999999986655 999999999877
Q ss_pred CCCCceeeeeeEEeeeeCCCccccCC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..... .....+|+.|+|||++....
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~ 183 (284)
T 3kk8_A 159 NDSEA-WHGFAGTPGYLSPEVLKKDP 183 (284)
T ss_dssp CSSCB-CCCSCSCGGGCCHHHHTTCC
T ss_pred ccCcc-ccCCCCCcCCcCchhhcCCC
Confidence 54433 23457899999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=239.25 Aligned_cols=169 Identities=27% Similarity=0.395 Sum_probs=141.7
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHh--cCCCCceeEEeEEeeC----CcE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEG----PEK 157 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~ 157 (266)
..++|++.+.||+|+||+||+|.. +++.||||++..... ..+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356799999999999999999987 789999999865432 445567777666 7999999999987543 457
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH--------EEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH--------~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
++||||+++++|.+++. ...+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999983 346899999999999999999999 777 999999999999999999999
Q ss_pred ecccccccCCCCCce----eeeeeEEeeeeCCCccccC
Q 024537 230 SDFGLARLFPGEDTH----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 230 ~DFG~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~e 263 (266)
+|||+|+........ .....||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 999999876544332 2234789999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=248.32 Aligned_cols=173 Identities=26% Similarity=0.349 Sum_probs=149.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4679999999999999999998 55789999999875421 12335668999999999999999999999999
Q ss_pred cEEEEEeccCCC-CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 156 EKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 156 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
..++||||+.+| +|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999766 99888843 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.+..... .....||+.|+|||++.+..
T Consensus 177 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 205 (335)
T 3dls_A 177 AAYLERGKL-FYTFCGTIEYCAPEVLMGNP 205 (335)
T ss_dssp CEECCTTCC-BCEECSCGGGCCHHHHTTCC
T ss_pred ceECCCCCc-eeccCCCccccChhhhcCCC
Confidence 998765433 34567899999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=238.12 Aligned_cols=173 Identities=27% Similarity=0.467 Sum_probs=152.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.+.|++++.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.+++.+.||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3569999999999999999998 4578999999987553 3445788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999883 246899999999999999999999998 9999999999999999999999999998876554
Q ss_pred ceeeeeeEEeeeeCCCccccCC
Q 024537 243 THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.......+++.|+|||++....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~ 195 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSA 195 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC
T ss_pred cccCccCCCcCccCHHHHhcCC
Confidence 4455667899999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=244.18 Aligned_cols=181 Identities=24% Similarity=0.405 Sum_probs=134.7
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-CCC---EEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQ---EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
+.+..++|++.+.||+|+||+||+|... ++. .||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3445678999999999999999999843 332 7999998765 334467889999999999999999999999887
Q ss_pred CcE------EEEEeccCCCCHHHHHhhcCC---CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 155 PEK------MLVYEYLPNKSLDYFIFDKTK---SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 155 ~~~------~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
+.. ++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 999999999999999854322 226899999999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccCC
Q 024537 226 NPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.+||+|||+|+....... ......+++.|+|||++.+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL 215 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCC
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCC
Confidence 999999999987644321 122234566799999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=250.47 Aligned_cols=172 Identities=22% Similarity=0.307 Sum_probs=137.9
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--------hhhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
....++|.+.+.||+|+||+||+|. ..+++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3446789999999999999999998 4578999999986542 111234778999999999999999999985
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC---CeEE
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKI 229 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~---~~kl 229 (266)
.+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999988773 3457999999999999999999999998 99999999999997544 5999
Q ss_pred ecccccccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 230 SDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 230 ~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
+|||+|+.+... ....+..||+.|+|||++.
T Consensus 284 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 314 (419)
T 3i6u_A 284 TDFGHSKILGET-SLMRTLCGTPTYLAPEVLV 314 (419)
T ss_dssp CCSSTTTSCC------------CTTCCTTTTC
T ss_pred eecccceecCCC-ccccccCCCCCccCceeee
Confidence 999999987543 3344568999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.58 Aligned_cols=170 Identities=25% Similarity=0.398 Sum_probs=147.9
Q ss_pred hhcCccccceecccCceEEEEEEec-CC-------CEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP-NG-------QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
..++|++.+.||+|+||+||+|... ++ ..||+|++........+.+.+|+.++++++||||+++++++..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3467999999999999999999843 33 479999997766666788999999999999999999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC--------e
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--------P 227 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~--------~ 227 (266)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 999999999999999998543 334889999999999999999999999 999999999999998887 9
Q ss_pred EEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 228 KISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
||+|||+++..... ....+|+.|+|||++..
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIEN 191 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCC
Confidence 99999999876432 23457888999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.18 Aligned_cols=179 Identities=22% Similarity=0.316 Sum_probs=149.1
Q ss_pred HHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~ 156 (266)
.+..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34457899999999999999999994 6899999999877766677889999999999999999999999873 346
Q ss_pred EEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 79999999999999988542 23457899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCc---------eeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDT---------HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~---------~~~~~~~t~~y~aPE~~~~e 263 (266)
+....... ......||+.|+|||++..+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccC
Confidence 87532111 01223468899999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=240.33 Aligned_cols=171 Identities=25% Similarity=0.296 Sum_probs=142.1
Q ss_pred hcCcccc-ceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDL-NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~-~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+.|++. +.||+|+||.||+|. ..+++.||||++..........+.+|+.++.++ +||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568875 789999999999999 557999999999776555567888999999885 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG~a~~~ 238 (266)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 46889999999999999999999998 999999999999988776 999999999876
Q ss_pred CCCC-------ceeeeeeEEeeeeCCCccc
Q 024537 239 PGED-------THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 239 ~~~~-------~~~~~~~~t~~y~aPE~~~ 261 (266)
.... .......||+.|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp -----------------CCSGGGCCHHHHH
T ss_pred ccCCccccccccccccccCCcCccChHHhh
Confidence 4221 1223345889999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=238.03 Aligned_cols=177 Identities=22% Similarity=0.356 Sum_probs=140.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4579999999999999999998 457999999998753 344567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988542 23456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..........+++.|+|||++....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENG 212 (310)
T ss_dssp -----------CCSSCCHHHHTTCC
T ss_pred CCCccccccCCCeeEeChHHhCCCC
Confidence 5555455667899999999886543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=235.83 Aligned_cols=172 Identities=24% Similarity=0.324 Sum_probs=146.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||+||+|.. .+++.||||++... .......+.+|+.++..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35699999999999999999995 47999999998754 233456788899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC---------------
Q 024537 161 YEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ--------------- 224 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~--------------- 224 (266)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999986432 1256899999999999999999999998 9999999999999844
Q ss_pred ----CCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 225 ----LNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 225 ----~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..+||+|||++........ ..+|+.|+|||++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~----~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQV----EEGDSRFLANEVLQEN 205 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCC----CCCCGGGCCHHHHTTC
T ss_pred cCCceEEEEcccccccccCCccc----cCCCccccChhHhcCC
Confidence 4799999999998755432 3589999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=241.86 Aligned_cols=179 Identities=26% Similarity=0.347 Sum_probs=138.0
Q ss_pred hHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEe-----
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCA----- 152 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~----- 152 (266)
.+++...+|++.+.||+|+||.||+|. ..+++.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 344556689999999999999999999 4578999999997777666778899999999996 999999999994
Q ss_pred ---eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 153 ---EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 153 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
.....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 3344799999995 788888865445567999999999999999999999976 34999999999999999999999
Q ss_pred ecccccccCCCCCce------------eeeeeEEeeeeCCCcc
Q 024537 230 SDFGLARLFPGEDTH------------VNTFRISVVTWPPNMH 260 (266)
Q Consensus 230 ~DFG~a~~~~~~~~~------------~~~~~~t~~y~aPE~~ 260 (266)
+|||+++.+...... .....+|+.|+|||++
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CCCTTCBCCSSCC------------------------------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 999999887543221 1144689999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=249.48 Aligned_cols=166 Identities=25% Similarity=0.434 Sum_probs=139.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK---- 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 157 (266)
.++|.+.+.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4679999999999999999998 457899999998754 334457788999999999999999999999887665
Q ss_pred --EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 158 --MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 158 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
++||||+. ++|...+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999996 6787666 234899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... .....+|+.|+|||++.+
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 192 RHADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSC
T ss_pred cccccC---cCCcccCccccCHHHhcC
Confidence 876443 234568999999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=254.23 Aligned_cols=169 Identities=26% Similarity=0.353 Sum_probs=138.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++++.||+|+||+||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999998 457899999998754 4445677889999999999999999999997653
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..|+||||++++ +...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999654 555552 24889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+...... ......||+.|+|||++.+.
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 238 (464)
T 3ttj_A 212 RTAGTSF-MMTPYVVTRYYRAPEVILGM 238 (464)
T ss_dssp -----CC-CC----CCCTTCCHHHHTTC
T ss_pred eecCCCc-ccCCCcccccccCHHHHcCC
Confidence 8775432 33456899999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.55 Aligned_cols=171 Identities=25% Similarity=0.351 Sum_probs=143.6
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCC--CCceeEEeEEeeCCcEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~ 158 (266)
+..++|++++.||+|+||.||+|...+++.||||++... .......+.+|+.++..++| |||+++++++..++..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345679999999999999999999878999999998754 34445778899999999986 99999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+|+.+
T Consensus 86 lv~e~-~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 58899999854 346889999999999999999999998 99999999999997 578999999999987
Q ss_pred CCCCc--eeeeeeEEeeeeCCCccc
Q 024537 239 PGEDT--HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 239 ~~~~~--~~~~~~~t~~y~aPE~~~ 261 (266)
..... ......||+.|+|||++.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~ 182 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIK 182 (343)
T ss_dssp ------------CCCCSSCCHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHh
Confidence 54432 233557899999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=250.38 Aligned_cols=172 Identities=26% Similarity=0.415 Sum_probs=133.0
Q ss_pred CccccceecccCceEEEEEEec--CC--CEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CCcEEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP--NG--QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv 160 (266)
.|++.+.||+|+||+||+|.+. ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677899999999999999843 22 36899988654 34456788999999999999999999998654 5678999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999843 3346788999999999999999999998 99999999999999999999999999987643
Q ss_pred CCc----eeeeeeEEeeeeCCCccccC
Q 024537 241 EDT----HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~----~~~~~~~t~~y~aPE~~~~e 263 (266)
... ......+++.|+|||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 271 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQ 271 (373)
T ss_dssp -------------CCGGGSCHHHHHHC
T ss_pred cccccccccCCCCCcccccChHHhcCC
Confidence 321 11223456679999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=252.56 Aligned_cols=173 Identities=27% Similarity=0.422 Sum_probs=146.4
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC-cEEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKML 159 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~l 159 (266)
+.+..++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.+.+|+.+|++++||||+++++++...+ ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 345567899999999999999999987 47899999997654 3467899999999999999999999987665 7899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999653 2334789999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
... ....+++.|+|||++...
T Consensus 341 ~~~---~~~~~~~~y~aPE~~~~~ 361 (450)
T 1k9a_A 341 STQ---DTGKLPVKWTAPEALREK 361 (450)
T ss_dssp ---------CCCTTTSCHHHHHSS
T ss_pred ccc---cCCCCCcceeCHHHhcCC
Confidence 322 223567789999988654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=246.62 Aligned_cols=169 Identities=22% Similarity=0.252 Sum_probs=134.4
Q ss_pred cCcccc-ceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHH-hcCCCCceeEEeEEee----CCcEE
Q 024537 86 NFFSDL-NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLL-KIQHKNLVTLFGCCAE----GPEKM 158 (266)
Q Consensus 86 ~~y~~~-~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~~ 158 (266)
++|.+. +.||+|+||+||+|. ..+++.||||++... ..+.+|+.++. ..+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 789999999999998 457899999998643 34567888874 4589999999999876 56789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEeccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLA 235 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a 235 (266)
+||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2346899999999999999999999998 999999999999987 788999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+...... ...+..||+.|+|||++..+.
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 239 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGPEK 239 (400)
T ss_dssp EECC------------CTTCCGGGSCCCC
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCCCC
Confidence 9765433 234568899999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=255.73 Aligned_cols=172 Identities=27% Similarity=0.381 Sum_probs=147.2
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++++.||+|+||+||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35699999999999999999994 47899999998643 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc---CCCCeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~---~~~~~kl~DFG~a~~~ 238 (266)
||+.+++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999998888543 46899999999999999999999999 99999999999995 4567999999999877
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......||+.|+|||++.+.
T Consensus 175 ~~~~-~~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 175 QQNT-KMKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGSC
T ss_pred CCCC-ccCCCcCCCCCCCHHHhCCC
Confidence 5433 33445789999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=239.46 Aligned_cols=185 Identities=28% Similarity=0.404 Sum_probs=153.8
Q ss_pred cchhhHHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeE
Q 024537 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTL 147 (266)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l 147 (266)
+....+....++|++.+.||+|+||+||+|.+ .+++.||||++... .....+.+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556667778999999999999999999973 35689999998765 334456788999999999 69999999
Q ss_pred EeEEeeCC-cEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCC
Q 024537 148 FGCCAEGP-EKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRD 213 (266)
Q Consensus 148 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrD 213 (266)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988765 48999999999999999854322 123889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 214 IKASNILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 214 lKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
|||+||+++.++.+||+|||+++.+.... .......+|+.|+|||++.+.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 225 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 225 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence 99999999999999999999998765433 223345677889999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.72 Aligned_cols=183 Identities=23% Similarity=0.372 Sum_probs=152.4
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeE
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGC 150 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 150 (266)
...+++..++|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3345566788999999999999999999743 4678999998754 33445678899999999999999999999
Q ss_pred EeeCCcEEEEEeccCCCCHHHHHhhcC-------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC
Q 024537 151 CAEGPEKMLVYEYLPNKSLDYFIFDKT-------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223 (266)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~ 223 (266)
+..++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 999999999999999999999985421 1245788999999999999999999998 999999999999999
Q ss_pred CCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 224 QLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 224 ~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
++.+||+|||+++....... ......+|+.|+|||++.+.
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 215 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccC
Confidence 99999999999987643321 12233567889999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=237.09 Aligned_cols=173 Identities=27% Similarity=0.353 Sum_probs=146.2
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|+||.||+|. ..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34679999999999999999998 4567899999986542 2224568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988543 45889999999999999999999998 9999999999999999999999999997664
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... .....+++.|+|||++.+..
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~ 183 (279)
T 3fdn_A 161 SSR--RTDLCGTLDYLPPEMIEGRM 183 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCC
T ss_pred ccc--ccccCCCCCccCHhHhccCC
Confidence 332 23457899999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=234.78 Aligned_cols=173 Identities=32% Similarity=0.464 Sum_probs=136.9
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccCh----hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|+||.||+|.. .++.||||++..... ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 356799999999999999999997 488999999875422 234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC--------CCCeEEec
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--------QLNPKISD 231 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~--------~~~~kl~D 231 (266)
||||+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998883 346899999999999999999999987445889999999999986 67799999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
||+++.+..... ....+|+.|+|||++.+.
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~ 189 (271)
T 3dtc_A 160 FGLAREWHRTTK--MSAAGAYAWMAPEVIRAS 189 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHC
T ss_pred CCcccccccccc--cCCCCccceeCHHHhccC
Confidence 999987654432 244789999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=233.40 Aligned_cols=173 Identities=28% Similarity=0.384 Sum_probs=149.6
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35699999999999999999994 47899999998654 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999988873 3456899999999999999999999998 9999999999999999999999999998764322
Q ss_pred --ceeeeeeEEeeeeCCCccccC
Q 024537 243 --THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 --~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~ 182 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRR 182 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCS
T ss_pred chhcccCCccccCccChHHHhcC
Confidence 223445788999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.91 Aligned_cols=172 Identities=18% Similarity=0.219 Sum_probs=138.0
Q ss_pred hcCccccceecccCceEEEEEEec----CCCEEEEEeecccChhh-----------HHHHHHHHHHHHhcCCCCceeEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDSRQG-----------LREFTNEVKLLLKIQHKNLVTLFG 149 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~ 149 (266)
.++|++.+.||+|+||+||+|... ++..||||++....... ...+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999954 67889999987653211 123667888999999999999999
Q ss_pred EEee----CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 150 CCAE----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 150 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 99999998432 37899999999999999999999998 99999999999999887
Q ss_pred --CeEEecccccccCCCCC-------ceeeeeeEEeeeeCCCccccC
Q 024537 226 --NPKISDFGLARLFPGED-------THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 226 --~~kl~DFG~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~e 263 (266)
.+||+|||+|+.+.... .......||+.|+|||++.+.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV 235 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC
Confidence 99999999998764321 112345789999999998765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=237.97 Aligned_cols=174 Identities=18% Similarity=0.196 Sum_probs=142.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46799999999999999999994 478899999987542 33346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CC-ceeeeeeEEeeeeCCCccccCC
Q 024537 241 ED-THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~-~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. .......+++.|+|||++.+..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~ 211 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESH 211 (309)
T ss_dssp ----------CCGGGCCGGGTCC--
T ss_pred cccccccccCCCcCccCHHHHcCCC
Confidence 32 2334557889999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=254.55 Aligned_cols=179 Identities=23% Similarity=0.388 Sum_probs=150.3
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..+++..++|++.+.||+|+||+||+|.+.++..||||++..... ..+.+.+|+.+|++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 345566778999999999999999999987888999999976543 3578999999999999999999999986 66789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999998532 1235788899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCce-eeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTH-VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~-~~~~~~t~~y~aPE~~~~e 263 (266)
...... .....++..|+|||++...
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 360 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFG 360 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHC
T ss_pred CCCceeccCCCcccccccCHHHhccC
Confidence 432111 1222456789999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.47 Aligned_cols=172 Identities=25% Similarity=0.321 Sum_probs=147.1
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45699999999999999999994 47999999999866544456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~~ 240 (266)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999888543 35889999999999999999999998 9999999999999 7788999999999987643
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. .....+|+.|+|||++....
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~ 183 (304)
T 2jam_A 162 GI--MSTACGTPGYVAPEVLAQKP 183 (304)
T ss_dssp BT--THHHHSCCCBCCTTTBSSCS
T ss_pred Cc--cccccCCCCccChHHhccCC
Confidence 32 23446899999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=232.12 Aligned_cols=174 Identities=24% Similarity=0.387 Sum_probs=143.5
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 456799999999999999999995 479999999986542 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998543 45889999999999999999999999 9999999999999999999999999998875
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.... .....+++.|+|||++.+..
T Consensus 163 ~~~~-~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 163 DGEF-LRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp C--------------CCTGGGTTSC
T ss_pred CCcc-eecccCCccccCHHHHcCCC
Confidence 4332 33457899999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=235.21 Aligned_cols=175 Identities=27% Similarity=0.455 Sum_probs=141.5
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh-----hhHHHHHHHHHHHHhc---CCCCceeEEeEEee
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-----QGLREFTNEVKLLLKI---QHKNLVTLFGCCAE 153 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~ 153 (266)
...++|++.+.||+|+||+||+|+ ..+++.||||++..... .....+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 446789999999999999999999 46789999999864321 1123455677776666 59999999999987
Q ss_pred CC-----cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeE
Q 024537 154 GP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228 (266)
Q Consensus 154 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~k 228 (266)
.. ..++||||+. ++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4799999996 6998888543 3345899999999999999999999999 99999999999999999999
Q ss_pred EecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 229 ISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|+|||+|+....... .....+|+.|+|||++...
T Consensus 161 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~ 194 (308)
T 3g33_A 161 LADFGLARIYSYQMA-LTPVVVTLWYRAPEVLLQS 194 (308)
T ss_dssp ECSCSCTTTSTTCCC-SGGGGCCCSSCCHHHHHTS
T ss_pred EeeCccccccCCCcc-cCCccccccccCchHHcCC
Confidence 999999987754433 3455789999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=243.41 Aligned_cols=172 Identities=26% Similarity=0.464 Sum_probs=143.6
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------- 154 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 154 (266)
.++|++++.||+|+||+||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999994 679999999986542 22235677899999999999999999999874
Q ss_pred -CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 155 -PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 155 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
+..++||||+++ ++...+.. ....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999965 66666633 3356899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCC----CceeeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGE----DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|+.+... ........||+.|+|||++.+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred hcccccccccccccccCCcccccCccCchhhcC
Confidence 99876422 222344567999999998865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=234.75 Aligned_cols=171 Identities=28% Similarity=0.530 Sum_probs=144.2
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChh-------hHHHHHHHHHHHHhcCCCCceeEEeEEeeCC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ-------GLREFTNEVKLLLKIQHKNLVTLFGCCAEGP 155 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 155 (266)
..++|++.+.||+|+||+||+|+. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 356799999999999999999994 57899999998654221 1157889999999999999999999997655
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC-----eEEe
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKIS 230 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~-----~kl~ 230 (266)
++||||+++++|.+.+.. ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999888743 3457899999999999999999999986 34999999999999988776 9999
Q ss_pred cccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 231 DFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|||+|+.... ......+|+.|+|||++..
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSC
T ss_pred CCCccccccc---cccccCCCccccCchhhcc
Confidence 9999986543 2345578999999999843
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=257.85 Aligned_cols=177 Identities=25% Similarity=0.443 Sum_probs=150.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
+++..++|++.+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.+|++++||||+++++++...+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 4455677999999999999999999954 588999999876533 35778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999998543 3356899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCce-eeeeeEEeeeeCCCcccc
Q 024537 240 GEDTH-VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~-~~~~~~t~~y~aPE~~~~ 262 (266)
..... .....+++.|+|||++..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~ 393 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAY 393 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhc
Confidence 43321 122245668999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=242.17 Aligned_cols=172 Identities=23% Similarity=0.392 Sum_probs=144.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46799999999999999999995 46899999999876666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999888542 345899999999999999999999998 99999999999999999999999999865432222
Q ss_pred eeeeeeEEeeeeCCCccc
Q 024537 244 HVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~ 261 (266)
......+|+.|+|||++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp C-----CCGGGCCHHHHH
T ss_pred ccccccCChhhcCCeeec
Confidence 233457899999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=237.41 Aligned_cols=176 Identities=22% Similarity=0.318 Sum_probs=136.2
Q ss_pred HHhhcCccccceecccCceEEEEEEec----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
++..++|++.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.++++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 344567999999999999999999853 2457999998754 3444577889999999999999999999984 567
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 89999999999999998543 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCc-eeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
....... ......+++.|+|||++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 192 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFR 192 (281)
T ss_dssp --------------CCGGGCCHHHHHHC
T ss_pred ccCcccccccccCCCcccccChhhcccC
Confidence 8754322 22233456689999987644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=255.49 Aligned_cols=172 Identities=24% Similarity=0.366 Sum_probs=144.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.+.|++++.||+|+||+||+|+. .++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35699999999999999999994 578999999987542 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC---CCeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~---~~~kl~DFG~a~~~ 238 (266)
||+++++|.+.+... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888543 45889999999999999999999998 9999999999999764 45999999999887
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......||+.|+|||++...
T Consensus 190 ~~~~-~~~~~~gt~~y~aPE~l~~~ 213 (494)
T 3lij_A 190 ENQK-KMKERLGTAYYIAPEVLRKK 213 (494)
T ss_dssp BTTB-CBCCCCSCTTTCCHHHHTTC
T ss_pred CCCc-cccccCCCcCeeCHHHHccc
Confidence 5443 33455799999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=237.46 Aligned_cols=172 Identities=27% Similarity=0.379 Sum_probs=147.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 46799999999999999999995 47899999998654 2334577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC---CCeEEecccccccC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLF 238 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~---~~~kl~DFG~a~~~ 238 (266)
||+++++|.+.+... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.+ +.+||+|||+++..
T Consensus 101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999998887543 35889999999999999999999998 9999999999999764 46999999999877
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..... .....+++.|+|||++.+.
T Consensus 175 ~~~~~-~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 175 QQNTK-MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp CCCSS-CSCHHHHHTTCCHHHHTTC
T ss_pred cCCCc-cccccCcccccChHHhcCC
Confidence 54432 2334688899999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-33 Score=241.08 Aligned_cols=181 Identities=28% Similarity=0.395 Sum_probs=151.5
Q ss_pred hHHHhhcCccccceecccCceEEEEEEec-CC-----CEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP-NG-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
.++...++|++.+.||+|+||.||+|... ++ ..||+|.+... .....+.+.+|+.++..+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45666788999999999999999999843 23 47999998765 334457788999999999 899999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcC-----------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceE
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKT-----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL 220 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nil 220 (266)
..++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986432 1346789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 221 LDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 221 l~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
++.++.+||+|||+|+.+..... ......+|+.|+|||++...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 241 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 241 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC
Confidence 99999999999999987643322 22344667789999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=240.96 Aligned_cols=177 Identities=29% Similarity=0.446 Sum_probs=144.5
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEee----
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE---- 153 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~---- 153 (266)
.+....++|++.+.||+|+||.||+|+. .+++.||||++...... ...+.+|+.+++++ .||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344567899999999999999999994 57899999998755332 36788999999998 79999999999987
Q ss_pred --CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 154 --GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 154 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999998543 2356889999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
||++..+...........+++.|+|||++.
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC
T ss_pred CcCceecCcCccccccccCCccccChhhhc
Confidence 999988765444445667899999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=237.82 Aligned_cols=174 Identities=29% Similarity=0.437 Sum_probs=146.7
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
...++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3456799999999999999999984 4689999999876432 357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 356899999999999999999999998 999999999999999999999999999887655
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
........+++.|+|||++.+.
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~ 200 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEI 200 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSS
T ss_pred ccccCccCCCCCccChhhcCCC
Confidence 4444556789999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=238.88 Aligned_cols=172 Identities=27% Similarity=0.418 Sum_probs=141.5
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHh--cCCCCceeEEeEEeeC----
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEG---- 154 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~---- 154 (266)
.....++|++.+.||+|+||.||+|.. +++.||||++..... .....|..++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 344457899999999999999999987 489999999865433 334455556555 4899999999999887
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc--------CCCCeEeCCCCCCceEEcCCCC
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE--------APARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~--------~~~~iiHrDlKp~Nill~~~~~ 226 (266)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 678999999999999999843 3589999999999999999999998 7 999999999999999999
Q ss_pred eEEecccccccCCCCCcee----eeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTHV----NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~----~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+|+.+....... ....||+.|+|||++.+.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 221 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc
Confidence 9999999998775443221 245789999999998654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=237.36 Aligned_cols=173 Identities=31% Similarity=0.484 Sum_probs=136.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++..++|++.+.||+|+||+||+|... ..||+|++... .....+.+.+|+.+++.++||||++++++. ..+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3555678999999999999999999853 35999998754 344567789999999999999999999955 556789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999988843 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC--CceeeeeeEEeeeeCCCccc
Q 024537 239 PGE--DTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 239 ~~~--~~~~~~~~~t~~y~aPE~~~ 261 (266)
... ........||+.|+|||++.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp -------------CCCTTCCHHHHC
T ss_pred ccccccccccccCCCccccCchhhc
Confidence 432 22334457899999999885
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=244.34 Aligned_cols=167 Identities=27% Similarity=0.443 Sum_probs=139.4
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++++.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999994 57999999998543 3444567889999999999999999999998763
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899998843 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... .....+|+.|+|||++.+
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 176 RQADSE---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHT
T ss_pred cccccc---cCcCcCCCCcCCHHHHhC
Confidence 986543 234578999999998765
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=254.91 Aligned_cols=173 Identities=27% Similarity=0.369 Sum_probs=150.3
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 346799999999999999999994 489999999986542 3345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccc
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLAR 236 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~ 236 (266)
||||+.+++|.+.+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988843 356899999999999999999999998 9999999999999 567889999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.+..... .....||+.|+|||++.+.
T Consensus 178 ~~~~~~~-~~~~~gt~~y~aPE~~~~~ 203 (484)
T 3nyv_A 178 HFEASKK-MKDKIGTAYYIAPEVLHGT 203 (484)
T ss_dssp HBCCCCS-HHHHTTGGGTCCHHHHHTC
T ss_pred Ecccccc-cccCCCCccccCceeecCC
Confidence 8754433 3345789999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=233.65 Aligned_cols=173 Identities=24% Similarity=0.343 Sum_probs=146.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccCh------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 45699999999999999999995 4789999999875421 1356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG 233 (266)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998542 46899999999999999999999998 99999999999998877 79999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+++....... .....+++.|+|||++..+.
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 187 (283)
T 3bhy_A 158 IAHKIEAGNE-FKNIFGTPEFVAPEIVNYEP 187 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCC
T ss_pred cceeccCCCc-ccccCCCcCccCcceecCCC
Confidence 9988754332 23446889999999886543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-33 Score=235.79 Aligned_cols=175 Identities=26% Similarity=0.477 Sum_probs=149.4
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
+..++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 345679999999999999999999878889999999765432 3678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999998543 346889999999999999999999998 9999999999999999999999999998764321
Q ss_pred -ceeeeeeEEeeeeCCCccccC
Q 024537 243 -THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 -~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~ 180 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFS 180 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHC
T ss_pred ccccccccccccccChhhhcCC
Confidence 111223456789999987644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=235.03 Aligned_cols=172 Identities=26% Similarity=0.405 Sum_probs=141.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE---------- 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 153 (266)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35699999999999999999994 57999999998653 3445778899999999999999999999865
Q ss_pred ---CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEe
Q 024537 154 ---GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS 230 (266)
Q Consensus 154 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~ 230 (266)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999854 2346788899999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCC--------------CceeeeeeEEeeeeCCCcccc
Q 024537 231 DFGLARLFPGE--------------DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 231 DFG~a~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|||+++..... ........+++.|+|||++.+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 99999876432 122345578899999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-33 Score=261.69 Aligned_cols=162 Identities=20% Similarity=0.258 Sum_probs=128.1
Q ss_pred eecccCceEEEEEE-ecCCCEEEEEeeccc----------ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEE
Q 024537 93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVD----------SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 93 ~iG~G~fg~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 160 (266)
..+.|++|.+..++ .-.|+.||+|.+... .....+.+.+|+.+|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777776665 446889999998653 123356799999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||++|++|.+++.. ...+++. .|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 3456654 47899999999999999 99999999999999999999999999998877
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
......+.+||+.|+|||++.++
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC---
T ss_pred CCccccCceechhhccHHHhCCC
Confidence 76667778899999999999765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=244.92 Aligned_cols=173 Identities=24% Similarity=0.352 Sum_probs=149.0
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
..++|++++.||+|+||+||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 346799999999999999999994 47899999998765 3444577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
||+++++|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 111 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999998543 3588999999999999999999996 7 99999999999999999999999999976532
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ......||+.|+|||++.+..
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~ 206 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTH 206 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCC
T ss_pred c--cccCCCCCCCeECHHHHcCCC
Confidence 2 223457899999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=234.91 Aligned_cols=174 Identities=20% Similarity=0.276 Sum_probs=148.7
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 160 (266)
+..++|++.+.||+|+||+||+|. ..+++.||||++...... ..+.+|+.+++.+ .|+|++++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 345679999999999999999999 468999999998654322 4567899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC-----eEEeccccc
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKISDFGLA 235 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~-----~kl~DFG~a 235 (266)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+|
T Consensus 85 ~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 99999998543 346899999999999999999999998 999999999999987776 999999999
Q ss_pred ccCCCCCc-------eeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDT-------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.+..... ......||+.|+|||++.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 194 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCC
Confidence 87754432 234557899999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=253.00 Aligned_cols=177 Identities=26% Similarity=0.429 Sum_probs=144.1
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+++..++|++.+.||+|+||.||+|.+..+..||||++..... ..+.+.+|+.+|++++||||+++++++.. +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 4455677999999999999999999987778899999876542 24678999999999999999999999876 678999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 257 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999998532 2245889999999999999999999998 99999999999999999999999999987753
Q ss_pred CCc-eeeeeeEEeeeeCCCccccC
Q 024537 241 EDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
... ......++..|+|||++...
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp ----------CCGGGSCHHHHHHC
T ss_pred CceecccCCcccccccCHhHHhcC
Confidence 321 12223456789999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=236.80 Aligned_cols=183 Identities=23% Similarity=0.432 Sum_probs=140.0
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEec----CCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
..+.+..++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344555678999999999999999999843 3458999998754 3445577899999999999999999999998
Q ss_pred eCCc-----EEEEEeccCCCCHHHHHhhc---CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC
Q 024537 153 EGPE-----KMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224 (266)
Q Consensus 153 ~~~~-----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~ 224 (266)
..+. .++||||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7653 59999999999999988432 23456999999999999999999999998 9999999999999999
Q ss_pred CCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 225 LNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 225 ~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.+||+|||+++.+.... .......+++.|+|||++....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSC
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC
Confidence 999999999998764432 1222335567899999886543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=243.54 Aligned_cols=176 Identities=22% Similarity=0.233 Sum_probs=145.2
Q ss_pred hHHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CC-----CceeEEeEEe
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HK-----NLVTLFGCCA 152 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~ 152 (266)
......++|++.+.||+|+||+||+|. ..+++.||||++... ......+..|+.+++.+. |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 334456789999999999999999998 447889999998754 333466778999988885 44 4999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh--cCCCCeEeCCCCCCceEEc--CCCCeE
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE--EAPARIIHRDIKASNILLD--EQLNPK 228 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~--~~~~~iiHrDlKp~Nill~--~~~~~k 228 (266)
..+..++||||+. ++|.+++... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 9999999999995 5998888543 23468999999999999999999995 55 99999999999995 477899
Q ss_pred EecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 229 ISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 229 l~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|+|||+|+...... ....+|+.|+|||++.+..
T Consensus 202 L~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~ 234 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI---YQYIQSRFYRSPEVLLGMP 234 (382)
T ss_dssp ECCCTTCEETTCCC---CSSCSCGGGCCHHHHTTCC
T ss_pred EEeccCceeccccc---ccccCCccccChHHHcCCC
Confidence 99999999875432 3457899999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=234.94 Aligned_cols=172 Identities=25% Similarity=0.336 Sum_probs=149.2
Q ss_pred hhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 446799999999999999999994 467899999986542 1224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999988543 35889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
... .....+++.|+|||++.+.
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~ 187 (284)
T 2vgo_A 166 SLR--RRTMCGTLDYLPPEMIEGK 187 (284)
T ss_dssp SSC--BCCCCSCGGGCCHHHHTTC
T ss_pred ccc--cccccCCCCcCCHHHhccC
Confidence 433 2345789999999988764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-32 Score=230.46 Aligned_cols=172 Identities=25% Similarity=0.362 Sum_probs=146.4
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 158 (266)
..|++.+.||+|+||.||+|. ..++..||+|++... .......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458888999999999999998 457889999998754 34456778899999999999999999999875 35589
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeEEeccccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARL 237 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~ 237 (266)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998543 45889999999999999999999986 3499999999999997 788999999999987
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
...... ....+|+.|+|||++.+.
T Consensus 182 ~~~~~~--~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 182 KRASFA--KAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp CCTTSB--EESCSSCCCCCGGGGGTC
T ss_pred cccccc--ccccCCcCcCCHHHHhcc
Confidence 654432 345789999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=235.37 Aligned_cols=174 Identities=22% Similarity=0.321 Sum_probs=134.0
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-h-hhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-R-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
+..++|++.+.||+|+||+||+|+. .+++.||||++.... . ...+.+.++...++.++||||+++++++..++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999999994 578999999987542 2 223334455556888899999999999999999999
Q ss_pred EEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 160 VYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
||||++ ++|.+++.. ......+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999996 587777643 22346799999999999999999999998 8 99999999999999999999999999987
Q ss_pred CCCCCceeeeeeEEeeeeCCCccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
....... ....+|+.|+|||++.
T Consensus 160 ~~~~~~~-~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 160 LVDDVAK-DIDAGCKPYMAPERIN 182 (290)
T ss_dssp -----------CCCCCCSCHHHHS
T ss_pred ccccccc-cccCCCccccChhhcC
Confidence 7544332 3346899999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=232.74 Aligned_cols=170 Identities=25% Similarity=0.352 Sum_probs=148.2
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---------hhhHHHHHHHHHHHHhcC-CCCceeEEeEEee
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 153 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46799999999999999999994 578999999986542 123456789999999996 9999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999998543 46889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
++..+.... ......+++.|+|||++.
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred chhhcCCCc-ccccccCCccccCHHHhc
Confidence 998875433 234457899999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=233.81 Aligned_cols=172 Identities=24% Similarity=0.439 Sum_probs=147.0
Q ss_pred hhcCccccceecccCceEEEEEEec-CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee---------
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--------- 153 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 153 (266)
..++|++.+.||+|+||.||+|... +++.||+|++..... .+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456999999999999999999954 799999999876543 45689999999999999999999864
Q ss_pred -------CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 154 -------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 154 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998543 2356899999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 227 PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+||+|||+++....... .....+++.|+|||++.+..
T Consensus 161 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 197 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQD 197 (284)
T ss_dssp EEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSC
T ss_pred EEECcchhheecccccc-ccccCCcccccChhhhccCC
Confidence 99999999988765432 23446899999999887653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=236.29 Aligned_cols=169 Identities=26% Similarity=0.381 Sum_probs=137.3
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.++|++.+.||+|+||+||+|.+ .++.||||++.... ..+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 45689999999999999999987 47889999986543 3467889999999999999999999887 4579999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh---cCCCCeEeCCCCCCceEEcCCCC-eEEecccccccCCC
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE---EAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPG 240 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~---~~~~~iiHrDlKp~Nill~~~~~-~kl~DFG~a~~~~~ 240 (266)
++++|.+++........+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999654333457889999999999999999999 66 999999999999998887 79999999987643
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ....||+.|+|||++.++.
T Consensus 159 ~~---~~~~gt~~y~aPE~~~~~~ 179 (307)
T 2eva_A 159 HM---TNNKGSAAWMAPEVFEGSN 179 (307)
T ss_dssp ---------CCTTSSCHHHHTCCC
T ss_pred cc---ccCCCCCceEChhhhCCCC
Confidence 32 2346899999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=243.01 Aligned_cols=175 Identities=20% Similarity=0.237 Sum_probs=141.4
Q ss_pred hhcCccccceecccCceEEEEEEecC------CCEEEEEeecccChhhH-----------HHHHHHHHHHHhcCCCCcee
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGL-----------REFTNEVKLLLKIQHKNLVT 146 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~ 146 (266)
..++|++.+.||+|+||+||+|.... ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998543 47899999876542211 12445666777889999999
Q ss_pred EEeEEeeC----CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc
Q 024537 147 LFGCCAEG----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222 (266)
Q Consensus 147 l~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~ 222 (266)
+++++... ...++||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4479999999 9999999854 3356999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEecccccccCCCCCc-------eeeeeeEEeeeeCCCccccCC
Q 024537 223 --EQLNPKISDFGLARLFPGEDT-------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 223 --~~~~~kl~DFG~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.++.+||+|||+|+.+..... ......||+.|+|||++.+..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 237 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA 237 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC
Confidence 889999999999987643321 113345999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=237.60 Aligned_cols=178 Identities=26% Similarity=0.386 Sum_probs=131.5
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+.+..++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|+.++.+++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 45567889999999999999999998 4578999999987543 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhc-----CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 159 LVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
+||||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999988531 12456899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCC-----ceeeeeeEEeeeeCCCccc
Q 024537 234 LARLFPGED-----THVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 234 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~ 261 (266)
+++.+.... .......+|+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhc
Confidence 998764321 1223456888999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=240.76 Aligned_cols=170 Identities=25% Similarity=0.331 Sum_probs=135.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++++.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4679999999999999999998 457899999998753 3444567889999999999999999999998765
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6899999996 46777763 24888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+...... ......||+.|+|||++.+..
T Consensus 175 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 202 (371)
T 2xrw_A 175 RTAGTSF-MMTPYVVTRYYRAPEVILGMG 202 (371)
T ss_dssp ----------------CTTCCHHHHTTCC
T ss_pred ccccccc-ccCCceecCCccCHHHhcCCC
Confidence 8765432 234557899999999987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=238.70 Aligned_cols=178 Identities=21% Similarity=0.302 Sum_probs=141.3
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccC-----------hhhHHHHHHHHHHHHhcCCCCcee
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-----------RQGLREFTNEVKLLLKIQHKNLVT 146 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~nIv~ 146 (266)
...+....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 455667779999999999999999999997779999999885431 222467889999999999999999
Q ss_pred EEeEEeeC-----CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE
Q 024537 147 LFGCCAEG-----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221 (266)
Q Consensus 147 l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill 221 (266)
+++++... ...++||||+. ++|.+.+. .....+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35799999997 57777774 23456899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 222 DEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 222 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.++.+||+|||+|+....... .....+|+.|+|||++.+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTT
T ss_pred cCCCCEEEEecCcccccccccc-cceecccceecCcHHhcC
Confidence 9999999999999986544332 234578899999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-33 Score=241.13 Aligned_cols=173 Identities=27% Similarity=0.481 Sum_probs=140.2
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCE----EEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQE----IAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|++++.||+|+||+||+|.+ .+++. ||+|.+.... ......+.+|+.++..++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 45799999999999999999984 34554 7888775432 222345678999999999999999999886 46789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999988532 346888999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCc--eeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDT--HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~--~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ......++..|+|||++...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 192 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFG 192 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHC
T ss_pred CcccccccccCCCCcccccChHHhccC
Confidence 54432 23344566789999987644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=232.45 Aligned_cols=174 Identities=25% Similarity=0.401 Sum_probs=142.6
Q ss_pred hcCccccceecccCceEEEEEEecC----CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEe-eCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA-EGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~ 158 (266)
..+|++.+.||+|+||+||+|...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3458899999999999999998432 235899988754 4445677899999999999999999999854 556789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999843 3456889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC----ceeeeeeEEeeeeCCCccccC
Q 024537 239 PGED----THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~----~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... .......+|+.|+|||++.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ 207 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred cccchhccccccCCCCCccccChHHhcCC
Confidence 4332 112233566789999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-34 Score=249.78 Aligned_cols=169 Identities=16% Similarity=0.178 Sum_probs=141.0
Q ss_pred hcCccccceecccCceEEEEEEec---------CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCcee---------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP---------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT--------- 146 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 146 (266)
.++|++.+.||+|+||.||+|... +++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 467999999999999999999854 3789999998754 35678999999999999987
Q ss_pred ------EEeEEee-CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCce
Q 024537 147 ------LFGCCAE-GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI 219 (266)
Q Consensus 147 ------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Ni 219 (266)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999543 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEecccccccCCCCCc-------eeeeeeEEeeeeCCCccccC
Q 024537 220 LLDEQL--NPKISDFGLARLFPGEDT-------HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 220 ll~~~~--~~kl~DFG~a~~~~~~~~-------~~~~~~~t~~y~aPE~~~~e 263 (266)
|++.++ .+||+|||+|+.+..... ......||+.|+|||++.+.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 999998 899999999987653321 12334789999999988764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=234.75 Aligned_cols=179 Identities=24% Similarity=0.367 Sum_probs=148.4
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 159 (266)
.++|++++.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45799999999999999999994 47899999998754 34455778899999999999999999998854 567899
Q ss_pred EEeccCCCCHHHHHhhcC-CCCCcCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 160 VYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEA--PARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yLH~~~--~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 2345899999999999999999999976 1239999999999999999999999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.............+++.|+|||++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 191 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRM 191 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC
T ss_pred eeccccccccccCCCccccChHHhccC
Confidence 876554444455788999999988654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=239.27 Aligned_cols=173 Identities=25% Similarity=0.487 Sum_probs=137.9
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCE----EEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|++.+.||+|+||+||+|++ .+++. ||+|.+... .......+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 45699999999999999999984 34444 588877543 3344577899999999999999999999998754 78
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+|+|++.+|+|.+++... ...+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCce--eeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTH--VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~--~~~~~~t~~y~aPE~~~~e 263 (266)
...... .....+|+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~ 194 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHR 194 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHC
T ss_pred cCCcccccccCCCccccccChHHhccC
Confidence 544322 2223456689999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=233.77 Aligned_cols=176 Identities=28% Similarity=0.459 Sum_probs=147.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+++..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 3445577999999999999999999987888999999875532 3467889999999999999999999986 4568999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999998432 1225889999999999999999999998 99999999999999999999999999988754
Q ss_pred CCce-eeeeeEEeeeeCCCcccc
Q 024537 241 EDTH-VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~~-~~~~~~t~~y~aPE~~~~ 262 (266)
.... .....++..|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~ 184 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINY 184 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHH
T ss_pred cccccccCCCCccCccChhhhcc
Confidence 3321 122245667999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=246.79 Aligned_cols=170 Identities=25% Similarity=0.367 Sum_probs=139.4
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc------EE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE------KM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~ 158 (266)
..+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4569999999999999999999766777999988654322 1269999999999999999999965443 78
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeEEeccccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARL 237 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~ 237 (266)
+||||++++.+..+.........+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999977554443322333467899999999999999999999998 99999999999999 789999999999998
Q ss_pred CCCCCceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+...... ....+|+.|+|||++.+
T Consensus 192 ~~~~~~~-~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 192 LIAGEPN-VSYICSRYYRAPELIFG 215 (394)
T ss_dssp CCTTCCC-CSSCSCGGGCCHHHHTT
T ss_pred ccCCCCC-cccccCcCccCHHHHcC
Confidence 7544332 34578999999998865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=240.05 Aligned_cols=172 Identities=24% Similarity=0.368 Sum_probs=150.2
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhh-----------------HHHHHHHHHHHHhcCCCCceeE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-----------------LREFTNEVKLLLKIQHKNLVTL 147 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 147 (266)
.++|++.+.||+|+||.||+|.. +++.||||++....... ...+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999998 89999999987542211 1678899999999999999999
Q ss_pred EeEEeeCCcEEEEEeccCCCCHHHH------HhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceE
Q 024537 148 FGCCAEGPEKMLVYEYLPNKSLDYF------IFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNIL 220 (266)
Q Consensus 148 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nil 220 (266)
++++..++..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999887 421 224679999999999999999999999 88 999999999999
Q ss_pred EcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 221 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++.++.+||+|||+++..... ......+++.|+|||++.+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSC
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCC
Confidence 999999999999999886543 34455789999999998765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=231.21 Aligned_cols=173 Identities=25% Similarity=0.454 Sum_probs=145.2
Q ss_pred hhcCccccc-eecccCceEEEEEEe---cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLN-QLGHGGFGPVYRGLM---PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~-~iG~G~fg~V~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|.+.+ .||+|+||.||+|.. .++..||||++... .....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345677776 999999999999974 25778999999765 344567889999999999999999999999 556799
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999998842 3456899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcee---eeeeEEeeeeCCCcccc
Q 024537 239 PGEDTHV---NTFRISVVTWPPNMHCM 262 (266)
Q Consensus 239 ~~~~~~~---~~~~~t~~y~aPE~~~~ 262 (266)
....... ....+|+.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF 187 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhcc
Confidence 5443221 22245778999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-33 Score=242.31 Aligned_cols=174 Identities=25% Similarity=0.350 Sum_probs=146.9
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChh------hHHHHHHHHHHHHhcC--CCCceeEEeEEe
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ--HKNLVTLFGCCA 152 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~ 152 (266)
....++|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+|+.+++++. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 4446779999999999999999998 557899999998654211 1234567999999996 599999999999
Q ss_pred eCCcEEEEEeccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeEEe
Q 024537 153 EGPEKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKIS 230 (266)
Q Consensus 153 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~kl~ 230 (266)
.++..++|||++.+ ++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 8999988543 46889999999999999999999998 99999999999999 77899999
Q ss_pred cccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 231 DFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 231 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|||+++.+.... .....||+.|+|||++...
T Consensus 193 Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 223 (320)
T 3a99_A 193 DFGSGALLKDTV--YTDFDGTRVYSPPEWIRYH 223 (320)
T ss_dssp CCTTCEECCSSC--BCCCCSCGGGSCHHHHHHS
T ss_pred eCcccccccccc--ccCCCCCccCCChHHhccC
Confidence 999999875433 2345789999999987644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=230.83 Aligned_cols=173 Identities=28% Similarity=0.352 Sum_probs=144.4
Q ss_pred CccccceecccCceEEEEEEec-CCC---EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE-EEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMP-NGQ---EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK-MLV 160 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lv 160 (266)
.|.+.+.||+|+||+||+|.+. ++. .||+|.+... .....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3666799999999999999842 333 7999998754 444567889999999999999999999999877665 999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999843 3456889999999999999999999998 99999999999999999999999999987643
Q ss_pred CC----ceeeeeeEEeeeeCCCccccCC
Q 024537 241 ED----THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~----~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. .......+++.|+|||++.+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 204 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYR 204 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCC
T ss_pred CcccccccCcCCCCCccccChhhhccCC
Confidence 21 2223346778899999886543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=237.60 Aligned_cols=177 Identities=30% Similarity=0.433 Sum_probs=143.2
Q ss_pred hhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
..++|++.+.||+|+||.||+|.+ .++..||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 456799999999999999999983 35778999998654 34455678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCC----CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEE
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKI 229 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl 229 (266)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999965422 245889999999999999999999998 999999999999984 446999
Q ss_pred ecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 230 SDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 230 ~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|||+++...... .......+++.|+|||++...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 220 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG 220 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCC
Confidence 9999998653222 122233567889999987554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=239.46 Aligned_cols=169 Identities=31% Similarity=0.507 Sum_probs=136.3
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHH--HHhcCCCCceeEEeEEee-----CC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL--LLKIQHKNLVTLFGCCAE-----GP 155 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~ 155 (266)
+..++|++.+.||+|+||+||+|+. +++.||||++..... ..+..|..+ +..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3457899999999999999999987 789999999875433 233344444 455899999999986542 23
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc---------CCCCeEeCCCCCCceEEcCCCC
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---------APARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~---------~~~~iiHrDlKp~Nill~~~~~ 226 (266)
..++||||+++++|.+++... ..++..+..++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred eEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 568999999999999998432 357889999999999999999998 7 999999999999999999
Q ss_pred eEEecccccccCCCCC--------ceeeeeeEEeeeeCCCcccc
Q 024537 227 PKISDFGLARLFPGED--------THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~ 262 (266)
+||+|||+|+.+.... .......||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9999999998764321 12223468999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=228.85 Aligned_cols=172 Identities=22% Similarity=0.366 Sum_probs=147.5
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC--CcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 159 (266)
..++|++.+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||||+++++++..+ +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 346799999999999999999997 4889999998765 344456789999999999999999999999887 77899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999542 2336899999999999999999999976 349999999999999999999999998886643
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ...+|+.|+|||++.+.
T Consensus 165 ~~-----~~~~t~~y~aPE~~~~~ 183 (271)
T 3kmu_A 165 SP-----GRMYAPAWVAPEALQKK 183 (271)
T ss_dssp CT-----TCBSCGGGSCHHHHHSC
T ss_pred cc-----CccCCccccChhhhccC
Confidence 32 23678999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=234.20 Aligned_cols=165 Identities=22% Similarity=0.378 Sum_probs=143.8
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEee--CCcEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE--GPEKMLV 160 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lv 160 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++..... ..+.+|+.+++.+. ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3679999999999999999998 46789999999875443 56789999999997 9999999999988 5678999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~ 239 (266)
|||+++++|..++. .+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988872 3788999999999999999999999 99999999999999777 79999999998775
Q ss_pred CCCceeeeeeEEeeeeCCCcccc
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.... .....++..|+|||++..
T Consensus 183 ~~~~-~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 183 PGQE-YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp TTCC-CCSCCSCGGGCCHHHHTT
T ss_pred CCCc-cccccccccccChhhhcC
Confidence 4433 344578899999998765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=242.44 Aligned_cols=172 Identities=23% Similarity=0.348 Sum_probs=140.2
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------ 154 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 154 (266)
+...++|++.+.||+|+||+||+|. ..+++.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999998 468999999998655322 23699999999999999999998543
Q ss_pred --------------------------------CcEEEEEeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHH
Q 024537 155 --------------------------------PEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYL 201 (266)
Q Consensus 155 --------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yL 201 (266)
...++||||++ ++|.+.+... .....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999997 5777766432 3345799999999999999999999
Q ss_pred hhcCCCCeEeCCCCCCceEEc-CCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 202 H~~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
|++| |+||||||+|||++ .++.+||+|||+|+.+..... .....+|+.|+|||++.+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~ 215 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLG 215 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTT
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcC
Confidence 9998 99999999999998 678999999999997754433 234578999999998765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-33 Score=246.58 Aligned_cols=171 Identities=16% Similarity=0.190 Sum_probs=138.2
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHH---HHHhcCCCCceeEE-------eE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVK---LLLKIQHKNLVTLF-------GC 150 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~H~nIv~l~-------~~ 150 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999 467999999998743 3344577889994 55556899999998 66
Q ss_pred EeeCCc-----------------EEEEEeccCCCCHHHHHhhcCC----CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024537 151 CAEGPE-----------------KMLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209 (266)
Q Consensus 151 ~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~yLH~~~~~~i 209 (266)
+..++. .++||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6899999864311 123445788889999999999999998 9
Q ss_pred EeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 210 iHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhccc
Confidence 9999999999999999999999999997532 3445567 999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=236.84 Aligned_cols=174 Identities=25% Similarity=0.349 Sum_probs=143.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcC--CCCceeEEeEEeeCCc
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGPE 156 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 156 (266)
+.+..++|++++.||+|+||.||+|...+++.||||++... .......+.+|+.++.++. ||||+++++++..++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 44456779999999999999999999778999999998654 3445678899999999997 5999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||| +.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+++ +.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 999999 5588999998543 46889999999999999999999998 999999999999975 789999999998
Q ss_pred cCCCCCc--eeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDT--HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~--~~~~~~~t~~y~aPE~~~~ 262 (266)
.+..... ......|++.|+|||++..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp C--------------CCGGGCCHHHHTT
T ss_pred cccCccccccccCCCCCCCcCCHHHHhh
Confidence 8754332 2234568999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=230.75 Aligned_cols=173 Identities=26% Similarity=0.318 Sum_probs=143.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC----hhhHHHHHHHHHHHHhcCCCCceeEEeEEe--eCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFGCCA--EGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 157 (266)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4679999999999999999999 4578999999987542 233567889999999999999999999984 45678
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||++++ +.+++.. .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 6666643 23457899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCC--CceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGE--DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~--~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.... ........+|+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANG 185 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred cCccccccccccCCCCCCCcChhhccC
Confidence 6432 233345568999999998765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=258.62 Aligned_cols=170 Identities=21% Similarity=0.294 Sum_probs=144.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEec--CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE- 156 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 156 (266)
.....++|++.+.||+|+||+||+|... +++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3445688999999999999999999954 6899999988654 34445678899999999999999999999988766
Q ss_pred ----EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 157 ----KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 157 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
.|+||||++|++|.+++. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp SCEEEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred CCceeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence 799999999999987662 26899999999999999999999999 9999999999999885 8999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
|+++..... ....||+.|+|||++...
T Consensus 226 G~a~~~~~~----~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 226 GAVSRINSF----GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp TTCEETTCC----SCCCCCTTTSCTTHHHHC
T ss_pred ccchhcccC----CccCCCccccCHHHHcCC
Confidence 999987544 344689999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=233.05 Aligned_cols=172 Identities=25% Similarity=0.343 Sum_probs=147.4
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHh--cCCCCceeEEeEEeeCC---
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEGP--- 155 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~--- 155 (266)
.....++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|+.++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345567899999999999999999987 68999999986543 3466788888887 78999999999998876
Q ss_pred -cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeCCCCCCceEEcCCCC
Q 024537 156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH--------EEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 156 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH--------~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999843 35899999999999999999999 777 999999999999999999
Q ss_pred eEEecccccccCCCCCce----eeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTH----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+++........ .....||+.|+|||++...
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 999999999877544322 2344689999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=239.27 Aligned_cols=170 Identities=24% Similarity=0.402 Sum_probs=144.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----CcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 157 (266)
.++|++++.||+|+||.||+|. ..+++.||||++... .......+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 3579999999999999999998 447889999998754 344457788999999999999999999999765 368
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999996 588888743 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCc---eeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDT---HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~---~~~~~~~t~~y~aPE~~~~ 262 (266)
...... ......||+.|+|||++..
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 205 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLN 205 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred cCCCCCccccccccccccCCCCCHHhcC
Confidence 753321 1244578999999998643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=235.60 Aligned_cols=175 Identities=30% Similarity=0.437 Sum_probs=142.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEE--EEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.+.||+|+||.||+|+ ..++..+ |+|.+... .....+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 3569999999999999999998 4466654 99988653 333456788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 160 VYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999985432 2346899999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+++....... .....+++.|+|||++...
T Consensus 181 ~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 216 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYS 216 (327)
T ss_dssp EEECCTTCEESSCEECC-C----CCTTTCCHHHHHHC
T ss_pred EEEcccCcCcccccccc-ccCCCCCccccChhhhccc
Confidence 99999999985432221 1223456789999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=236.35 Aligned_cols=170 Identities=22% Similarity=0.301 Sum_probs=141.3
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh--------hhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
..++|++.+.||+|+||.||+|. ..+++.||||++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999998 45688999999865421 1234578899999999999999999998765
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEec
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISD 231 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~D 231 (266)
+ .++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999998883 3457899999999999999999999998 999999999999987664 99999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
||+++...... ......||+.|+|||++.
T Consensus 161 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 161 FGHSKILGETS-LMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CTTCEECCCCH-HHHHHHSCCTTCCHHHHH
T ss_pred Cccceeccccc-ccccccCCcCccCchhhc
Confidence 99998875432 233456899999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=241.66 Aligned_cols=167 Identities=28% Similarity=0.439 Sum_probs=128.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------C
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 155 (266)
.++|++++.||+|+||.||+|. ..+++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3679999999999999999998 557899999998653 344556788999999999999999999999764 5
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7889887732 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... .....+|+.|+|||++.+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp --------------CCCTTCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcC
Confidence 876433 234578999999998765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=237.26 Aligned_cols=177 Identities=24% Similarity=0.285 Sum_probs=133.4
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc--
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-- 156 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-- 156 (266)
......++|++.+.||+|+||+||+|.. .+++.||||++...... .....+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455668899999999999999999994 57899999988654322 2455678888899999999999999976443
Q ss_pred -----EEEEEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHh--hcCCCCeEeCCCCCCceEEcC-CCCe
Q 024537 157 -----KMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLH--EEAPARIIHRDIKASNILLDE-QLNP 227 (266)
Q Consensus 157 -----~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH--~~~~~~iiHrDlKp~Nill~~-~~~~ 227 (266)
.++||||++++ +...+.. ......+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999764 4433322 234567889999999999999999999 888 999999999999997 8999
Q ss_pred EEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 228 KISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
||+|||+|+.+...... ....||+.|+|||++.+
T Consensus 172 kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN-VAYICSRYYRAPELIFG 205 (360)
T ss_dssp EECCCTTCBCCCTTSCC-CSTTSCGGGCCHHHHTT
T ss_pred EEeeCCCceecCCCCCc-ccccCCcceeCHHHHcC
Confidence 99999999987654332 34468999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=241.72 Aligned_cols=174 Identities=24% Similarity=0.294 Sum_probs=144.0
Q ss_pred HHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC--------CCCceeEEeEEe
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--------HKNLVTLFGCCA 152 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~ 152 (266)
....++|++.+.||+|+||+||+|+ ..+++.||||++... ....+.+.+|+.+++.+. |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3445789999999999999999998 457889999998754 334467889999999985 788999999998
Q ss_pred ----eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCC--
Q 024537 153 ----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQL-- 225 (266)
Q Consensus 153 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~-- 225 (266)
.....++||||+ ++++.+.+... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence 456789999999 55665555332 335689999999999999999999998 8 99999999999998775
Q ss_pred -----------------------------------------------CeEEecccccccCCCCCceeeeeeEEeeeeCCC
Q 024537 226 -----------------------------------------------NPKISDFGLARLFPGEDTHVNTFRISVVTWPPN 258 (266)
Q Consensus 226 -----------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE 258 (266)
.+||+|||+|+...... ....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---CSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---ccCCCCCcccCCh
Confidence 79999999998875432 3447899999999
Q ss_pred ccccCC
Q 024537 259 MHCMDI 264 (266)
Q Consensus 259 ~~~~e~ 264 (266)
++.+..
T Consensus 264 ~~~~~~ 269 (397)
T 1wak_A 264 VLIGSG 269 (397)
T ss_dssp HHHTSC
T ss_pred hhcCCC
Confidence 987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=233.45 Aligned_cols=169 Identities=19% Similarity=0.229 Sum_probs=121.1
Q ss_pred hcCccccc-eecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEE
Q 024537 85 TNFFSDLN-QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKM 158 (266)
Q Consensus 85 ~~~y~~~~-~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 158 (266)
.++|.+.+ .||+|+||+||+|.. .+++.||||++...... ..+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45688855 699999999999994 47999999998654221 1223334667799999999999976 44589
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEeccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLA 235 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a 235 (266)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998543 3357999999999999999999999998 999999999999976 455999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+...... .....+|+.|+|||++...
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~ 204 (336)
T 3fhr_A 179 KETTQNA--LQTPCYTPYYVAPEVLGPE 204 (336)
T ss_dssp EEC------------------------C
T ss_pred eeccccc--cccCCCCcCccChhhhCCC
Confidence 8765332 3455789999999998543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=255.64 Aligned_cols=178 Identities=26% Similarity=0.428 Sum_probs=148.7
Q ss_pred hHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.+++..++|++.+.||+|+||.||+|.+..+..||||++..... ..+.+.+|+.+|++++||||+++++++.. +..++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 34556677999999999999999999987778899999976542 24678999999999999999999999876 67899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++++|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 339 v~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999998532 2245889999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCc-eeeeeeEEeeeeCCCccccC
Q 024537 240 GEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ......++..|+|||++...
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~ 439 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG 439 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC
T ss_pred CCceecccCCcCcccccCHHHhccC
Confidence 3211 11122456789999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.79 Aligned_cols=174 Identities=26% Similarity=0.402 Sum_probs=142.8
Q ss_pred hhcCccccceecccCceEEEEEEecC----CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
..++|++.+.||+|+||+||+|.+.. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45679999999999999999998432 336999998765 34456788999999999999999999999875 4578
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998543 345889999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCc-eeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ......+++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 189 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFR 189 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHC
T ss_pred ccccccccccCCCCcceeCchhhccC
Confidence 54322 22233567789999987644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=243.07 Aligned_cols=168 Identities=27% Similarity=0.386 Sum_probs=136.5
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC----C--cEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG----P--EKM 158 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~--~~~ 158 (266)
.+|++.+.||+|+||+||+|+. .+++.||||++...... ..+|+.+++.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4699999999999999999995 46999999998654322 23699999999999999999998542 1 367
Q ss_pred EEEeccCCCCHHHHHhh-cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEecccccc
Q 024537 159 LVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLAR 236 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG~a~ 236 (266)
+||||+++ ++..++.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 55555532 223457899999999999999999999998 9999999999999965 568999999999
Q ss_pred cCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+...... ....+|+.|+|||++.+
T Consensus 206 ~~~~~~~~-~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 206 QLVRGEPN-VSYICSRYYRAPELIFG 230 (420)
T ss_dssp ECCTTCCC-CSCCSCTTSCCHHHHTT
T ss_pred hcccCCCc-eeeeeCCCcCCHHHHcC
Confidence 76543322 34578999999998864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=230.78 Aligned_cols=170 Identities=27% Similarity=0.456 Sum_probs=137.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEe-----------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA----------- 152 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 152 (266)
.++|++++.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46799999999999999999995 468999999998777777788999999999999999999999874
Q ss_pred ---eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeE
Q 024537 153 ---EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPK 228 (266)
Q Consensus 153 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~k 228 (266)
..+..++||||++ ++|.+++. ...+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 68988883 246889999999999999999999998 99999999999997 567899
Q ss_pred EecccccccCCCCC---ceeeeeeEEeeeeCCCcccc
Q 024537 229 ISDFGLARLFPGED---THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 229 l~DFG~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~ 262 (266)
|+|||+++...... .......+|..|+|||++..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 99999999764321 12233356888999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=232.60 Aligned_cols=171 Identities=27% Similarity=0.427 Sum_probs=137.6
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-CcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-PEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~ 161 (266)
+..++|++.+.||+|+||.||+|.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++... +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3456799999999999999999987 58899999987553 346788999999999999999999997654 5789999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999985431 223788899999999999999999998 999999999999999999999999999876433
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
. ....+++.|+|||++...
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~ 189 (278)
T 1byg_A 171 Q---DTGKLPVKWTAPEALREK 189 (278)
T ss_dssp --------CCTTTSCHHHHHHC
T ss_pred c---cCCCccccccCHHHhCCC
Confidence 2 233567789999987644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=229.13 Aligned_cols=173 Identities=26% Similarity=0.414 Sum_probs=143.1
Q ss_pred HhhcCccccc-eecccCceEEEEEEe---cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc
Q 024537 83 VATNFFSDLN-QLGHGGFGPVYRGLM---PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156 (266)
Q Consensus 83 ~~~~~y~~~~-~iG~G~fg~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 156 (266)
+..++|++.+ .||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788888 999999999999953 356889999987553 23356788999999999999999999999 5678
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999854 345889999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCceee---eeeEEeeeeCCCcccc
Q 024537 237 LFPGEDTHVN---TFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~~~~~---~~~~t~~y~aPE~~~~ 262 (266)
.+........ ...+++.|+|||++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhcc
Confidence 8755443221 1234567999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=250.93 Aligned_cols=172 Identities=25% Similarity=0.447 Sum_probs=139.2
Q ss_pred cCccccc-eecccCceEEEEEEec---CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLN-QLGHGGFGPVYRGLMP---NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~-~iG~G~fg~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....+.+.+|+.+|++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444445 7999999999999853 4567999999765 33456789999999999999999999999976 569999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999843 3456899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCcee---eeeeEEeeeeCCCccccC
Q 024537 241 EDTHV---NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~---~~~~~t~~y~aPE~~~~e 263 (266)
..... ....+++.|+|||++...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp -------------CCTTSCHHHHHHC
T ss_pred CCceeeeccCCCCccceeCHhhhcCC
Confidence 33211 122345679999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=232.54 Aligned_cols=170 Identities=25% Similarity=0.375 Sum_probs=142.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----CcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 157 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46799999999999999999994 47899999998754 344456788999999999999999999988764 678
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 688888743 35899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCc----------eeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDT----------HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~----------~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... ......||+.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHS
T ss_pred cccccccccCccccccchhhccccccccCCeeecc
Confidence 753321 1223467889999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=242.54 Aligned_cols=171 Identities=24% Similarity=0.395 Sum_probs=127.3
Q ss_pred cCccc-cceecccCceEEEEEEec---CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEE
Q 024537 86 NFFSD-LNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKML 159 (266)
Q Consensus 86 ~~y~~-~~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 159 (266)
+.|++ .++||+|+||+||+|+.. +++.||||++...... ..+.+|+.+|+.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44666 458999999999999854 5789999998755332 467789999999999999999999954 677899
Q ss_pred EEeccCCCCHHHHHhhc------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE----cCCCCeEE
Q 024537 160 VYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKI 229 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill----~~~~~~kl 229 (266)
||||+. ++|.+++... .....+++..++.|+.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 5777766421 12235899999999999999999999999 9999999999999 67789999
Q ss_pred ecccccccCCCCC---ceeeeeeEEeeeeCCCcccc
Q 024537 230 SDFGLARLFPGED---THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 230 ~DFG~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|||+|+.+.... .......||+.|+|||++.+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTT
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 9999999875432 23345678999999998865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=234.19 Aligned_cols=174 Identities=25% Similarity=0.492 Sum_probs=137.0
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCE----EEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.++|++++.||+|+||+||+|.. .+++. ||+|.+... .......+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46799999999999999999984 45554 577776543 3344577889999999999999999999998754 88
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+|+|++.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 346899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCCce--eeeeeEEeeeeCCCccccCC
Q 024537 239 PGEDTH--VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 239 ~~~~~~--~~~~~~t~~y~aPE~~~~e~ 264 (266)
...... .....+|+.|+|||++.+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 195 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRI 195 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCC
T ss_pred cCccccccccCCCccccccCHHHHcCCC
Confidence 543322 22234466799999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=230.56 Aligned_cols=174 Identities=20% Similarity=0.278 Sum_probs=146.9
Q ss_pred HHhhcCccccceecccCceEEEEEEe--cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC------CceeEEeEEee
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK------NLVTLFGCCAE 153 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~ 153 (266)
....++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+++.++|+ +|+++++++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34457899999999999999999984 36889999998754 33446788999999988765 49999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC----------
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---------- 223 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---------- 223 (266)
.+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 88998888543 3346889999999999999999999998 999999999999987
Q ss_pred ---------CCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 224 ---------QLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 224 ---------~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
++.+||+|||+|+...... ....||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~ 210 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALG 210 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC---CSSCSCGGGCCHHHHTTSC
T ss_pred cccccccccCCCceEeeCcccccCcccc---ccccCCccccChHHhhCCC
Confidence 6689999999998764432 3457899999999987643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=227.64 Aligned_cols=175 Identities=23% Similarity=0.340 Sum_probs=128.5
Q ss_pred HHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHH-HHHhcCCCCceeEEeEEeeCCcEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+..++|++++.||+|+||.||+|.. .+++.||||++... .......+..|+. +++.++||||+++++++..++..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 34457899999999999999999995 57899999998765 2333445566665 677789999999999999999999
Q ss_pred EEEeccCCCCHHHHHhh--cCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 159 LVYEYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
+||||+++ +|.+++.. ......+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999975 77776642 12245789999999999999999999998 8 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
+.+..... .....||+.|+|||++.
T Consensus 174 ~~~~~~~~-~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 174 GQLVDSIA-KTRDAGCRPYMAPERID 198 (327)
T ss_dssp CC------------------------
T ss_pred eecccccc-cccCCCCccccCceeec
Confidence 88754432 23347899999999983
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=227.01 Aligned_cols=172 Identities=26% Similarity=0.345 Sum_probs=140.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEE-eeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||+||+|. ..+++.||||++...... ..+..|+.+++.++|++++..+..+ ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4679999999999999999999 467899999987654332 3567899999999988877666655 66778899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~ 239 (266)
|+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998532 346899999999999999999999999 9999999999999 788999999999998775
Q ss_pred CCCc-------eeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDT-------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~-------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.... ......+|+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE 191 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCC
Confidence 4332 223557899999999987653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=251.71 Aligned_cols=165 Identities=27% Similarity=0.417 Sum_probs=135.8
Q ss_pred ceecccCceEEEEEEe---cCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLM---PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
+.||+|+||+||+|.+ .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 356789999987642 3345789999999999999999999999864 568999999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc---
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT--- 243 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--- 243 (266)
++|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999843 356899999999999999999999998 99999999999999999999999999998754432
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......+|+.|+|||++...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~ 547 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYY 547 (635)
T ss_dssp -------CGGGSCHHHHHHC
T ss_pred cccCCCCceeeeChhhhcCC
Confidence 12222456679999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=225.26 Aligned_cols=172 Identities=26% Similarity=0.345 Sum_probs=143.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEE-eeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||.||+|+ ..+++.||||++...... ..+.+|+.+++.+.|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4679999999999999999999 468999999998755432 3578999999999988876666555 56677899999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~ 239 (266)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+|+...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999853 2346899999999999999999999998 9999999999999 478899999999998875
Q ss_pred CCCc-------eeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDT-------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~-------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.... ......||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 191 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE 191 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC
T ss_pred ccccccccccccccccccccccCChhhhcCCC
Confidence 4432 124557899999999987653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=236.40 Aligned_cols=168 Identities=10% Similarity=0.064 Sum_probs=124.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhc--CCCCceeEE-------eEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI--QHKNLVTLF-------GCCA 152 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~~ 152 (266)
..|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4589999999999999999994 578999999998753 23445677885544444 699988755 4444
Q ss_pred eC-----------------CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHH------HHHHHHHHHHHHHHhhcCCCCe
Q 024537 153 EG-----------------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR------YRIVMGVARGLLYLHEEAPARI 209 (266)
Q Consensus 153 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~qi~~al~yLH~~~~~~i 209 (266)
.+ ...|+||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 23799999998 89999986532 22344444 677799999999999999 9
Q ss_pred EeCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 210 iHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++..
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccC
Confidence 99999999999999999999999999976432 223456799999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=250.05 Aligned_cols=179 Identities=22% Similarity=0.320 Sum_probs=145.7
Q ss_pred hhHHHhhcCccccceecccCceEEEEEEec----CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 79 ~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
....+..++|++.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344555678999999999999999999853 2457999998754 3444577899999999999999999999985
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 46789999999999999998532 346889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGEDT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
+|+....... ......+|+.|+|||++...
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 567 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR 567 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC
Confidence 9998754332 22233456789999987644
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=231.96 Aligned_cols=166 Identities=25% Similarity=0.430 Sum_probs=139.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc-----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----- 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 156 (266)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3679999999999999999998 457899999998654 33445678899999999999999999999987654
Q ss_pred -EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 157 -KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 157 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.++||||+. ++|.+++ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 5776655 234899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+..... .....+|+.|+|||++.+
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSC
T ss_pred cCCCCC---ccccccCcCcCCHHHHhC
Confidence 876433 234578999999998765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=226.69 Aligned_cols=173 Identities=32% Similarity=0.466 Sum_probs=135.8
Q ss_pred hcCccccceecccCceEEEEEEec--CCC--EEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP--NGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++.+.||+|+||+||+|.+. +++ .||||++... .....+.+.+|+.+++.++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999842 333 6899998754 2344577889999999999999999999998765 8
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 245889999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCcee---eeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTHV---NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~~---~~~~~t~~y~aPE~~~~e 263 (266)
+....... ....++..|+|||++..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR 199 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCC
Confidence 75443321 223456679999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=229.16 Aligned_cols=175 Identities=25% Similarity=0.443 Sum_probs=142.9
Q ss_pred hhcCccccceecccCceEEEEEEe--cCCCEEEEEeecccCh--hhHHHHHHHHHHHHhc---CCCCceeEEeEEe----
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKI---QHKNLVTLFGCCA---- 152 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 152 (266)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346799999999999999999995 4688999999865421 1123455677777666 8999999999987
Q ss_pred -eCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEec
Q 024537 153 -EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231 (266)
Q Consensus 153 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~D 231 (266)
.....++||||+. ++|.+++... ....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 6998888543 3345899999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 232 FGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 232 FG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||+++...... ......+|+.|+|||++....
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 195 (326)
T 1blx_A 164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSS 195 (326)
T ss_dssp CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCC
T ss_pred CcccccccCCC-CccccccccceeCHHHHhcCC
Confidence 99998765332 233457899999999886543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=232.40 Aligned_cols=175 Identities=27% Similarity=0.370 Sum_probs=139.2
Q ss_pred HHHhhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh------hhHHHHHHHHHHHHhc----CCCCceeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKI----QHKNLVTLFG 149 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~nIv~l~~ 149 (266)
.+...++|++.+.||+|+||.||+|. ..+++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34456789999999999999999998 45789999999875532 1223455799999988 8999999999
Q ss_pred EEeeCCcEEEEEec-cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCe
Q 024537 150 CCAEGPEKMLVYEY-LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNP 227 (266)
Q Consensus 150 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~ 227 (266)
++...+..++|||+ +.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999998543 35899999999999999999999998 99999999999999 78899
Q ss_pred EEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 228 KISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
||+|||+++...... .....++..|+|||++...
T Consensus 180 kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 213 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRH 213 (312)
T ss_dssp EECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHS
T ss_pred EEEEcchhhhcccCc--ccccCCcccccCceeeecC
Confidence 999999999875443 2345689999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.37 Aligned_cols=172 Identities=25% Similarity=0.332 Sum_probs=144.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC-CCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ..+..|+.+++.+.| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4679999999999999999999 467999999987655332 356789999999987 566666667778888999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE---cCCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill---~~~~~~kl~DFG~a~~~~ 239 (266)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999853 2356999999999999999999999998 9999999999999 688899999999998875
Q ss_pred CCCce-------eeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTH-------VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~-------~~~~~~t~~y~aPE~~~~e~ 264 (266)
..... .....||+.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 189 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIE 189 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCC
Confidence 44321 22557899999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=227.30 Aligned_cols=174 Identities=22% Similarity=0.348 Sum_probs=129.3
Q ss_pred HHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC-hhh-HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.....++|++++.||+|+||.||+|.. .+++.||||++.... ... .+.+.++..+++.++||||+++++++..++..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 344457799999999999999999995 478999999987653 222 23344555678888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
++||||+ ++.+..+.... ...+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++
T Consensus 100 ~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 9999999 66666555322 35689999999999999999999995 8 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccc
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHC 261 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~ 261 (266)
.+..... .....+++.|+|||++.
T Consensus 174 ~~~~~~~-~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 174 RLVDDKA-KDRSAGCAAYMAPERID 197 (318)
T ss_dssp --------------CCTTCCHHHHC
T ss_pred hccCCcc-ccccCCCccccChhhcc
Confidence 7654332 23447899999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=228.00 Aligned_cols=173 Identities=21% Similarity=0.271 Sum_probs=143.6
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCC-CEEEEEeecccChhhHHHHHHHHHHHHhcCCCC------ceeEEeEEeeC
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNG-QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN------LVTLFGCCAEG 154 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~ 154 (266)
...++|++.+.||+|+||+||+|.. .++ +.||+|++... ....+.+.+|+.+++.+.|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3457899999999999999999984 344 68999998754 333467788999999987665 99999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE-------------
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL------------- 221 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill------------- 221 (266)
+..++||||+ ++++.+.+... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 9999999999 66666666432 3356899999999999999999999998 9999999999999
Q ss_pred ------cCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 222 ------DEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 222 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.++.+||+|||+|+...... ....||+.|+|||++....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~ 215 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELG 215 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHHHTTCC
T ss_pred cccccccCCCcEEEeecCccccccccc---cCCcCCCcccCCeeeecCC
Confidence 567889999999998764433 3457899999999986543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=246.75 Aligned_cols=176 Identities=24% Similarity=0.373 Sum_probs=148.8
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee------CCc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GPE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 156 (266)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999984 57899999998764 44556778999999999999999999999765 667
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC---eEEeccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFG 233 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~---~kl~DFG 233 (266)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.| |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999966554557899999999999999999999998 999999999999997765 8999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+++....... .....||+.|+|||++.+..
T Consensus 170 ~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~ 199 (676)
T 3qa8_A 170 YAKELDQGEL-CTEFVGTLQYLAPELLEQKK 199 (676)
T ss_dssp CCCBTTSCCC-CCCCCSCCTTCSSCSSCCSC
T ss_pred cccccccccc-cccccCCcccCChHHhccCC
Confidence 9998754432 34457899999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=238.15 Aligned_cols=171 Identities=24% Similarity=0.306 Sum_probs=134.3
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
+...+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+.+..|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 334568999999999999976555558999999998654322 245799999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-----CCCeEEecccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----QLNPKISDFGLAR 236 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-----~~~~kl~DFG~a~ 236 (266)
||+. ++|.+++... .....+..++.++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+|+
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9995 6998888543 233444556789999999999999998 999999999999953 2357899999999
Q ss_pred cCCCCC---ceeeeeeEEeeeeCCCcccc
Q 024537 237 LFPGED---THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 237 ~~~~~~---~~~~~~~~t~~y~aPE~~~~ 262 (266)
.+.... .......||+.|+|||++..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhc
Confidence 875432 23344578999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=231.90 Aligned_cols=178 Identities=23% Similarity=0.410 Sum_probs=144.1
Q ss_pred chhhHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC
Q 024537 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154 (266)
Q Consensus 77 ~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 154 (266)
....+.+..++|++.+.||+|+||.||+|.... .||+|++.... ....+.+.+|+.++++++||||+++++++..+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344556667889999999999999999998643 49999987542 22234567899999999999999999999999
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccc
Q 024537 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234 (266)
Q Consensus 155 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~ 234 (266)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999843 2346889999999999999999999998 99999999999998 67999999999
Q ss_pred cccCCCC-----CceeeeeeEEeeeeCCCcccc
Q 024537 235 ARLFPGE-----DTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 235 a~~~~~~-----~~~~~~~~~t~~y~aPE~~~~ 262 (266)
++..... ........|++.|+|||++..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred ccccccccccccccccccCCCcccccChHHhhh
Confidence 8765321 122333458889999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=235.83 Aligned_cols=170 Identities=25% Similarity=0.285 Sum_probs=130.7
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4466678899999999987766689999999986543 24567899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC----CcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-------------CCe
Q 024537 165 PNKSLDYFIFDKTKSS----SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-------------LNP 227 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~----~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-------------~~~ 227 (266)
. ++|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.. +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999985432111 1123345779999999999999998 9999999999999754 479
Q ss_pred EEecccccccCCCCCc----eeeeeeEEeeeeCCCcccc
Q 024537 228 KISDFGLARLFPGEDT----HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 228 kl~DFG~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~ 262 (266)
||+|||+|+.+..... ......||+.|+|||++.+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 9999999998754432 2334579999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=230.73 Aligned_cols=172 Identities=23% Similarity=0.308 Sum_probs=143.9
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-----------CCCceeEEeEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----------HKNLVTLFGCC 151 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~ 151 (266)
..++|++.+.||+|+||+||+|. ..+++.||||++.... .....+.+|+.+++++. ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34679999999999999999999 4578999999987543 33467788999998886 89999999999
Q ss_pred eeCC----cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEc----
Q 024537 152 AEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLD---- 222 (266)
Q Consensus 152 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~---- 222 (266)
...+ ..++|||++ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 8654 689999999 89999988543 334689999999999999999999998 8 99999999999994
Q ss_pred --CCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 223 --EQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 223 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..+.+||+|||+|+...... ....+|+.|+|||++.+..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~~~~~~ 211 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAP 211 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCC
T ss_pred CcCcceEEEcccccccccCCCC---CCCCCCccccCcHHHhCCC
Confidence 34479999999998775432 3347899999999987653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=214.73 Aligned_cols=146 Identities=12% Similarity=0.046 Sum_probs=128.8
Q ss_pred HhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
+..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++..++||||+++++++..++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 3457799999999999999999995 468999999997652 344577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
+||||++|++|.+++.. ......+..|+.|++.||.|||++| |+||||||+|||++.++.+||+++|...
T Consensus 108 lv~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EEEECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEEEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999999832 1355678889999999999999999 9999999999999999999999887654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=209.74 Aligned_cols=146 Identities=25% Similarity=0.304 Sum_probs=126.7
Q ss_pred cCcccc-ceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHH-HhcCCCCceeEEeEEee----CCcEE
Q 024537 86 NFFSDL-NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLL-LKIQHKNLVTLFGCCAE----GPEKM 158 (266)
Q Consensus 86 ~~y~~~-~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 158 (266)
++|.+. +.||+|+||.||+|. ..+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457776 789999999999998 457899999998643 3456788887 66689999999999987 66789
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEeccccc
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLA 235 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a 235 (266)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998653 3356899999999999999999999998 999999999999998 788999999999
Q ss_pred ccCCC
Q 024537 236 RLFPG 240 (266)
Q Consensus 236 ~~~~~ 240 (266)
....+
T Consensus 168 ~~~~~ 172 (299)
T 3m2w_A 168 KETTG 172 (299)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 87654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=235.19 Aligned_cols=157 Identities=16% Similarity=0.189 Sum_probs=122.9
Q ss_pred cccceecccCceEEEEEEecCCCEEEEEeecccC--------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
...+.||+|+||+||+|.+ .++.+++|+..... ....+.+.+|+.++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 57889999864431 11235578999999999999999666666677888999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998832 4578999999999999998 999999999999999 999999999998865
Q ss_pred CCce-------eeeeeEEeeeeCCCcccc
Q 024537 241 EDTH-------VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 241 ~~~~-------~~~~~~t~~y~aPE~~~~ 262 (266)
.... ..++.||+.|+|||++..
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 4321 236689999999999754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=217.64 Aligned_cols=167 Identities=17% Similarity=0.168 Sum_probs=127.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh---hhHHHHHHHHHHHHhcCC-CCce---------------
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQH-KNLV--------------- 145 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nIv--------------- 145 (266)
..|...+.||+|+||+||+|. ..+++.||||++..... ...+.+.+|+.+++.+.| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 447788999999999999999 55799999999874422 235678899999999987 2211
Q ss_pred ------eEEeEEee-----CCcEEEEEeccCCCCHHHHHhh----cCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024537 146 ------TLFGCCAE-----GPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210 (266)
Q Consensus 146 ------~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~ii 210 (266)
.+...+.. ....+++|+++ +++|.+++.. ......+++..++.++.|++.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111111 22457777766 7899888741 122345778889999999999999999998 99
Q ss_pred eCCCCCCceEEcCCCCeEEecccccccCCCCCceeeeeeEEeeeeCCCcc
Q 024537 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260 (266)
Q Consensus 211 HrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~ 260 (266)
||||||+|||++.++.+||+|||+|+..... ..+..| +.|+|||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETT 279 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhh
Confidence 9999999999999999999999999876433 445567 999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=196.40 Aligned_cols=142 Identities=18% Similarity=0.160 Sum_probs=114.3
Q ss_pred hHHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccCh------------------hhHHHHHHHHHHHHhcCC
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR------------------QGLREFTNEVKLLLKIQH 141 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H 141 (266)
.+......|.+.+.||+|+||.||+|...+|+.||||.+..... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444566778899999999999999987799999999864321 13456889999999998
Q ss_pred CCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEE
Q 024537 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221 (266)
Q Consensus 142 ~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill 221 (266)
| +++.+++.. +..++||||++|++|.+ +. . .....++.|++.||.|||+.| |+||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 555555543 56699999999999976 41 1 224468999999999999999 9999999999999
Q ss_pred cCCCCeEEecccccccCC
Q 024537 222 DEQLNPKISDFGLARLFP 239 (266)
Q Consensus 222 ~~~~~~kl~DFG~a~~~~ 239 (266)
+ ++.+||+|||+|+...
T Consensus 227 ~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp E-TTEEEECCCTTCEETT
T ss_pred E-CCcEEEEECCCCeECC
Confidence 9 9999999999998653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=179.39 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=108.6
Q ss_pred CccccceecccCceEEEEEEe-cCCCE--EEEEeecccChh------------------------hHHHHHHHHHHHHhc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQE--IAVKKLSVDSRQ------------------------GLREFTNEVKLLLKI 139 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 139 (266)
.|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999996 78889 999987543111 113577899999999
Q ss_pred CCCCc--eeEEeEEeeCCcEEEEEeccCC-C----CHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHh-hcCCCCeEe
Q 024537 140 QHKNL--VTLFGCCAEGPEKMLVYEYLPN-K----SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH-EEAPARIIH 211 (266)
Q Consensus 140 ~H~nI--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH-~~~~~~iiH 211 (266)
.|+++ ..++.. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.| |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 356899999942 3 67665421 224457789999999999999 888 999
Q ss_pred CCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 212 RDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 212 rDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||||+|||++. .++|+|||+|.....+
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 8999999999876544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-20 Score=165.28 Aligned_cols=145 Identities=13% Similarity=0.140 Sum_probs=102.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccCh--------------hhHH--------HHHHHHHHHHh
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--------------QGLR--------EFTNEVKLLLK 138 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~ 138 (266)
+.....-|.+..+||+|+||.||+|...+|+.||||+++.... .... ....|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333345999999999999999999988899999998753210 0000 12346666666
Q ss_pred cCCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 139 l~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
+.+.++....-+.. ...+|||||++|++|..+.. . .....++.|++.+|.|||..| ||||||||.|
T Consensus 170 L~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp HHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred HHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 65444322111111 12379999999988854321 1 123567899999999999998 9999999999
Q ss_pred eEEcCCC----------CeEEecccccccCC
Q 024537 219 ILLDEQL----------NPKISDFGLARLFP 239 (266)
Q Consensus 219 ill~~~~----------~~kl~DFG~a~~~~ 239 (266)
||++.++ .+.|+||+=+....
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9998876 38999999776543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-14 Score=122.63 Aligned_cols=145 Identities=12% Similarity=0.055 Sum_probs=112.1
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 162 (266)
..+.|++...++.|+++.||++.. .+..+++|+...........+..|+.+++.+. +..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345688888899999999999975 36899999987532122245778999999885 6778899999999899999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA------------------------------------- 205 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~------------------------------------- 205 (266)
+++|.++.+.+. +......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 11123367788999999999811
Q ss_pred -------------------CCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 206 -------------------PARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 206 -------------------~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
+..++|+|++|.||+++....+.|+||+.|..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998765667999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=114.58 Aligned_cols=138 Identities=17% Similarity=0.108 Sum_probs=100.0
Q ss_pred CccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC--ceeEEeEEeeCCcEEEEEecc
Q 024537 87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~ 164 (266)
.|.+....+.|..+.||++...+|..+++|...... ...+..|+.+++.+.+.+ +.+++++...++..++|||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 344433334666799999987677889999876541 235668999998886544 556888888888899999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA--------------------------------------- 205 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~--------------------------------------- 205 (266)
+|.++. .. . .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998873 21 0 11 1245667777777777642
Q ss_pred ----------------CCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 206 ----------------PARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 206 ----------------~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+..++|+|++|.||+++.++.+.|+|||.|...
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999988766779999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.2e-12 Score=112.34 Aligned_cols=142 Identities=15% Similarity=0.284 Sum_probs=105.8
Q ss_pred ccceecccCceEEEEEEecCCCEEEEEeec--ccC-hhhHHHHHHHHHHHHhcC--CCCceeEEeEEeeC---CcEEEEE
Q 024537 90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLS--VDS-RQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEG---PEKMLVY 161 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lv~ 161 (266)
.++.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4678999999999998864 4678888876 332 122346778999999987 45678888888776 4589999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA------------------------------------ 205 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~------------------------------------ 205 (266)
|+++|..+.+. ....++......++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998777321 1234677788889999999999999731
Q ss_pred -------------------CCCeEeCCCCCCceEEcCCCC--eEEeccccccc
Q 024537 206 -------------------PARIIHRDIKASNILLDEQLN--PKISDFGLARL 237 (266)
Q Consensus 206 -------------------~~~iiHrDlKp~Nill~~~~~--~kl~DFG~a~~ 237 (266)
+..++|+|++|.|||++.++. +.|+||+.|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235899999999999987753 68999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4.1e-09 Score=90.30 Aligned_cols=137 Identities=20% Similarity=0.216 Sum_probs=96.1
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCC--ceeEEeEEeeCC---cEEEEEecc
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKN--LVTLFGCCAEGP---EKMLVYEYL 164 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lv~e~~ 164 (266)
++.++.|.+..||++. ..+++|+.... .....+..|..+++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 56888885432 33467889999998873 333 345555443333 348999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---------------------------------------- 204 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~---------------------------------------- 204 (266)
+|..+..... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988764331 1355666667777777777777751
Q ss_pred ---------------CCCCeEeCCCCCCceEEcC--CCCeEEecccccccC
Q 024537 205 ---------------APARIIHRDIKASNILLDE--QLNPKISDFGLARLF 238 (266)
Q Consensus 205 ---------------~~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~ 238 (266)
.+..++|+|++|.||+++. ...+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1234799999999999998 456799999998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=5e-08 Score=83.74 Aligned_cols=136 Identities=21% Similarity=0.196 Sum_probs=90.3
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC---CceeEEeEEe-eCCcEEEEEeccCC
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK---NLVTLFGCCA-EGPEKMLVYEYLPN 166 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~~ 166 (266)
++.++.|....||+. +..+++|+.. .......+..|..+|..+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 466888999999987 5668888743 233346788999999998742 3556666664 45567899999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE------------------------------------------ 204 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~------------------------------------------ 204 (266)
..+..... ..++......++.++...|.-||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 87765221 0122333333334444444433321
Q ss_pred ---------------CCCCeEeCCCCCCceEEcC---CCC-eEEeccccccc
Q 024537 205 ---------------APARIIHRDIKASNILLDE---QLN-PKISDFGLARL 237 (266)
Q Consensus 205 ---------------~~~~iiHrDlKp~Nill~~---~~~-~kl~DFG~a~~ 237 (266)
.+..++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=6.5e-08 Score=81.06 Aligned_cols=135 Identities=21% Similarity=0.181 Sum_probs=93.1
Q ss_pred eecccCce-EEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 93 QLGHGGFG-PVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 93 ~iG~G~fg-~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
.+..|..+ .||+.. ..++..+++|+-... ....+..|..+|+.+. +--+.+++.++.+++..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44555554 689877 345678899986533 2356778999998874 33467788899999999999999999887
Q ss_pred HHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 024537 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE--------------------------------------------- 204 (266)
Q Consensus 170 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~--------------------------------------------- 204 (266)
.+..... ......+..+++..|.-||+.
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6654211 111223444555555555531
Q ss_pred ----------CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 205 ----------APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 205 ----------~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.+..++|+|+.+.|||++..+.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112279999999999999877778999999864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=5.5e-08 Score=84.95 Aligned_cols=79 Identities=5% Similarity=-0.019 Sum_probs=54.0
Q ss_pred ccee-cccCceEEEEEEec-------CCCEEEEEeecccC---hhhHHHHHHHHHHHHhcC-C--CCceeEEeEEeeC--
Q 024537 91 LNQL-GHGGFGPVYRGLMP-------NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQ-H--KNLVTLFGCCAEG-- 154 (266)
Q Consensus 91 ~~~i-G~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~-- 154 (266)
.+.| +.|....+|+.... ++..+++|+..... ......+..|+.+++.+. + ..+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999988753 26688998765432 101134567888888774 2 3566788777655
Q ss_pred -CcEEEEEeccCCCCH
Q 024537 155 -PEKMLVYEYLPNKSL 169 (266)
Q Consensus 155 -~~~~lv~e~~~~~~L 169 (266)
+..|+|||+++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-06 Score=75.40 Aligned_cols=142 Identities=12% Similarity=0.172 Sum_probs=78.5
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC--CCCceeEEe------EEeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--HKNLVTLFG------CCAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~------~~~~~~~~~lv~e 162 (266)
++.|+.|..+.||++...++ .+++|+.... . ..+..|..++..+. .-.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566678899999886444 5899988753 2 22334455554442 112333332 1234667899999
Q ss_pred ccCCCCHH-----H------H---HhhcCC----CC-------CcCHHH-------------------------------
Q 024537 163 YLPNKSLD-----Y------F---IFDKTK----SS-------SLDWTT------------------------------- 186 (266)
Q Consensus 163 ~~~~~~L~-----~------~---l~~~~~----~~-------~~~~~~------------------------------- 186 (266)
|++|..+. . . ++.... .. ...|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 0 1 111100 00 011211
Q ss_pred HHHHHHHHHHHHHHHhh----------cCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 187 RYRIVMGVARGLLYLHE----------EAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 187 ~~~i~~qi~~al~yLH~----------~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
...+..++..++.+|.+ ..+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223445666653 1234599999999999998778899999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.5e-07 Score=78.59 Aligned_cols=75 Identities=13% Similarity=0.194 Sum_probs=49.3
Q ss_pred cceecccCceEEEEEEec-CCCEEEEEeecccCh-------hhHHHHHHHHHHHHhcCC--CC-ceeEEeEEeeCCcEEE
Q 024537 91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-------QGLREFTNEVKLLLKIQH--KN-LVTLFGCCAEGPEKML 159 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-Iv~l~~~~~~~~~~~l 159 (266)
.+.||.|.++.||++... +++.|+||....... .....+..|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999743 568899997653211 122455678888887742 33 3455543 3556789
Q ss_pred EEeccCCC
Q 024537 160 VYEYLPNK 167 (266)
Q Consensus 160 v~e~~~~~ 167 (266)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.5e-06 Score=69.64 Aligned_cols=80 Identities=19% Similarity=0.194 Sum_probs=57.7
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC---CCceeEEeEEeeCCcEEEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH---KNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~~~~~lv~ 161 (266)
.....-++.+|.|..+.||+....+|+.|++|+...........+..|+..|+.+.- --+.+++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 344556788999999999999988999999998765433333456789999988742 2344555542 348899
Q ss_pred eccCCCC
Q 024537 162 EYLPNKS 168 (266)
Q Consensus 162 e~~~~~~ 168 (266)
|+++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.20 E-value=3e-05 Score=66.64 Aligned_cols=75 Identities=17% Similarity=0.115 Sum_probs=59.6
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC---CCCceeEEeEEeeCCcEEEEEeccCCC
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLPNK 167 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~~ 167 (266)
.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++|||+++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 5678899986543 2456778988888874 356788888888888899999999987
Q ss_pred CH
Q 024537 168 SL 169 (266)
Q Consensus 168 ~L 169 (266)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.9e-05 Score=70.49 Aligned_cols=73 Identities=11% Similarity=0.202 Sum_probs=44.8
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecc-----cCh----hhHHHHHHHHHHHH-hcCCCCceeEEeEEeeCCcEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-----DSR----QGLREFTNEVKLLL-KIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~-----~~~----~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
.+.||.|..+.||++.. ++..++||.... ... .....+..|+..+. ......+.+++.+. ++..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 57799999999999965 567899994221 110 01222333333322 22234566677665 5677999
Q ss_pred Eecc-CC
Q 024537 161 YEYL-PN 166 (266)
Q Consensus 161 ~e~~-~~ 166 (266)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.6e-06 Score=76.57 Aligned_cols=142 Identities=18% Similarity=0.276 Sum_probs=82.1
Q ss_pred cceecccCceEEEEEEec--------CCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCCcEEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~ 161 (266)
++.|..|-...+|++... +++.|++|+.... ........+|..+++.+.-.+ ..++++.+.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888999998854 2478999886332 122345568999888774222 3566666543 3999
Q ss_pred eccCCCCHHH-----------H---H---hhcC--CCCCc--CHHHHHHHHHHHHH-------------------HHHHH
Q 024537 162 EYLPNKSLDY-----------F---I---FDKT--KSSSL--DWTTRYRIVMGVAR-------------------GLLYL 201 (266)
Q Consensus 162 e~~~~~~L~~-----------~---l---~~~~--~~~~~--~~~~~~~i~~qi~~-------------------al~yL 201 (266)
||++|..+.. + + +... ..... -+..+..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998754421 0 1 1100 01111 23455555544322 23333
Q ss_pred h----hc-CCCCeEeCCCCCCceEEcCC----CCeEEeccccccc
Q 024537 202 H----EE-APARIIHRDIKASNILLDEQ----LNPKISDFGLARL 237 (266)
Q Consensus 202 H----~~-~~~~iiHrDlKp~Nill~~~----~~~kl~DFG~a~~ 237 (266)
. .. .+..++|+|+.+.||+++.+ +.+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22 23348999999999999876 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00035 Score=59.75 Aligned_cols=142 Identities=13% Similarity=0.143 Sum_probs=79.3
Q ss_pred ceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCC--CceeEEeE-----EeeCCcEEEEEecc
Q 024537 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGC-----CAEGPEKMLVYEYL 164 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lv~e~~ 164 (266)
..++ |....||++...+|+.+++|....... ....+..|..++..+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 788899988766677899999863311 224556678777766421 23444432 22345668899999
Q ss_pred CCCCHH-----HH---------Hhhc---CC---CCCcCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 024537 165 PNKSLD-----YF---------IFDK---TK---SSSLDWTTR----YRI---------------VMGVARGLLYLHEE- 204 (266)
Q Consensus 165 ~~~~L~-----~~---------l~~~---~~---~~~~~~~~~----~~i---------------~~qi~~al~yLH~~- 204 (266)
+|..+. .+ ++.. .. ....++... ..+ ...+-..++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 11 1110 00 011221111 000 01111122233221
Q ss_pred ---CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 205 ---APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 205 ---~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233489999999999999 4 899999988864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00014 Score=61.76 Aligned_cols=71 Identities=10% Similarity=0.119 Sum_probs=43.8
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEEecc-CCCC
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYL-PNKS 168 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~~~ 168 (266)
++.|+.|....+|++ ..+++|+........ .....|..+++.+...++ .+++.. .++.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678988999999998 568888876432211 112357777776643233 355544 344457899999 6644
Q ss_pred H
Q 024537 169 L 169 (266)
Q Consensus 169 L 169 (266)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.75 E-value=9e-05 Score=66.46 Aligned_cols=72 Identities=11% Similarity=0.242 Sum_probs=49.0
Q ss_pred cceecccCceEEEEEEecC--------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~ 161 (266)
++.|+.|....+|++...+ +..+++|+...... ...+..|..+++.+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888899999998642 57899998743211 1345578888888753334 567766542 3899
Q ss_pred eccCCCC
Q 024537 162 EYLPNKS 168 (266)
Q Consensus 162 e~~~~~~ 168 (266)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00027 Score=60.72 Aligned_cols=142 Identities=18% Similarity=0.140 Sum_probs=71.4
Q ss_pred ceecccCceE-EEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC--CCceeEEeEEeeCCcEEEEEeccCCCC
Q 024537 92 NQLGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 92 ~~iG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
+.|+.|.... +|+....++..+++|....... ..+..|+.++..+.. -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565554444 6676653467788876543321 223356666665532 23455666533333 78999997766
Q ss_pred HHHHHhhc---------------------CC--CCCcCHHHHH-------H-H------------HHHHHHHHHHHhh--
Q 024537 169 LDYFIFDK---------------------TK--SSSLDWTTRY-------R-I------------VMGVARGLLYLHE-- 203 (266)
Q Consensus 169 L~~~l~~~---------------------~~--~~~~~~~~~~-------~-i------------~~qi~~al~yLH~-- 203 (266)
+...+... .. ...++..... . + ...+...+..+-.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54333110 00 0112211110 0 0 0011122222211
Q ss_pred -cCCCCeEeCCCCCCceEEcCC----CCeEEecccccccC
Q 024537 204 -EAPARIIHRDIKASNILLDEQ----LNPKISDFGLARLF 238 (266)
Q Consensus 204 -~~~~~iiHrDlKp~Nill~~~----~~~kl~DFG~a~~~ 238 (266)
..+..++|+|+.+.||+++.+ +.+.|+||+.|..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123459999999999999874 67899999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00028 Score=60.17 Aligned_cols=144 Identities=13% Similarity=0.140 Sum_probs=77.6
Q ss_pred cceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC--ceeEEeE------EeeCCcEEEEEe
Q 024537 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGC------CAEGPEKMLVYE 162 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~------~~~~~~~~lv~e 162 (266)
++.|+.|....+|+....++ .+++|+...... ...+..|+.++..+...+ +.+++.. ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45677788899999886555 688998765311 123445777766653212 2233321 123456789999
Q ss_pred ccCCCCHHH-----H---------HhhcCCC---C---Cc---CHHHHHH------------HHHHHHHHHHHHhhc---
Q 024537 163 YLPNKSLDY-----F---------IFDKTKS---S---SL---DWTTRYR------------IVMGVARGLLYLHEE--- 204 (266)
Q Consensus 163 ~~~~~~L~~-----~---------l~~~~~~---~---~~---~~~~~~~------------i~~qi~~al~yLH~~--- 204 (266)
+++|..+.. . ++..... . .. .|..... +...+...++++...
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998754311 0 1111000 0 01 1111000 001133445555432
Q ss_pred -CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 205 -APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 205 -~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123489999999999999876668999998854
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00038 Score=62.93 Aligned_cols=74 Identities=9% Similarity=0.085 Sum_probs=47.1
Q ss_pred cceecccCceEEEEEEecC-CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEEeccCCCC
Q 024537 91 LNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYLPNKS 168 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~~~ 168 (266)
++.|+.|-...+|++...+ +..+++|+......... ....|..++..+...++ .++++.+. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678888889999998654 47888888643321111 11478888888875555 46777663 2 35999998743
Q ss_pred H
Q 024537 169 L 169 (266)
Q Consensus 169 L 169 (266)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00066 Score=60.69 Aligned_cols=73 Identities=10% Similarity=0.078 Sum_probs=46.8
Q ss_pred cceecccCceEEEEEEecC--------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCCcEEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~ 161 (266)
++.|..|-...+|++...+ +..|++++........ -...+|..+++.+.-.+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4677778889999998642 5789998865432211 12246788877774222 345565432 27899
Q ss_pred eccCCCC
Q 024537 162 EYLPNKS 168 (266)
Q Consensus 162 e~~~~~~ 168 (266)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998855
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00029 Score=61.58 Aligned_cols=73 Identities=8% Similarity=0.063 Sum_probs=43.5
Q ss_pred cceecccCceEEEEEEecC---------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCC-ceeEEeEEeeCCcEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPN---------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv 160 (266)
.+.|+.|....+|++...+ +..+++|+........ .....|..+++.+.-.+ ..++++.+ + -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567788889999988543 2688888865432211 12346787877775333 34666554 2 3789
Q ss_pred EeccCCCC
Q 024537 161 YEYLPNKS 168 (266)
Q Consensus 161 ~e~~~~~~ 168 (266)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0038 Score=53.89 Aligned_cols=32 Identities=28% Similarity=0.338 Sum_probs=27.7
Q ss_pred CCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 207 ~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35899999999999998788999999887543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00045 Score=61.25 Aligned_cols=29 Identities=31% Similarity=0.477 Sum_probs=24.8
Q ss_pred eEeCCCCCCceEE------cCCCCeEEeccccccc
Q 024537 209 IIHRDIKASNILL------DEQLNPKISDFGLARL 237 (266)
Q Consensus 209 iiHrDlKp~Nill------~~~~~~kl~DFG~a~~ 237 (266)
++|+|+.+.|||+ +....+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456799999998854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.44 E-value=0.67 Score=37.19 Aligned_cols=88 Identities=11% Similarity=0.057 Sum_probs=62.5
Q ss_pred CCCCceeEEeEEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHH-HHhhcCCCCeEeCCCCCCc
Q 024537 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL-YLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 140 ~H~nIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~-yLH~~~~~~iiHrDlKp~N 218 (266)
.||.+ --..-.+++.+.+.++.-+++.-...+ ..++....++++..|+.... ++++ -++--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57888 333346677777777765443322333 23667888888888877666 5544 6788999999
Q ss_pred eEEcCCCCeEEecccccccCCC
Q 024537 219 ILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~ 240 (266)
|+++.++.++|.-.|+-..+++
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998765543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.61 E-value=0.45 Score=38.07 Aligned_cols=89 Identities=10% Similarity=0.072 Sum_probs=64.6
Q ss_pred CCCCceeEEeEEeeCCcEEEEEeccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCc
Q 024537 140 QHKNLVTLFGCCAEGPEKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218 (266)
Q Consensus 140 ~H~nIv~l~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~N 218 (266)
.+|+++.. .+-.+++.+.+.++.-+. -++.. + ..++....++++..|+....++++ -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68988876 455666766666665442 22322 2 346778888899998887766654 5688999999
Q ss_pred eEEcCCCCeEEecccccccCCCC
Q 024537 219 ILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 219 ill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|+++.++.+++.-.|+-..+++.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC
T ss_pred EEEcCCCCEEEEEccCccCCCCC
Confidence 99999999999999987655433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.14 E-value=0.031 Score=50.38 Aligned_cols=62 Identities=11% Similarity=0.091 Sum_probs=18.6
Q ss_pred cccceecccCceEEEEEEecC-CCEEEE------Eeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee
Q 024537 89 SDLNQLGHGGFGPVYRGLMPN-GQEIAV------KKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153 (266)
Q Consensus 89 ~~~~~iG~G~fg~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 153 (266)
.+.+.|| ||.||+|.+.. ..+||+ |..... .......+.+|..++..++|||+++.+++-..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 99999998643 457888 655432 22233567789999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 266 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-46
Identities = 39/166 (23%), Positives = 82/166 (49%), Gaps = 7/166 (4%)
Query: 81 LQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLK 138
+++ + F +++LG G G V++ P+G +A K + ++ + +R E+++L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
+V +G E + E++ SLD + + + ++ + V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
YL E+ +I+HRD+K SNIL++ + K+ DFG++ +
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-46
Identities = 41/176 (23%), Positives = 75/176 (42%), Gaps = 6/176 (3%)
Query: 85 TNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
+F+ + +LG G FG VY+ A K + S + L ++ E+ +L H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+V L ++ E+ ++D + + + L + + L YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
+IIHRD+KA NIL + K++DFG++ ++F + P +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 4e-46
Identities = 56/169 (33%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQ 140
FSDL ++GHG FG VY + N + +A+KK+S +Q ++ EV+ L K++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H N + GC LV EY + D K L + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
LH +IHRD+KA NILL E K+ DFG A + ++ V T
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY 176
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-45
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 6/163 (3%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+ ++G G FG VY+G + + ++ + Q L+ F NEV +L K +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
G P+ +V ++ SL + + + + I A+G+ YLH +
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
IIHRD+K++NI L E L KI DFGLA + ++
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-45
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 6/176 (3%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+ +LG G FG V+ G ++AVK L S F E L+ ++QH+ LV L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+ + P ++ EY+ N SL F+ L + +A G+ ++ E
Sbjct: 74 YAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
IHRD++A+NIL+ + L+ KI+DFGLARL + + W
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-43
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 6/176 (3%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+ L +LG G FG V G ++A+K + S EF E K+++ + H+ LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+G C + ++ EY+ N L ++ + + V + YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
+ +HRD+ A N L+++Q K+SDFGL+R ++ + V W P M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 2e-42
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 6/177 (3%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
+ ++LG G +G VY G +AVK L D+ + + EF E ++ +I+H NLV
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 77
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
L G C P ++ E++ +L ++ + + + + ++ + YL ++
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-- 134
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
IHRD+ A N L+ E K++DFGL+RL G+ + + W
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-42
Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 8/180 (4%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNL 144
+ L +G G +G + +G+ + K+L S + +EV LL +++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 145 VTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYL 201
V + + L V EY L I TK LD R++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 202 HE--EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
H + ++HRD+K +N+ LD + N K+ DFGLAR+ + + F + P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (360), Expect = 1e-41
Identities = 48/205 (23%), Positives = 82/205 (40%), Gaps = 19/205 (9%)
Query: 76 FDLRTLQVATNFFSD---------LNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD- 121
F A F+ +G G FG V G + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS 181
+ + R+F +E ++ + H N++ L G + M++ E++ N SLD F+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
++ G+A G+ YL +HRD+ A NIL++ L K+SDFGL+R +
Sbjct: 127 --VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 242 DTHVNTFRISVVTWPPNMHCMDICQ 266
+ P + Q
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQ 206
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-41
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 6/170 (3%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+ + ++G G FG V+ G N ++A+K + + +F E ++++K+ H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+G C E LV+E++ + L ++ + T + + V G+ YL E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA--- 120
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPP 257
+IHRD+ A N L+ E K+SDFG+ R + +T V W
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-41
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 6/176 (3%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
+LG G FG V+ G +A+K L F E +++ K++H+ LV L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
+ +E P +V EY+ SL F+ +T + +A G+ Y+
Sbjct: 78 YAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RM 132
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
+HRD++A+NIL+ E L K++DFGLARL + + W +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 6e-40
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLR-EF 129
L +L+ N + +G G FG V++ P +AVK L ++ ++ +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------- 181
E L+ + + N+V L G CA G L++EY+ L+ F+ + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 182 -------------LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
L + I VA G+ YL E + +HRD+ N L+ E + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 229 ISDFGLARLFPGED-THVNTFRISVVTWPPNMHCMDIC 265
I+DFGL+R D + + W P
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-40
Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 15/179 (8%)
Query: 91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
+G G FG V+RG G+E+AVK S + E+ + ++H+N++
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 151 CAEG----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
+ + LV +Y + SL ++ ++ ++ + A GL +LH E
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 207 A-----RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260
I HRD+K+ NIL+ + I+D GLA ++ V M
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-40
Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 8/175 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++ ++G G G VY + + GQE+A++++++ + NE+ ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E +V EYL SL + + D + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSN-- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
++IHRDIK+ NILL + K++DFG E + +T + P +
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-39
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 8/161 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
L +G G FG V G G ++AVK + D+ + F E ++ +++H NLV L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65
Query: 148 FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
G E + +V EY+ SL ++ + S L + + V + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
+HRD+ A N+L+ E K+SDFGL +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-38
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGLM---PNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH 141
N +LG G FG V +G+ ++A+K L + + E E +++ ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
+V L G C + MLV E L F+ K + + + ++ V+ G+ YL
Sbjct: 69 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL 125
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVT 254
E+ +HRD+ A N+LL + KISDFGL++ +D++
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-38
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 10/161 (6%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F LG G FG VY + +A+K L ++ + EV++ ++H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
++ L+G + L+ EY P ++ + K S D + +A L Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS 124
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
R+IHRDIK N+LL KI+DFG + P
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-38
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 18/186 (9%)
Query: 74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN---GQEIAVKKLSVDSRQG--LRE 128
++ D + L + + +LG G FG V +G + +AVK L ++ E
Sbjct: 1 VYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 54
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
E ++ ++ + +V + G C E MLV E L+ ++ +
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNII 110
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
+V V+ G+ YL E +HRD+ A N+LL Q KISDFGL++ ++ +
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 249 RISVVT 254
Sbjct: 168 THGKWP 173
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-38
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 8/165 (4%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
+ + LG G +G V + +AVK + + E E+ + + H+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
+G EG + L EY L I + R + G++YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
I HRDIK N+LLDE+ N KISDFGLA +F + ++
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-37
Identities = 53/183 (28%), Positives = 72/183 (39%), Gaps = 26/183 (14%)
Query: 88 FSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI- 139
S LG G FG V +AVK L + RE +E+K+L +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS---------------SLDW 184
H N+V L G C G +++ EY L F+ K S +LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
VA+G+ +L + IHRD+ A NILL KI DFGLAR + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 245 VNT 247
V
Sbjct: 202 VVK 204
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-37
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 33/197 (16%)
Query: 91 LNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHK 142
LG G FG V ++AVK L + RE +E+K++ ++ H+
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS--------------------L 182
N+V L G C L++EY L ++ K + S L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
+ VA+G+ +L + +HRD+ A N+L+ KI DFGLAR +
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 243 THV--NTFRISVVTWPP 257
+V R+ V P
Sbjct: 219 NYVVRGNARLPVKWMAP 235
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-37
Identities = 57/175 (32%), Positives = 75/175 (42%), Gaps = 13/175 (7%)
Query: 88 FSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ 140
L +LG G FG V RG +AVK L D + + +F EV + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
H+NL+ L+G P KM V E P SL + T R + VA G+ Y
Sbjct: 70 HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGY 126
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTW 255
L + R IHRD+ A N+LL + KI DFGL R P D H V +
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 5/170 (2%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHK 142
+++L+ +G G +G V N +A+KK+S Q + E+K+LL+ +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N++ + + + YL + ++ K+ L + + RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISV 252
++HRD+K SN+LL+ + KI DFGLAR+ + H V
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-36
Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 12/161 (7%)
Query: 92 NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLF 148
++G G F VY+G E+A +L ++ + F E ++L +QH N+V +
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 149 GCCAEGPEK----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ +LV E + + +L ++ + + + +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 205 APARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGEDTH 244
P IIHRD+K NI + + KI D GLA L
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 171
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (328), Expect = 2e-36
Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 8/160 (5%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
+LG G FG V+R G A K + E++ + ++H LV L
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
+ E +++YE++ L + D+ + + V +GL ++HE
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNY 145
Query: 210 IHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNT 247
+H D+K NI+ + + K+ DFGL + + T
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-36
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 11/178 (6%)
Query: 91 LNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
+G G FG V++G+ + +A+K + +RE F E + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G E P ++ E L F+ + S LD + ++ L YL +
Sbjct: 72 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK- 127
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
R +HRDI A N+L+ K+ DFGL+R + + + W
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-36
Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQE----IAVKKLS-VDSRQGLREFTNEVKLLLKIQH 141
F + LG G FG VY+G +P G++ +A+K+L S + +E +E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
++ L G C L+ + +P L ++ + + + +A+G+ YL
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
R++HRD+ A N+L+ + KI+DFGLA+L E+ +
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-36
Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 11/176 (6%)
Query: 92 NQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVT 146
+G G FG VY G + + AVK L+ + G + +F E ++ H N+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 147 LFGCCAEGPEK-MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L G C ++V Y+ + L FI ++T + ++ + + + + A
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
+ +HRD+ A N +LDE+ K++DFGLAR ++ + M
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-36
Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 11/181 (6%)
Query: 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQE-----IAVKKLSVDSRQGLR-EFTNEV 133
T ++ + + +G G FG VY+G++ +A+K L + R +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
++ + H N++ L G ++ M++ EY+ N +LD F+ +K ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRG 118
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVV 253
+A G+ YL +HRD+ A NIL++ L K+SDFGL+R+ + T +
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 254 T 254
Sbjct: 176 P 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-35
Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
+ +G G FG V + + + A+K++ S+ R+F E+++L K+ H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYR 189
N++ L G C L EY P+ +L F+ + +S+L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
VARG+ YL ++ + IHRD+ A NIL+ E KI+DFGL+R
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 126 bits (318), Expect = 4e-35
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 8/165 (4%)
Query: 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
+++ L +LG G FG V+R + G+ K ++ NE+ ++ ++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ L + E +L+ E+L L I + + + GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145
Query: 205 APARIIHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNT 247
I+H DIK NI+ + + KI DFGLA ++ T
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-35
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 12/176 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F LG G F V + +E A+K L + + T E ++ ++ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
V L+ + + Y N L +I K S D T + L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
+ IIHRD+K NILL+E ++ +I+DFG A++ E S V +
Sbjct: 127 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYV 177
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (312), Expect = 3e-34
Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 13/164 (7%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEV---KLLLKIQ 140
FS +G GGFG VY G+ A+K L + +QG NE L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
+V + + + + + L Y + + GL +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEH 122
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+H +++RD+K +NILLDE + +ISD GLA F + H
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (300), Expect = 4e-33
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 8/176 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLV 145
+ L ++G G +G VY+ G+ A+KK+ ++ E+ +L +++H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
L+ +LV+E+L + L+ T ++ + G+ Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD-- 118
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
R++HRD+K N+L++ + KI+DFGLAR F +++ P++
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 9e-33
Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 9/172 (5%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
LG G FG V+R + + + K + V E+ +L +H+N++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHE 68
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
E ++++E++ + I T + L+ V V L +LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 210 IHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
H DI+ NI+ + + KI +FG AR D F P
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-32
Identities = 38/177 (21%), Positives = 75/177 (42%), Gaps = 17/177 (9%)
Query: 88 FSDLNQLGHGGFGPVYRGL------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ 140
+ +LG G FG VY G+ +A+K ++ S + EF NE ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTRYRIVMG 193
++V L G ++G +++ E + L ++ + + + ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
+A G+ YL+ + +HRD+ A N ++ E KI DFG+ R D + +
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-32
Identities = 50/194 (25%), Positives = 75/194 (38%), Gaps = 25/194 (12%)
Query: 91 LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH-K 142
LG G FG V + +AVK L + R +E+K+L+ I H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 143 NLVTLFGCCAE-GPEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTRY 188
N+V L G C + G M++ E+ +L ++ K L
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
VA+G+ +L + IHRD+ A NILL E+ KI DFGLAR + +V
Sbjct: 138 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 249 RISVVTWPPNMHCM 262
+ +
Sbjct: 195 DARLPLKWMAPETI 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-32
Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 16/186 (8%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
++D +G+G FG VY+ L +G+ +A+KK+ D R E++++ K+ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 147 LFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
L EK LV +Y+P +L + + R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 201 LHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
+H I HRDIK N+LLD + K+ DFG A+ ++ S P +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPEL 193
Query: 260 HCMDIC 265
Sbjct: 194 IFGATD 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-31
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 26/195 (13%)
Query: 91 LNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
LG G FG V ++AVK L D + + L + +E++++ I +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTR 187
HKN++ L G C + ++ EY +L ++ + L
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
VARG+ YL + + IHRD+ A N+L+ E KI+DFGLAR D + T
Sbjct: 138 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 248 FRISVVTWPPNMHCM 262
+ +
Sbjct: 195 TNGRLPVKWMAPEAL 209
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 3e-31
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVT 146
L LG G FG V+ NG+ A+K L V + + +E +L + H ++
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
++G + + ++ +Y+ L + + V L YLH
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHS--- 122
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
II+RD+K NILLD+ + KI+DFG A+ P +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (286), Expect = 4e-31
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 20/172 (11%)
Query: 87 FFSD---LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---------RQGLREFTNEV 133
F+ + LG G V R + P +E AVK + V ++ EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 134 KLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
+L K+ H N++ L LV++ + L ++ +K L +I+
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMR 117
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
+ + LH+ I+HRD+K NILLD+ +N K++DFG + +
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-31
Identities = 50/178 (28%), Positives = 71/178 (39%), Gaps = 11/178 (6%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVD---SRQGLREFTNEVKLL-LKIQHK 142
F LG G FG V+ Q A+K L D + E ++L L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
L +F V EYL L Y I K D + + GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260
+ I++RD+K NILLD+ + KI+DFG+ + D NTF + P +
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-31
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 12/178 (6%)
Query: 91 LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNL 144
L+ LG G F VY+ Q +A+KK+ + R R E+KLL ++ H N+
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
+ L LV++++ + L + ++ +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQH 119
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262
I+HRD+K +N+LLDE K++DFGLA+ F + ++ P +
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-30
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 8/173 (4%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
F + ++G G +G VY+ G+ +A+KK+ +D + E+ LL ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L + LV+E+L + D + + + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPP 257
R++HRD+K N+L++ + K++DFGLAR F +++ P
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 2e-30
Identities = 38/179 (21%), Positives = 69/179 (38%), Gaps = 6/179 (3%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHK 142
+ + + LG G F V + +A+K ++ + +G NE+ +L KI+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
N+V L G L+ + + L I +K R++ V + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
+ + LDE ISDFGL+++ + ++T + P +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVLA 182
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 3e-30
Identities = 44/190 (23%), Positives = 82/190 (43%), Gaps = 17/190 (8%)
Query: 88 FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG--LREFTNEVKLLLKIQHKNL 144
+ L ++G G FG V++ GQ++A+KK+ +++ + E+K+L ++H+N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 145 VTLFGCCAEGPEKM--------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
V L C LV+++ + K + R++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 128
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWP 256
GL Y+H +I+HRD+KA+N+L+ K++DFGLAR F + V
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 257 PNMHCMDICQ 266
+
Sbjct: 186 WYRPPELLLG 195
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 108 bits (270), Expect = 1e-28
Identities = 38/180 (21%), Positives = 69/180 (38%), Gaps = 14/180 (7%)
Query: 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ 140
++ + LG GG V+ + +++AVK L D F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 141 HKNLVTLFGCCAE----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
H +V ++ GP +V EY+ +L + + + ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWP 256
L + H+ IIHRD+K +NI++ K+ DFG+AR V + T
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-28
Identities = 40/179 (22%), Positives = 79/179 (44%), Gaps = 9/179 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
+ L ++G G +G V++ + +A+K++ +D E+ LL +++HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
V L + LV+E+ YF D + + +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSR 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263
++HRD+K N+L++ K+++FGLAR F + +++ PP++
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-28
Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 91 LNQLGHGGFGPVYRG--LMPNGQEIAVKKLSVDSRQG--LREFTNEVKLLLKI---QHKN 143
+ ++G G +G V++ L G+ +A+K++ V + + EV +L + +H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLD---YFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
+V LF C L + +D DK + T ++ + RGL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260
LH R++HRD+K NIL+ K++DFGLAR++ + + +++ P +
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVL 187
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 3e-26
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 10/163 (6%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F + LG G FG V +G A+K L V + + NE ++L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
LV L + +V EY+ + + + + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
+I+RD+K N+L+D+Q +++DFG A+ G +
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-26
Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 10/178 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
F L LG G FG V G+ A+K L + ++ + E ++L +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
L L V EY L + + ++ + L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
+++RDIK N++LD+ + KI+DFGL + + + TF + P +
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-26
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 10/176 (5%)
Query: 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHK 142
+ DL +G G +G V + G ++A+KKL S + E++LL ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 143 NLVTLFGCCAEGPEKMLVYE-YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
N++ L + YL + + K L +V + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPP 257
H A IIHRD+K N+ ++E KI DFGLAR D+ + + ++ P
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAP 187
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 9e-26
Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 19/175 (10%)
Query: 94 LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
LG G G V + ++ A+K L Q + EV+L + Q ++V +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 152 ----AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
A ++V E L L I D+ + I+ + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 208 RIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISVVTWPPNM 259
I HRD+K N+L + K++DFG A+ ++ T + P +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-TTPCYTPYYVAPEV 184
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 4e-25
Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 17/177 (9%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE------FTNEVKLLLKIQ--H 141
LG GGFG VY G+ + + +A+K + D E EV LL K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
++ L +L+ E + + +L V + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHC 126
Query: 202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPP 257
H ++HRDIK NIL+D + K+ DFG L +DT F + V PP
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPP 178
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 7e-25
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)
Query: 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLK 138
+++ +LG G F V + G + A K + + + EV +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
IQH N++TL + +L+ E + L F+ +K L + + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTH 244
YLH +I H D+K NI+L ++ P KI DFGLA +
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 2e-24
Identities = 43/177 (24%), Positives = 67/177 (37%), Gaps = 13/177 (7%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
++G G FG +Y G + G+E+A+K V ++ + E K+ +Q +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIR 69
Query: 150 -CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
C AEG ++V E L D F F K T + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KN 123
Query: 209 IIHRDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCM 262
IHRD+K N L + I DFGLA+ + TH +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.4 bits (239), Expect = 4e-24
Identities = 29/171 (16%), Positives = 59/171 (34%), Gaps = 15/171 (8%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLF 148
++G G FG ++ G + N Q++A+K R + +E + + + ++
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
EG +LV + L T + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 209 IIHRDIKASNILLDEQLNP-----KISDFGLARLFPGEDTHVNTFRISVVT 254
+++RDIK N L+ + + DFG+ + + T +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 4e-23
Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 15/181 (8%)
Query: 91 LNQLGHGGFGPVYRG----LMPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
L LG G +G V+ G+ A+K L V + E ++L I+
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 143 -NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
LVTL + L+ +Y+ L + + + V + L +L
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHL 145
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHC 261
H+ II+RDIK NILLD + ++DFGL++ F ++T + +
Sbjct: 146 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 262 M 262
Sbjct: 203 R 203
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.4 bits (231), Expect = 7e-23
Identities = 37/178 (20%), Positives = 77/178 (43%), Gaps = 20/178 (11%)
Query: 75 FFDLRTLQVATNFFSD---LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT 130
++D + V D + +LG G + V+ + + N +++ VK L ++ +
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 77
Query: 131 NEVKLLLKIQ-HKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTR 187
E+K+L ++ N++TL + + LV+E++ N +L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 131
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTH 244
+ + + L Y H I+HRD+K N+++D E ++ D+GLA + +
Sbjct: 132 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 8e-22
Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 10/177 (5%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNL 144
+ +L+ +G G +G V G +AVKKLS S + E++LL ++H+N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 145 VTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
+ L YL + + + K L ++ + RGL Y+H
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPNMH 260
IIHRD+K SN+ ++E KI DFGLAR D + + + P +
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIM 190
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 2e-20
Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 19/183 (10%)
Query: 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
+ +L +G G G V + +A+KKLS ++ + E+ L+ + HKN+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 145 VTLFGCCA------EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
++L E + LV E + + D ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGI 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISVVTWPPN 258
+LH IIHRD+K SNI++ KI DFGLAR G + + ++ P
Sbjct: 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPE 188
Query: 259 MHC 261
+
Sbjct: 189 VIL 191
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 3e-20
Identities = 27/155 (17%), Positives = 45/155 (29%), Gaps = 20/155 (12%)
Query: 92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----------QGLREFTNEVKLLLKIQH 141
+G G V+ E VK V G F+ + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
+ L L G VY + N L I K ++ + +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
+ I+H D+ N+L+ E+ I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.8 bits (190), Expect = 4e-17
Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 23/179 (12%)
Query: 91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
+ +LG G F V+ M N +A+K + D + +E+KLL ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIVMGVAR 196
A K+L + + + + K + + +I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP------KISDFGLARLFPGEDTHVNTFR 249
GL Y+H IIH DIK N+L++ +P KI+D G A + T+ R
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 266 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.99 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=303.35 Aligned_cols=172 Identities=24% Similarity=0.419 Sum_probs=156.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++........+.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999999 5679999999998665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
+||+|.+++.. ..+++..++.|+.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988743 35899999999999999999999999 999999999999999999999999999988766666
Q ss_pred eeeeeEEeeeeCCCccccCC
Q 024537 245 VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~e~ 264 (266)
.....||+.|+|||++.++.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSC
T ss_pred ccccccCCCccChhhhcCCC
Confidence 66778999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=300.05 Aligned_cols=173 Identities=28% Similarity=0.382 Sum_probs=149.6
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++++.||+|+||+||+|+ ..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3579999999999999999999 4579999999987653 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
||++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998883 3457999999999999999999999999 9999999999999999999999999999874332
Q ss_pred --ceeeeeeEEeeeeCCCccccC
Q 024537 243 --THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 --~~~~~~~~t~~y~aPE~~~~e 263 (266)
....+..||+.|+|||++.++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~ 180 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRR 180 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCS
T ss_pred ccccccceeeCcCccCHhHhcCC
Confidence 234456799999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=302.92 Aligned_cols=172 Identities=24% Similarity=0.382 Sum_probs=154.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
+.|++++.||+|+||+||+|+ ..+++.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 569999999999999999999 4578999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCce
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 244 (266)
++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 999999887543 346999999999999999999999999 999999999999999999999999999877544444
Q ss_pred eeeeeEEeeeeCCCcccc
Q 024537 245 VNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 245 ~~~~~~t~~y~aPE~~~~ 262 (266)
..+..||+.|+|||++.+
T Consensus 167 ~~~~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMC 184 (288)
T ss_dssp HTCCCSCCTTCCHHHHTT
T ss_pred ccccccccccCCHHHHhh
Confidence 456789999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=302.78 Aligned_cols=175 Identities=24% Similarity=0.285 Sum_probs=157.7
Q ss_pred hhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
..++|++++.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 35679999999999999999999 568999999999754 22345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||+||+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999988543 46899999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.......+.+||+.|+|||++.++.
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~ 181 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred cCCcccccceeCHHHhhhhhccCCC
Confidence 6666677789999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=293.31 Aligned_cols=172 Identities=27% Similarity=0.354 Sum_probs=152.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999994 578999999986432 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998543 46899999999999999999999998 999999999999999999999999999887544
Q ss_pred CceeeeeeEEeeeeCCCccccCCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
. .....||+.|+|||++.++.+
T Consensus 160 ~--~~~~~Gt~~Y~APE~~~~~~~ 181 (263)
T d2j4za1 160 R--RTTLCGTLDYLPPEMIEGRMH 181 (263)
T ss_dssp C--CEETTEEGGGCCHHHHTTCCC
T ss_pred c--ccccCCCCcccCHHHHcCCCC
Confidence 3 345689999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=294.19 Aligned_cols=179 Identities=23% Similarity=0.357 Sum_probs=140.8
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--CCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv 160 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.++++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 569999999999999999998 457999999998765 34456778899999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHhhc-CCCCCcCHHHHHHHHHHHHHHHHHHhhcCC--CCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAP--ARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yLH~~~~--~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
||||++|+|.+++... .....+++..++.++.|++.||.|||+++. .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998543 234579999999999999999999998652 3499999999999999999999999999998
Q ss_pred CCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+........+..||+.|+|||++..+.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~ 190 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMS 190 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCC
Confidence 876665566778999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-42 Score=295.30 Aligned_cols=180 Identities=25% Similarity=0.440 Sum_probs=155.2
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+++..++|++.+.||+|+||+||+|++ .+++.||||+++.+.. ..+.+.+|+.+|++++|||||++++++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3445567899999999999999999995 4688999999876543 3467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+++|+|..++... ....+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999988543 4467899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCce-eeeeeEEeeeeCCCccccCC
Q 024537 239 PGEDTH-VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 239 ~~~~~~-~~~~~~t~~y~aPE~~~~e~ 264 (266)
...... .....|++.|+|||++..+.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~ 192 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNK 192 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCCceeeccccccccccChHHHcCCC
Confidence 654432 23345788899999887653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=305.82 Aligned_cols=174 Identities=24% Similarity=0.353 Sum_probs=151.5
Q ss_pred HhhcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
+..++|++++.||+|+||+||+|+ ..+|+.||+|+++.. .......+.+|+.+|++++|||||+++++|.+++..|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346789999999999999999999 457899999998765 333456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc-CCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||++||+|.+++.+. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999998543 4589999999999999999999974 7 9999999999999999999999999999764
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.. ...+..||+.|+|||++.++.
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~ 179 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTH 179 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSC
T ss_pred CC--ccccccCCccccCchHHcCCC
Confidence 32 234568999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=294.20 Aligned_cols=173 Identities=27% Similarity=0.357 Sum_probs=149.4
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999994 579999999987542 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||++||+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999888543 46899999999999999999999999 999999999999999999999999999987533
Q ss_pred --CceeeeeeEEeeeeCCCccccCC
Q 024537 242 --DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 --~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.....+..||+.|+|||++.++.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~ 186 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKS 186 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCC
T ss_pred CcccccccccCCccccCceeeccCC
Confidence 33344567999999999987764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=287.82 Aligned_cols=174 Identities=26% Similarity=0.474 Sum_probs=142.8
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.++|++++.||+|+||+||+|++.+++.||||++...... .+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4679999999999999999999888889999998765433 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc-
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT- 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 243 (266)
++|+|.+++.. ....+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999998843 3456889999999999999999999998 99999999999999999999999999988754432
Q ss_pred eeeeeeEEeeeeCCCccccCC
Q 024537 244 HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e~ 264 (266)
......||+.|+|||++..+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~ 178 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSR 178 (263)
T ss_dssp -------CTTSCCHHHHTTCC
T ss_pred eecceecCcccCChHHhcCCC
Confidence 233456788999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-41 Score=295.44 Aligned_cols=174 Identities=21% Similarity=0.326 Sum_probs=155.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999999 457999999999877766678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC--CCCeEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~--~~~~kl~DFG~a~~~~~~ 241 (266)
|+||+|.+++.. ....+++..++.|+.||+.||+|||++| ||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988843 3356999999999999999999999999 999999999999964 578999999999987654
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ...+..||+.|+|||++.++.
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~ 201 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKP 201 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCC
T ss_pred c-ccceecCcccccCHHHHcCCC
Confidence 4 345668999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-41 Score=294.68 Aligned_cols=173 Identities=24% Similarity=0.359 Sum_probs=154.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++..........+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 569999999999999999999 4579999999998776666678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc--CCCCeEEecccccccCCCCC
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~--~~~~~kl~DFG~a~~~~~~~ 242 (266)
+||+|.+.+. .....+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999988763 33456999999999999999999999999 99999999999997 57889999999999886543
Q ss_pred ceeeeeeEEeeeeCCCccccCC
Q 024537 243 THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
...+..||+.|+|||++.++.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~ 204 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREP 204 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCC
T ss_pred -ceeeccCcccccCHHHHcCCC
Confidence 345568999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-41 Score=291.73 Aligned_cols=166 Identities=33% Similarity=0.530 Sum_probs=146.9
Q ss_pred CccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.|+.++.||+|+||+||+|+ ..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999998 5578999999987553 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
||++|++..++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999998766533 356899999999999999999999999 999999999999999999999999999976433
Q ss_pred ceeeeeeEEeeeeCCCcccc
Q 024537 243 THVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~ 262 (266)
....||+.|+|||++.+
T Consensus 169 ---~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTT
T ss_pred ---CccccCccccCHHHHhc
Confidence 34579999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=287.90 Aligned_cols=174 Identities=31% Similarity=0.498 Sum_probs=144.4
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
++..++|++.+.||+|+||+||+|++. ..||||+++.. .....+.+.+|+.+|++++|||||++++++. .+..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 344678999999999999999999863 36999998654 3445678999999999999999999999875 456899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999843 2356999999999999999999999998 9999999999999999999999999998875
Q ss_pred CC--CceeeeeeEEeeeeCCCccccC
Q 024537 240 GE--DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~--~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. .....+..||+.|+|||++..+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTC
T ss_pred ccCCcccccccccCcccCCHHHHhcc
Confidence 33 2334456789999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=282.11 Aligned_cols=170 Identities=25% Similarity=0.360 Sum_probs=145.3
Q ss_pred ccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee----CCcEEEE
Q 024537 88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLV 160 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv 160 (266)
|++.++||+|+||+||+|+ ..+++.||+|++... .....+.+.+|+.+|++++|||||++++++.+ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4677789999999999999 457889999998654 34456778999999999999999999999875 3457999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc-CCCCeEEecccccccCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFP 239 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~-~~~~~kl~DFG~a~~~~ 239 (266)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998543 46899999999999999999999986 3499999999999996 57899999999998764
Q ss_pred CCCceeeeeeEEeeeeCCCccccC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ...+..||+.|+|||++...
T Consensus 167 ~~--~~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 167 AS--FAKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp TT--SBEESCSSCCCCCGGGGGTC
T ss_pred CC--ccCCcccCccccCHHHhCCC
Confidence 43 33466899999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-41 Score=292.07 Aligned_cols=170 Identities=26% Similarity=0.351 Sum_probs=151.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999 457999999998754 2234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
|||+||++..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888843 346788899999999999999999999 999999999999999999999999999987543
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. .+.+||+.|+|||++.++.
T Consensus 158 ~---~~~~Gt~~Y~APE~l~~~~ 177 (316)
T d1fota_ 158 T---YTLCGTPDYIAPEVVSTKP 177 (316)
T ss_dssp B---CCCCSCTTTCCHHHHTTCC
T ss_pred c---ccccCcccccCHHHHcCCC
Confidence 3 3568999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-41 Score=289.61 Aligned_cols=173 Identities=24% Similarity=0.309 Sum_probs=134.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
.+.|++.+.||+|+||+||+|+ ..+++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4679999999999999999999 4578999999987653 2233567799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEc---CCCCeEEecccccccCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFP 239 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~---~~~~~kl~DFG~a~~~~ 239 (266)
||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999843 456999999999999999999999999 99999999999995 47889999999998765
Q ss_pred CCCceeeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... ...+..||+.|+|||++.++.
T Consensus 162 ~~~-~~~~~~GT~~y~APE~~~~~~ 185 (307)
T d1a06a_ 162 PGS-VLSTACGTPGYVAPEVLAQKP 185 (307)
T ss_dssp ------------CTTSCHHHHTTCC
T ss_pred CCC-eeeeeeeCccccCcHHHcCCC
Confidence 433 345668999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=285.95 Aligned_cols=176 Identities=28% Similarity=0.465 Sum_probs=149.3
Q ss_pred HHhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 82 ~~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++..++|++.+.||+|+||+||+|.+.+++.||||++..... ..+.+.+|+.++++++|||||++++++.+ +..++||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 344567999999999999999999988888999999976543 34678999999999999999999998754 5679999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 999999998877432 2235899999999999999999999998 999999999999999999999999999987544
Q ss_pred Cc-eeeeeeEEeeeeCCCccccC
Q 024537 242 DT-HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~-~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......||+.|+|||++...
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~ 185 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYG 185 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHC
T ss_pred ccccccccCCcccccChHHHhCC
Confidence 32 22334678899999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-40 Score=291.04 Aligned_cols=170 Identities=22% Similarity=0.290 Sum_probs=151.8
Q ss_pred cCccccceecccCceEEEEEEe-cCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 161 (266)
++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999994 57999999998653 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+.+|+|...+... ..+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.+.
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999888543 46899999999999999999999999 999999999999999999999999999987543
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..+..||+.|+|||++.++.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~ 214 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCC
T ss_pred ---cccccCccccCCHHHHcCCC
Confidence 34568999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=281.73 Aligned_cols=173 Identities=25% Similarity=0.345 Sum_probs=151.3
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccC------hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999994 579999999986432 12357789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC----CeEEeccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG 233 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~----~~kl~DFG 233 (266)
|||||||++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998543 46999999999999999999999999 99999999999998876 49999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+.+.... ...+..+|+.|+|||++..+.
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~ 192 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEP 192 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCC
Confidence 999875443 234557899999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-40 Score=284.17 Aligned_cols=174 Identities=26% Similarity=0.454 Sum_probs=137.1
Q ss_pred hcCccccceecccCceEEEEEEec-CCC---EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ---EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.+.||+|+||+||+|+.. +++ .||||.+... .....+.+.+|+.+|++++|||||++++++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 456888999999999999999853 332 5889988654 44556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
|||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998843 3456899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCce-----eeeeeEEeeeeCCCccccC
Q 024537 240 GEDTH-----VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~-----~~~~~~t~~y~aPE~~~~e 263 (266)
..... .....+|+.|+|||++..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 208 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR 208 (299)
T ss_dssp ----------------CGGGSCHHHHHSC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcC
Confidence 43221 1223567889999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=277.22 Aligned_cols=173 Identities=26% Similarity=0.444 Sum_probs=151.3
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.++|+++++||+|+||+||+|++++++.||||+++..... .+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 4679999999999999999999888889999998765433 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc-
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT- 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 243 (266)
++|+|..++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999888743 2346888999999999999999999998 99999999999999999999999999987654432
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......+|+.|+|||++...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~ 176 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYS 176 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHC
T ss_pred eecccCCCCCcCCcHHhcCC
Confidence 23345788899999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=285.37 Aligned_cols=181 Identities=25% Similarity=0.377 Sum_probs=149.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-CC-----CEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEe
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NG-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA 152 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 152 (266)
+++..++|++.+.||+|+||+||+|++. .+ ..||+|.+... .......+.+|+.+|.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 3455678999999999999999999843 22 36999988654 333446788999999998 8999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhcCC--------------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeC
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDKTK--------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHr 212 (266)
+++..++|||||++|+|.+++..... ...+++..++.|+.|++.||+|||+++ ||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999965321 235889999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccCC
Q 024537 213 DIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 213 DlKp~Nill~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e~ 264 (266)
||||+|||++.++.+||+|||+|+....... ...+..||+.|+|||++..+.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC
Confidence 9999999999999999999999987654432 334557899999999886554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-39 Score=277.27 Aligned_cols=171 Identities=25% Similarity=0.347 Sum_probs=150.5
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---------hhhHHHHHHHHHHHHhcC-CCCceeEEeEEee
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 153 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3679999999999999999999 4579999999986542 112346889999999997 9999999999999
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..||||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999543 46899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+|+.+..... .....||+.|+|||++.+
T Consensus 156 ~a~~~~~~~~-~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 156 FSCQLDPGEK-LREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp TCEECCTTCC-BCCCCSCGGGCCHHHHHH
T ss_pred heeEccCCCc-eeeeeccCCCCCHHHhhc
Confidence 9998765433 344679999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=283.39 Aligned_cols=173 Identities=28% Similarity=0.338 Sum_probs=151.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHHHHHHHHHH-hcCCCCceeEEeEEeeCCcEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLL-KIQHKNLVTLFGCCAEGPEKMLV 160 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv 160 (266)
++|++++.||+|+||+||+|+ ..+++.||||++.... ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999 4579999999997542 233456677777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCC
Q 024537 161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240 (266)
Q Consensus 161 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~ 240 (266)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999998543 45889999999999999999999999 99999999999999999999999999998766
Q ss_pred CCceeeeeeEEeeeeCCCccccCC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
.........||+.|+|||++.+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~ 179 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQK 179 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred ccccccccCCCCCcCCHHHHcCCC
Confidence 666666678999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=277.17 Aligned_cols=175 Identities=26% Similarity=0.474 Sum_probs=141.6
Q ss_pred hcCccccceecccCceEEEEEEecCC-----CEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNG-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 158 (266)
.+.|++.+.||+|+||+||+|.+... ..||||++... .......+.+|+.++++++|||||++++++.+++..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999985432 37999998754 3444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccC
Q 024537 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238 (266)
Q Consensus 159 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~ 238 (266)
+||||+.++++.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887743 3456899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCc---eeeeeeEEeeeeCCCccccCC
Q 024537 239 PGEDT---HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 239 ~~~~~---~~~~~~~t~~y~aPE~~~~e~ 264 (266)
..... ......||+.|+|||++..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRK 189 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCC
T ss_pred cCCCccceEeccCCCCccccCHHHHccCC
Confidence 54322 222345788899999887654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=278.48 Aligned_cols=173 Identities=23% Similarity=0.315 Sum_probs=150.5
Q ss_pred hcCccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++|++++.||+|+||+||+|.. .+++.||||++...... ...+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36799999999999999999994 57899999999876543 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC--CCeEEecccccccCCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ--LNPKISDFGLARLFPGE 241 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~--~~~kl~DFG~a~~~~~~ 241 (266)
|+||+|.+++.. ....+++.+++.|+.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 3346899999999999999999999999 9999999999999854 47999999999987544
Q ss_pred CceeeeeeEEeeeeCCCccccCC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
. ...+..+|+.|+|||++.+..
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~ 179 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCE
T ss_pred C-cccccccccccccchhccCCC
Confidence 3 345668899999999876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=276.48 Aligned_cols=173 Identities=25% Similarity=0.447 Sum_probs=145.3
Q ss_pred hcCccccc-eecccCceEEEEEEec---CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLN-QLGHGGFGPVYRGLMP---NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~-~iG~G~fg~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|.+.+ +||+|+||+||+|.+. ++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+ +..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35577777 4999999999999743 4557999998755 44556789999999999999999999999865 56899
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998732 3456999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCce---eeeeeEEeeeeCCCccccC
Q 024537 240 GEDTH---VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~~~---~~~~~~t~~y~aPE~~~~e 263 (266)
..... .....||+.|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred ccccccccccccccCccccChHHHhCC
Confidence 54322 2234678899999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=279.68 Aligned_cols=167 Identities=28% Similarity=0.424 Sum_probs=143.1
Q ss_pred ccceecccCceEEEEEE-ecCCCEEEEEeecccChhh-----HHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 90 DLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 90 ~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
.++.||+|+||+||+|+ ..+|+.||||++....... .+.+.+|+.++++++|||||++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999 4579999999987543221 24678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9888776554 34567889999999999999999999999 99999999999999999999999999998876665
Q ss_pred eeeeeeEEeeeeCCCcccc
Q 024537 244 HVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~ 262 (266)
...+..||+.|+|||++..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTT
T ss_pred cccceecChhhccHHHHcc
Confidence 5666789999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-40 Score=280.09 Aligned_cols=173 Identities=27% Similarity=0.431 Sum_probs=142.9
Q ss_pred hcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEecc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL 164 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 164 (266)
.++|++.+.||+|+||+||+|++.+++.||||++..... ..+.+.+|+.++++++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 467999999999999999999988888999999975543 3467999999999999999999999985 46689999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC-c
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED-T 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 243 (266)
++|+|..++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+.+.... .
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999998887543 2346899999999999999999999998 9999999999999999999999999999875332 3
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......||+.|+|||++..+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~ 189 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYG 189 (285)
T ss_dssp ------CCGGGSCHHHHHHC
T ss_pred eeccccccccccChHHHhCC
Confidence 33345788999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-39 Score=286.15 Aligned_cols=170 Identities=24% Similarity=0.264 Sum_probs=145.4
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccC---hhhHHHH---HHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREF---TNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++.... ......+ ..|+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4689999999999999999999 4579999999986432 1112223 3456777788899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
|+||||++||+|.+++... ..+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998543 46889999999999999999999999 99999999999999999999999999998
Q ss_pred CCCCCceeeeeeEEeeeeCCCcccc
Q 024537 238 FPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 238 ~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+.... .....||+.|+|||++..
T Consensus 157 ~~~~~--~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 157 FSKKK--PHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp CSSSC--CCSCCSCGGGCCHHHHST
T ss_pred cCCCc--ccccccccccchhHHhhc
Confidence 75443 345589999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=279.41 Aligned_cols=173 Identities=24% Similarity=0.403 Sum_probs=148.6
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|+++++||+|+||+||+|. ..+++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999 4679999999996543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
|+.++.+ .++.. .....+++..++.++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965544 44422 34557999999999999999999999999 9999999999999999999999999999887666
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......||+.|+|||++...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~ 177 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGC 177 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTC
T ss_pred ccceeecccceeeehhhhccc
Confidence 666677899999999986554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=272.35 Aligned_cols=165 Identities=27% Similarity=0.414 Sum_probs=137.7
Q ss_pred ceecccCceEEEEEEec---CCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEeccCC
Q 024537 92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 92 ~~iG~G~fg~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 166 (266)
++||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 3568999998654 23345679999999999999999999999865 567899999999
Q ss_pred CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCcee-
Q 024537 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV- 245 (266)
Q Consensus 167 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~- 245 (266)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 356899999999999999999999998 9999999999999999999999999999875543322
Q ss_pred --eeeeEEeeeeCCCccccC
Q 024537 246 --NTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 246 --~~~~~t~~y~aPE~~~~e 263 (266)
....||+.|+|||++...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp C----CCCGGGCCHHHHHHC
T ss_pred cccccCCCceecCchhhcCC
Confidence 234678899999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-38 Score=270.60 Aligned_cols=174 Identities=21% Similarity=0.333 Sum_probs=143.0
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE---- 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 156 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999 468999999999754 33445678999999999999999999999987543
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||++|++|..++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 79999999999999887443 46899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCC---ceeeeeeEEeeeeCCCccccCC
Q 024537 237 LFPGED---THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 237 ~~~~~~---~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
...... ....+..||+.|+|||++.++.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 190 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190 (277)
T ss_dssp ECC----------------TTCCHHHHTTCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCC
Confidence 664332 3445567999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=276.03 Aligned_cols=170 Identities=22% Similarity=0.259 Sum_probs=143.8
Q ss_pred hcCccccc-eecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHh-cCCCCceeEEeEEee----CCcE
Q 024537 85 TNFFSDLN-QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLFGCCAE----GPEK 157 (266)
Q Consensus 85 ~~~y~~~~-~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~ 157 (266)
.++|+++. .||+|+||+||+|+ ..+++.||||++... ..+.+|+.++.+ .+|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35798875 59999999999998 467999999998643 345689988765 489999999999976 3568
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEecccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGL 234 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~ 234 (266)
|+|||||+||+|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999543 3457999999999999999999999999 999999999999986 45799999999
Q ss_pred cccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 235 ARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 235 a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|+....... ..+..||+.|+|||++.+..
T Consensus 161 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 189 (335)
T d2ozaa1 161 AKETTSHNS-LTTPCYTPYYVAPEVLGPEK 189 (335)
T ss_dssp CEECCCCCC-CCCCSCCCSSCCCCCCCGGG
T ss_pred eeeccCCCc-cccccCCcccCCcHHHcCCC
Confidence 998765443 34568999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-38 Score=272.08 Aligned_cols=172 Identities=24% Similarity=0.415 Sum_probs=146.7
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccC--hhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 163 (266)
++|+++++||+|+||+||+|+..+++.||||++.... ......+.+|+.+|++++|||||++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999998889999999997653 22356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 243 (266)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|.....+..
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9877766655 33467999999999999999999999998 99999999999999999999999999998766655
Q ss_pred eeeeeeEEeeeeCCCccccC
Q 024537 244 HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ~~~~~~~t~~y~aPE~~~~e 263 (266)
......+++.|+|||++.+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~ 175 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGS 175 (286)
T ss_dssp ------CCCTTCCHHHHTTC
T ss_pred ccceecccchhhhHHHHhCC
Confidence 55666789999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=274.23 Aligned_cols=186 Identities=27% Similarity=0.400 Sum_probs=145.4
Q ss_pred cchhhHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeE
Q 024537 76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTL 147 (266)
Q Consensus 76 ~~~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l 147 (266)
++...+++..++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+..|..++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 355666777789999999999999999999842 3468999998754 344456778888888776 68999999
Q ss_pred EeEEeeC-CcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCC
Q 024537 148 FGCCAEG-PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRD 213 (266)
Q Consensus 148 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrD 213 (266)
++++..+ +..++|||||++|+|.+++..... ...+++..++.++.||+.||+|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9998765 468999999999999999864321 235889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 214 IKASNILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 214 lKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|||+|||++.++.+||+|||+|+...... .......||+.|+|||++..+.
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 212 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 212 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC
Confidence 99999999999999999999998765432 2334557899999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-38 Score=273.43 Aligned_cols=184 Identities=29% Similarity=0.474 Sum_probs=153.3
Q ss_pred hhhHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeecccC-hhhHHHHHHHHHHHHhcCCCCceeEEeE
Q 024537 78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGC 150 (266)
Q Consensus 78 ~~~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 150 (266)
...++...++|++++.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445666788999999999999999999853 45789999987653 3445679999999999999999999999
Q ss_pred EeeCCcEEEEEeccCCCCHHHHHhhcC---------------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024537 151 CAEGPEKMLVYEYLPNKSLDYFIFDKT---------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209 (266)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~i 209 (266)
+...+..++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999985422 1234889999999999999999999998 9
Q ss_pred EeCCCCCCceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 210 iHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|||||||+|||++.++.+||+|||+|+...+.. ....+..+++.|+|||++....
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 999999999999999999999999998664332 2233456788999999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=269.56 Aligned_cols=176 Identities=22% Similarity=0.313 Sum_probs=137.4
Q ss_pred HhhcCccccceecccCceEEEEEEecC----CCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
+..++|++.+.||+|+||+||+|++.. +..||||.+... .....+.+.+|+.++++++|||||++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998532 346899988654 4444577999999999999999999999986 5678
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||+++|++.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999888743 3456899999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCC-ceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGED-THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~-~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.... .......||+.|+|||++....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~ 185 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRR 185 (273)
T ss_dssp -------------CCGGGCCHHHHHHCC
T ss_pred ccCCcceeccceecCcccchhhHhccCC
Confidence 75432 2333446788999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=270.61 Aligned_cols=172 Identities=26% Similarity=0.338 Sum_probs=145.3
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccCh------hhHHHHHHHHHHHHhcC--CCCceeEEeEEeeCC
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGP 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~ 155 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++..... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3579999999999999999999 45799999999865321 11234568999999987 899999999999999
Q ss_pred cEEEEEeccCC-CCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCC-CCeEEeccc
Q 024537 156 EKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFG 233 (266)
Q Consensus 156 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~-~~~kl~DFG 233 (266)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777743 346899999999999999999999999 9999999999999854 789999999
Q ss_pred ccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 234 LARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 234 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+|+..... ...+..||+.|+|||++.++.
T Consensus 157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~ 185 (273)
T d1xwsa_ 157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHR 185 (273)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSC
T ss_pred cceecccc--cccccccCCCcCCHHHHcCCC
Confidence 99876443 334568999999999987653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-38 Score=270.44 Aligned_cols=173 Identities=25% Similarity=0.492 Sum_probs=140.7
Q ss_pred cCccccceecccCceEEEEEEe-cCCC----EEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 159 (266)
.+|++++.||+|+||+||+|.+ .+|+ .||+|++... .....+.+.+|+.++++++|||||++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 4699999999999999999984 3444 5889988654 33446789999999999999999999999986 45778
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+||++.+++|.+.+.. ....+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999888744 3457899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCce--eeeeeEEeeeeCCCccccCC
Q 024537 240 GEDTH--VNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 240 ~~~~~--~~~~~~t~~y~aPE~~~~e~ 264 (266)
..... .....||+.|+|||++..+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~ 189 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRI 189 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCC
T ss_pred cccccccccccccCccccChHHHhcCC
Confidence 44332 23346788999999886553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=267.01 Aligned_cols=183 Identities=23% Similarity=0.381 Sum_probs=153.6
Q ss_pred hHHHhhcCccccceecccCceEEEEEEec------CCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEe
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 152 (266)
.+++..++|++.+.||+|+||+||+|.+. ++..||||++... .......+.+|+.++++++|||||++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34555678999999999999999999852 3578999999754 3444567899999999999999999999999
Q ss_pred eCCcEEEEEeccCCCCHHHHHhhc-------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC
Q 024537 153 EGPEKMLVYEYLPNKSLDYFIFDK-------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL 225 (266)
Q Consensus 153 ~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~ 225 (266)
.++..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 999999999999999999987532 22245788999999999999999999998 99999999999999999
Q ss_pred CeEEecccccccCCCCCc--eeeeeeEEeeeeCCCccccCCC
Q 024537 226 NPKISDFGLARLFPGEDT--HVNTFRISVVTWPPNMHCMDIC 265 (266)
Q Consensus 226 ~~kl~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~e~~ 265 (266)
++||+|||+|+.+..... ......+|+.|+|||.+..+.+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence 999999999987644322 2233468899999998876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=264.65 Aligned_cols=181 Identities=29% Similarity=0.391 Sum_probs=153.5
Q ss_pred hHHHhhcCccccceecccCceEEEEEEe------cCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEE
Q 024537 80 TLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151 (266)
Q Consensus 80 ~~~~~~~~y~~~~~iG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 151 (266)
.+++..++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3455667899999999999999999974 34678999999764 344456788999999999 699999999999
Q ss_pred eeCCcEEEEEeccCCCCHHHHHhhcC---------------CCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCC
Q 024537 152 AEGPEKMLVYEYLPNKSLDYFIFDKT---------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA 216 (266)
Q Consensus 152 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp 216 (266)
.+++..++|||||++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999986532 2236889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccC
Q 024537 217 SNILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 217 ~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|||++.++.+||+|||+++...... .......||+.|+|||++...
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 222 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence 99999999999999999999875443 223345789999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=265.09 Aligned_cols=171 Identities=27% Similarity=0.424 Sum_probs=138.7
Q ss_pred HhhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CCcEEEEE
Q 024537 83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLVY 161 (266)
Q Consensus 83 ~~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~ 161 (266)
+..++|++.+.||+|+||.||+|++ .|..||||+++.+.. .+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH--HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3456789999999999999999998 578899999975533 3678999999999999999999999865 46689999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~ 241 (266)
||+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999998543 2235889999999999999999999998 999999999999999999999999999976433
Q ss_pred CceeeeeeEEeeeeCCCccccC
Q 024537 242 DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 242 ~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.....+++.|+|||++...
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~ 175 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREK 175 (262)
T ss_dssp --------CCTTTSCHHHHHHC
T ss_pred ---CccccccccCCChHHHhCC
Confidence 2344678899999987644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-37 Score=265.74 Aligned_cols=175 Identities=30% Similarity=0.450 Sum_probs=144.4
Q ss_pred hcCccccceecccCceEEEEEEec-CCC--EEEEEeeccc-ChhhHHHHHHHHHHHHhc-CCCCceeEEeEEeeCCcEEE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 159 (266)
.++|++.++||+|+||+||+|.+. ++. .||||++... .....+.+.+|+.+|.++ +|||||++++++.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 367999999999999999999853 454 4678877543 334456789999999998 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhc-------------CCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCC
Q 024537 160 VYEYLPNKSLDYFIFDK-------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~ 226 (266)
||||+++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999998543 23467999999999999999999999998 999999999999999999
Q ss_pred eEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 227 PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 ~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+||+|||+|+........ ....||..|+|||.+...
T Consensus 166 ~kl~DfG~a~~~~~~~~~-~~~~gt~~y~aPE~l~~~ 201 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKK-TMGRLPVRWMAIESLNYS 201 (309)
T ss_dssp EEECCTTCEESSCEECCC-----CCTTTCCHHHHHHC
T ss_pred eEEccccccccccccccc-cceecCCcccchHHhccC
Confidence 999999999876543332 345788999999988643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-37 Score=263.67 Aligned_cols=181 Identities=28% Similarity=0.415 Sum_probs=147.9
Q ss_pred HHHhhcCccccceecccCceEEEEEEec-C-------CCEEEEEeecccC-hhhHHHHHHHHHHHHhc-CCCCceeEEeE
Q 024537 81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-N-------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGC 150 (266)
Q Consensus 81 ~~~~~~~y~~~~~iG~G~fg~V~~~~~~-~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 150 (266)
+.+..++|++.+.||+|+||.||+|+.. . +..||||++.... ......+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4455678999999999999999999832 2 2479999997653 44457788899998888 79999999999
Q ss_pred EeeCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCC
Q 024537 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217 (266)
Q Consensus 151 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~ 217 (266)
+.+++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ ||||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 9999999999999999999999965431 246899999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEecccccccCCCCC--ceeeeeeEEeeeeCCCccccCC
Q 024537 218 NILLDEQLNPKISDFGLARLFPGED--THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 218 Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|||++.++.+||+|||+++...... .......+|+.|+|||++..+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 213 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 213 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence 9999999999999999999774332 2234457888999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-37 Score=260.41 Aligned_cols=172 Identities=24% Similarity=0.406 Sum_probs=152.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcEEEEEe
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 162 (266)
++|++++.||+|+||+||+|+ ..+++.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999999 468899999998654 33446788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCC
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~ 242 (266)
++.++++..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998887763 3467889999999999999999999998 9999999999999999999999999999887665
Q ss_pred ceeeeeeEEeeeeCCCccccC
Q 024537 243 THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 243 ~~~~~~~~t~~y~aPE~~~~e 263 (266)
.......+++.|+|||++..+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~ 176 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTC
T ss_pred ccceeeccccchhhhhHhccC
Confidence 555555677889999987754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=262.58 Aligned_cols=173 Identities=32% Similarity=0.462 Sum_probs=135.6
Q ss_pred hcCccccceecccCceEEEEEEec--CC--CEEEEEeeccc---ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCcE
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLMP--NG--QEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK 157 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 157 (266)
.++|++++.||+|+||+||+|++. ++ ..||||++... .....+.+.+|+.+|++++|||||++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 456999999999999999999842 22 37899998654 33445789999999999999999999999976 467
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 158 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
++||||++++++.+.+... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999998877543 345899999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCce---eeeeeEEeeeeCCCccccC
Q 024537 238 FPGEDTH---VNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 238 ~~~~~~~---~~~~~~t~~y~aPE~~~~e 263 (266)
+...... .....++..|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 189 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTR 189 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCC
Confidence 7544332 2223456689999988654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=262.18 Aligned_cols=173 Identities=25% Similarity=0.314 Sum_probs=138.8
Q ss_pred cCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC----cEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~ 161 (266)
..|.+.+.||+|+||+||+|++ +|+.||||++....... .....|+..+.+++|||||++++++.+++ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3577889999999999999997 68899999987553321 22234555566789999999999998654 579999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA-----PARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~-----~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
||+++|+|.+++.+ ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999954 25889999999999999999999731 1239999999999999999999999999999
Q ss_pred cCCCCCc----eeeeeeEEeeeeCCCccccCC
Q 024537 237 LFPGEDT----HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 237 ~~~~~~~----~~~~~~~t~~y~aPE~~~~e~ 264 (266)
....... ......||+.|+|||++.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred cccCCCcceeccccceecccCcCChhhccccc
Confidence 8754432 223457899999999987654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-36 Score=263.34 Aligned_cols=165 Identities=22% Similarity=0.375 Sum_probs=141.9
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeC--CcEEEEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG--PEKMLVY 161 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~ 161 (266)
++|+++++||+|+||+||+|+ ..+++.||||+++.... +.+.+|+.+|+++. ||||++++++|... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 679999999999999999999 46799999999875443 56788999999995 99999999999854 5689999
Q ss_pred eccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccCCC
Q 024537 162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPG 240 (266)
Q Consensus 162 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~~~ 240 (266)
||+.+++|..+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999986543 46899999999999999999999999 99999999999998765 589999999998754
Q ss_pred CCceeeeeeEEeeeeCCCccccC
Q 024537 241 EDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 241 ~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.. ......+|+.|+|||++.+.
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTC
T ss_pred CC-cccccccCccccCcccccCC
Confidence 43 23455789999999997653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=264.91 Aligned_cols=171 Identities=24% Similarity=0.382 Sum_probs=141.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCCc----EEE
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----KML 159 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~l 159 (266)
++|++++.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.+|++++||||+++++++..+.. .++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 569999999999999999998 568999999999754 34455678999999999999999999999976532 344
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~ 239 (266)
+++++.+++|.+++.. ..+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4556669999999843 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC---ceeeeeeEEeeeeCCCccccC
Q 024537 240 GED---THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 240 ~~~---~~~~~~~~t~~y~aPE~~~~e 263 (266)
... .......||+.|+|||++..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred CCCccceeeccccccceechHHHhhcC
Confidence 322 223455789999999998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=266.00 Aligned_cols=167 Identities=27% Similarity=0.432 Sum_probs=139.7
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeCC------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------ 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 155 (266)
.++|++++.||+|+||+||+|. ..+|+.||||++... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4679999999999999999999 457999999999754 3444577889999999999999999999998765
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
.+|+||||+ +.+|..+.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 677877663 246999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeEEeeeeCCCcccc
Q 024537 236 RLFPGEDTHVNTFRISVVTWPPNMHCM 262 (266)
Q Consensus 236 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 262 (266)
+...... ....||+.|+|||++.+
T Consensus 169 ~~~~~~~---~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 169 RQADSEM---TGYVVTRWYRAPEVILN 192 (346)
T ss_dssp EECCSSC---CSSCSCGGGCCTHHHHT
T ss_pred eccCCcc---ccccccccccCHHHHcC
Confidence 9875443 34579999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=265.89 Aligned_cols=169 Identities=27% Similarity=0.368 Sum_probs=139.6
Q ss_pred CccccceecccCceEEEEEEe-cCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------CcEEE
Q 024537 87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------PEKML 159 (266)
Q Consensus 87 ~y~~~~~iG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 159 (266)
.|+.+++||+|+||+||+|+. .+|+.||||++...... ..+|+.+|++++||||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 488899999999999999994 57999999999765322 23799999999999999999998543 34789
Q ss_pred EEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCC-CeEEecccccccC
Q 024537 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLF 238 (266)
Q Consensus 160 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~-~~kl~DFG~a~~~ 238 (266)
|||||+++.+..+.........+++..++.|+.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999977655444433344567999999999999999999999998 99999999999999775 8999999999987
Q ss_pred CCCCceeeeeeEEeeeeCCCccccC
Q 024537 239 PGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 239 ~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
..... ..+..||+.|+|||++..+
T Consensus 174 ~~~~~-~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 174 VRGEP-NVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CTTSC-CCSCCSCTTSCCHHHHTTC
T ss_pred cCCcc-cccccccccccChHHhhcc
Confidence 54433 3456799999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-36 Score=257.99 Aligned_cols=168 Identities=26% Similarity=0.420 Sum_probs=140.7
Q ss_pred cceecccCceEEEEEEecCC----CEEEEEeeccc-ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee-CCcEEEEEecc
Q 024537 91 LNQLGHGGFGPVYRGLMPNG----QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLVYEYL 164 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~ 164 (266)
.++||+|+||+||+|++..+ ..||||++... .....+.+.+|+.+|++++||||+++++++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999985332 25899998743 55566889999999999999999999999876 46789999999
Q ss_pred CCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccccCCCCCc-
Q 024537 165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT- 243 (266)
Q Consensus 165 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 243 (266)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998843 3456778889999999999999999998 99999999999999999999999999998653322
Q ss_pred ---eeeeeeEEeeeeCCCccccC
Q 024537 244 ---HVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 244 ---~~~~~~~t~~y~aPE~~~~e 263 (266)
......||+.|+|||.+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~ 209 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQ 209 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHC
T ss_pred cceecccccccccccChHHHhcC
Confidence 12234678899999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=260.82 Aligned_cols=173 Identities=25% Similarity=0.454 Sum_probs=142.1
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEee--------
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-------- 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-------- 153 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++... ......++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3679999999999999999999 458999999998654 23334678899999999999999999999865
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccc
Q 024537 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233 (266)
Q Consensus 154 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG 233 (266)
++..|+||||+.++.+.... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34679999999877665443 34567899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCC----ceeeeeeEEeeeeCCCccccC
Q 024537 234 LARLFPGED----THVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 234 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~e 263 (266)
+|+.+.... ....+..||+.|+|||++.++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 998775332 223344689999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=260.52 Aligned_cols=174 Identities=25% Similarity=0.448 Sum_probs=141.1
Q ss_pred hcCccccceecccCceEEEEEEe-cC-CCEEEEEeecccC--hhhHHHHHHHHHHHHhc---CCCCceeEEeEEee----
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM-PN-GQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAE---- 153 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 153 (266)
.++|++++.||+|+||+||+|+. .+ ++.||||++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999984 34 5679999986542 22223455677776665 79999999999863
Q ss_pred -CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecc
Q 024537 154 -GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232 (266)
Q Consensus 154 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DF 232 (266)
....+++||++.++.+.... ......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 24679999999887765443 234567899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeEEeeeeCCCccccCC
Q 024537 233 GLARLFPGEDTHVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 233 G~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
|+++...... ......||+.|+|||++....
T Consensus 161 g~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~ 191 (305)
T d1blxa_ 161 GLARIYSFQM-ALTSVVVTLWYRAPEVLLQSS 191 (305)
T ss_dssp CSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCC
T ss_pred hhhhhhcccc-cCCCcccChhhcCcchhcCCC
Confidence 9998764433 345668999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-35 Score=254.03 Aligned_cols=172 Identities=19% Similarity=0.263 Sum_probs=145.2
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC-CCceeEEeEEeeCCcEEEEEe
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 162 (266)
.++|++.+.||+|+||+||+|+ ..+++.||||++...... ..+.+|+.+++.+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999 457899999988654322 346688999999975 899999999999999999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC-----CCCeEEeccccccc
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----QLNPKISDFGLARL 237 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~-----~~~~kl~DFG~a~~ 237 (266)
|+ +++|.+++.. ....+++..+..++.|++.||+|||++| |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899888743 3456899999999999999999999999 999999999999974 56799999999987
Q ss_pred CCCCC-------ceeeeeeEEeeeeCCCccccCC
Q 024537 238 FPGED-------THVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 238 ~~~~~-------~~~~~~~~t~~y~aPE~~~~e~ 264 (266)
+.... ....++.||+.|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~ 189 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCC
Confidence 64332 2234567999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=257.82 Aligned_cols=169 Identities=27% Similarity=0.404 Sum_probs=140.9
Q ss_pred hcCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC-----Cc
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE 156 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 156 (266)
.++|++++.||+|+||+||+|+ ..+|+.||||++... .......+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4679999999999999999999 568999999999754 344456788999999999999999999999643 33
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.+++|+++.+++|.+++. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 466677788999999883 246999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
.... ...+..|++.|+|||++.+.
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~ 193 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNW 193 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCC
Confidence 7643 33455789999999986553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-36 Score=259.95 Aligned_cols=173 Identities=25% Similarity=0.296 Sum_probs=148.4
Q ss_pred hcCccccceecccCceEEEEEEe----cCCCEEEEEeeccc----ChhhHHHHHHHHHHHHhcCC-CCceeEEeEEeeCC
Q 024537 85 TNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGP 155 (266)
Q Consensus 85 ~~~y~~~~~iG~G~fg~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~ 155 (266)
.++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999973 25889999998643 12234567789999999976 89999999999999
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEeccccc
Q 024537 156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235 (266)
Q Consensus 156 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a 235 (266)
..+++|||+.+++|.+.+... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998543 35678899999999999999999998 999999999999999999999999999
Q ss_pred ccCCCC-CceeeeeeEEeeeeCCCccccC
Q 024537 236 RLFPGE-DTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 236 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~e 263 (266)
+.+... .....+..|++.|+|||++.+.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred hhhcccccccccccccccccchhHHhhcC
Confidence 877433 3344556789999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-35 Score=256.07 Aligned_cols=168 Identities=26% Similarity=0.360 Sum_probs=133.0
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeeccc--ChhhHHHHHHHHHHHHhcCCCCceeEEeEEeeC------Cc
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------PE 156 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 156 (266)
++|+++++||+|+||+||+|+ ..+|+.||||++... .......+.+|+.++++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999 457999999999754 344556788999999999999999999999643 57
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEEecccccc
Q 024537 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236 (266)
Q Consensus 157 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~ 236 (266)
.|+||||+.++.+. .+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hh-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999765554 33 235889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 237 LFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 237 ~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
...... ......+|+.|+|||++.+.
T Consensus 168 ~~~~~~-~~~~~~~t~~y~aPE~l~~~ 193 (355)
T d2b1pa1 168 TAGTSF-MMTPYVVTRYYRAPEVILGM 193 (355)
T ss_dssp --------------CCTTCCHHHHTTC
T ss_pred cccccc-ccccccccccccChhhhcCC
Confidence 765443 33455789999999998764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-34 Score=248.56 Aligned_cols=171 Identities=26% Similarity=0.328 Sum_probs=139.1
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEEec
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEY 163 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~ 163 (266)
++|++.+.||+|+||+||+|+ ..+++.||||++...... ..+..|+.+++.++|+|+ +.+..++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 579999999999999999998 457899999998765332 356789999999987765 4556666778888999999
Q ss_pred cCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcC---CCCeEEecccccccCCC
Q 024537 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARLFPG 240 (266)
Q Consensus 164 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~---~~~~kl~DFG~a~~~~~ 240 (266)
+ ++++...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5666555532 3457899999999999999999999999 999999999999864 45799999999998754
Q ss_pred CCc-------eeeeeeEEeeeeCCCccccCC
Q 024537 241 EDT-------HVNTFRISVVTWPPNMHCMDI 264 (266)
Q Consensus 241 ~~~-------~~~~~~~t~~y~aPE~~~~e~ 264 (266)
... ...+..||+.|+|||++.+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 189 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIE 189 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCC
Confidence 321 234557999999999987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=8.1e-30 Score=223.23 Aligned_cols=171 Identities=21% Similarity=0.236 Sum_probs=136.3
Q ss_pred cCccccceecccCceEEEEEE-ecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-----------CCCceeEEeEEee
Q 024537 86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----------HKNLVTLFGCCAE 153 (266)
Q Consensus 86 ~~y~~~~~iG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~ 153 (266)
++|+++++||+|+||+||+|+ ..+|+.||||+++.... ..+.+.+|+.+++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 459999999999999999999 46899999999976533 2356778999888775 5789999998864
Q ss_pred --CCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhh-cCCCCeEeCCCCCCceEEcCCCC----
Q 024537 154 --GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLN---- 226 (266)
Q Consensus 154 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~-~~~~~iiHrDlKp~Nill~~~~~---- 226 (266)
....+++|+++..+..............+++..++.++.|++.||.|||+ .| |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35566777776555443333334556678999999999999999999998 77 999999999999987654
Q ss_pred --eEEecccccccCCCCCceeeeeeEEeeeeCCCccccC
Q 024537 227 --PKISDFGLARLFPGEDTHVNTFRISVVTWPPNMHCMD 263 (266)
Q Consensus 227 --~kl~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~~~~e 263 (266)
++|+|||.|....... ....||+.|+|||++...
T Consensus 169 ~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp EEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTC
T ss_pred ceeeEeeccccccccccc---ccccccccccChhhcccc
Confidence 8999999998764333 345799999999987643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.5e-26 Score=183.78 Aligned_cols=136 Identities=19% Similarity=0.190 Sum_probs=107.5
Q ss_pred ccccceecccCceEEEEEEecCCCEEEEEeecccCh------------------hhHHHHHHHHHHHHhcCCCCceeEEe
Q 024537 88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR------------------QGLREFTNEVKLLLKIQHKNLVTLFG 149 (266)
Q Consensus 88 y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~ 149 (266)
+.+.++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 456789999999999999987899999998753211 01223456888999999999998886
Q ss_pred EEeeCCcEEEEEeccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhcCCCCeEeCCCCCCceEEcCCCCeEE
Q 024537 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229 (266)
Q Consensus 150 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~~~~~iiHrDlKp~Nill~~~~~~kl 229 (266)
+.. .+++|||+++..+.. +++.....++.|++.||.|||++| |+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 642 379999998765532 233445678999999999999999 9999999999999975 4899
Q ss_pred ecccccccCCCC
Q 024537 230 SDFGLARLFPGE 241 (266)
Q Consensus 230 ~DFG~a~~~~~~ 241 (266)
+|||+|+....+
T Consensus 144 iDFG~a~~~~~~ 155 (191)
T d1zara2 144 IDFPQSVEVGEE 155 (191)
T ss_dssp CCCTTCEETTST
T ss_pred EECCCcccCCCC
Confidence 999999876544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.92 E-value=7.6e-09 Score=84.36 Aligned_cols=145 Identities=12% Similarity=0.062 Sum_probs=96.3
Q ss_pred hhcCccccceecccCceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcC-CCCceeEEeEEeeCCcEEEEEe
Q 024537 84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE 162 (266)
Q Consensus 84 ~~~~y~~~~~iG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 162 (266)
....|+..+..+.++.+.||+... +++.+++|+...........+..|...+..+. +--+.+++.+...++..++||+
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 345676666655556678998865 56678889876554433345667888887764 3335678888888899999999
Q ss_pred ccCCCCHHHHHhhcCCCCCcCHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 024537 163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-------------------------------------- 204 (266)
Q Consensus 163 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yLH~~-------------------------------------- 204 (266)
+++|..+....... .. ...++.+++..+.-||+.
T Consensus 91 ~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 91 EADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred eccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99988775543110 01 112233344444444421
Q ss_pred ------------------CCCCeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 205 ------------------APARIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 205 ------------------~~~~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 011278999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=1.4e-06 Score=70.06 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=52.5
Q ss_pred eecccCc-eEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCC--CCceeEEeEEeeCCcEEEEEeccCCCCH
Q 024537 93 QLGHGGF-GPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNKSL 169 (266)
Q Consensus 93 ~iG~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~~~L 169 (266)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 678999877788889998655433 235567777776643 3356788888888889999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=8.5e-06 Score=70.15 Aligned_cols=76 Identities=14% Similarity=0.184 Sum_probs=47.7
Q ss_pred cceecccCceEEEEEEec-CCCEEEEEeeccc----C---hhhHHHHHHHHHHHHhcC-C--CCceeEEeEEeeCCcEEE
Q 024537 91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD----S---RQGLREFTNEVKLLLKIQ-H--KNLVTLFGCCAEGPEKML 159 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~-~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l 159 (266)
.+.||.|....||++... +++.|+||.-... . .....+...|...|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 467999999999999854 4678999964321 1 112234456787777653 2 335555544 4556789
Q ss_pred EEeccCCCC
Q 024537 160 VYEYLPNKS 168 (266)
Q Consensus 160 v~e~~~~~~ 168 (266)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.54 E-value=0.00024 Score=59.06 Aligned_cols=67 Identities=12% Similarity=0.087 Sum_probs=44.3
Q ss_pred ceEEEEEEecCCCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-----eeE--EeEEeeCCcEEEEEeccCC
Q 024537 99 FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-----VTL--FGCCAEGPEKMLVYEYLPN 166 (266)
Q Consensus 99 fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l--~~~~~~~~~~~lv~e~~~~ 166 (266)
--.||++...+|..|++|+.+.... ..+++..|...+..|...+| +.. -..+...+..+.++++++|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4689999988999999999765422 23567788888877642222 111 1122345667889999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.34 E-value=0.00037 Score=59.47 Aligned_cols=73 Identities=12% Similarity=0.293 Sum_probs=48.2
Q ss_pred cceecccCceEEEEEEecC--------CCEEEEEeecccChhhHHHHHHHHHHHHhcCCCCc-eeEEeEEeeCCcEEEEE
Q 024537 91 LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVY 161 (266)
Q Consensus 91 ~~~iG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~ 161 (266)
++.|+.|-.-.+|++...+ .+.|.+++.. ..... ....+|..+++.+.-.++ .++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678889999999987533 3567776654 22222 234578888888753344 477777653 6899
Q ss_pred eccCCCCH
Q 024537 162 EYLPNKSL 169 (266)
Q Consensus 162 e~~~~~~L 169 (266)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99986433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.99 E-value=0.0022 Score=52.50 Aligned_cols=30 Identities=23% Similarity=0.273 Sum_probs=26.8
Q ss_pred CeEeCCCCCCceEEcCCCCeEEeccccccc
Q 024537 208 RIIHRDIKASNILLDEQLNPKISDFGLARL 237 (266)
Q Consensus 208 ~iiHrDlKp~Nill~~~~~~kl~DFG~a~~ 237 (266)
.+||+|+.++||+++.+...-|+||+.|..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999887778999999853
|